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ABSTRACT 
 
Vaginal microbes exert a strong influence on women's reproductive health. Perturbations in the 
vaginal microbiome have been associated with serious sequelae, such as bacterial vaginosis (BV) 
and pregnancy complications. The etiology of BV is multifactorial. To gain a mechanistic 
understanding of BV, there is a need to understand what pathogens initiate it and how they do so. 
However, a minority of existing research on BV focused on the latter. Sialidase assists the 
colonization of pathogens by destroying mucin. Therefore, we hypothesized that sialidase could 
serve as a biomarker for BV (chapter 2). We used the BVBlue sialidase test to measure the 
sialidase activity, 454-pyrosequencing of amplicons from the V1-V3 region of the 16S rRNA 
gene to classify sequence to bacteria, and Illumina high-throughput sequencing to classify 
sequence to bacteria and functional genes in microbial samples from 38 Chinese women with 
and without BV from 20 to 52 years (means ± SEM 35.6 ± 1.2 years). The samples were 
collected by swabs from cervix, middle, and upper vagina walls. Elevated sialidase activity (>= 
7.8U) was detected in all BV patients but not in any Chinese women without BV. Sequence-
based analysis indicated that Prevotella and Gardnerella species were more abundant in Chinese 
BV patients by linear discriminant analysis (LDA) effect size (LEfSe). The conclusion was that 
the sialidase test could separate diseased vaginal microbiomes from non-diseased ones. 
Prevotella and Gardnerella species were associated with high sialidase levels.  
 
An alternative way to study how pathogens initiate BV is to study how pathogens are involved in 
the production of BV symptoms. Yeoman et al. 1 found vaginal bacteria and metabolites that are 
correlated with BV symptoms. Therefore, we hypothesized that BV symptom-associated bacteria 
could serve as potential biomarkers to improve the development of therapeutic targets (chapter 
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3). To better understand how pathogens are involved in the production of BV symptoms, we took 
a subset of the population (n=4) from Yeoman et al. 1. All women were of reproductive age from 
20 to 40 years. The samples were collected by swabs, scrapings, and lavage. 454-pyrosequencing 
of amplicons from the V1-V3 region of the 16S rRNA gene was used to classify sequence to 
bacteria. Illumina high-throughput sequencing was used to classify sequence to bacteria and 
functional genes. We then used Spearman's rank correlation coefficients to examine the 
correlation among vaginal bacteria, vaginal discharge-associated metabolites, and functional 
genes. The bacteria Aquabacterium, Chryseobacterium, Elizabethkingia, Finegoldia, 
Morganella, Negativicoccus, Phenylobacterium, Propionibacterium, Serratia, Siphonobacter, 
and the enzymes ‘malate dehydrogenase’ (K00024), ‘5-amino-6-(5-phosphoribosylamino) uracil 
reductase’ (K11752), and ‘undecaprenyl-diphosphatase’ (K06153) were positively associated 
with 2-Methyl-2-hydroxybutanoic acid (r=1, p=0) that was the only metabolite revealed by 
Yeoman et al. 1 that positively correlated with discharge. Moreover, these three enzymes were 
positively linked to these ten bacterial genera (r=1, p=0). We conclude that the bacteria 
Aquabacterium, Chryseobacterium, Elizabethkingia, Finegoldia, Morganella, Negativicoccus, 
Phenylobacterium, Propionibacterium, Serratia, and Siphonobacter are potential therapeutic 
targets.  
 
Healthy women’s vaginas are mainly dominated by Lactobacilli at reproductive age. The 
predominance of Lactobacilli is coincident with the rise in estrogen levels and glycogen content 
in the vaginal epithelium. Estrogen levels increase gradually during pregnancy and drop down at 
post-partum. Glycogen is converted to lactic acid mainly by Lactobacilli. Therefore, we 
hypothesized that the abundance of Lactobacilli and functional genes for metabolic activity in 
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Lactobacilli would increase as pregnancy progresses and decrease following parturition (chapter 
4). Vaginal samples were collected from 5 Caucasian women with and without a history of 
preterm birth at 8–12, 17–21, 26–30, and 35–38 weeks of gestation, during labor, and at 6 weeks 
post-partum. All women lived in Rochester, MN, USA from 23 to 43 years. The samples were 
collected by swabs from the posterior fornix and cervix. We used a metagenomic approach to 
classify sequences to bacterial species, GroopM 102 and CheckM 104 to recover the Lactobacillus 
population genomes, and DIAMOND 105 to blast the predicted genes in the Lactobacillus 
population genomes against the KEGG database (v56) to classify sequences to metabolic 
pathways. Generally, the majority of vaginal bacteria (defined as more than half of the vaginal 
bacteria) were Lactobacillus species in women who delivered at term and who did not have a 
previous preterm birth history during pregnancy. However, the trend was not seen in women who 
had a previous preterm birth history but still delivered at term. The abundance of Lactobacilli 
and functional genes for metabolic activity in Lactobacilli were higher in the samples collected 
in late pregnancy than in the samples collected at post-partum in all women with term birth. The 
abundance of Lactobacilli and functional genes for metabolic activity in Lactobacilli did not 
increase in any women as pregnancy progressed from 8 weeks of gestational age to 30 weeks of 
gestational age. We conclude that the vaginal microbiomes of women who delivered at term and 
who did not have a previous preterm birth history were generally dominated by Lactobacillus 
species during pregnancy. The vaginal microbiomes of women who delivered at term but had a 
previous preterm birth history were more diverse than those of women who delivered at term and 
who did not have a previous preterm birth history. 
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CHAPTER 1. LITERATURE REVIEW  
 
1.1 The human microbiome 
1.1.1 Living in a microbial world 
We live in a microbial world. Humans are mainly composed of microorganisms. Human-
associated microbes outnumber human cells by 10:1 2,3. The genes of human-associated 
microbes outnumber human genes by 100:1 3. Microorganisms inhabit almost every part 
of the human body 4,5. There are microbes in the nasal and oral cavities, on the skin, in 
the gut and in the urogenital tract 4,5. The oral cavities, skin, gut, and urogenital tract each 
harbor distinct bacteria 5. Bacterial diversity was highest in oral cavities and lowest in 
urogenital tract 5. Although no one bacteria is present in all samples of any one body site, 
most people’s oral cavities, skin, gut, and vagina are dominated by Streptococcus, 
Propionibacterium, Bacteroides, and Lactobacillus, respectively 5.  
 
1.1.2 Symbiotic relationship between microorganisms and humans 
Human-associated microbes not only live in and on human bodies, but also form 
symbiotic relationships with humans. There are three types of symbiosis: mutualism, 
commensalism, and parasitism. Mutualism is the win-win type of symbiosis where two 
organisms benefit from collaboration. For instance, the host provides nutrients, like 
glycogen, to vaginal microorganisms to support their growth. In turn, vaginal 
microorganisms inhibit the colonization of pathogens by producing antimicrobial 
compounds, such as lactic acid, hydrogen peroxide and bacteriocins. The host provides 
nutrients, like dietary fiber, to gut microorganisms to support their growth. In turn, gut 
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microorganisms provide vitamins to human beings. Commensalism is the symbiosis 
where one organism is benefited while the other is not impacted. Parasitism is the 
symbiosis where one organism benefits at the cost of the other. All pathogens are 
parasites. Disease occurs when homeostasis is disturbed. 
 
Human-associated microbes exert a strong influence on human health and diseases. 
However, the relationship between microorganisms and human health is poorly 
understood. In this study, I focus on the relationship between the vaginal microbiome and 
women’s reproductive health. 
 
1.2 The vaginal microbiome 
1.2.1 The composition of the vaginal microbiome 
Lactobacilli have been thought to be the keystone vaginal species for a long time because 
they can generate lactic acid to maintain vagina acidity as well as hydrogen peroxide and 
bacteriocins to kill pathogens in the vagina 6,7. This point of view is rooted in a previous 
study dating from 1892, in which Döderlein isolated Lactobacilli from vaginal discharge 
using a culture-dependent method and found that the bacteria could produce lactic acid to 
inhibit the colonization of pathogens both in vitro and in vivo 6,8.  
 
With the advances in culture-independent methods, researchers found that Lactobacilli 
were not the keystone vaginal species for all healthy women. Researchers used 16S-
rRNA based approaches to disclose the profile of healthy vaginal microbiomes and found 
that Lactobacillus species dominated in a majority of healthy women’s vaginas 7. 
  
3 
 
However, appreciable amounts of healthy women had vaginal microbiome predominated 
by other various anaerobic microorganisms 7. For example, Ravel et al. 9 studied the 
vaginal microbiomes of 396 non-pregnant healthy American women representing four 
ethnic groups (white, black, Hispanic, and Asian). They showed that vaginal microbial 
community composition varies among non-pregnant healthy women 9. Non-pregnant 
women’s vaginal microbiomes could be clustered into five different community state 
types (CSTs) 9. Four out of five CSTs, representing 73% of the non-pregnant healthy 
women’s vaginal microbiomes, are dominated by one species of Lactobacillus 9. The 
remaining CST is not dominated by Lactobacillus or by any one bacterium 9. Instead, it is 
dominated by various anaerobes 9. The same research group found that healthy pregnant 
women’s vaginal microbiome could be clustered into four different CSTs 10. Three out of 
four CSTs are dominated by one species of Lactobacillus 10. The remaining CST is not 
dominated by Lactobacillus or by any one bacterium 10. 
 
1.2.2 The effect of estrogen on the vaginal microbiome composition 
Researchers also found that Lactobacilli were not always the keystone vaginal species for 
the same woman over a lifetime 6. The vaginal microbiome composition changes over a 
woman’s lifetime and is related to the level of estrogen 6,11. Hickey et al. 6 and Farage et 
al. 11 showed that in early childhood, the estrogen levels are low. Low estrogen levels 
lead to the thinning of the vaginal epithelium, a decrease of glycogen content in the 
vaginal epithelium, a nearly neutral vaginal pH value, and poly-microbial communities in 
the vagina 6,11. During puberty and reproductive years, estrogen production rises, 
resulting in an increase in the thickness of the vaginal epithelium, an increase of glycogen 
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content in the vaginal epithelium, an acidic vaginal pH value, and the predominance of 
Lactobacilli in the vagina 6,11.  At postmenopause, estrogen levels decrease, causing a 
decrease of glycogen content in the vaginal epithelium and a nearly neutral vaginal pH 
value 6,11. The vaginal microbiome shifts from a Lactobacilli dominated niche to poly-
microbial communities during this time 6,11. The vaginal microbiome composition was 
also reported to change throughout the menstrual cycle 3,12. At menses, estrogen levels 
are at their lowest in the menstrual cycle and non-Lactobacillus species increase 
compared with other times in the menstrual cycle 12. The vaginal microbiome 
composition was reported to differ during pregnancy compared to when not pregnant 
10,13,14. Vaginal microbiomes during pregnancy were reported to have more Lactobacillus 
species 10,13-15. The change in the vaginal microbiome composition during pregnancy is 
probably caused by increases in estrogen levels during pregnancy. For example, the 
estrogen levels during pregnancy are 100-1000 fold higher than those at 1-week 
postpartum 13,16,17. High estrogen levels increase glycogen content in the vaginal 
epithelium and promote the growth of Lactobacillus species 11,18.  
 
So far, only two studies longitudinally examined the change in the vaginal microbiomes 
during pregnancy 13,14. Both of them only studied the change in the vaginal microbiome 
taxonomic composition during pregnancy 13,14. They did not recover the Lactobacillus 
genome or determine how functional composition of vaginal microbiome changes during 
pregnancy. 
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1.2.3 The effect of race and hygiene on the vaginal microbiome composition 
The above paragraph shows how estrogen influences the vaginal microbiome 
composition. The vaginal microbiome composition is also affected by race and hygiene. 
For instance, Ravel et al. 9 revealed that Lactobacillus is the predominant vaginal 
bacterial species in 80% of non-pregnant healthy Asian American women, 90% of non-
pregnant healthy Caucasian women, 60% of non-pregnant healthy African American 
women, and 62% of non-pregnant healthy Hispanic women 9. Various anaerobes 
dominated in the vagina of 20% of non-pregnant healthy Asian American women, 10% 
of non-pregnant healthy Caucasian women, 40% of non-pregnant healthy African 
American women, and 38 % of non-pregnant healthy Hispanic women 9. When compared 
to non-pregnant healthy African American and Hispanic women, non-pregnant healthy 
Caucasian and Asian American women were more likely to have vaginal communities 
dominated by Lactobacillus 9. Fettweis et al. 19 revealed that there are significant 
differences in the vaginal microbiome composition between African American women 
and women of European ancestry. Bacteria associated with bacterial vaginosis were more 
commonly found in the vaginas of African American women compared with women of 
European ancestry 19.  
 
Douching has also been to be reported to change the vaginal microbiome composition 
20,21. For example, Onderdonk et al. 20 revealed that the use of acetic acid and saline 
douches significantly reduce the total bacterial counts within ten minutes.  
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1.3 Women’s reproductive health 
1.3.1 Bacterial vaginosis 
BV is one of the most common, major problems impacting women’s reproductive health 
worldwide 22. The prevalence of BV in the United States is about 29.2% or approximately 
21.2 million women of reproductive age 23 and is associated with serious sequelae. In 
non-pregnant women, BV has been linked predominantly to the upper genital tract and 
poses an increased risk for sexually transmitted infections 3,24-27 and susceptibility to 
human immunodeficiency virus (HIV) 27-29. In pregnant women, BV has been linked to 
miscarriages 27,30-32, post-abortion infections 27,33, postpartum endometritis 27,34,35, preterm 
pre-labor rupture of membranes (PPROM) 36, and preterm birth 3,27,37,38. The United 
States annually spends nearly $1 billion on treating BV-related pregnancy complications 
39. 
 
The etiology of BV is multifactorial. BV is often ambiguously characterized as 
perturbations in normal vaginal microbiome 7, and believed is a result of a shift from a 
Lactobacilli-dominated to a poly-microbial community 38. For example, BV patients are 
believed to have less Lactobacilli and more Gardnerella and Mobiluncus compared with 
healthy asymptomatic women. The potential mechanisms  supporting  the ambiguous 
characterization of BV are: (1) Lactobacillus species produce lactic acid to maintain an 
acidic vaginal environment (pH < 4.5), hydrogen peroxide and bacteriocin to kill 
pathogens in vagina; and (2) anaerobic bacteria produce polyamines that cause a “fishy” 
odor in the vaginal discharge, as well as mucinases and sialidases enzymes, which 
destroy mucosal tissue and facilitate colonization of pathogens in the vagina 40. However, 
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recent studies suggest that Lactobacilli do not always predominate in the vaginal 
microbiomes of healthy women. In 10 to 42% of healthy asymptomatic women, 
Lactobacilli were outnumbered by other vaginal microbes, such as Atopobium vaginae, 
Leptotrichia, and Megasphaera 9,41-48. Species like Gardnerella vaginalis and 
Mobiluncus curtisii, which have been traditionally associated with BV, are also 
commonly found in healthy asymptomatic women 49. Although the exact cause of BV is 
still unknown, Gardnerella vaginalis, Atopobium, Prevotella, Porphyromonas, 
Peptostreptococcus, Mobiluncus, Mycoplasma, Eggerthella-like bacterium, 
Megasphaera, Leptotrichia, Dialister, and several BV associated bacteria (BVABs) from 
the Clostridiales order were generally believed to be associated with BV 50,51.  
 
Gradually, researchers found that a simple understanding of the taxonomic composition 
of the vaginal microbiomes of BV patients could not comprehensively describe the exact 
mechanism of BV. For example, it has been reported that the genome of Gardnerella 
vaginalis strains that were isolated from BV patients encode for mucin degradation 
enzymes 52. However, the genomes of Gardnerella vaginalis strains isolated from healthy 
women did not encode these genes 52. The degradation of mucin facilitates colonization 
of pathogens and initiation of BV. Therefore, to gain a mechanistic understanding of BV, 
there is a need to understand what pathogens initiate it and how they do so. However, a 
minority of existing research on BV focused on answering the question of how pathogens 
initiate BV. Both Yeoman et al. 1 and Srinivasan et al. 53 revealed that women with and 
without BV have distinct metabolite profiles and found metabolites that are correlated 
with BV symptoms: discharge and odor. Yeoman et al. 1 found that BV discharge is 
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associated with 2-methyl-2-hydroxybutanoic acid that were linked to Mobiluncus species 
and the characteristic odor is associated with putrescine and cadaverine that were linked 
to Dialister species. Srinivasan et al. 53 found that discharge is associated with agmatine 
and cadaverine and the odor is associated with putrescine. Agmatine, cadaverine, and 
putrescine were linked to 10 BV-associated bacteria including Dialister sp. type 2 53. 
 
Because current understanding of BV etiology is not complete, there are no uniform 
criteria for diagnosing BV. In clinical practice, BV is diagnosed by Amsel criteria 
comprising the following four signs: 1) vaginal pH > 4.5; 2) release of  “fishy” odor after 
adding 10% potassium hydroxide (KOH) solution to the vaginal discharge; 3) 
microscopy - clue cells (vaginal epithelial cells coated with bacteria); 4) white, skim 
milk-like vaginal discharge 54. At least three of these four symptoms need to be present to 
diagnose BV. However, the criteria are not objective and rely on the perspicacity of the 
clinician and equipment 55. Because of this, the misdiagnosis and recurrence rate of BV is 
high. In the research arena, BV is detected by the Nugent criteria that use a score of 0-10 
to grade three types of bacteria in Gram-stained vaginal smears: Lactobacillus, 
Gardnerella, and Mobiluncus 56 Scores of 0-3 are considered normal, indicating that 
Lactobacillus dominates in the woman’s vagina 56. Scores of 7-10 indicate BV, showing 
that few Lactobacillus are present and Gardnerella and/or Mobiluncus dominates in the 
woman’s vagina 56. Scores of 4-6 are considered intermediate, indicating that 
Lactobacillus, Gardnerella and/or Mobiluncus are present in the woman’s vagina at the 
same time 56. The drawbacks of this method are as follows: 1) it is time-consuming and 
2) it is not very sensitive 55-57. For example, Nugent et al. 56 admitted that the Nugent 
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criteria have a false positive rate of 20%; recent studies have shown that only 16%–37% 
of women with BV diagnosed by the Nugent criteria show BV symptoms 23,58.  
 
Both the Nugent and Amsel criteria require microscopy. Because of this, the use of these 
two methods is limited in some countries which do not have the necessary equipment. 
The BVBlue sialidase test is one of the methods to diagnose BV which does not rely on 
microscopy. It is a chromogenic diagnostic test - a blue or green color indicates that an 
elevated level of sialidase enzyme is detected in the vaginal discharge and the woman is 
therefore diagnosed as a BV patient 59. It has been demonstrated that the enzyme secreted 
by anaerobes, such as Bacteroides, Gardnerella, and Prevotella, destroys mucosal tissue 
by hydrolyzing sialic acid from mucin 60-65. The function of mucin is to protect the 
vaginal epithelium from the colonization of pathogens 66,67. Sialidases therefore assist the 
adherence, colonization, and invasion of pathogens 67. Studies have shown that the level 
of sialidase activity is significantly higher in BV patients compared with that in women 
without BV 61,62,68-70. For example, Briselden et al. 61 observed elevated sialidase activity 
in 42 (84%) of 50 BV patients, and did not observe elevated activity in any of 19 woman 
without BV. The drawback of the BVBlue sialidase test is that the sensitivity is low 71. 
There have been no methods to accurately diagnose BV until now. 
 
The incomplete current understanding of the mechanism for BV makes its treatment 
ineffective. Metronidazole and clindamycin are commonly used antibiotics to treat BV. 
These two antibiotics are directed to restore the normal vaginal microbiome by killing 
pathogenic bacteria 40,72. However, recurrence rates of BV in women treated with these 
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two antibiotics are high, with 1-month, 3-month, and 1-year recurrence rates of 23%, 
43%, and 58%, respectively 72. 
 
1.3.2 Preterm birth 
Preterm birth is another major problems impacting women’s reproductive health 
worldwide 73. Preterm birth is birth that takes place before 37 weeks of gestational age. 
Every year, about 15 million babies are born preterm in the world 74. That is more than 
one in ten babies 74. The number is still rising. The societal cost for preterm birth in the 
United States of America alone is more than $26.2 billion in 2005 38.  
 
The causes of preterm birth are multifactorial. Intrauterine infection accounts for 30% of 
preterm birth 75. Preterm premature rupture of membranes (PPROM) accounts for 25% of 
preterm birth 75. The remaining 45% of preterm birth are idiopathic 75. This potential 
mechanism which links intrauterine infection to preterm birth is that pathogens in the 
vagina ascend up toward the uterus, cross the placental barrier and induce preterm birth 
73,75. The potential mechanism has been supported by the previous studies that find the 
vaginal-related bacteria, such as Ureaplasma urealyticum, Fusobacterium sp., 
Mycoplasma hominis, Streptococcus agalactiae, Peptostreptococcus sp., Staphylococcus 
aureus, Gardenerella vaginalis, Streptococcus viridians, Bacteroides sp., Prevotella sp., 
Delftia sp., Neisseria sp., Sneathia sp., and Leptotrichia sp.,  in amniotic fluid of women 
with preterm birth 76-80. Among the above vaginal bacteria, Ureaplasma urealyticum, 
Mycoplasma hominis, Peptostreptococcus sp., Gardenerella vaginalis, Prevotella sp., 
and Leptotrichia sp. were BV associated bacteria 50,51. Some researchers thought that the 
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potential mechanism which links intrauterine infection to preterm birth is that bacterial 
products in the pathogens, such as endotoxin or peptidoglycans or lipoteichoic acid, are 
recognized by Toll-like receptors (TLRs) and activate nuclear factor kappa B (NF-κB), 
which in turn leads to the production of cytokines and the induction of preterm birth 81. 
This potential mechanism has been supported by the previous studies that find the 
concentrations of cytokines are higher in amniotic fluid of women with preterm birth than 
those in women with term birth 82,83. 
 
1.4 Metagenomic approaches 
Given the important role of the vaginal microbiome in the women’s reproductive health, 
it is important to understand what microorganisms are present in the vaginal microbiome, 
how many of which microbes are present in the vaginal microbiome, and what the 
microbes are doing. Currently, there are two popular culture-independent methods, 
amplicon sequencing and whole genome shotgun (WGS) sequencing, to analyze 
microbiomes without the need of culture 84-86. Amplicon sequencing is the use of 
polymerase chain reaction (PCR) to amplify marker genes, such as the 16S ribosomal 
RNA (rRNA) gene, from genomic DNA and map marker genes into known sequence 
databases. This method can answer the questions of what microorganisms are present in 
the vaginal microbiome and how many of which microbes are present in the vaginal 
microbiome. WGS sequencing is the sequencing of genomic DNA directly from any 
environment (without PCR) to reveal genes present in an environment. This method can 
answer the questions of what microorganisms are present in the vaginal microbiome, how 
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many of which microbes are present in the vaginal microbiome, and what functions the 
microbes perform.  
 
1.4.1 16S rRNA gene sequencing 
16S rRNA genes are the most commonly used marker for microbial species identification 
87. 16S rRNA genes exist in all bacteria and contain hypervariable regions, which are 
species-specific and can be used to identify bacteria, and strongly conserved regions, 
which are located at the sides of the hypervariable regions and can be used to design 
primers and amplify the hypervariable regions 88. 16S rRNA genes contain nine 
hypervariable regions (V1-V9) 86. All or some of the nine regions can be used to identify 
bacteria. Although 16S rRNA gene sequencing is very powerful to identify bacteria, it 
has three drawbacks. (1) PCR amplification potentially introduces bias. Known bias can 
come from the design of the universal primers for 16S rRNA genes and PCR conditions 
for the analysis of 16S rRNA genes that can cause amplification bias and chimera 
formation 89,90; (2) 16S rRNA genes are not single copy genes. The copy numbers vary 
from 1 up to 15 91,92. This leads to the underestimation or overestimation of bacterial 
community composition; (3) analysis of 16S rRNA genes fails to provide functional 
information. Although Phylogenetic Investigation of Communities by Reconstruction of 
Unobserved States (PICRUSt) can be used to predict function from 16S sequence data, 
PICRUSt predicts function from phylogeny based on the shared gene content and does 
not consider the variations among species 93. Moreover, the prediction accuracy of 
PICRUSt depends on the closeness between reference genomes and query microbiome 93. 
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Therefore, 16S rRNA gene sequencing is not sufficient to elucidate the relationship 
between the vaginal microbiome and women’s reproductive health, such as BV etiology. 
 
The general workflow for 16S rRNA genes hypervariable tag sequencing technologies is 
(1) extraction of genomic DNA; (2) PCR amplification of the whole 16S rRNA genes or 
certain region of 16S rRNA genes; (3) amplicon sequencing; and (4) bioinformatics 
analysis, such as alignment, classification, operational taxonomic unit (OTU) analysis, 
and phylogenetic analysis 90,94. 
 
1.4.2 Whole genome shotgun sequencing 
An alternative to the 16S rRNA-based PCR method to identify microorganisms is WGS 
sequencing. WGS sequencing does not use PCR to amplify genomic DNA. Therefore, it 
overcomes the bias induced by PCR amplification. However, it has its own drawbacks. 
Genes present in an environment are sequenced based on the abundance of the organism. 
In general, WGS sequencing is not deep enough to detect rare organisms 86,95.  
 
One of the important functions of WGS sequencing is to assign short reads to taxa and/or 
function. There are two different approaches to annotate metagenomic data, namely short 
reads-based annotation and assembly-based annotation. Short reads-based annotation can 
only provide taxonomic information. Assembly-based annotation can provide not only 
taxonomic information but also functional information.  
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1.4.2.1 Short reads-based annotation 
Short reads-based annotation, as the name suggests, annotates metagenomic data directly 
from short reads. This method can be further classified into three groups, namely 
similarity-based, composition-based, and marker gene-based approach 85,96,97.  Similarity-
based approach classifies metagenomic short reads based on the comparison of short 
reads with known sequences in a reference database 96,97. The comparison is usually 
performed using Basic local alignment search tool (BLAST) 96-98. Composition-based 
approach classifies metagenomic short reads based on DNA base composition signatures, 
such as oligonucleotide frequency 96,97. For example, Phylopythia uses oligonucleotide 
composition to classify metagenomic short reads with multi-class support vector machine 
99. Marker gene-based approach classifies metagenomic short reads based on the 
comparison of short reads with a reference database that is built from taxonomically 
informative marker genes 85. For example, Taxonomic identification and phylogenetic 
profiling (TIPP) uses 30 phylogenetic marker genes that are single copy and universally 
present in all bacteria to identify bacterial species and determine their abundance from 
the metagenomic short reads 100. TIPP builds a “backbone alignment” and “backbone 
tree” on each of the 30 marker genes, and then uses the “backbone alignment” and 
“backbone tree” to find the optimal placement of the query sequence in the tree 100. From 
the placement, the read can be taxonomically annotated 100. 
 
The advantages of marker gene analysis are (1) it is a relatively rapid way to annotate 
bacteria from the metagenomic short reads because it compares query metagenomic short 
reads with marker gene database instead of all bacterial genomes 85; (2) it is a relatively 
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accurate way to annotate bacteria from the metagenomic short reads because marker 
genes are single-copy genes 85.  It may be more accurate to determine bacterial 
abundance when compared with genes with multiple copies across bacterial genomes, 
such as 16S rRNA gene 85. The disadvantages of marker gene analysis are (1) the choice 
of marker genes and the technique used to bin the reads to the markers influence the 
taxonomic annotation 100; (2) all marker genes do not exist in every bacterium.  
 
1.4.2.2 Assembly-based annotation 
Assembly-based annotation, as the name suggests, annotates metagenomic data from 
assembly. In this method, metagenomic short reads are assembled into a single 
contiguous sequence (contig). Assembly-based annotation is thought to provide more 
accurate annotation when compared with short reads-based annotation because it works 
on longer sequences. Working on small number of longer sequences also reduces the 
computational burden when compared with working on large number of short sequences 
85. According to whether a reference database exists or not, sequence assembly could be 
divided into two different types of assembly, reference-based assembly and de novo 
assembly 101. The general workflow for reference-based assembly is (1) map short reads 
to a reference genome; and (2) assemble short reads that are mapped to the same 
reference genome to contigs. The advantages of reference-based assembly are (1) contigs 
are longer; (2) the lengths of contigs are bigger; and (3) it does not require a lot of 
computational resources 101. The disadvantages of reference-based assembly are (1) short 
reads that are not aligned to the reference genome are not used; and (2) contigs that are 
different from the reference genome cannot be produced 101. In a de novo assembly, short 
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reads that overlap are linked into contigs without the need of using a reference genome. 
The advantage of de novo assembly is that contigs that are different from the reference 
genome can be produced 101. The disadvantages of de novo assembly are (1) contigs are 
shorter; (2) the lengths of contigs are smaller; and (3) it requires a lot of computational 
resources 101. 
 
Two different pipelines can be used to annotate metagenomes. The first pipeline is (1) bin 
contigs into different population genomes according to tetranucleotide frequencies, GC 
contents, and coverage of contigs 102,103; and (2) use single-copy marker genes 103 or 
marker genes that are specific to a genome’s inferred lineage within a reference genome 
tree 104 to identify the population genomes and to estimate the completeness and 
contamination of the population genomes. Population genomes refer to genome bins that 
belong to one species and some closely related strains. Binning is used because it is very 
difficult to get complete genomes from metagenomes at strain level. A genome bin 
includes a number of contigs that belong to the same species but different strains. The 
second pipeline is (1) predict genes present in the assembled contigs; and (2) blast the 
predicted genes against a reference database for taxonomic and functional annotation, 
such as HMP urogenital tract reference genomes, NCBI bacterial genomes, or KEGG 
(Kyoto Encyclopedia of Genes and Genomes) 98,105,106. 
 
1.5 Project summary 
Vaginal microbes exert a strong influence on women's reproductive health. Perturbations 
in the vaginal microbiome have been associated with serious sequelae, such as bacterial 
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vaginosis (BV). Although BV has been known for centuries, the etiology of it is 
multifactorial. BV is often ambiguously characterized as a shift from a Lactobacilli-
dominated to a poly-microbial community 38. However, recent studies found that 
appreciable amounts of healthy women had vaginal microbiome predominated by other 
various anaerobic microorganisms other than Lactobacilli 7, which implies that a simple 
understanding of the taxonomic composition of the vaginal microbiome of BV patients 
could not comprehensively describe the exact mechanism of BV. It has been reported that 
the genome of Gardnerella vaginalis strains that were isolated from BV patients encode 
for mucin degradation enzymes 52. However, the genomes of Gardnerella vaginalis 
strains isolated from healthy women did not encode these genes 52. The degradation of 
mucin facilitates colonization of pathogens and initiation of BV. Therefore, to gain a 
mechanistic understanding of BV, there is a need to understand what pathogens initiate it 
and how they do so. Amplicon sequencing can answer the question of what pathogens 
initiate it. Whole genome shotgun sequencing can answer both questions. However, a 
minority of existing research on BV used whole genome shotgun sequencing to answer 
the question of how pathogens initiate BV.  
 
Sialidase has been thought to have the potential to unveil the mechanism of BV for the 
following reasons: (1) The enzyme can degrade mucin by hydrolyzing sialic acid from 
mucin 66,67. The function of mucin is to protect the vaginal epithelium from the 
colonization of pathogens 66,67; (2) Studies have shown that the level of sialidase activity 
is significantly higher in BV patients compared with that in women without BV 61,62,68-70; 
and (3) Prevotella, Gardnerella, and Bacteroides species, which are reported to be 
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associated with BV, were reported to have the ability to secrete sialidase 59,61-63,65. 
Therefore, in chapter 2, we hypothesized that sialidase could serve as a biomarker for 
BV. The objectives of this study are to determine whether sialidase activity is elevated in 
Chinese BV patients, whether the relative abundance value of sialidase-encoding genes 
increases in Chinese BV patients, and whether the relative abundances of Prevotella, 
Gardnerella, and Bacteroides species are higher in Chinese BV patients.  
 
Yeoman et al. 1 revealed that women with and without BV have distinct metabolite 
profiles and found metabolites that are correlated with BV symptoms. They found 
vaginal bacteria that were correlated with BV symptom-associated metabolites. However, 
they did not connect functional genes to vaginal bacteria and metabolites. BV symptom-
associated metabolites are encoded by functional genes in vaginal bacteria. Therefore, 
studying the correlation among bacteria, functional genes, and metabolites could help 
better understand how pathogens initiate BV. Therefore, in chapter 3, we hypothesized 
that BV symptom-associated bacteria could serve as potential biomarkers to improve the 
development of therapeutic targets. To help test this hypothesis, we took a subset of the 
population from Yeoman et al. 1 and examined the correlation among vaginal bacteria, 
vaginal discharge-associated metabolites, and functional genes. We then pursued the 
following two objectives: (1) Identify bacteria and functional genes associated with 
metabolites that Yeoman et al. 1 found to be correlated with vaginal discharge, and (2) 
Identify which identified bacteria were correlated with the identified functional genes.  
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The vaginal microbiomes are mainly dominated by Lactobacilli during pregnancy 10,13-15. 
The predominance of Lactobacilli in the vagina has been reported to be related to high 
estrogen levels and glycogen content in the vaginal epithelium 6,11. Estrogen levels 
increase gradually during pregnancy, reaching a maximum near term, and drop down 
quickly during labor 107. Glycogen is converted to lactic acid mainly by Lactobacilli. 
Therefore, in chapter 4, we hypothesized that the abundance of Lactobacilli and 
functional genes for metabolic activity in Lactobacilli would increase as pregnancy 
progresses and decrease following parturition. The objectives of this study are to 
determine whether the abundance of Lactobacilli and functional genes for metabolic 
activity in Lactobacilli increase as pregnancy progresses and decrease following 
parturition.  
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CHAPTER 2. TAXONOMIC AND FUNCTIONAL GENE COMPOSITION                                            
DIFFERS BETWEEN CHINESE WOMEN WITH AND WITHOUT BACTERIAL 
VAGINOSIS 
 
2.1 Abstract 
Bacterial vaginosis (BV) is common vaginal disorder globally in women of reproductive 
age, and has been associated with serious sequelae such as sexually transmitted diseases 
and preterm birth. Although BV has been known for centuries, the etiology of it is still 
poorly understood. Sialidase has been thought to have the potential to unveil the 
mechanism of BV. It assists the adherence, colonization, and invasion of pathogens. This 
study was conducted to determine whether sialidase could serve as a biomarker for BV. 
We used the BVBlue sialidase test to measure the sialidase activity, 454-pyrosequencing 
of amplicons from the V1-V3 region of the 16S rRNA gene to classify sequence to 
bacteria, and Illumina high-throughput sequencing to classify sequence to bacteria and 
functional genes in microbial samples from 38 Chinese women with and without BV 
from 20 to 52 years (means ± SEM 35.6 ± 1.2 years). The samples were collected by 
swabs from cervix, middle, and upper vagina walls. Elevated sialidase activity (>= 7.8U) 
was detected in all BV patients but not in any women without BV. Analysis of 16S rRNA 
gene and whole genome shotgun sequences data revealed that Prevotella and 
Gardnerella species as well as thiol-activated cytolysin (K11031) and putative 
peptidoglycan lipid II flippase (K03980) were more abundant in BV patients. We 
conclude that the sialidase test could separate diseased vaginal microbiomes from non-
diseased ones. Prevotella and Gardnerella species were associated with high sialidase 
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levels. Gardnerella vaginalis may initiate BV through the produce of thiol-activated 
cytolysin. 
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2.2 Introduction 
Bacterial vaginosis (BV) is one of the most common, yet major problems impacting 
women’s reproductive health worldwide 22. The prevalence of BV in the United States is 
about 29.2% or approximately 21.2 million women of reproductive age 23 and is 
associated with serious sequelae. In non-pregnant women, BV has been linked 
predominantly to the upper genital tract and poses an increased risk for sexually 
transmitted infections 3,24-27 and susceptibility to human immunodeficiency virus (HIV) 
27-29. In pregnant women, BV has been linked to miscarriages 27,30-32, post-abortion 
infections 27,33, postpartum endometritis 27,34,35, preterm pre-labor rupture of membranes 
(PPROM) 36, and preterm birth 3,27,37,38. The United States annually spends nearly $1 
billion on treating BV-related pregnancy complications 39. 
 
Considering medical and economic importance of vaginal health, there is a great interest 
in understanding of the etiology of BV. BV is often ambiguously characterized as 
perturbations in the normal vaginal microbiome 7, and is believed to be a result of a shift 
from a Lactobacilli-dominated to a poly-microbial community 38. For example, BV 
patients are believed to have less Lactobacilli and more Gardnerella and Mobiluncus 
compared to healthy asymptomatic women. However, species like Gardnerella vaginalis 
and Mobiluncus curtisii, which have been traditionally associated with BV, are also 
commonly found in healthy asymptomatic women 49. Moreover, recent studies suggest 
that Lactobacilli do not always predominate in the vaginal microbiome. In 10 to 42% of 
healthy asymptomatic women, Lactobacilli were outnumbered by other vaginal microbes, 
such as Atopobium vaginae, Leptotrichia and Megasphaera, which have the ability to 
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produce lactic acid and keep the vaginal environment acidic 9,41-48. This implies that a 
simple understanding of the taxonomic composition of the vaginal microbiome of BV 
patients could not comprehensively describe the exact mechanism of BV.  
 
Sialidase (or neuraminidase) production is thought to play a mechanistic role in the 
development of BV. It has been demonstrated that sialidase secreted by vaginal bacteria 
degrades mucin by hydrolyzing sialic acid from mucin 66,67. The function of mucin is to 
protect the vaginal epithelium from the colonization of pathogens 66,67. Sialidases 
therefore assist the adherence, colonization, and invasion of pathogens 67. Studies have 
shown that the level of sialidase activity is significantly higher in BV patients compared 
with that in women without BV 61,62,68-70. For example, Briselden et al. 61 observed 
elevated sialidase activity in 42 (84%) of 50 BV patients, and did not observe elevated 
activity in any of 19 woman without BV. Additionally, Prevotella, Gardnerella, and 
Bacteroides species, which are reported to be associated with BV, were reported to have 
the ability to secrete sialidase 59,61-63,65. 
 
Therefore, we hypothesized that sialidase could serve as a biomarker for BV. The 
objectives of this study are to determine whether sialidase activity is elevated in Chinese 
BV patients, whether the relative abundance value of sialidase-encoding genes increases 
in Chinese BV patients, and whether the relative abundances of Prevotella, Gardnerella, 
and Bacteroides species are higher in Chinese BV patients. We used the BVBlue 
sialidase test to measure the sialidase activity and analyzed 16S rRNA genes and whole 
genome shotgun sequences in microbial samples from Chinese women with and without 
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BV to identify bacterial species and functional genes that were more abundant in Chinese 
BV patients. 
 
2.3 Methods 
2.3.1. Ethics statement 
This study was approved by NanFang Hospital in Guangzhou, China (BV_2011_01P). 
Informed written consent was obtained from all study participants prior to sample 
collection. 
 
2.3.2. Sample collection 
For this study, vaginal samples were collected from 38 Chinese women. None of the 
women were pregnant, and all were of reproductive age from 20 to 52 years (means ± 
SEM 35.6 ± 1.2 years). All subjects lived in Guangzhou, China. The sample descriptions 
are given in Table 1. Twenty-six patients were diagnosed for BV by a Chinese physician 
who collected their vaginal samples by taking swabs from cervix, middle, and upper 
vagina walls. Two swabs were taken from each woman. One swab was used for the 
BVBlue sialidase test kit (Huajin Biotechnology Co. Ltd., China, Cat. No. 2400018) that 
is a chromogenic diagnostic test; a blue or green color indicates an elevated level of 
sialidase enzyme in the vaginal discharge 59. The BVBlue sialidase test kit detects vaginal 
fluid sialidase activity at levels of >=7.8 U 59. One unit of sialidase activity is defined as 
the amount of enzyme required to liberate 1 nmol of substrate/ml/min at 37°C 59. The 
second swab was saved in a sterile cryovial with 1 ml saline for the purpose of DNA 
extraction and further analysis.  
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2.3.3. Genomic DNA extraction 
The vaginal swabs were vigorously agitated to dislodge the bacterial cells. The cells were 
pelleted by centrifugation at 5,000 g for 10 min. Bacterial genomic DNA was extracted 
using QIAamp DNeasy Blood and Tissue Kit (QIAGEN, Hilden, Germany; Cat. No. 
69504) following the manufacturer’s instructions. Briefly, the bacterial pellet was re-
suspended in 200 µl of saline with 20 µl of proteinase K solution and 200 µl of lysis 
buffer (Buffer AL). The mixtures were homogenized by vortexing, and incubated at 56°C 
for 30 min. After incubation, 200 µl of 100% ethanol was added and mixed by vortexing. 
The mixture was transferred into QIAamp spin column and centrifuged at 8,000 g for 1 
min. The QIAamp spin column was replaced in a new 2 ml collection tube and washed 
twice with 500 µl buffer AW1 and AW2 provided in the kit. The genomic DNA was 
eluted with 100 µl of elution buffer (Buffer AE). Concentration of DNA was determined 
using NanoDrop ND-1000 spectrophotometer (Thermo Electron Corporation, USA). The 
integrity and fragment size of the extracted DNA were determined by 1% agarose gel 
electrophoresis.  
 
2.3.4. Pyrosequencing 
The V1-V3 region of the 16S ribosomal RNA gene of 38 samples was amplified from 
extracted DNA by polymerase chain reaction (25 cycles of 94°C (30 s), 48°C (30 s), 
72°C (2 min)) using primers 27f-YM (CGTATCGCCTCCCTCGCGCCATCAG-
AGAGTTTGATYMTGGCTCAG); and 534r 
(CTATGCGCCTTGCCAGCCCGCTCAG-[MID tag 1 – 50]-
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ATTACCGCGGCTGCTGGCA). The primers were validated previously and shown to 
broadly encompass vaginal bacteria 108. Negative control PCRs were performed without 
1) template DNA and 2) without polymerase. No products were detected in any negative 
control. The amplicons were pyrosequenced on 454 FLX-Titanium Technology at the J. 
Craig Venter Institute (Rockville, MD).  
 
2.3.5. Illumina high-throughput sequencing 
Four out of 38 DNA samples (IDs: SMUB9, SMUB27, SMUN23, SMUN25) were 
selected for metagenomic analysis by sequencing on Illumina HiSeq 2000. The four 
purified DNA samples were solubilized in EB (1 mM TrisHCl pH 8), amplified by 
multiple displacement amplification (MDA) using phi29 enzyme mix (GenomiPhi V2 
DNA Amplification Kit; GE Healthcare), according to the manufacturer’s protocol. 10-50 
ng of each sample was used as a template and reactions were carried out for 16 hours. 
500 ng of amplified DNA was used for libraries construction with standard Illumina 
protocols with few modifications. DNA was sheared using the Covaris S2 or E210 
system, followed by ligation of sequencing adaptors containing unique barcode 
sequences to allow pooling of all samples. Libraries were purified using Agencourt 
AMPure XP beads, and DNA concentration was measured using the Agilent High 
Sensitivity DNA Kit. Quality control steps were completed with qPCR using the KAPA 
Biosystems Library Quantification Kit. Pooled libraries were sequenced on one lane of a 
HighSeq 2000 machine, paired-end 2x101bp.  
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2.3.6. 16S rRNA sequencing data analysis and statistics 
The resulting sequences were quality trimmed using the methods described in a previous 
study 109, with the minor modification of the use of an average quality score ≤ 30 instead 
of 25. A total of 553,888 high quality sequence reads were generated from 38 samples, 
with an average sequence length 484 nt (Table 2). For taxonomic analysis, the resulting 
sequences were assigned to operational taxonomic units (OTUs) as previously described 
1,109,110. Briefly, sequences were aligned against the Silva database and pre-clustered 
using mothur 111. The remaining sequences were clustered at 97% sequence similarity 
using ModalClust, utilizing a complete linkage clustering method 
(https://bitbucket.org/msipos/modalclust). OTUs detected in fewer than three samples and 
three times were removed as possible artifacts. The taxonomic similarities among 
microbial communities were compared using Bray-Curtis dissimilarity statistics. To 
calculate relative abundance of each OTU in each sample, the number of sequences in 
each OTU in the OTU table was divided by the total number of sequences in each 
sample. The relative abundance matrix was transformed by square root to reduce the 
effect of more abundant over less abundant OTUs. Resemblance matrices and principal 
coordinate analysis (PCoA) plots were created and visualized in Primer (Primer-E 2007). 
To test the null hypothesis that there was no difference between Chinese women with and 
without BV, we used permutational multivariate analysis of variance (PERMANOVA) in 
Primer (Primer-E 2007). The representative sequence in each OTU was assigned to 
genera using RDP classifier v2.5 with a bootstrap cutoff of 80% 112. Significantly 
different bacterial genera were identified using linear discriminant analysis (LDA) effect 
size (LEfSe) Galaxy version with default parameters 113 and visualized with a heatmap 
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which was generated using heatmap.2 function of the gplots package in R. Women with 
and without BV were two classes without any subclasses. Shannon diversity indices were 
calculated in mothur 111. Significantly different Shannon diversity indices were detected 
using a Kruskal-Wallis rank sum test 114. P-values < 0.05 were regarded as significant 
unless specifically stated otherwise. 
 
2.3.7. Metagenomic sequencing data analysis and statistics 
2.3.7.1 Reads trimming 
The qualities of the raw Illumina sequencing data were first assessed using FastQC 
v0.10.1 (http://www.bioinformatics.babraham.ac.uk/projects/fastqc/). The first few bases 
of each sequence, which showed a bias in the FastQC report, were trimmed using the 
FASTX toolkit 115. Leading and trailing low quality bases (Q score below 20) and 
sequences shorter than 50 nucleotides and with an average quality score < 20 were 
removed using trimmomatic v0.30 116. This quality filtering resulted in the quality values 
of all bases being higher than 28 in the FastQC report. To remove potential 
contamination with human DNA, the remaining reads were further mapped against 
human genome reference sequence (NCBI build 37 p13) with one mismatch permitted 
per read in Bowtie 2 117.  
 
2.3.7.2 Assembly #1 
To obtain a reliable assembly, the resulting clean reads were aligned against the HMP 
urogenital tract reference genomes downloaded on January 10, 2015 (Table 3). The read 
alignments with mapping qualities > 20 were considered to be true alignments. The reads 
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whose breadth of coverage (defined as the percentage of bases covered in the entire 
reference genome) was more than 2% at least one in sample were further assembled to 
contigs using SOAPdenovo v2.04, with k-mer corresponding to the longest N50 contig 
length (Table 4) 118. The assembled contigs of each sample were aligned against HMP 
urogenital tract reference genomes using ABACAS with default parameters, except 80% 
minimum percent identity 119. The contigs that shared at least 80% identity with the HMP 
urogenital tract reference genomes were called “assembly #1” and were combined with 
the following “assembly #2” and “assembly #3” for functional gene annotation.  
 
2.3.7.3 Assembly #2 and assembly #3 
The reads that were not used in “assembly #1” were assembled into contigs as previously 
described 103. Briefly, the paired-end reads were digital normalized to k-mer coverage 
(defined as the number of times a k-mer was found in a read) of 20 using normalize-by-
median.py in khmer v1.3. 120. Highly repetitive k-mers, which could belong to multiple 
species, were removed using filter-below-abund.py with C=100 in khmer v1.3. 120. The 
resulting paired-end reads were de novo assembled using Ray Meta at k=23 121. Scaffold 
coverage and length were calculated using Bowtie 2 117 and samtools v0.1.18  122. 
Tetranucleotide frequency, GC content, and conserved marker genes were identified as 
described 103. The binning of scaffolds into genomes was performed as described 103. 
Scaffolds whose sequencing depths were bigger than 20X in any two subjects and which 
were classified by essential single copy gene were chosen (Table 5). The unassembled 
reads associated with these scaffolds were extracted and reassembled using SOAPdenovo 
v2.04 at k=23, thus, resulting new assembly 118. The new assemblies were called 
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“assembly #2”. The unassembled reads that were not used in “assembly #1” or “assembly 
#2” were de novo assembled using Ray Meta at k=23 121. This assembly was called 
“assembly #3”.  “Assembly #2” and “assembly #3” were combined with “assembly #1” 
for the taxonomic and functional annotation of genes.  
 
2.3.7.4 Taxonomic and functional annotation of genes 
Assemblies 1, 2, and 3 were combined for each sample for the taxonomic and functional 
annotation of genes. A total of 13 Mbp of contigs (>= 300 bp) were generated in the 
combined contigs from four samples with longest contig length of 36 Kbp (Table 6). 
Microbial genes were also searched for in all contig sequences longer than 300 bp using 
the Prokaryotic Dynamic Programming Genefinding Algorithm (Prodigal) 123. The 
predicted genes of all samples were combined to create a gene set. To build a non-
redundant gene set, genes with 95% sequence identity and aligned length covered over 
90% of the sequence were clustered together using cd-hit v4.6.1 124. To create a gene 
abundance matrix in which both pairs that mapped to the same gene would only be 
counted once, clean short reads in each sample were mapped back to the non-redundant 
gene set using bwa v0.7.5a 125 and samtools v0.1.18 122. For taxonomic annotation, non-
redundant genes were queried using BLASTN 98 (default parameters except E=1e-5) 
against the HMP urogenital tract reference database downloaded on January 10, 2015 
(Table 3) and the NCBI complete bacteria genome, downloaded on September 6, 2014. 
For functional gene annotation, non-redundant genes were queried using DIAMOND 105 
(default parameters except E=1e-5) against the KEGG database (v56) 106. Only the best 
  
31 
 
hits with at least 80% identity over 100 bp-aligned lengths were selected for comparison 
between Chinese women with and without BV. 
 
2.3.7.5 Genomic analyses 
The combined contigs from each sample (>= 300 bp) were aligned to the HMP urogenital 
tract reference genomes downloaded on January 10, 2015 (Table 3) using BLASTN 98 
(default parameters except E=1e-5). Only the best hits with at least 80% identity over 100 
bp-aligned lengths were selected. Contigs aligned against the Gardnerella vaginalis 315-
A, Gardnerella vaginalis 409-05, Gardnerella vaginalis ATCC 14019, Gardnerella 
vaginalis HMP9231, and Prevotella timonensis CRIS 5C-B1 reference genome in each 
sample were compared with the corresponding reference genome using GView server 
with BLAST atlas analysis type and default parameters except e-value < 0.00001 126. 
 
2.4 Results 
2.4.1 Sialidase enzyme analysis 
To determine whether sialidase activity is elevated in Chinese BV patients but not in 
Chinese women without BV, we used the BVBlue sialidase test to measure the sialidase 
activity in samples from Chinese women with and without BV. A blue or green color was 
observed in all samples collected from Chinese BV patients indicating elevated sialidase 
activity was detected in all patients with BV. A yellow color was observed in all samples 
collected from Chinese women without BV indicating sialidase activity was not observed 
to increase in any patients without BV. Therefore, the test was able to distinguish 
between women with and without BV. 
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2.4.2 Diversity and microbial community structure analyses 
To further determine whether the sialidase test could separate women with and without 
BV, we examined the microbiome diversity and microbial community structure of 
women with and without BV. The vaginal microbiomes of BV patients were more 
diverse than those of women without BV (Figure 1). Bray-Curtis dissimilarity-based 
PCoA plot exhibited a disparate clustering between women with and without BV 
(PERMANOVA p=0.001; Figure 2). Therefore, women with and without BV harbored 
distinctly different vaginal microbiomes. 
 
2.4.3 Functional analysis of metagenomic sequence data 
Elevated sialidase enzyme were detected in all Chinese BV patients and not detected in 
any Chinese women without BV. It implies that sialidase-encoding genes are more 
abundant in Chinese BV patients when compared with Chinese women without BV. To 
determine possible genetic underpinnings for this measurement, we annotated all open 
reading frames to KEGG orthologous groups. Gene sequence encoding a sialidase 
enzyme was not found in all Chinese women. It means that the sequencing of all Chinese 
women may be not deep to find sialidase enzyme. To find an alternative to sialidase-
encoding genes, we compared all predicted enzymes of Chinese women with BV with 
those of Chinese women without BV. We found that the relative abundance of 223 
KEGG orthologous groups were higher in the vaginal microbiomes of both Chinese BV 
patients when compared with both Chinese women without BV (Table 7). Among these 
223 KEGG orthologous groups, thiol-activated cytolysin (K11031), which is a toxin, and 
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putative peptidoglycan lipid II flippase (K03980), which is virulence factor, may serve as 
biomarkers for BV (Figure 3).   
 
2.4.4 Taxonomic analysis of 16S rRNA gene and whole genome shotgun sequence 
data 
To determine whether the relative abundance value of Prevotella, Gardnerella, and 
Bacteroides species were higher in Chinese BV patients when compared with Chinese 
women without BV, the LEfSe was used to identify which bacterial genera were more 
abundant in BV patients 113. At a p-value of 0.05, 16S rRNA sequence data revealed that 
eight bacterial genera including Prevotella and Gardnerella were significantly more 
abundant in Chinese BV patients (Figure 4; Table 8). Genus Bacteroides was not found 
to be significantly more abundant in Chinese BV patients (Figure 4; Table 8). At the 
strain level, metagenomic sequence data revealed that the relative abundance of 
Gardnerella vaginalis 315-A, Gardnerella vaginalis 409-05, Gardnerella vaginalis 
ATCC 14019, Gardnerella vaginalis HMP9231, and Prevotella timonensis CRIS 5C-B1 
were higher in the vaginal microbiomes of both Chinese BV patients when compared 
with both Chinese women without BV (Figure 5; Table 9). The relative abundance of 
bacterial strains affiliated with genus Bacteroides were not found to be higher in the 
vaginal microbiomes of both Chinese BV patients when compared with both Chinese 
women without BV (Table 9). 
 
2.4.5 Genomic analysis 
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To find out how many nucleotides of each of the Gardnerella vaginalis 315-A, 
Gardnerella vaginalis 409-05, Gardnerella vaginalis ATCC 14019, Gardnerella 
vaginalis HMP9231, and Prevotella timonensis CRIS 5C-B1 reference genome was 
covered in our assemblies, we aligned individual assembly against all HMP urogenital 
tract reference genomes and compared contigs that were aligned to the above five 
reference genomes with the corresponding reference genome. More nucleotides from the 
Gardnerella vaginalis 315-A, Gardnerella vaginalis ATCC 14019, Gardnerella vaginalis 
HMP9231, and Prevotella timonensis CRIS 5C-B1 reference genomes had the alignment 
with the assemblies from two Chinese BV patients when compared with two Chinese 
women without BV (Figure 6).  
 
2.5 Discussion 
Our study revealed that elevated sialidase activity was detected in all BV patients but not 
in any women without BV and women with and without BV harbored distinctly different 
vaginal microbiomes. These suggest that sialidase test could separate diseased vaginal 
microbiomes from non-diseased ones. The separation of diseased vaginal microbiome 
from non-diseased one was also observed in the previous study where researchers used 
Amsel and Nugent criteria to diagnose BV and revealed that microbiome richness and 
diversity are increased in BV patients and the abundances of vaginal bacterial species in 
BV patients significantly differ from those in healthy controls 127. 
 
In our study, we observed that Prevotella and Gardnerella species were more abundant in 
women with BV. These findings support the findings from previous studies where 
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researchers reported that Prevotella, Gardnerella, and Bacteroides species have the 
ability to secrete sialidases 59,61-63,65. Our whole genome shotgun sequences data further 
revealed that Gardnerella vaginalis 315-A, Gardnerella vaginalis 409-05, Gardnerella 
vaginalis ATCC 14019, Gardnerella vaginalis HMP9231, and Prevotella timonensis 
CRIS 5C-B1 were more abundant in both BV patients. Sialidases-encoding genes were 
found in the Gardnerella vaginalis 315-A and Gardnerella vaginalis ATCC 14019 
reference genome. This implies that sialidases may be produced by Gardnerella vaginalis 
315-A and Gardnerella vaginalis ATCC 14019.  
 
Sialidases-encoding genes were not found in all samples. This might be because the 
coverage of our metagenome data sets was low. However, we found that the relative 
abundance of thiol-activated cytolysin (K11031) was higher in BV patients than women 
without BV. Thiol-activated cytolysin is a toxin, and is reported to be made by 
Gardnerella vaginalis 48,128.  Thiol-activated cytolysin plays a role in BV pathogenesis 
through lysing vaginal epithelial cells and activating the generation of IgA antibodies, 
further inducing mucosal immune response 48. This implies that Gardnerella vaginalis 
may also initiate BV through the produce of thiol-activated cytolysin.  
 
One of the limitations of this study is the small sample size. To alleviate the influence of 
small sample size, only bacterial strains or KEGG orthologous groups whose relative 
abundance values were higher in all individuals in one group than the other group, were 
considered to be more abundant ones. The second limitation of this study is low 
metagenome coverage. Studies based on 16S rRNA gene sequences revealed that there 
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were about 400 bacteria in the vagina 9,10,12. We assume the average bacterial genome 
size is 3MB. The rough estimate of the number of bases in the vaginal metagenome at 30 
X sequencing depth was 36,000 MB (3 Mb * 400 * 30). The highest number of bases in 
our quality-filtered metagenome was about 568 MB, which corresponded to 2% of 
metagenome coverage. To alleviate the influence of low metagenome coverage, we used 
relative abundance values and only consider high abundance bacterial strains or KEGG 
orthologous groups.   
 
2.6 Conclusions 
Sialidase test could separate diseased vaginal microbiomes from non-diseased ones. 
Prevotella and Gardnerella species were associated with high sialidase levels. 
Gardnerella vaginalis may initiate BV through the produce of thiol-activated cytolysin. 
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CHAPTER 3. IDENTIFICATION OF VAGINAL DISCHARGE ASSOCIATED 
BACTERIA BY METAGENOMIC AND NETWORK ANALYSIS 
 
3.1 Abstract 
Bacterial vaginosis (BV) is a common vaginal disorder globally in women of 
reproductive age, and has been associated with serious sequelae such as sexually 
transmitted diseases and preterm birth. Although BV has been known for centuries, the 
etiology of it is still poorly understood. Because of this, the diagnosis and treatment of 
BV are ineffective. Yeoman et al. 1 found that thirty-three metabolites correlated with the 
presence of BV-associated vaginal discharge. This study was conducted to identify 
discharge-associated bacteria that can serve as potential biomarkers to improve the 
development of therapeutic targets. To better understand how pathogens are involved in 
the production of BV symptoms, we took a subset of the population (n=4) from Yeoman 
et al. 1. All women were of reproductive age from 20 to 40 years. The samples were 
collected by swabs, scrapings, and lavage. 454-pyrosequencing of amplicons from the 
V1-V3 region of the 16S rRNA gene was used to classify sequence to bacteria. Illumina 
high-throughput sequencing was used to classify sequence to bacteria and functional 
genes. We then used Spearman's rank correlation coefficients to examine the correlation 
among vaginal bacteria, vaginal discharge-associated metabolites, and functional genes. 
Sixty-five functional genes and sixteen bacterial genera were significantly linked to 
discharge-associated metabolites (r=1, p=0). Twelve bacterial genera were significantly 
positively linked to eleven functional genes (r=1, p=0). Among the twelve bacterial 
genera and eleven functional genes, the genera Aquabacterium, Chryseobacterium, 
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Elizabethkingia, Finegoldia, Morganella, Negativicoccus, Phenylobacterium, 
Propionibacterium, Serratia, Siphonobacter, and the enzymes ‘malate dehydrogenase’ 
(K00024), ‘5-amino-6-(5-phosphoribosylamino) uracil reductase’ (K11752), and 
‘undecaprenyl-diphosphatase’ (K06153) were positively associated with 2-Methyl-2-
hydroxybutanoic acid (r=1, p=0) that was the only metabolite revealed by Yeoman et al. 1 
that positively correlated with discharge. Moreover, these three KEGG orthologous 
groups were positively linked to these ten bacterial genera (r=1, p=0). We conclude that 
the bacteria Aquabacterium, Chryseobacterium, Elizabethkingia, Finegoldia, 
Morganella, Negativicoccus, Phenylobacterium, Propionibacterium, Serratia, and 
Siphonobacter are potential therapeutic targets. 
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3.2 Introduction 
Bacterial vaginosis (BV) is one of the most common, yet major problems impacting 
women’s reproductive health worldwide 22. The prevalence of BV in the United States is 
about 29.2% or approximately 21.2 million women of reproductive age 23 and is 
associated with serious sequelae. In non-pregnant women, BV has been linked 
predominantly to the upper genital tract and poses an increased risk for sexually 
transmitted infections 3,24-27 and susceptibility to human immunodeficiency virus (HIV) 
27-29. In pregnant women, BV has been linked to miscarriages 27,30-32, post-abortion 
infections 27,33, postpartum endometritis 27,34,35, preterm pre-labor rupture of membranes 
(PPROM) 36, and preterm birth 3,27,37,38. The United States annually spends nearly $1 
billion on treating BV-related pregnancy complications 39. 
 
The etiology of BV is multifactorial. BV is often ambiguously characterized as 
perturbations in normal vaginal microbiome 7, and believed is a result of a shift from a 
Lactobacilli-dominated to a poly-microbial community 38. For example, BV patients are 
believed to have less Lactobacilli and more Gardnerella and Mobiluncus compared with 
healthy asymptomatic women. The potential mechanisms  supporting  the ambiguous 
characterization of BV are: (1) Lactobacillus species produce lactic acid to maintain an 
acidic vaginal environment (pH < 4.5), hydrogen peroxide and bacteriocin to kill 
pathogens in vagina; and (2) anaerobic bacteria produce polyamines that cause a “fishy” 
odor in the vaginal discharge, as well as mucinases and sialidases enzymes, which 
destroy mucosal tissue and facilitate colonization of pathogens in the vagina 40. However, 
recent studies suggest that Lactobacilli do not always predominate in the vaginal 
  
40 
 
microbiomes of healthy women. In 10 to 42% of healthy asymptomatic women, 
Lactobacilli were outnumbered by other vaginal microbes, such as Atopobium vaginae, 
Leptotrichia, and Megasphaera 9,41-48. Species like Gardnerella vaginalis and 
Mobiluncus curtisii, which have been traditionally associated with BV, are also 
commonly found in healthy asymptomatic women 49. The incomplete current 
understanding of the mechanism for BV makes its diagnosis and treatment ineffective. 
 
Gradually, researchers found that a simple understanding of the taxonomic composition 
of the vaginal microbiomes of BV patients could not comprehensively describe the exact 
mechanism of BV. For example, it has been reported that the genome of Gardnerella 
vaginalis strains that were isolated from BV patients encode for mucin degradation 
enzymes 52. However, the genomes of Gardnerella vaginalis strains isolated from healthy 
women did not encode these genes 52. The degradation of mucin facilitates colonization 
of pathogens and initiation of BV. Therefore, to gain a mechanistic understanding of BV, 
there is a need to understand what pathogens initiate it and how they do so. However, a 
minority of existing research on BV focused on answering the question of how pathogens 
initiate BV.  
 
To answer the question of how pathogens initiate BV, Yeoman et al. 1 and Srinivasan et 
al. 53 related vaginal bacteria to distinct BV metabolites.  Specifically, Yeoman et al. 1 
revealed that women with and without BV have distinct metabolite profiles and found 
metabolites that are correlated with BV symptoms: white, skim milk-like vaginal 
discharge; “fishy” vaginal odor; vaginal itching; and pain during urination. Yeoman and 
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his colleagues 1 related Mobiluncus species to vaginal discharge via 2-methyl-2-
hydroxybutanoic acid; related Dialister species to vaginal odor via putrescine and 
cadaverine; and related Gardnerella species to pain via diethylene glycol. Similarly, 
Srinivasan et al. 53 also revealed that metabolite profile of BV patients differ from that of 
women without BV. However, among the metabolites that distinguish metabolite profiles 
of BV patients from those of women without BV, only 12 metabolites were found in both 
studies 1,53. Srinivasan and his colleagues 53 also found BV symptom-associated 
metabolites 53.  They found that discharge is associated with agmatine and cadaverine and 
the odor is associated with putrescine 53. Agmatine, cadaverine, and putrescine were 
linked to ten BV-associated bacteria including Dialister sp. type 2 53. 
 
Although Yeoman et al. 1 and Srinivasan et al. 53 found vaginal bacteria that were 
correlated with BV symptom-associated metabolites, neither study connected functional 
genes to vaginal bacteria and metabolites. BV symptom-associated metabolites are 
encoded by functional genes in vaginal bacteria. Therefore, studying the correlation 
among bacteria, functional genes, and metabolites could help better understand how 
pathogens initiate BV.  
 
Therefore, we hypothesized that BV symptom-associated bacteria could serve as 
potential biomarkers to improve the development of therapeutic targets. To help test this 
hypothesis, we took a subset of the population from Yeoman et al. 1 and examined the 
correlation among vaginal bacteria, vaginal discharge-associated metabolites, and 
functional genes. We then pursued the following two objectives: (1) Identify bacteria and 
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functional genes associated with metabolites that Yeoman et al. 1 found to be correlated 
with vaginal discharge, and (2) Identify which identified bacteria were correlated with the 
identified functional genes. We followed metagenomic approaches using samples from 
women with and without BV from the US to determine the taxonomic and functional 
composition of the vaginal microbiome and build a network among vaginal bacteria, 
functional genes, and metabolites. 
 
3.3 Methods 
3.3.1. Ethics statement 
This study was approved by the Institutional Review Board of the University of Illinois at 
Urbana-Champaign, USA (#05079, obtained 10-31-11) and Carle Foundation Hospital in 
Urbana, USA (#89689-4, obtained 06-17-11). Informed written consent was obtained 
from all study participants prior to sample collection. 
 
3.3.2. Samples collection 
For this study, vaginal samples were collected from five US women, a subset of the 
population from Yeoman et al. 1. None of the women were pregnant, and all were of 
reproductive age from 20 to 40 years. All subjects lived in Champaign-Urbana, Illinois, 
USA, and represented three ethnicities (Caucasian, Asian American, and African 
American). The sample descriptions are given in Table 10. The patients were evaluated 
for BV via the Amsel criteria (vaginal discharge, pH > 4.5, odor, clue cells) 54 by a 
trained clinician with >20 years experience. The samples were collected by swabs, 
scrapings, and lavage. Swabs were collected from the outer surface of the cervix, the 
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large posterior portion of the fornix, and the outer third of the vaginal canal. Scrapings 
were collected from the upper third and lower third of the vagina. Ectocervicovaginal 
lavage samples were collected by injecting 15ml of sterile saline solution (Health Care 
Logistics, Circleville, Ohio) in a continuous stream toward the cervix and then collected 
in the posterior fornix using a syringe fitted with a catheter. The scheme of sample 
collection sites is described in a previous study 129. Each sample was aspirated five times 
prior to removal and storage. All samples were stored in sterile saline solution (Health 
Care Logistics, Circleville, Ohio) in 15-ml tubes, frozen immediately upon collection, 
and stored at -80°C for up to three years until use. Vaginal smears were also obtained for 
each subject at the time of clinical examination by rolling a swab across and along the 
length of the vaginal wall and then onto a glass slide, which was stored at -80°C until 
being Gram stained for independent evaluation by a second trained professional, also 
with >20 years experience, according to the Nugent criteria 56.   
 
3.3.3. Genomic DNA extraction 
Genomic DNA was isolated from 0.5 ml aliquots of each collected sample. To each 
aliquot, a solution of 125 µl of 0.5 M Na.EDTA (pH 8) containing 75 mg/ml of lysozyme 
was added and samples were lysed at 37°C for 30 min. To each sample, 70 µl of sodium-
dodecyl-sulfate was added and the protein content was degraded by incubation with 
proteinase K (0.05 mg/ml final concentration) at 55°C for 30 min. Further lysis was 
facilitated by three cycles of rapid freeze-thaw involving immersion in dry-ice/ethanol 
slurry until frozen followed by heating in a heatblock to 37°C. Protein was precipitated 
by the addition of 70 µl of 5 M NaCl and 30 min incubation on ice. Precipitated protein 
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was removed by centrifugation at 14,000 rpm for 20 min and residual organic matter was 
removed by phenol:chloroform washes followed by ethanol precipitation to remove 
residual salts.  
 
3.3.4. Pyrosequencing 
The V1-V3 region of the 16S ribosomal RNA gene of five samples was amplified from 
extracted DNA by polymerase chain reaction (25 cycles of 94°C (30 s), 48°C (30 s), 
72°C (2 min)) using primers 27f-YM (CGTATCGCCTCCCTCGCGCCATCAG-
AGAGTTTGATYMTGGCTCAG); and 534r 
(CTATGCGCCTTGCCAGCCCGCTCAG-[MID tag 1 – 50]-
ATTACCGCGGCTGCTGGCA). The primers were validated previously and shown to 
broadly encompass vaginal bacteria 108. Negative control PCRs were performed without 
1) template DNA and 2) without polymerase. No products were detected in any negative 
control. The amplicons were pyrosequenced on 454 FLX-Titanium Technology at the J. 
Craig Venter Institute (Rockville, MD). 
 
3.3.5. Illumina high-throughput sequencing 
The purified DNA samples collected by lavage were solubilized in EB (1 mM TrisHCl 
pH 8), amplified by multiple displacement amplification (MDA) using phi29 enzyme mix 
(GenomiPhi V2 DNA Amplification Kit; GE Healthcare), according to the 
manufacturer’s protocol. 10-50 ng of each sample was used as a template and reactions 
were carried out for 16 hours. 500 ng of amplified DNA was used for libraries 
construction with standard Illumina protocols with few modifications. DNA was sheared 
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using Covaris S2 or E210 system, followed by ligation of sequencing adaptors containing 
unique barcode sequences to allow pooling of all samples. Libraries were purified using 
Agencourt AMPure XP beads, and DNA concentration was measured using the Agilent 
High Sensitivity DNA Kit. Quality control steps were completed with qPCR using the 
KAPA Biosystems Library Quantification Kit. Pooled libraries were sequenced on one 
lane of HighSeq 2000 machine, paired-end 2x101bp.  
 
3.3.6. 16S rRNA sequencing data analysis and statistics 
The resulting sequences collected by swabs, scrapings, and lavage were combined by 
subject. The combined sequences were quality trimmed using the methods described in a 
previous study 109, with the minor modification of the use of an average quality score ≤ 
30 instead of 25. A total of 437,176 high quality sequence reads were generated from five 
samples, with an average sequence length 455 nt (Table 11). For taxonomic analysis, the 
resulting sequences were assigned to operational taxonomic units (OTUs) as previously 
described 1,109,110. Briefly, sequences were aligned against the Silva database and pre-
clustered using mothur 111. The remaining sequences were clustered at 97% sequence 
similarity using ModalClust, utilizing a complete linkage clustering method 
(https://bitbucket.org/msipos/modalclust). The representative sequence in each OTU was 
assigned to genera using RDP classifier v2.5 with a bootstrap cutoff of 80% 112. To 
calculate relative abundance of each genus in each sample, the number of sequences in 
each genus in the genus table was divided by the total number of sequences in each 
sample.  
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3.3.7. Metagenomic sequencing data analysis and statistics 
3.3.7.1 Reads trimming 
The qualities of the raw Illumina sequencing data were first assessed using FastQC 
v0.10.1 (http://www.bioinformatics.babraham.ac.uk/projects/fastqc/). The first few bases 
of each sequence, which showed a bias in the FastQC report, were trimmed using the 
FASTX toolkit 115. Leading and trailing low quality bases (Q score below 20) and 
sequences shorter than 50 nucleotides and with an average quality score < 20 were 
removed using trimmomatic v0.30 116. This quality filtering resulted in the quality values 
of all bases being higher than 28 in the FastQC report. To remove potential 
contamination with human DNA, the remaining reads were further mapped against 
human genome reference sequence (NCBI build 37 p13) with one mismatch permitted 
per read in Bowtie 2 117.   
 
3.3.7.2 Assembly #1 
To obtain a reliable assembly, the resulting clean reads were aligned against the HMP 
urogenital tract reference genomes downloaded on January 10, 2015 (Table 3). The read 
alignments with mapping qualities > 20 were considered to be true alignments. The reads 
whose breadth of coverage (defined as the percentage of bases covered in the entire 
reference genome) was more than 2% at least one in sample were further assembled to 
contigs using SOAPdenovo v2.04, with k-mer corresponding to the longest N50 contig 
length (Table 12) 118. The assembled contigs of each sample were aligned against HMP 
urogenital tract reference genomes using ABACAS with default parameters, except 80% 
minimum percent identity 119. The contigs that shared at least 80% identity with the HMP 
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urogenital tract reference genomes were called “assembly #1” and were combined with 
the following “assembly #2” and “assembly #3” for functional gene annotation.  
 
3.3.7.3 Assembly #2 and assembly #3 
The reads that were not used in “assembly #1” were assembled into contigs as previously 
described 103. Briefly, the paired-end reads were digital normalized to k-mer coverage 
(defined as the number of times a k-mer was found in a read) of 20 using normalize-by-
median.py in khmer v1.3. 120. Highly repetitive k-mers, which could belong to multiple 
species, were removed using filter-below-abund.py with C=100 in khmer v1.3. 120. The 
resulting paired-end reads were de novo assembled using Ray Meta at k=23 121. Scaffold 
coverage and length were calculated using Bowtie 2 117 and samtools v0.1.18 122. 
Tetranucleotide frequency, GC content, and conserved marker genes were identified as 
described 103. The binning of scaffolds into genomes was performed as described 103. 
Scaffolds whose sequencing depths were bigger than 20X in any two subjects and which 
were classified by essential single copy gene were chosen (Table 13). The unassembled 
reads associated with these scaffolds were extracted and reassembled using SOAPdenovo 
v2.04 at k=23, thus, resulting new assembly 118. The new assemblies were called 
“assembly #2”. The unassembled reads that were not used in “assembly #1” or “assembly 
#2” were de novo assembled using Ray Meta at k=23 121.   This assembly was called 
“assembly #3”.  “Assembly #2” and “assembly #3” were combined with “assembly #1” 
for the taxonomic and functional annotation of genes.  
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3.3.7.4 Functional annotation of genes 
Assemblies 1, 2, and 3 were combined for each sample for functional annotation of 
genes. A total of 35 Mbp of contigs (>= 300 bp) were generated in the combined contigs 
from five samples with a longest contig length of 255 Kbp (Table 14). Microbial genes 
were also searched for in all contig sequences longer than 300 bp using the Prokaryotic 
Dynamic Programming Genefinding Algorithm (Prodigal) 123. The predicted genes of all 
samples were combined to create a gene set. To build a non-redundant gene set, genes 
with 95% sequence identity and aligned length covered over 90% of the sequence were 
clustered together using cd-hit v4.6.1 124. To create a gene abundance matrix in which 
both pairs that mapped to the same gene would only be counted once, clean short reads in 
each sample were mapped back to the non-redundant gene set using bwa v0.7.5a 125 and 
samtools v0.1.18 122. Non-redundant genes were queried using DIAMOND 105 (default 
parameters except E=1e-5) against the KEGG database (v56) 106. Only the best hits with 
at least 80% identity over 100 bp-aligned lengths were selected. 
 
3.3.8. Network analysis 
Vaginal discharge is the only BV symptom that was commonly found in all symptomatic 
BV patients. Yeoman et al. 1 found 33 metabolites correlated with vaginal discharge 
(Table 15). To explore the correlation among bacterial genus, KEGG orthologous groups, 
and the above 33 metabolites, Spearman's rank correlation coefficients and false 
discovery rate (FDR)-adjusted p-values associated with these correlation coefficients 
were generated using the "corr.test()" function in R. FDR-adjusted p-values < 0.05 were 
considered significant unless specifically stated. Significant correlations among bacterial 
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genus, KEGG orthologous groups, and discharge-associated metabolites were 
transformed into a visible interaction network in Cytoscape 130.   
 
3.4 Results 
3.4.1 Association between metabolites and KEGG orthologous groups abundance 
Since vaginal discharge is the only common BV symptom found in symptomatic BV 
patients in our study, we only studied metabolites correlated with vaginal discharge. 
Thirty-three metabolites were filtered from Yeoman et al. 1 (Table 15). To determine 
whether we can find functional genes associated with vaginal discharge-associated 
metabolites, Spearman's rank correlation coefficients were used to investigate 
associations between all KEGG orthologous groups and these metabolites. Thirty-one 
and thirty-four KEGG orthologous groups were significantly positively and negatively 
linked to discharge-associated metabolites, respectively (Figure 7 and Table 16). 2-
Methyl-2-hydroxybutanoic acid that was the only metabolite revealed by Yeoman et al. 1 
was positively correlated with discharge. In our study, we detected that ‘malate 
dehydrogenase’ (K00024), ‘5-amino-6-(5-phosphoribosylamino) uracil reductase’ 
(K11752), and ‘undecaprenyl-diphosphatase’ (K06153) were positively linked to this 
metabolite (Figure 8 and Table 16; r=1, p=0). Yeoman et al. 1 revealed that 2-Ethyl-4-
methyl-1,3-Dioxolane, which was reported to exhibit pleasant odor 131, was negatively 
associated with discharge. In our study, three KEGG orthologous groups were positively 
linked to this metabolite (Figure 8 and Table 16; r=1, p=0). Three KEGG orthologous 
groups were positively linked to lactic acid (Figure 8 and Table 16; r=1, p=0) which was 
negatively associated with discharge in Yeoman et al. 1.   
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3.4.2 Association between metabolites and bacterial genera abundance 
To determine whether we can find bacteria associated with vaginal discharge-associated 
metabolites, Spearman's rank correlation coefficients were used to investigate 
associations between all bacterial genera and discharge-associated metabolites. Fourteen 
and two bacterial genera were significantly positively and negatively linked to discharge-
associated metabolites, respectively (Figure 7 and Table 16). Yeoman et al. 1 revealed 
that Mobiluncus was positively correlated with 2-Methyl-2-hydroxybutanoic acid. 
However, we did not find the correlation between Mobiluncus and 2-Methyl-2-
hydroxybutanoic acid in our study. Instead, ten bacterial genera were positively 
associated with 2-Methyl-2-hydroxybutanoic acid in our study (Figure 9 and Table 16; 
r=1, p=0).  
 
3.4.3 Association between KEGG orthologous groups and bacterial genera 
abundance 
To better understand how vaginal bacteria generate discharge-associated metabolites, 
Spearman's rank correlation coefficients were used to investigate associations between 
previously found KEGG orthologous groups and bacterial genera. Twelve bacterial 
genera were significantly positively linked to eleven KEGG orthologous groups (Figure 7 
and Table 16; r=1, p=0). Among these twelve bacterial genera and eleven KEGG 
orthologous groups, ten bacterial genera were positively associated with the metabolites 
‘malate dehydrogenase’ (K00024), ‘5-amino-6-(5-phosphoribosylamino) uracil 
reductase’ (K11752), and ‘undecaprenyl-diphosphatase’ (K06153) (Figure 10 and Table 
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16; r=1, p=0). These three KEGG orthologous groups and ten bacterial genera were 
directly and positively linked to 2-Methyl-2-hydroxybutanoic acid, which was the only 
metabolite revealed by Yeoman et al. 1 that positively correlated with discharge (Figure 
8-9 and Table 16; r=1, p=0). These suggest that these ten bacterial genera can serve as 
potential biomarkers to improve the development of therapeutic targets. 
 
3.4.4 Annotation of functional genes involved in the generation of discharge- 
associated metabolites 
To identify the most likely bacterial species that possess the functional genes involved in 
the generation of discharge-associated metabolites, these gene sequences were queried 
using BLASTN 98 with E=1e-5 against nucleotide collection reference database on July 
10, 2015. Only the best hits with 100% query coverage and at least 80% identity were 
regarded as reliable hits. Under the criteria, 56 out of 408 genes were assigned to specific 
bacterial strains (Table 17). None of them belongs to genus Aquabacterium, 
Chryseobacterium, Elizabethkingia, Finegoldia, Morganella, Negativicoccus, 
Phenylobacterium, Propionibacterium, Serratia, and Siphonobacter that are potential 
therapeutic targets. This finding may result from the fact that most genomes of bacterial 
strains are not sequenced and therefore were not present in the reference sequence 
database.   
 
3.5 Discussion 
Studying the connection among bacteria, functional genes, and metabolites can lead to a 
better understanding of how pathogens initiate BV. Yeoman et al. 1 and Srinivasan et al. 
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53 connected vaginal bacteria with BV symptom-associated metabolites and found vaginal 
bacteria that may be responsible for BV symptoms. Our study further investigated how 
vaginal bacteria produced BV symptom-associated metabolites by integrating the 
analysis of predicted gene functions. Our study found that the bacteria Aquabacterium, 
Chryseobacterium, Elizabethkingia, Finegoldia, Morganella, Negativicoccus, 
Phenylobacterium, Propionibacterium, Serratia, and Siphonobacter were directly or 
indirectly correlated with the metabolite ‘2-Methyl-2-hydroxybutanoic acid’ via the 
enzymes ‘malate dehydrogenase’ (K00024), ‘5-amino-6-(5-phosphoribosylamino) uracil 
reductase’ (K11752), and ‘undecaprenyl-diphosphatase’ (K06153).  This suggests that 
these ten bacteria may produce the metabolite ‘2-Methyl-2-hydroxybutanoic acid’ 
through these three functional genes. Future studies to determine whether or how these 
ten bacteria produce the metabolite ‘2-Methyl-2-hydroxybutanoic acid’ through these 
three functional genes are needed.   
 
We used the subset of study population in Yeoman et al. 1 to study the correlation 
between vaginal bacteria and vaginal discharge-associated metabolites like Yeoman and 
his colleagues did in their study. We did not find the same vaginal bacterium that was 
correlated with 2-Methyl-2-hydroxybutanoic acid, the only metabolite positively 
correlated with vaginal discharge. However, we found that Aquabacterium, 
Chryseobacterium, Elizabethkingia, Finegoldia, Morganella, Negativicoccus, 
Phenylobacterium, Propionibacterium, Serratia, and Siphonobacter were positively 
associated with 2-Methyl-2-hydroxybutanoic acid.  The differences observed between 
these two studies could be due to two factors: (1) Due to small sample size (n=5), the 
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Spearman's rank correlation coefficient was used to investigate the correlations between 
bacterial genera and metabolites in this study. However, Pearson's correlation coefficient 
was used in Yeoman et al. 1; (2) in this study, sequences collected from cervix, fornix, 
and vaginal canal by swabs, scrapings, and lavage were combined to be assigned to 
bacterial genera. However, Yeoman et al. 1 only used sequences collected from the 
vaginal canal by lavage. Sampling position and method may greatly affect analysis 
results: Kim et al. 129 showed that the vaginal microbiome was heterogeneous and three 
different sampling methods (swabbing, scraping, lavaging) characterized three 
considerably different vaginal microbiome profiles.  
 
One of the limitations of this study is the small sample size. The limitation prevents us 
from finding more functional genes that are significantly correlated with vaginal bacteria 
and vaginal discharge-associated metabolites. The limitation also prevents us from 
finding the correlation among bacteria, functional genes, and other BV symptom-
associated metabolites. The second limitation of this study is that samples collected by 
swabs, scrapings, and lavage were used for annotation of bacterial genera. However, only 
lavage samples were used for annotation of functional genes and measurement of 
metabolites.  
 
3.6 Conclusions 
Studying the correlation among vaginal bacteria, functional genes, and BV symptom-
associated metabolites has allowed us to better understand how pathogens initiate BV. 
The bacteria Aquabacterium, Chryseobacterium, Elizabethkingia, Finegoldia, 
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Morganella, Negativicoccus, Phenylobacterium, Propionibacterium, Serratia, and 
Siphonobacter may be involved in the generation of vaginal discharge by producing the 
metabolite 2-Methyl-2-hydroxybutanoic acid via the functional genes ‘malate 
dehydrogenase’ (K00024), ‘5-amino-6-(5-phosphoribosylamino) uracil reductase’ 
(K11752), ‘undecaprenyl-diphosphatase’ (K06153). This suggests that these ten bacteria 
are potential therapeutic targets. 
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CHAPTER 4. A METAGENOMIC METHOD TO CHARACTERIZE THE 
VAGINAL MICROBIOME THROUGHOUT PREGNANCY AND IN THE 
POSTPARTUM PERIOD 
 
4.1 Abstract 
Healthy women’s vaginas are mainly dominated by Lactobacilli at reproductive age. The 
predominance of Lactobacilli is coincident with the rise in estrogen levels and glycogen 
content in the vaginal epithelium. Estrogen levels increase gradually during pregnancy, 
reaching a maximum near term, and drop down quickly during labor. Glycogen is 
converted to lactic acid mainly by Lactobacilli. Therefore, we hypothesized that the 
abundance of Lactobacilli and functional genes for metabolic activity in Lactobacilli 
would increase as pregnancy progresses and decrease following parturition. Vaginal 
samples were collected from 5 Caucasian women with and without a history of preterm 
birth at 8–12, 17–21, 26–30, and 35–38 weeks of gestation, during labor, and at 6 weeks 
post-partum. All women lived in Rochester, MN, USA from 23 to 43 years. The samples 
were collected by swabs from the posterior fornix and cervix. We used a metagenomic 
approach to classify sequences to bacterial species, GroopM 102 and CheckM 104 to 
recover the Lactobacillus population genomes, and DIAMOND 105 to blast the predicted 
genes in the Lactobacillus population genomes against the KEGG database (v56) to 
classify sequences to metabolic pathways. The majority of vaginal bacteria (defined as 
more than half of the vaginal bacteria) were Lactobacillus species in 17 out of 20 samples 
collected during pregnancy from women who delivered at term and who did not have a 
previous preterm birth history. On the other hand, for women who had a previous preterm 
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birth history but still delivered at term, the majority of vaginal bacteria were not 
Lactobacillus species in 10 out of 12 samples collected during pregnancy. Among these 
ten samples, the majority of vaginal bacteria in seven samples were Gardnerella 
vaginalis. Seven out of nine vaginal microbiomes collected from women with and 
without a previous preterm birth history were not dominated by any Lactobacillus species 
at 6 weeks post-partum. The relative abundance of Lactobacilli, the number of short 
reads participating in the recovery of the Lactobacillus population genomes, and the 
number of short reads predicted to participate in the metabolic activity in the 
Lactobacillus population genomes were higher in the samples collected at 35–38 weeks 
of gestation than in the samples collected at post-partum in all women with term birth. 
The relative abundance of Lactobacilli, the number of short reads participating in the 
recovery of the Lactobacillus population genomes, and the number of short reads 
predicted to participate in the metabolic activity in the Lactobacillus population genomes 
did not increase for any woman as pregnancy progressed from 8 weeks of gestational age 
to 30 weeks of gestational age. We conclude that the vaginal microbiomes of women who 
delivered at term and who did not have a previous preterm birth history were generally 
dominated by Lactobacillus species during pregnancy. The vaginal microbiomes of 
women who delivered at term but had a previous preterm birth history were more diverse 
than those of women who delivered at term and who did not have a previous preterm 
birth history.  
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4.2 Introduction 
During the course of long-term evolutionary history, vaginal microorganisms have 
formed a mutualism relationship with humans. In this relationship, the host provides 
nutrients, like glycogen, to vaginal microorganisms to support their growth. In turn, 
vaginal microorganisms inhibit the colonization of pathogens. Perturbations in the 
vaginal microbiome have been associated with serious sequelae, such as bacterial 
vaginosis (BV), aerobic vaginitis, preterm birth, and miscarriage 3,7,38,51,132,133.  BV is one 
of the most common, major problems impacting women’s reproductive health worldwide 
22. The prevalence of BV in the United States is about 29.2% or approximately 21.2 
million women of reproductive age 23 and is associated with serious sequelae, such as 
pregnancy complications 3,27,37,38. The United States annually spends nearly $1 billion on 
treating BV-related pregnancy complications 39. Preterm birth is another major problems 
impacting women’s reproductive health worldwide 73. Every year, about 15 million 
babies are born preterm in the world 74. The societal cost for preterm birth in the United 
States of America alone is more than $26.2 billion in 2005 38.  
 
Healthy women’s vaginas are mainly dominated by Lactobacilli at reproductive age 134. 
For example, Ravel et al. 9 used 16S-rRNA based approaches to study the vaginal 
microbiomes of 396 non-pregnant healthy American women representing four ethnic 
groups (white, black, Hispanic, and Asian). They showed that 73% of the non-pregnant 
healthy women’s vaginal microbiomes were dominated by one species of Lactobacillus 9. 
The same research group found that 94% of the healthy pregnant women’s vaginal 
microbiomes are also dominated by one species of Lactobacillus 10. The potential 
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mechanisms  supporting  the domination of Lactobacilli in vagina are: (1) they can 
generate lactic acid to maintain vagina acidity and inhibit the growth of pathogens 
6,7,134,135; (2) they can produce hydrogen peroxide and bacteriocins to kill pathogens in the 
vagina 6,7,134,135; (3) they can competitively adhere to the vaginal epithelial cell receptors 
and form barrier to inhibit the adherence of pathogens 134,135; and (4) they can stimulate 
host defense mechanisms to protect the host from the colonization of pathogens 134,135.   
 
Researchers found that the predominance of Lactobacilli in the vaginal microbiomes of 
women of reproductive age is related to higher level of estrogen during reproductive 
years compared with other times in a woman’s life 6,11. Hickey et al. 6 and Farage et al. 11 
showed that during puberty and reproductive years, estrogen production rises, resulting in 
an increase in the thickness of the vaginal epithelium, an increase of glycogen content in 
the vaginal epithelium, an acidic vaginal pH value, and the predominance of Lactobacilli 
in the vagina. In early childhood, the estrogen levels are low 6,11. Low estrogen levels 
lead to the thinning of the vaginal epithelium, a decrease of glycogen content in the 
vaginal epithelium, a nearly neutral vaginal pH value, and the predominance of other 
various anaerobic bacteria in the vagina 6,11. At postmenopause, estrogen levels decrease, 
causing a decrease of glycogen content in the vaginal epithelium and a nearly neutral 
vaginal pH value 6,11. The vaginal microbiome shifts from a Lactobacilli dominated niche 
to poly-microbial communities during this time 6,11.  
 
Estrogen levels are also reported to change the vaginal microbiome composition 
throughout the menstrual cycle and during pregnancy 3,12. At menses, estrogen levels are 
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at their lowest in the menstrual cycle and non-Lactobacillus species increase compared 
with other times in the menstrual cycle 12. The vaginal microbiomes of pregnant women 
were reported to be significantly different from those of non-pregnant women 10. The 
vaginal microbiomes during pregnancy were also reported to significantly differ from 
those at 6 weeks post-partum 13. Vaginal microbiomes during pregnancy have more 
Lactobacillus species compared with when not pregnant 10,13-15. Estrogen level increases 
gradually during pregnancy, reaching a maximum near term, and drop down quickly 
during labor 107. For example, the estrogen levels during pregnancy are 100-1000 fold 
higher than those at 1-week postpartum 13,16,17. High estrogen levels increase glycogen 
content in the vaginal epithelium and promote the growth of Lactobacillus species 11,18.  
 
The connection between the vaginal glycogen content, the colonization of Lactobacillus 
in vagina, and the vaginal pH value has also been reported by Mirmonsef et al. 136. 
Mirmonsef et al. 136 revealed that the vaginal pH value is lower and the Lactobacillus 
colonization is higher in vaginal samples with high vaginal glycogen levels than vaginal 
samples with low vaginal glycogen levels. The potential mechanisms supporting the 
coincidence among the glycogen content, Lactobacillus colonization, and vaginal pH 
value are (1) glycogen is anaerobically converted to lactic acid; (2) Lactobacilli are the 
main component of lactic acid bacteria group; and (3) the function of lactic acid is to 
lower pH.  
 
Therefore, we hypothesized that the abundance of Lactobacilli and functional genes for 
metabolic activity in Lactobacilli would increase as pregnancy progresses and decrease 
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following parturition. The objectives of this study are to determine whether the 
abundance of Lactobacilli and functional genes for metabolic activity in Lactobacilli 
increase as pregnancy progresses and decrease following parturition. We followed a 
metagenomic approach using vaginal samples from women with and without a history of 
preterm birth at 8–12, 17–21, 26–30, and 35–38 weeks of gestation, during labor, and at 6 
weeks post-partum to determine the taxonomic and functional composition of the vaginal 
microbiome collected at different time points. 
 
4.3 Methods 
4.3.1. Ethics statement 
This study was approved and reviewed by the Mayo Clinic Institutional Review Board, 
USA (IRB #10-006257). Informed written consent was obtained from all study 
participants prior to sample collection. 
 
4.3.2. Sample collection 
Vaginal samples were collected from women with (IDs: 110, 117, 119, 120, 125) and 
without (IDs: 201, 202, 203, 205, 206) a history of preterm birth at 8–12, 17–21, 26–30, 
and 35–38 weeks of gestation, during labor, and at 6 weeks post-partum. The inclusion 
and exclusion criteria for participation in the study were the same as described in a 
previous study 14. The sample descriptions are given in Table 18. Subjects 201 and 205 
gave birth at 34 4/7 and 36 5/7 weeks of gestation, respectively. The remaining eight 
subjects gave birth after 37 weeks of gestation. The samples were collected by swabs that 
were collected by the obstetrician or certified nurse midwife from the posterior fornix and 
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cervix and placed in a NAT (Nucleic Acid Transport, CentraCare Laboratory Services, 
St. Cloud, MN) collection tube. After collection, the samples were stored at -80°C until 
use.  
 
4.3.3. Sample processing 
The vaginal swabs were vigorously agitated to dislodge the bacterial cells. The cells were 
pelleted by centrifugation at 10,000 g for 10 min. Bacterial genomic DNA was extracted 
using a MoBio PowerSoil DNA Isolation Kit (MoBio Laboratories Inc., Carlsbad, CA, 
USA) following the manufacturer’s instructions. Concentration of DNA was determined 
using High Sensitivity Qubit (Life Technologies Corporation, Carlsbad, CA, USA). The 
integrity and fragment size of the extracted DNA were determined by 1% agarose gel 
electrophoresis. All DNA samples were sequenced on Illumina HiSeq 2000 at the W. M. 
Keck Center for Biotechnology at the University of Illinois at Urbana-Champaign. 
 
4.3.4. Metagenomic sequencing data analysis and statistics 
4.3.4.1 Reads trimming 
The qualities of the raw Illumina sequencing data were first assessed using FastQC 
v0.10.1 (http://www.bioinformatics.babraham.ac.uk/projects/fastqc/). The first few bases 
of each sequence, which showed a bias in the FastQC report, were trimmed using the 
FASTX toolkit 115. Leading and trailing low quality bases (Q score below 20) and 
sequences shorter than 50 nucleotides and with an average quality score < 20 were 
removed using trimmomatic v0.30 116. This quality filtering resulted in the quality values 
of all bases being higher than 28 in the FastQC report. To remove potential 
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contamination with human DNA, the remaining reads were further mapped against 
human genome reference sequence (NCBI build 37 p13) with one mismatch permitted 
per read in Bowtie 2 117. A total of 3,406,720,858 raw short reads from fifty-three 
samples were generated with an average number of reads of 64,277,752 per sample 
(Table 19). After quality filtering and human DNA contamination removing, a total of 
469,315,112 short reads remained with an average number of reads of 8,855,002 per 
sample (Table 19). 
 
4.3.4.2 Taxonomic analyses 
We used two different approaches to assign the resulting clean reads to bacteria: (1) 
direct assignment of unassembled reads and (2) indirect assignment of unassembled reads 
through contigs. For direct assignment, bacterial species were identified using Taxonomic 
identification and phylogenetic profiling (TIPP) 100. TIPP uses 40 phylogenetic marker 
genes that are single copy and universally present in all bacteria to identify bacterial 
species and determine their abundance from metagenomic shotgun sequencing data 100. 
For indirect assignment, metagenomic short reads were first assembled into contigs. 
Bacterial species were then identified from contigs.  
 
4.3.4.2.1 Assembly #1 
To obtain a reliable assembly, the resulting clean reads from samples collected at 
different time point were combined by subject. The combined metagenomic data were 
aligned against the HMP urogenital tract reference genomes downloaded on January 10, 
2015 (Table 3). The read alignments with mapping qualities > 20 were considered to be 
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true alignments. The reads whose breadth of coverage (defined as the percentage of bases 
covered in the entire reference genome) was more than 2% at least one in sample were 
further assembled to contigs using SOAPdenovo v2.04 with k-mer 31 (Table 20) 118. The 
assembled contig for each bacterium were combined by subject. The combined assembly 
were called “assembly #1” and were combined with the following “assembly #2” for the 
further analyses.  
 
4.3.4.2.2 Assembly #2 
The reads that were not used in “assembly #1” were de novo assembled using Ray Meta 
at k=23 121. This assembly was called “assembly #2”.  “Assembly #2” was combined 
with “assembly #1” for the further analyses 
 
4.3.4.2.3 Taxonomic classification of contigs 
A total of 76 Mbp of contigs (>= 500 bp) were generated in the combined contigs from 
fifty-three samples with longest contig length of 536 Kbp (Table 21). Microbial genes 
were also searched for in all contig sequences longer than 500 bp using the Prokaryotic 
Dynamic Programming Genefinding Algorithm (Prodigal) 123. The predicted genes of all 
subjects were combined to create a gene set. To build a non-redundant gene set, genes 
with 95% sequence identity and aligned length covered over 90% of the sequence were 
clustered together using cd-hit v4.6.1 124. To create a gene abundance matrix in which 
both pairs that mapped to the same gene would only be counted once, clean short reads in 
each sample were mapped back to the non-redundant gene set using bwa v0.7.5a 125 and 
samtools v0.1.18 122. The non-redundant genes were queried using BLASTN 98 (default 
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parameters except E=1e-5) against the HMP urogenital tract reference database 
downloaded on January 10, 2015 (Table 3) and the NCBI complete bacteria genome, 
downloaded on September 6, 2014. Only the best hits with at least 80% identity over 100 
bp-aligned lengths were selected to build the species abundance matrix.  
 
4.3.4.3 Population genomes analyses 
To obtain coverage profiles, the clean short reads from each sample were separately 
mapped to the corresponding “assembly #1 and 2” using Bowtie 2 117. The resulting SAM 
files were converted to sorted-indexed BAM files using samtools v0.1.18 122. The 
coverage profiles (sorted-indexed BAM files) and combined contigs (>= 500 bp) were 
parsed into GroopM v0.3.4 102 to bin contigs, resulting in the generation of a total of 111 
population genomes bins across ten subjects (Table 21). After estimating the 
completeness and contamination of each population genomes bin using CheckM 104, 
twelve high-quality population genomes were recovered with at least >88% completeness 
and <9% contamination (Table 22 and Figure 11). Interestingly, all of the twelve high-
quality population genomes were classified as Lactobacillus using CheckM 104 (Table 
22). Moreover, at least one high-quality Lactobacillus population genomes was recovered 
from each person (Table 22). To determine whether the high-quality Lactobacillus 
population genomes was mainly contributed by the samples collected during pregnancy, 
the clean short reads in each sample were mapped against the corresponding 
Lactobacillus population genomes in Bowtie 2 117. The absolute number of short reads in 
each sample mapped against the Lactobacillus population genomes was then divided by 
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the total number of clean reads and multiplied by 1,000,000 for the purposes of 
normalization. 
 
To determine whether the functional genes for metabolic activity in Lactobacilli 
increases as pregnancy progresses and decrease following parturition, contigs participated 
in the Lactobacillus population genomes in each sample were predicted to microbial 
genes using Prokaryotic Dynamic Programming Genefinding Algorithm (Prodigal) 123. 
The predicted genes were queried using DIAMOND 105 (default parameters except E=1e-
5) against the KEGG database (v56) 106. Only the best hits with at least 80% identity over 
100 bp-aligned lengths were selected. The clean short reads in each sample were mapped 
against the predicted metabolic genes in Bowtie 2 117. The absolute number of short reads 
in each sample mapped against the predicted metabolic genes was then divided by the 
total number of clean reads and multiplied by 100,000,000 for the purposes of 
normalization. 
 
4.4 Results 
4.4.1 Taxonomic analysis 
To determine whether Lactobacillus species are the majority vaginal bacteria during 
pregnancy but not at post-partum, unassembled reads were directly assigned to bacteria 
using TIPP 100 or indirectly assigned to bacteria via contigs. The two different methods 
generated similar results (Figure 12 and 13, Table 23 and 24). The majority of vaginal 
bacteria are defined as more than half of the bacteria in vagina. The majority of vaginal 
bacteria were Lactobacillus species in 17 out of 20 samples collected during pregnancy 
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from women who delivered at term and who did not have a previous preterm birth history 
(Figure 12 and 13, Table 23 and 24). Four out of five vaginal microbiomes collected from 
women who delivered at term and who did not have a previous preterm birth history were 
not dominated by any Lactobacillus species at 6 weeks post-partum (Figure 12 and 13, 
Table 23 and 24). Although the majority vaginal bacteria in subject 120 (without a 
previous preterm birth history) at the early state of pregnancy (8–12, 17–21, and 26–30 
weeks of gestation for directly assignment method; 8–12 and 26–30 weeks of gestation 
for indirectly assignment method) were Gardnerella vaginalis, Lactobacillus crispatus 
became the majority vaginal bacterium at 35–38 weeks of gestation (Figure 12 and 13, 
Table 23 and 24). Therefore, the majority of vaginal bacteria in women who delivered at 
term and who did not have a previous preterm birth history were Lactobacillus species at 
35–38 weeks of gestation (Figure 12 and 13, Table 23 and 24).  
 
The above trends were not seen in the women with a previous preterm birth history 
(Figure 12 and 13, Table 23 and 24). The vaginal microbiomes of women with a previous 
preterm birth history were more diverse than those of women without a previous preterm 
birth history (Figure 12 and 13, Table 23 and 24). For women who had preterm delivery 
and a previous preterm birth history, the majority vaginal bacterium during pregnancy 
was Lactobacillus iners and crispatus, respectively (Figure 12 and 13, Table 23 and 24). 
However, for women who had a previous preterm birth history but still delivered at term, 
the majority of vaginal bacteria were not Lactobacillus species in 10 out of 12 samples 
collected during pregnancy (Figure 12 and 13, Table 23 and 24). Among these ten 
samples, the majority of vaginal bacteria in seven samples were Gardnerella vaginalis 
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(Figure 12, Table 23 and 24). The vaginal bacteria in women who had a previous preterm 
birth history but still delivered at term at 6 weeks post-partum were evenly distributed -- 
that is to say, the relative abundance of all vaginal bacteria was below 50% (Figure 12 
and 13, Table 23 and 24). The vaginal microbiome of subject 205, who had preterm 
delivery and a previous preterm birth history, was dominated by Lactobacillus crispatus 
at 6 weeks post-partum (Figure 12 and 13, Table 23 and 24). Interestingly, the relative 
abundance of Lactobacilli at 35–38 weeks of gestation in women who had a previous 
preterm birth history but still delivered at term was below 50% (Figure 12 and 13, Table 
23 and 24). 
 
The vaginal microbiomes of five out of ten women persisted to be dominated by one 
species of Lactobacillus throughout pregnancy The remaining five women showed a 
transition from one majority vaginal bacterium to another majority vaginal bacterium 
throughout pregnancy (Figure 12 and 13, Table 23 and 24). The vaginal microbiomes of 
any women who had a previous preterm birth history but still delivered at term did not 
persist in any one bacterial species throughout pregnancy (Figure 12 and 13, Table 23 
and 24). 
 
To determine whether the relative abundance of Lactobacilli increases as pregnancy 
progresses and decrease following parturition, the relative abundances of all 
Lactobacillus species at 8–12, 17–21, 26–30, and 35–38 weeks of gestation and 6 weeks 
post-partum were added up. The relative abundances of Lactobacilli at 8–12, 17–21, 26–
30, and 35–38 weeks of gestation were compared with those at 6 weeks post-partum.  For 
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women without a history of preterm birth, the relative abundances of Lactobacilli were 
higher in the samples collected during pregnancy than in the samples collected at 6 weeks 
post-partum (Figure 14A and B, Table 23 and 24). However, for women with a history of 
preterm birth, this trend was only seen in subject 202 (Figure 14C and D, Table 23 and 
24). The relative abundances of Lactobacilli were lower in the samples collected at 6 
weeks post-partum than in the samples collected at 8–12 and 17–21 weeks of gestation in 
subjects 203 and 206 (Figure 14C and D, Table 23 and 24).  The relative abundance of 
Lactobacilli in subject 205 did not have significantly change throughout pregnancy and 
post-partum (Figure 14C and D, Table 23 and 24). However, the relative abundance of 
Lactobacilli was higher in the samples collected at 26–30 and 35–38 weeks of gestation 
than in the samples collected at post-partum in all women who delivered at term (Figure 
14, Table 23 and 24). Moreover, the relative abundance of Lactobacilli did not 
significantly increase in any of the ten women as pregnancy progressed from 8 weeks of 
gestational age to 30 weeks of gestational age (Figure 14, Table 23 and 24). These 
observations held true whether the relative abundances of Lactobacilli were determined 
from the metagenomic short reads or from the assembly. 
 
4.4.2 Population genomes analysis 
The above focuses on the genes of Lactobacilli. What happened to the Lactobacillus 
population genomes as a whole? To recover population genomes from metagenomes, we 
used GroopM to bin contigs into bins, where each contig belonged to a single genome or 
some closely related genomes 102. Binning was performed based on the co-assembly of all 
samples in each subject. After estimating the completeness and contamination of each bin 
  
69 
 
using CheckM 104, the high-quality population genomes were members of the genus 
Lactobacillus (Table 22). To determine whether the high-quality Lactobacillus 
population genomes were mainly contributed by the samples collected during pregnancy, 
we counted and normalized the number of clean short reads in each sample that were 
used to assemble corresponding Lactobacillus population genomes. For women who 
delivered at term and who did not have a previous preterm birth history, the number of 
short reads participating in the recovery of the Lactobacillus population genomes was 
higher in the samples collected during pregnancy than in the samples collected at 6 weeks 
post-partum except subject 120 (Figure 15A and Table 19). However, for women with a 
history of preterm birth, this trend was only seen in subject 202 (Figure 15B and Table 
19). The number of short reads participating in the recovery of the Lactobacillus 
population genomes from subjects 203 and 206 at 6 weeks post-partum were similar to 
those at 8–12 and 17–21 weeks of gestation (Figure 15B and Table 19). The number of 
short reads participating in the recovery of the Lactobacillus population genomes was 
higher in the samples collected at 6 weeks post-partum than in the samples collected 
during pregnancy in subject 205  (Figure 15B and Table 19). However, the number of 
short reads participating in the recovery of the Lactobacillus population genomes was 
higher in the samples collected at 35–38 weeks of gestation than in the samples collected 
at post-partum in all women who delivered at term (Figure 15 and Table 19). It did not 
increase in any of the ten women as pregnancy progressed from 8 weeks of gestational 
age to 30 weeks of gestational age (Figure 15 and Table 19). 
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To determine whether the number of short reads predicted to participate in the metabolic 
activity in the Lactobacillus population genomes increase as pregnancy progresses and 
decrease following parturition, open reading frames (ORFs) were predicted in contigs 
participating in the Lactobacillus population genomes in each sample, and then aligned to 
the genes in the KEGG pathways 106. The number of short reads predicted to participate 
in the metabolic activity in the Lactobacillus population genomes were counted and 
normalized in each sample. The number of short reads predicted to participate in the 
metabolic activity in the Lactobacillus population genomes had the same pattern as the 
number of short reads participating in the recovery of the Lactobacillus population 
genomes (Figure 16 and Table 19). The number of short reads predicted to participate in 
the metabolic activity in the Lactobacillus population genomes was higher in the samples 
collected at 35–38 weeks of gestation than in the samples collected at post-partum in all 
women who delivered at term (Figure 16 and Table 19). It did not significantly increase 
in any of the ten women as pregnancy progressed from 8 weeks of gestational age to 30 
weeks of gestational age (Figure 16 and Table 19). 
 
4.5 Discussion 
Our longitudinal study revealed that Lactobacillus iners or crispatus were enriched in the 
vaginal microbiomes collected during pregnancy from women who delivered at term and 
who did not have a previous preterm birth history. This is consistent with the results from 
a previous study from twelve women with a healthy pregnancy progression and outcome, 
which revealed that Lactobacillus iners or crispatus dominated in the vaginal 
microbiomes of these women 14. In our study, whole genome shotgun sequencing was 
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used to characterize the vaginal microbiome profile in Caucasian women. In Walther-
Antonio et al. 14, they used 16S rRNA gene sequencing to characterize the vaginal 
microbiome profile in Caucasian women. There was only an overlap of one subject 
between the two studies 14.  The results of both studies suggest that the vaginal 
microbiomes of Caucasian women who delivered at term and who did not have a 
previous preterm birth history are characterized by the enrichment of Lactobacillus iners 
or crispatus during pregnancy. The predominance of Lactobacillus spp. in the vaginal 
microbiomes of pregnant women is also observed in another two longitudinal studies 10,13 
and one cross–sectional study 15.  
 
Our longitudinal study revealed that the vaginal microbiomes of women who delivered at 
term and who did not have a previous preterm birth history became less Lactobacillus 
spp. enriched at post-partum compared with pregnancy. The finding agrees with a 
previous study revealing that vaginal microbiomes shift from more Lactobacillus species 
during pregnancy to less Lactobacillus species when not pregnant 13. The shift is 
coincident with the rise in estrogen levels and glycogen content in the vaginal epithelium 
during pregnancy 11,13,16,17,107. Glycogen in the vaginal epithelium provides a carbon 
source to support the growth of Lactobacillus spp. and keeps the vagina acidic to inhibit 
the colonization of other various bacteria through the generation of lactic acid 17.  
 
The non-Lactobacillus dominated vaginal community has long been regarded as an 
unhealthy vaginal community that increases the risk of preterm birth. However, in our 
study, three out of ten women whose vaginal microbiomes collected during pregnancy 
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were not dominated by Lactobacillus delivered mature babies. These results suggest that 
the loss of Lactobacillus is not a reliable sign of preterm birth. In accordance with our 
finding, Hyman et al. 137 concluded that the relative absence of Lactobacillus and the 
presence of other various bacteria are not related to preterm birth 137. Similar finding was 
also found by Romero et al. 138. They showed that 27 out of 72 women who delivered at 
term had at least one vaginal microbiome collected during pregnancy that was not 
dominated by Lactobacillus. In our study, when compared with women who delivered at 
term and who did not have a previous preterm birth history, women who delivered at 
term but had a previous preterm birth history were more likely to have vaginal 
microbiomes not dominated by Lactobacillus throughout pregnancy. This implies that a 
previous history of preterm birth affects the distribution of vaginal bacteria.  
 
Our study observed that vaginal microbiomes collected during pregnancy from women 
who had preterm delivery were dominated by one species of Lactobacillus. Similar 
finding was found by Hyman et al. 137. They observed that vaginal microbiomes collected 
during pregnancy from two Caucasian women who delivered preterm were dominated by 
Lactobacillus crispatus. This suggests that the predominance of Lactobacillus does not 
guarantee term birth. However, previous studies demonstrated that the predominance of 
Lactobacilli in vagina is the signature of term pregnancy 14,15. Therefore, it is possible 
that vaginal microbiome composition does not make a difference for preterm birth. For 
example, Romero et al. 138 revealed that the vaginal microbiomes of pregnant women 
who delivered preterm did not differ from those of pregnant women who delivered at 
term. It is also possible that the predominance of Lactobacilli is an important factor 
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indicating term birth. However, other things could go wrong, such as preterm premature 
rupture of membranes (PPROM), which we hypothesize was the cause of the preterm 
birth for the two women whose vagina dominated by one species of Lactobacillus. One 
of these two women (subject 201) presented to hospital with preterm labor at 34 4/7 
weeks of gestation and her previous preterm delivery was due to PPROM at 33 weeks of 
gestation; the other (subject 205) presented to hospital at 36 5/7 weeks of gestation with 
premature rupture of membranes and she had a previous history of PPROM. PPROM is a 
rupture of fetal membrane before 37 weeks of gestation and accounts for 25% of preterm 
birth 75. The cause of PPROM is still unknown. However, infection/inflammation, 
decidual bleeding (abruption), uterine overdistention, genetic predispositions, and 
cigarette smoking have been reported to be associated with PPROM 139. 
 
Our study observed the transition from one majority vaginal bacterium to another 
majority vaginal bacterium throughout pregnancy in five out of ten women. This finding 
is consistent with two studies of Romero and his colleagues 10,138. In these two studies, 
they observed the shift of vaginal community state types (CSTs) throughout pregnancy in 
both women who delivered at term and those that delivered preterm 10,138. The shift could 
be from CST dominated by one species of Lactobacillus to CST dominated by another 
species of Lactobacillus or from CST dominated by one species of Lactobacillus to CST 
not dominated by Lactobacillus or from CST not dominated by Lactobacillus to CST 
dominated by one species of Lactobacillus 10,138.  
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Our study revealed that for subjects 203 and 206 who had a previous preterm birth 
history but still delivered at term, the relative abundance of Lactobacilli, the number of 
short reads participating in the recovery of the Lactobacillus population genomes, and the 
number of short reads for predicted metabolic genes in the Lactobacillus population 
genomes were similar or lower at the early stage of pregnancy compared to post-partum. 
However, those values increased at the later stage of pregnancy. This may result from the 
increase of levels of circulating glucose in pregnant women in late pregnancy 140. In late 
pregnancy, increase of levels of circulating glucose may provide more substrate to 
Lactobacillus species to be fermented to lactate.   
 
Our study found that the abundance of Lactobacilli and functional genes for metabolic 
activity in Lactobacilli did not significantly increase in any of the ten women as 
pregnancy progressed from 8 weeks of gestational age to 30 weeks of gestational age. For 
six out of ten women whose vaginal microbiomes were dominated by Lactobacilli during 
pregnancy, the increase of the abundance of Lactobacilli and functional genes for 
metabolic activity in Lactobacilli may have happened before 8 weeks of gestational age. 
For women of reproductive age, the level of estrogen is at its highest during the middle of 
the menstrual cycle when women are ovulating 12. The presence of a fertilized egg will 
trigger the increased production of estrogen which makes the lining of the uterus grow 
and thicken to prepare for the embryo implantation. High estrogen levels increase 
glycogen content in the vaginal epithelium and promote the growth of Lactobacillus 
species 11,18. For the remaining four women whose vaginal microbiomes were not 
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dominated by Lactobacilli during pregnancy, other factors except estrogen probably 
influenced the vaginal microbiome composition. 
 
One of the limitations of this study is that we did not collect vaginal samples before 8 
weeks of gestation during pregnancy, before pregnancy, or during the middle of the 
menstrual cycle. Therefore, we do not know how the abundance of Lactobacilli changes 
in very early pregnancy, the vaginal microbiomes composition when these ten women 
were not pregnant or breast-feeding, and whether the vaginal microbiome composition 
during the middle of the menstrual cycle was similar to that in the early pregnancy. The 
second limitation of this study is that we did not measure estrogen level, vaginal 
glycogen content, or vaginal pH value. Therefore, it is difficult to establish the direct 
relationship among estrogen level, vaginal glycogen content, colonization of 
Lactobacillus in vagina, and vaginal pH value. The third limitation of this study is the 
small sample size. The limitation prevents us from drawing statistical conclusions. 
 
4.6 Conclusions 
The vaginal microbiomes of women who delivered at term and who did not have a 
previous preterm birth history were generally dominated by Lactobacillus species during 
pregnancy. The vaginal microbiomes of women who delivered at term but had a previous 
preterm birth history were more diverse than those of women who delivered at term and 
who did not have a previous preterm birth history. The abundance of Lactobacilli and 
functional genes for metabolic activity in Lactobacilli did not increase as pregnancy 
progressed from 8 weeks of gestational age to 30 weeks of gestational age. The 
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abundance of Lactobacilli and functional genes for metabolic activity in Lactobacilli 
were higher in the samples collected in late pregnancy than in the samples collected at 
post-partum in all women with term birth. 
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CHAPTER 5. DISSERTATION SUMMARY AND FUTURE RESEARCH 
 
5.1 Dissertation summary 
BV is one of the major problems impacting women’s reproductive health worldwide. It is 
caused by the perturbations in the vaginal microbiome. The etiology of BV is 
multifactorial. Because of this, the diagnosis and treatment of BV are effective. To better 
understand the mechanism of BV, we have to understand what bacteria cause BV and 
how they do it. Most existing research has focused on what bacteria cause BV -- a 
minority of existing research focuses on what the pathogens are doing. A metagenomic 
approach can answer both the question of what bacteria are in the microbiome and 
provide insight into what they are doing. Therefore, in the first and second projects 
(Chinese and US BV project) in this dissertation, I used a metagenomic approach to 
understand the relationship between the vaginal microbiome and bacterial vaginosis 
(BV).  
 
The hypothesis of Chinese BV project is that sialidase can serve as a biomarker for BV 
(chapter 2). The rationales behind the hypothesis are (1) It has been demonstrated that 
sialidase secreted by vaginal bacteria degrades mucin by hydrolyzing sialic acid from 
mucin 66,67. The function of mucin is to protect the vaginal epithelium from the 
colonization of pathogens 66,67. Sialidases therefore assist the adherence, colonization, 
and invasion of pathogens 67. (2) Studies have shown that the level of sialidase activity is 
significantly higher in BV patients compared with that in women without BV 61,62,68-70. 
(3) Prevotella, Gardnerella, and Bacteroides species, which are reported to be associated 
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with BV, were reported to have the ability to secrete sialidase 59,61-63,65. In my first study, 
there were three objectives to address. First, I determined whether sialidase activity is 
elevated in Chinese BV patients. Second, I determined whether the relative abundance 
value of sialidase-encoding genes increases in Chinese BV patients. Finally, I determined 
whether the relative abundances of Prevotella, Gardnerella, and Bacteroides species are 
higher in Chinese BV patients.  
 
If sialidase can serve as a biomarker for BV, sialidase activity should be elevated in 
Chinese BV patients but not in Chinese women without BV. To determine this, we used 
the BVBlue sialidase test to measure the sialidase activity in each Chinese sample. 
Elevated sialidase activity was detected in all BV patients but not in any women without 
BV. Therefore, the test was able to distinguish between women with and without BV. To 
further determine whether the sialidase test could separate women with and without BV, 
we examined the microbiome diversity and microbial community structure of women 
with and without BV.  The vaginal microbiomes of BV patients were more diverse than 
those of women without BV. Bray-Curtis dissimilarity-based PCoA plot exhibited a 
disparate clustering between women with and without BV. Therefore, women with and 
without BV harbored distinctly different vaginal microbiomes. 
 
The sialidase enzymes secreted by vaginal bacteria are encoded by functional genes in 
those bacteria. To determine whether the relative abundance value of sialidase-encoding 
genes increases in BV patients, we analyzed whole genome shotgun (WGS) sequences in 
microbial samples from Chinese women with and without BV and identified functional 
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genes that were more abundant in Chinese BV patients. The microbiomes of all Chinese 
women lacked gene sequences encoding a sialidase enzyme. This finding may be due to 
inadequate sequencing depth.  
 
Since sialidase-encoding genes were not found in all samples, what other genes could 
differentiate the BV patients from non-BV patients? To find an alternative to sialidase-
encoding genes, we compared all predicted enzymes of Chinese women with BV with 
those of Chinese women without BV. We found that thiol-activated cytolysin (K11031), 
which is a toxin, and putative peptidoglycan lipid II flippase (K03980), which is 
virulence factor, were more abundant in BV patients.  
 
To determine whether Prevotella, Gardnerella, and Bacteroides species are more 
abundant in BV patients, we analyzed 16S-rRNA gene and WGS sequences in microbial 
samples from Chinese women with and without BV and identified bacterial genera and 
species that were more abundant in Chinese BV patients. Analysis of 16S rRNA gene and 
WGS sequence data revealed that Prevotella and Gardnerella genera and species were 
more abundant in BV patients.  
 
The conclusions of Chinese BV project were that the sialidase test could separate 
diseased vaginal microbiomes from non-diseased ones. Prevotella and Gardnerella 
species were associated with high sialidase levels. 
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The hypothesis of US BV project is that BV symptom-associated bacteria can serve as 
potential biomarkers to improve the development of therapeutic targets (chapter 3). The 
rationales behind the hypothesis are (1) Yeoman et al. 1 and Srinivasan et al. 53 revealed 
that women with and without BV have distinct metabolite profiles and found metabolites 
that are correlated with BV symptoms: discharge, odor, itching, and pain. (2) The same 
studies found vaginal bacteria that were correlated with BV symptom-associated 
metabolites. However, neither study connected functional genes to vaginal bacteria and 
metabolites. BV symptom-associated metabolites are encoded by functional genes in 
vaginal bacteria. Therefore, studying the correlation among bacteria, functional genes, 
and metabolites could help better understand how pathogens initiate BV. To help test this 
hypothesis, we took a subset of the population from Yeoman et al. 1 and examined the 
correlation among vaginal bacteria, vaginal discharge-associated metabolites, and 
functional genes. We then pursued the following two objectives: (1) Identify bacteria and 
functional genes associated with metabolites that Yeoman et al. 1 found to be correlated 
with vaginal discharge, and (2) Identify which identified bacteria were correlated with the 
identified functional genes.  
 
Vaginal discharge-associated metabolites are encoded by functional genes in vaginal 
bacteria. Moreover, Yeoman et al. 1 found vaginal bacteria that were correlated with 
discharge-associated metabolites. To determine whether we can find bacteria and 
functional genes associated with vaginal discharge-associated metabolites, we analyzed 
16S-rRNA gene and WGS sequences in microbial samples from the US women with and 
without BV and performed a Spearman’s rank correlation on bacterial genera, functional 
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genes, and discharge-associated metabolites. The enzymes ‘malate dehydrogenase’ 
(K00024), ‘5-amino-6-(5-phosphoribosylamino) uracil reductase’ (K11752), and 
‘undecaprenyl-diphosphatase’ (K06153), and the bacteria Aquabacterium, 
Chryseobacterium, Elizabethkingia, Finegoldia, Morganella, Negativicoccus, 
Phenylobacterium, Propionibacterium, Serratia, and Siphonobacter were significantly 
positively linked to the metabolite ‘2-Methyl-2-hydroxybutanoic acid’.  
 
To better understand how vaginal bacteria generate discharge-associated metabolites, we 
performed a Spearman’s rank correlation test between bacteria and functional genes. The 
bacteria Aquabacterium, Chryseobacterium, Elizabethkingia, Finegoldia, Morganella, 
Negativicoccus, Phenylobacterium, Propionibacterium, Serratia, and Siphonobacter 
were significantly positively linked to the enzymes ‘malate dehydrogenase’ (K00024), 
‘5-amino-6-(5-phosphoribosylamino) uracil reductase’ (K11752), and ‘undecaprenyl-
diphosphatase’ (K06153). Finally, to identify the most likely bacterial strains that possess 
the functional genes involved in the generation of discharge-associated metabolites, these 
gene sequences were queried using BLASTN 98 against the nucleotide collection 
reference database. A small percentage of genes were assigned to specific bacterial 
strains. Among the classified bacterial strains, none of them belongs to genus 
Aquabacterium, Chryseobacterium, Elizabethkingia, Finegoldia, Morganella, 
Negativicoccus, Phenylobacterium, Propionibacterium, Serratia, and Siphonobacter. 
This finding may result from the fact that most genomes of bacterial strains are not 
sequenced and therefore were not present in the reference sequence database.  
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We found that the bacteria Aquabacterium, Chryseobacterium, Elizabethkingia, 
Finegoldia, Morganella, Negativicoccus, Phenylobacterium, Propionibacterium, 
Serratia, and Siphonobacter may be involved in the generation of vaginal discharge by 
producing the metabolite ‘2-Methyl-2-hydroxybutanoic acid’ via the enzymes ‘malate 
dehydrogenase’ (K00024), ‘5-amino-6-(5-phosphoribosylamino) uracil reductase’ 
(K11752), and ‘undecaprenyl-diphosphatase’ (K06153).  This suggests that these ten 
bacteria are potential therapeutic targets. 
 
In my third project (pregnancy project), I used a metagenomic approach to characterize 
the vaginal microbiome throughout pregnancy and in the postpartum period. The 
hypothesis of this project is that the abundance of Lactobacilli and functional genes for 
metabolic activity in Lactobacilli will increase as pregnancy progresses and decrease 
following parturition. The rationales behind the hypothesis are (1) Vaginal microbiomes 
are mainly dominated by Lactobacilli during pregnancy 10,13-15; (2) The predominance of 
Lactobacilli in the vagina has been reported to be related to high estrogen levels and 
glycogen content in the vaginal epithelium 6,11; (3) Estrogen levels increase gradually 
during pregnancy, reaching a maximum near term, and drop down quickly during labor 
107;  (4) Glycogen is anaerobically converted to lactic acid in the vagina; and (5) 
Lactobacilli are the main component of lactic acid bacteria group. I formulated two 
objectives to address the hypothesis. The two objectives are to (1) Determine whether the 
abundance of Lactobacilli increases as pregnancy progresses and decreases following 
parturition; and (2) Determine whether the functional genes for metabolic activity in 
Lactobacilli increases as pregnancy progresses and decrease following parturition.  
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To realize these two objectives, we followed a metagenomic approach using vaginal 
samples from women with and without a history of preterm birth at 8–12, 17–21, 26–30, 
and 35–38 weeks of gestation, during labor, and at 6 weeks post-partum to determine the 
taxonomic and functional composition of the vaginal microbiome collected at different 
time points.  
 
The vaginal microbiome composition was reported to differ during pregnancy compared 
to when not pregnant 10,13,14. Vaginal microbiomes during pregnancy were reported to 
have more Lactobacillus species 10,13-15. To determine whether Lactobacillus species are 
the majority vaginal bacteria during pregnancy but not at post-partum, unassembled reads 
were directly assigned to bacteria using TIPP 100 or indirectly assigned to bacteria via 
contigs. The majority of vaginal bacteria are defined as more than half of the bacteria in 
vagina. The majority of vaginal bacteria were Lactobacillus species in 17 out of 20 
samples collected during pregnancy from women who delivered at term and who did not 
have a previous preterm birth history. On the other hand, for women who had a previous 
preterm birth history but still delivered at term, the majority of vaginal bacteria were not 
Lactobacillus species in 10 out of 12 samples collected during pregnancy. Among these 
ten samples, the majority of vaginal bacteria in seven samples were Gardnerella 
vaginalis. Seven out of nine vaginal microbiomes collected from women with and 
without a previous preterm birth history were not dominated by any Lactobacillus species 
at 6 weeks post-partum. These observations held true whether the relative abundance of 
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Lactobacillus species was determined from the metagenomic short reads or from the 
assembly.  
 
Estrogen levels increase gradually during pregnancy, reaching a maximum near term, and 
drop down quickly during labor 107. To determine whether the relative abundance of 
Lactobacilli increases as pregnancy progresses and decrease following parturition, the 
relative abundances of all Lactobacillus species at 8–12, 17–21, 26–30, and 35–38 weeks 
of gestation and 6 weeks post-partum were added up. The relative abundances of 
Lactobacilli at 8–12, 17–21, 26–30, and 35–38 weeks of gestation were compared with 
those at 6 weeks post-partum. The relative abundances of Lactobacilli were higher in the 
samples collected at 26–30 and 35–38 weeks of gestation than in the samples collected at 
post-partum in all women with term birth. The relative abundance of Lactobacilli did not 
increase in any women as pregnancy progressed from 8 weeks of gestational age to 30 
weeks of gestational age.  
 
The above focuses on the genes of Lactobacilli. What happened to the Lactobacillus 
population genomes as a whole? To determine whether the number of short reads 
participating in the recovery of the Lactobacillus population genomes increases as 
pregnancy progresses and decreases following parturition, we used GroopM to bin 
contigs into bins, where each contig belonged to a single genome or several closely 
related genomes 102. Binning was performed based on the co-assembly of all samples in 
each subject. Then, we counted and normalized the number of clean short reads in each 
sample that were used to assemble corresponding Lactobacillus population genomes. The 
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number of short reads participating in the recovery of the Lactobacillus population 
genomes was higher in the samples collected at 35–38 weeks of gestation than in the 
samples collected at post-partum in all women with term birth. The number of 
Lactobacillus reads in each woman’s microbiome did not increase as pregnancy 
progressed from 8 weeks of gestational age to 30 weeks of gestational age.  
 
Glycogen is anaerobically converted to lactic acid in the vagina. Lactobacilli are the main 
component of lactic acid bacteria group. To determine whether the number of short reads 
predicted to participate in the metabolic activity in the Lactobacillus population genomes 
increase as pregnancy progresses and decrease following parturition, open reading frames 
(ORFs) were predicted in contigs participating in the Lactobacillus population genomes 
in each sample, and then aligned to the genes in the KEGG pathways 106. The number of 
short reads predicted to participate in the metabolic activity in the Lactobacillus 
population genomes was counted and normalized in each sample. The number of short 
reads for predicted metabolic genes in the Lactobacillus population genomes was higher 
in the samples collected at 35–38 weeks of gestation than in the samples collected at 
post-partum in all women with term birth. It did not increase for any women as 
pregnancy progressed from 8 weeks of gestational age to 30 weeks of gestational age.  
 
The conclusion from this study was that the vaginal microbiomes of women who 
delivered at term and who did not have a previous preterm birth history were generally 
dominated by Lactobacillus species during pregnancy. The vaginal microbiomes of 
women who delivered at term but had a previous preterm birth history were more diverse 
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than those of women who delivered at term and who did not have a previous preterm 
birth history. 
 
5.2 Future research 
In Chinese BV project, the level of sialidase activity and the relative abundances of 
Prevotella and Gardnerella species were detected to increase in all BV patients. 
However, we do not know whether Prevotella and Gardnerella species are the source of 
sialidase activity. Further study to isolate Prevotella and Gardnerella species from 
vaginal discharge of BV patients using culture-dependent methods and test their sialidase 
activity would help understand whether they are responsible for the increase of sialidase 
activity in BV patients.  
 
In US BV project, I found that the bacteria Aquabacterium, Chryseobacterium, 
Elizabethkingia, Finegoldia, Morganella, Negativicoccus, Phenylobacterium, 
Propionibacterium, Serratia, and Siphonobacter were positively associated with the 
metabolite ‘2-Methyl-2-hydroxybutanoic acid’ via the enzymes ‘malate dehydrogenase’ 
(K00024), ‘5-amino-6-(5-phosphoribosylamino) uracil reductase’ (K11752), and 
‘undecaprenyl-diphosphatase’ (K06153). Future studies to determine whether or how 
these ten bacteria produce the metabolite ‘2-Methyl-2-hydroxybutanoic acid’ through 
these three functional genes are needed.   
 
In pregnancy project, I found that the abundance of Lactobacilli and functional genes for 
metabolic activity in Lactobacilli did not significantly increase in women whose vaginal 
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microbiomes were dominated by Lactobacilli during pregnancy as pregnancy progressed 
from 8 weeks of gestational age to 30 weeks of gestational age. The increase may have 
happened before 8 weeks of gestational age. Future study to collect vaginal samples 
before 8 weeks of gestation during pregnancy would help understand how Lactobacilli 
change in very early pregnancy. Moreover, further studies to measure estrogen level, 
vaginal glycogen content, or vaginal pH value would help understand the direct 
relationship among estrogen level, vaginal glycogen content, colonization of 
Lactobacillus in vagina, and vaginal pH value. 
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CHAPTER 6. FIGURES 
 
Figure 1. Shannon diversity indices of the vaginal microbiomes collected from 
women with and without bacterial vaginosis. The OTUs in the analysis are estimated 
based on 97% 16S rRNA sequence similarity. The average Shannon index was 
significantly different between women with and without BV, as identified by the 
Kruskal-Wallis rank sum test. P-values < 0.05 were regarded as significant. Error bar 
represents the standard error of the mean (SEM). 
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Figure 2. Bray-Curtis dissimilarity-based PCoA analysis showing clustering of 
vaginal microbiomes. Bray-Curtis dissimilarity-based PCoA was performed on OTUs 
from each vaginal sample. The OTUs in the analysis were estimated based on 97% 16S 
rRNA sequence similarity. Microbial communities that were significantly different 
between women with and without BV were identified by the PERMANOVA. P-values < 
0.05 were regarded as significant. The oval in the figure represents that there is 
significant difference between two groups. 
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Figure 3. Selected KEGG orthologous groups whose relative abundances were 
higher in both Chinese BV patients compared to non-BV patients. The green color 
represents Chinese BV patients. The blue color represents Chinese women without BV.  
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Figure 4. Bacterial genera more abundant in Chinese BV patients. Genera with 
significantly different abundances between Chinese women with and without BV were 
identified by the LEfSe. P-values < 0.05 were regarded as significant. The cell in the 
heatmap represents the relative percentage of each bacterium within each sample. The red 
color in the heatmap represents high abundance bacterial genera. The yellow color in the 
heatmap represents low abundance bacterial genera.  
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Figure 5. Selected bacterial strains whose relative abundances were higher in both 
Chinese BV patients. The green color represents Chinese BV patients. The blue color 
represents Chinese women without BV. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
93 
 
Figure 6. Comparative analysis of five reference genomes with assemblies from 
Chinese women with and without BV. (A) Comparative analysis of the Gardnerella 
vaginalis 315-A with the assemblies of Chinese samples, (B) Comparative analysis of the 
Gardnerella vaginalis 409-05 with the assemblies of Chinese samples,  (C) Comparative 
analysis of the Gardnerella vaginalis ATCC-14019 with the assemblies of Chinese 
samples, (D) Comparative analysis of the Gardnerella vaginalis HMP9231 with the 
assemblies of Chinese samples, (E) Comparative analysis of the Prevotella timonensis 
CRIS 5C-B1 with the assemblies of Chinese samples. The inner purple ring represents the 
reference genome. Counting from inside, the first and second orange rings represent the 
assemblies from Chinese women with BV. The third and fourth green rings represent the 
assemblies from Chinese women without BV. The image was generated with GView 
server 126. Samples that do not have assemblies against the reference genomes were not 
shown. 
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Figure 6 (cont.) 
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Figure 7. Overall network view of the correlations among bacterial genera, KEGG 
orthologous groups, and discharge-associated metabolites. Significant Spearman's 
rank correlation coefficients (p < 0.05) are shown as edges between genera/KEGG 
orthologous groups and genera/KEGG orthologous groups/metabolites. The p-values 
associated with these correlation coefficients are listed in Table 16. Pink nodes represent 
genera, yellow nodes KEGG orthologous groups, and green nodes metabolites. Red edges 
represent negative correlations; blue edges represent positive correlations. 
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Figure 8. Sub-network view of the correlations between KEGG orthologous groups 
and discharge-associated metabolites. Significant Spearman's rank correlation 
coefficients (p < 0.05) are shown as edges between KEGG orthologous groups and 
KEGG orthologous groups/metabolites. The p-values associated with these correlation 
coefficients are listed in Table 16. Yellow nodes represent KEGG orthologous groups 
and green nodes metabolites. Red edges represent negative correlations; blue edges 
represent positive correlations. 
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Figure 8 (cont.) 
 
  
98 
 
Figure 9. Sub-network view of the correlations between bacterial genera and 
discharge-associated metabolites. Significant Spearman's rank correlation coefficients 
(p < 0.05) are shown as edges between genera and genera/metabolites. The p-values 
associated with these correlation coefficients are listed in Table 16. Pink nodes represent 
genera and green nodes metabolites. Blue edges represent positive correlations. 
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Figure 10. Sub-network view of the correlations between bacterial genera and 
KEGG orthologous groups. Significant Spearman's rank correlation coefficients (p < 
0.05) are shown as edges between genera/KEGG orthologous groups and genera/KEGG 
orthologous groups. The p-values associated with these correlation coefficients are listed 
in Table 16. Pink nodes represent genera and yellow nodes KEGG orthologous groups. 
Blue edges represent positive correlations. 
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Figure 11. GroopM plots of twelve high-quality Lactobacillus population genomes. 
Dots represent contigs, colored by GC content. The size of each dot is proportional to the 
length of the contig. Subject 1XX represents women without a history of preterm birth. 
Subject 2XX represents women with a history of preterm birth. 
 
  
101 
 
Figure 12. Heatmap of the relative abundance of bacterial species throughout 
pregnancy, during labor, and at post-partum. (A) The relative abundance of bacterial 
species was determined from the metagenomic short reads, (B) The relative abundance of 
bacterial species was determined from the metagenomic assembly. Each column 
represents one sample. Each row represents one bacterium. Only bacterial species at >5% 
abundance in at least one sample were shown in the heatmap. The red color represents 
high abundant bacterial species. The yellow color represents low abundant bacterial 
species. Samples in each subject are separated by vertical line. Women without a 
previous preterm birth history are named as low risk women. Women with a previous 
preterm birth history are named as high risk women. 
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Figure 12 (cont.) 
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Figure 13. Majority vaginal bacteria throughout pregnancy, during labor, and at 
post-partum. (A) The majority vaginal bacteria were determined from the metagenomic 
short reads, (B) The majority vaginal bacteria was determined from the metagenomic 
assembly. Majority vaginal bacteria indicate that more than half of the bacteria in vagina. 
Others indicate that the majority vaginal bacteria are not any Lactobacillus species. NA 
represents that no sample is collected at this time point. Women without a previous 
preterm birth history are named as low risk women. Women with a previous preterm 
birth history are named as high risk women. 
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Figure 14. Relative abundance of Lactobacillus spp. in each subject at different time 
points. (A) The relative abundance of Lactobacillus spp. in women without a history of 
preterm birth determined from the metagenomic short reads, (B) The relative abundance 
of Lactobacillus spp. in women without a history of preterm birth determined from 
metagenomic assembly, (C) The relative abundance of Lactobacillus spp. in women with 
a history of preterm birth determined from the metagenomic short reads, (D) The relative 
abundance of Lactobacillus spp. in women with a history of preterm birth determined 
from metagenomic assembly. Subject 1XX represents women without a history of 
preterm birth. Subject 2XX represents women with a history of preterm birth. Subject 
201 did not have samples collected at 35–38 weeks of gestation and post-partum. Subject 
205 did not have samples collected at 35–38 weeks of gestation. 
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Figure 15. The number of short reads participating in the recovery of the 
Lactobacillus population genomes in each subject at different time points. (A) The 
number of short reads participating in the recovery of the Lactobacillus population 
genomes in women without a history of preterm birth, (B) The number of short reads 
participating in the recovery of the Lactobacillus population genomes in women with a 
history of preterm birth. Subject 1XX represents women without a history of preterm 
birth. Subject 2XX represents women with a history of preterm birth. Subject 201 did not 
have samples collected at 35–38 weeks of gestation and post-partum. Subject 205 did not 
have samples collected at 35–38 weeks of gestation. The number of short reads in y-axis 
is calculated based on the following formula: (number of short reads mapped to 
Lactobacillus population genomes / total number of clean reads) * 1,000,000. 
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Figure 16. The number of short reads predicted to participate in the metabolic 
activity in the Lactobacillus population genomes in each subject at different time 
points. (A) The number of short reads predicted to participate in the metabolic activity in 
the Lactobacillus population genomes in women without a history of preterm birth, (B) 
the number of short reads predicted to participate in the metabolic activity in the 
Lactobacillus population genomes in women with a history of preterm birth. Subject 
1XX represents women without a history of preterm birth. Subject 2XX represents 
women with a history of preterm birth. Subject 201 did not have samples collected at 35–
38 weeks of gestation and post-partum. Subject 205 did not have samples collected at 35–
38 weeks of gestation. The number of short reads in y-axis is calculated based on the 
following formula: (number of short reads predicted to participate in the metabolic 
activity in the Lactobacillus population genomes / total number of clean reads) * 
100,000,000. 
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Figure 16 (cont.) 
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CHAPTER 7. TABLES 
 
Table 1. Sample descriptions. 
 
Sample 
ID
Disease 
Status Race/Ethnicity
Sialidase 
Test
Age In 
Years
Length Of 
Residence 
Marital 
Status
Sexual 
Orientation
Days 
Since 
Last 
Period
Tampon 
Use 
During 
Periods
SMUB7 BV Han Positive 38 38 Married Heterosexual 5 Yes
SMUB8 BV Han Positive 25 25 Married Heterosexual 15 Yes
SMUB9 BV Han Positive 24 24 Single Heterosexual 8 Yes
SMUB19 BV Han Positive 36 36 Married Heterosexual 3 Yes
SMUB23 BV Han Positive 32 32 Married Heterosexual 6 Yes
SMUB25 BV Han Positive 36 36 Married Heterosexual 3 Yes
SMUB26 BV Han Positive 26 26 Married Heterosexual 10 Yes
SMUB27 BV Han Positive 47 47 Married Heterosexual 20 Yes
SMUB29 BV Han Positive 42 42 Married Heterosexual 17 Yes
SMUB30 BV Han Positive 29 29 Married Heterosexual 6 Yes
SMUB31 BV Han Positive 20 20 Single Heterosexual 5 Yes
SMUB37 BV Han Positive 34 34 Married Heterosexual 9 Yes
SMUB74 BV Han Positive 43 43 Married Heterosexual 11 Yes
SMUB75 BV Han Positive 37 37 Married Heterosexual 11 Yes
SMUB77 BV Han Positive 26 26 Married Heterosexual 5 Yes
SMUB78 BV Han Positive 38 38 Married Heterosexual 8 Yes
SMUB79 BV Han Positive 37 37 Divorced Heterosexual 18 Yes
SMUB81 BV Han Positive 35 35 Married Heterosexual 4 Yes
SMUB82 BV Han Positive 43 43 Married Heterosexual 3 Yes
SMUB83 BV Han Positive 50 50 Married Heterosexual 20 Yes
SMUB84 BV Han Positive 37 37 Married Heterosexual 16 Yes
SMUB85 BV Han Positive 46 46 Married Heterosexual 24 Yes
SMUB86 BV Han Positive 40 40 Married Heterosexual 10 Yes
SMUB87 BV Han Positive 38 38 Married Heterosexual 20 Yes
SMUB88 BV Han Positive 31 31 Married Heterosexual 6 Yes
SMUB89 BV Han Positive 44 44 Married Heterosexual 3 Yes
SMUN5 NBV Han Negative 30 30 Married Heterosexual 8 Yes
SMUN11 NBV Han Negative 33 33 Married Heterosexual 19 Yes
SMUN12 NBV Han Negative 26 26 Married Heterosexual 5 Yes
SMUN15 NBV Han Negative 35 35 Married Heterosexual 6 Yes
SMUN20 NBV Han Negative 33 33 Married Heterosexual 8 Yes
SMUN23 NBV Han Negative 32 32 Single Heterosexual 12 Yes
SMUN25 NBV Han Negative 35 35 Married Heterosexual 14 Yes
SMUN26 NBV Han Negative 34 34 Married Heterosexual 3 Yes
SMUN27 NBV Han Negative 29 29 Married Heterosexual 5 Yes
SMUN29 NBV Han Negative 52 52 Married Heterosexual MenopausYes
SMUN31 NBV Han Negative 33 33 Divorced Heterosexual 8 Yes
SMUN33 NBV Han Negative 48 48 Married Heterosexual 16 Yes
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Table 1 (cont.) 
 
 
 
 
 
Sample 
ID
Number Of 
Previous 
Pregnancies
Number 
Of 
Sexual 
Partners 
In the 
Past 6 
Gender 
of 
Sexual 
Partners 
In the 
Past 6 
New 
Sexual 
Partner 
In the 
Past 6 
Months
Days Since 
Intercourse
Number 
Of Vaginal 
Sex/Week
Number 
Of Oral 
Sex/Week
Number 
Of Anal 
Sex/Week
Condom 
Use
Number Of 
Bath/Week
Days 
Since 
Last 
Douche
SMUB7 2 1 Male No 2 2 0 0 Yes 7
SMUB8 0 1 Male Yes 3 3 1 0 Yes 7 3
SMUB9 0 2 Male Yes 1 4 0 0 Yes 7
SMUB19 1 1 Male No 3 2 0 0 No 7
SMUB23 1 1 Male No 6 3 0 0 No 7
SMUB25 1 1 Male No 2 3 0 0 No 7
SMUB26 1 1 Male No 3 2 0 0 Yes 7
SMUB27 2 1 Male No 1 2 0 0 No 7 2
SMUB29 1 1 Male No 5 1 0 0 No 7 5
SMUB30 2 1 Male No 2 2 1 0 No 7
SMUB31 0 1 Male Yes 2 3 0 0 Yes 7
SMUB37 1 1 Male No 10 1 0 0 No 7
SMUB74 1 1 Male No 2 2 0 0 No 7
SMUB75 1 1 Male No 4 2 0 0 No 7
SMUB77 1 1 Male No 3 3 0 0 Yes 7 3
SMUB78 2 1 Male No 2 3 0 0 No 7
SMUB79 3 1 Male Yes 6 1 0 0 No 7
SMUB81 1 0 Male No 190 1 0 0 No 7 2
SMUB82 1 1 Male No 3 2 0 0 No 7
SMUB83 1 1 Male No 30 1 0 0 No 7
SMUB84 1 1 Male No 2 3 0 0 No 7 3
SMUB85 1 1 Male No 6 1 0 0 No 7
SMUB86 1 1 Male No 4 1 0 0 No 7
SMUB87 2 1 Male No 2 3 0 0 No 7
SMUB88 2 1 Male No 3 2 0 0 No 7
SMUB89 3 1 Male No 3 2 0 0 No 7
SMUN5 1 1 Male No 1 3 0 0 Yes 7
SMUN11 1 1 Male No 2 2 0 0 No 7
SMUN12 1 1 Male No 2 3 0 0 Yes 7
SMUN15 4 1 Male No 5 1 0 0 No 7
SMUN20 1 1 Male No 4 1 0 0 No 7
SMUN23 1 1 Male No 2 3 0 0 No 7
SMUN25 1 1 Male No 7 1 0 0 No 7
SMUN26 1 1 Male No 3 2 0 0 No 7
SMUN27 1 1 Male No 2 3 0 0 Yes 7
SMUN29 1 0 Male No 360 1 0 0 No 7
SMUN31 1 1 Male No 5 1 0 0 No 7
SMUN33 1 1 Male No 10 1 0 0 No 7
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Table 2. 16S rRNA sequence statistics of vaginal samples. 
 
 
 
 
 
 
Sample ID Total sequences number Quality-filtered sequences number Average quality-filtered sequence length (nt)
SMUB7 8847 6735 485
SMUB8 11327 9053 479
SMUB9 14521 10336 483
SMUB19 15049 11600 474
SMUB23 11364 8024 488
SMUB25 14503 9973 484
SMUB26 14862 10959 484
SMUB27 16205 12057 484
SMUB29 16397 12183 488
SMUB30 14624 10625 481
SMUB31 17130 10978 484
SMUB37 9654 6793 492
SMUB74 10978 7695 492
SMUB75 23701 17900 485
SMUB77 4657 3646 490
SMUB78 12131 9288 487
SMUB79 4322 3255 485
SMUB81 9387 6669 487
SMUB82 13074 8865 486
SMUB83 11046 7904 490
SMUB84 10454 8110 484
SMUB85 23757 18956 485
SMUB86 9647 7288 488
SMUB87 10905 8283 483
SMUB88 24229 17486 487
SMUB89 29088 19111 485
SMUN5 13469 9999 478
SMUN11 11294 6993 489
SMUN12 12286 9356 490
SMUN15 15392 12027 484
SMUN20 13088 7145 476
SMUN23 15406 10700 483
SMUN25 17523 13281 475
SMUN26 23210 18295 478
SMUN27 16216 12554 481
SMUN29 25617 19750 482
SMUN31 14241 11507 481
SMUN33 14287 9661 485
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Table 3. List of Human Microbiome Project urogenital tract reference genomes. 
 
Acinetobacter baumannii ATCC 19606 = CIP 70.34
Actinobaculum massiliae ACS-171-V-Col2
Actinomyces coleocanis DSM 15436
Actinomyces neuii BVS029A5
Actinomyces turicensis ACS-279-V-Col4
Actinomyces urogenitalis DSM 15434
Aerococcus urinae ACS-120-V-Col10a
Aerococcus viridans ATCC 11563
Anaerococcus hydrogenalis ACS-025-V-Sch4
Anaerococcus lactolyticus ATCC 51172
Anaerococcus prevotii ACS-065-V-Col13
Anaerococcus tetradius ATCC 35098
Atopobium vaginae DSM 15829
Atopobium vaginae PB189-T1-4
Bifidobacterium breve ACS-071-V-Sch8b
Bifidobacterium dentium ATCC 27679
Bifidobacterium dentium JCVIHMP022
Brevibacterium mcbrellneri ATCC 49030
Chryseobacterium gleum ATCC 35910
Clostridiales genomosp. BVAB3 str. UPII9-5
Corynebacterium aurimucosum ATCC 700975
Corynebacterium genitalium ATCC 33030
Corynebacterium glucuronolyticum ATCC 51866
Corynebacterium glucuronolyticum ATCC 51867
Corynebacterium jeikeium ATCC 43734
Corynebacterium lipophiloflavum DSM 44291
Corynebacterium pseudogenitalium ATCC 33035
Corynebacterium striatum ATCC 6940
Dialister micraerophilus DSM 19965
Dialister microaerophilus UPII 345-E
Enterococcus durans FB129-CNAB-4
Enterococcus faecalis ATCC 29200
Enterococcus faecalis ERV81
Enterococcus faecalis ERV85
Enterococcus faecalis ERV93
Enterococcus faecalis HH22
Enterococcus faecalis TX0312
Enterococcus faecalis TX0635
Enterococcus faecalis TX0855
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Table 3. (cont.) 
 
Enterococcus faecium E422
Enterococcus faecium P1139
Enterococcus faecium S447
Eremococcus coleocola ACS-139-V-Col8
Escherichia coli 83972
Finegoldia magna ACS-171-V-Col3
Finegoldia magna ATCC 53516
Finegoldia magna BVS033A4
Finegoldia magna SY403409CC001050417
Fusobacterium nucleatum subsp. nucleatum ATCC 23726
Gardnerella vaginalis 315-A
Gardnerella vaginalis 409-05
Gardnerella vaginalis ATCC 14019
Gardnerella vaginalis HMP9231
Haemophilus parainfluenzae HK262
Klebsiella oxytoca 10-5245
Klebsiella oxytoca 10-5250
Lactobacillus coleohominis 101-4-CHN
Lactobacillus crispatus 125-2-CHN
Lactobacillus crispatus 214-1
Lactobacillus crispatus CTV-05
Lactobacillus crispatus FB049-03
Lactobacillus crispatus FB077-07
Lactobacillus crispatus JV-V01
Lactobacillus crispatus MV-1A-US
Lactobacillus crispatus MV-3A-US
Lactobacillus crispatus SJ-3C-US
Lactobacillus delbrueckii subsp. bulgaricus PB2003/044-T
Lactobacillus fermentum 28-3-CHN
Lactobacillus gasseri 202-4
Lactobacillus gasseri 224-1
Lactobacillus gasseri JV-V03
Lactobacillus gasseri MV-22
Lactobacillus gasseri SJ-9E-US
Lactobacillus gasseri SV-16A-US
Lactobacillus iners ATCC 55195
Lactobacillus iners DSM 13335
Lactobacillus iners LactinV 01V1-a
Lactobacillus iners LactinV 03V1-b
  
113 
 
Table 3. (cont.) 
 
Lactobacillus iners LactinV 09V1-c
Lactobacillus iners LactinV 11V1-d
Lactobacillus iners LEAF 2052A-d
Lactobacillus iners LEAF 2053A-b
Lactobacillus iners LEAF 2062A-h1
Lactobacillus iners LEAF 3008A-a
Lactobacillus iners SPIN 1401G
Lactobacillus iners SPIN 2503V10-D
Lactobacillus iners UPII 143-D
Lactobacillus iners UPII 60-B
Lactobacillus jensenii 1153
Lactobacillus jensenii 115-3-CHN
Lactobacillus jensenii 269-3
Lactobacillus jensenii 27-2-CHN
Lactobacillus jensenii JV-V16
Lactobacillus jensenii SJ-7A-US
Lactobacillus johnsonii ATCC 33200
Lactobacillus oris PB013-T2-3
Lactobacillus salivarius ACS-116-V-Col5a
Lactobacillus vaginalis ATCC 49540
Megasphaera genomosp. type_1 str. 28L
Megasphaera sp. UPII 135-E
Megasphaera sp. UPII 199-6
Mobiluncus curtisii ATCC 43063
Mobiluncus curtisii ATCC 51333
Mobiluncus curtisii subsp. curtisii ATCC 35241
Mobiluncus curtisii subsp. holmesii ATCC 35242
Mobiluncus mulieris 28-1
Mobiluncus mulieris ATCC 35239
Mobiluncus mulieris ATCC 35243
Mobiluncus mulieris FB024-16
Mycobacterium parascrofulaceum ATCC BAA-614
Myroides odoratimimus CCUG 12901
Myroides odoratimimus CCUG 3837
Pasteurella bettyae CCUG 2042
Peptoniphilus duerdenii ATCC BAA-1640
Peptoniphilus harei ACS-146-V-Sch2b
Peptoniphilus lacrimalis 315-B
Porphyromonas asaccharolytica PR426713P-I
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Table 3. (cont.) 
 
 
 
 
 
 
 
Porphyromonas uenonis 60-3
Prevotella amnii CRIS 21A-A
Prevotella bivia JCVIHMP010
Prevotella buccalis ATCC 35310
Prevotella denticola CRIS 18C-A
Prevotella disiens FB035-09AN
Prevotella oralis ATCC 33269
Prevotella timonensis CRIS 5C-B1
Propionibacterium sp. 409-HC1
Propionibacterium sp. 434-HC2
Proteus mirabilis ATCC 29906
Roseomonas cervicalis ATCC 49957
Sphingobacterium spiritivorum ATCC 33300
Sphingobacterium spiritivorum ATCC 33861
Staphylococcus aureus subsp. aureus MN8
Staphylococcus epidermidis BVS058A4
Staphylococcus lugdunensis ACS-027-V-Sch2
Staphylococcus simulans ACS-120-V-Sch1
Streptococcus bovis ATCC 700338
Streptococcus pseudoporcinus SPIN 20026
Streptococcus urinalis FB127-CNA-2
Treponema phagedenis F0421
Veillonella atypica ACS-049-V-Sch6
Veillonella atypica ACS-134-V-Col7a
Veillonella parvula ACS-068-V-Sch12
Veillonella ratti ACS-216-V-Col6b
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Table 4. Summary of the percentage of bases covered for each HMP urogenital tract 
reference genome in each sample. 
 
BV_SMUB9 BV_SMUB27 NBV_SMUN23 NBV_SMUN25
Acinetobacter_baumannii_ATCC_19606_=_CIP_70.34 0.00% 0.08% 0.01% 0.13%
Actinobaculum_massiliae_ACS-171-V-Col2 0.00% 0.00% 0.00% 0.00%
Actinomyces_coleocanis_DSM_15436 0.00% 0.00% 0.00% 0.00%
Actinomyces_neuii_BVS029A5 0.00% 0.16% 0.00% 0.00%
Actinomyces_turicensis_ACS-279-V-Col4 0.00% 0.00% 0.00% 0.00%
Actinomyces_urogenitalis_DSM_15434 0.00% 0.00% 0.00% 0.00%
Aerococcus_urinae_ACS-120-V-Col10a 0.02% 0.00% 0.00% 0.00%
Aerococcus_viridans_ATCC_11563 0.00% 0.00% 0.00% 0.00%
Anaerococcus_hydrogenalis_ACS-025-V-Sch4 2.10% 0.73% 0.02% 0.01%
Anaerococcus_lactolyticus_ATCC_51172 1.22% 0.00% 0.00% 0.00%
Anaerococcus_prevotii_ACS-065-V-Col13 0.08% 0.01% 0.00% 0.00%
Anaerococcus_tetradius_ATCC_35098 0.12% 0.01% 0.00% 0.00%
Atopobium_vaginae_DSM_15829 87.97% 0.25% 0.47% 0.52%
Atopobium_vaginae_PB189-T1-4 0.72% 0.00% 0.04% 0.00%
Bifidobacterium_breve_ACS-071-V-Sch8b 0.00% 0.00% 0.00% 0.00%
Bifidobacterium_dentium_ATCC_27679 0.00% 0.00% 0.00% 0.00%
Bifidobacterium_dentium_JCVIHMP022 0.00% 0.00% 0.03% 0.02%
Brevibacterium_mcbrellneri_ATCC_49030 0.00% 0.00% 0.00% 0.00%
Chryseobacterium_gleum_ATCC_35910 0.00% 0.00% 0.38% 0.00%
Clostridiales_genomosp._BVAB3_str._UPII9-5 0.26% 0.10% 0.05% 0.05%
Corynebacterium_aurimucosum_ATCC_700975 0.00% 0.00% 0.00% 0.00%
Corynebacterium_genitalium_ATCC_33030 0.00% 0.00% 0.00% 0.00%
Corynebacterium_glucuronolyticum_ATCC_51866 0.01% 0.00% 0.01% 0.00%
Corynebacterium_glucuronolyticum_ATCC_51867 0.00% 0.00% 0.00% 0.00%
Corynebacterium_jeikeium_ATCC_43734 0.00% 0.00% 0.00% 0.00%
Corynebacterium_lipophiloflavum_DSM_44291 0.00% 0.00% 0.00% 0.01%
Corynebacterium_pseudogenitalium_ATCC_33035 0.01% 0.00% 0.00% 0.00%
Corynebacterium_striatum_ATCC_6940 0.00% 0.00% 0.01% 0.01%
Dialister_micraerophilus_DSM_19965 0.88% 0.24% 0.15% 0.00%
Dialister_microaerophilus_UPII_345-E 0.85% 0.06% 0.05% 0.00%
Enterococcus_durans_FB129-CNAB-4 0.00% 0.00% 0.00% 0.00%
Enterococcus_faecalis_ATCC_29200 0.00% 0.00% 0.00% 0.00%
Enterococcus_faecalis_ERV81 0.00% 0.00% 0.00% 0.00%
Enterococcus_faecalis_ERV85 0.00% 0.00% 0.00% 0.00%
Enterococcus_faecalis_ERV93 0.00% 0.00% 0.00% 0.00%
Enterococcus_faecalis_HH22 0.00% 0.00% 0.00% 0.00%
Enterococcus_faecalis_TX0312 0.00% 0.00% 0.00% 0.00%
Enterococcus_faecalis_TX0635 0.00% 0.00% 0.00% 0.00%
Enterococcus_faecalis_TX0855 0.00% 0.00% 0.00% 0.00%
Enterococcus_faecium_E422 0.00% 0.00% 0.00% 0.00%
Enterococcus_faecium_P1139 0.01% 0.00% 0.00% 0.00%
Enterococcus_faecium_S447 0.00% 0.00% 0.00% 0.00%
Eremococcus_coleocola_ACS-139-V-Col8 0.03% 0.00% 0.00% 0.00%
Escherichia_coli_83972 0.00% 0.00% 0.36% 0.33%
Finegoldia_magna_ACS-171-V-Col3 0.94% 0.07% 0.00% 0.00%
Finegoldia_magna_ATCC_53516 0.07% 0.03% 0.00% 0.00%
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Table 4. (cont.) 
 
Finegoldia_magna_BVS033A4 0.71% 0.07% 0.00% 0.00%
Finegoldia_magna_SY403409CC001050417 0.70% 0.05% 0.01% 0.00%
Fusobacterium_nucleatum_subsp._nucleatum_ATCC_23726 0.01% 0.00% 0.00% 0.00%
Gardnerella_vaginalis_315-A 10.76% 2.91% 0.40% 1.04%
Gardnerella_vaginalis_409-05 74.44% 56.97% 12.14% 17.02%
Gardnerella_vaginalis_ATCC_14019 7.48% 1.75% 0.44% 0.39%
Gardnerella_vaginalis_HMP9231 7.36% 1.66% 0.21% 1.82%
Haemophilus_parainfluenzae_HK262 0.00% 0.00% 0.00% 0.00%
Klebsiella_oxytoca_10-5245 0.00% 0.00% 0.01% 0.00%
Klebsiella_oxytoca_10-5250 0.00% 0.00% 0.00% 0.00%
Lactobacillus_coleohominis_101-4-CHN 0.00% 0.00% 0.00% 0.00%
Lactobacillus_crispatus_125-2-CHN 0.00% 0.00% 0.01% 0.01%
Lactobacillus_crispatus_214-1 0.00% 0.00% 0.00% 0.02%
Lactobacillus_crispatus_CTV-05 0.01% 0.00% 0.00% 0.00%
Lactobacillus_crispatus_FB049-03 0.00% 0.00% 0.00% 0.00%
Lactobacillus_crispatus_FB077-07 0.01% 0.00% 0.01% 0.01%
Lactobacillus_crispatus_JV-V01 0.00% 0.00% 0.00% 0.00%
Lactobacillus_crispatus_MV-1A-US 0.00% 0.00% 0.00% 0.00%
Lactobacillus_crispatus_MV-3A-US 0.00% 0.00% 0.00% 0.00%
Lactobacillus_crispatus_SJ-3C-US 0.00% 0.00% 0.00% 0.00%
Lactobacillus_delbrueckii_subsp._bulgaricus_PB2003/044-T3 0.00% 0.00% 0.00% 0.00%
Lactobacillus_fermentum_28-3-CHN 0.00% 0.00% 0.00% 0.00%
Lactobacillus_gasseri_202-4 0.00% 0.01% 0.00% 0.04%
Lactobacillus_gasseri_224-1 0.05% 0.02% 0.11% 0.11%
Lactobacillus_gasseri_JV-V03 0.00% 0.01% 0.01% 0.01%
Lactobacillus_gasseri_MV-22 0.00% 0.00% 0.00% 0.00%
Lactobacillus_gasseri_SJ-9E-US 0.00% 0.00% 0.00% 0.00%
Lactobacillus_gasseri_SV-16A-US 0.00% 0.00% 0.00% 0.00%
Lactobacillus_iners_ATCC_55195 0.11% 0.24% 0.03% 0.55%
Lactobacillus_iners_DSM_13335 0.10% 0.14% 0.00% 0.72%
Lactobacillus_iners_LactinV_01V1-a 0.07% 0.03% 0.00% 0.60%
Lactobacillus_iners_LactinV_03V1-b 0.21% 0.21% 0.00% 1.04%
Lactobacillus_iners_LactinV_09V1-c 0.15% 0.11% 0.00% 0.55%
Lactobacillus_iners_LactinV_11V1-d 0.07% 0.03% 0.00% 0.43%
Lactobacillus_iners_LEAF_2052A-d 0.11% 0.15% 0.00% 0.41%
Lactobacillus_iners_LEAF_2053A-b 0.26% 0.21% 0.13% 0.86%
Lactobacillus_iners_LEAF_2062A-h1 0.08% 0.08% 0.00% 0.30%
Lactobacillus_iners_LEAF_3008A-a 0.10% 0.06% 0.00% 0.52%
Lactobacillus_iners_SPIN_1401G 0.12% 0.12% 0.01% 1.54%
Lactobacillus_iners_SPIN_2503V10-D 0.07% 0.01% 0.00% 0.22%
Lactobacillus_iners_UPII_143-D 0.03% 0.10% 0.00% 0.17%
Lactobacillus_iners_UPII_60-B 0.22% 0.40% 0.00% 0.41%
Lactobacillus_jensenii_1153 0.01% 0.00% 0.01% 0.00%
Lactobacillus_jensenii_115-3-CHN 0.00% 0.00% 0.00% 0.00%
Lactobacillus_jensenii_269-3 0.00% 0.00% 0.00% 0.00%
Lactobacillus_jensenii_27-2-CHN 0.00% 0.00% 0.00% 0.00%
Lactobacillus_jensenii_JV-V16 0.00% 0.01% 0.01% 0.00%
Lactobacillus_jensenii_SJ-7A-US 0.01% 0.10% 0.02% 0.01%
Lactobacillus_johnsonii_ATCC_33200 0.00% 0.00% 0.00% 0.00%
  
117 
 
Table 4. (cont.) 
 
Lactobacillus_oris_PB013-T2-3 0.00% 0.00% 0.00% 0.00%
Lactobacillus_salivarius_ACS-116-V-Col5a 0.00% 0.00% 0.00% 0.00%
Lactobacillus_vaginalis_ATCC_49540 0.01% 0.01% 0.06% 0.05%
Megasphaera_genomosp._type_1_str._28L 0.02% 0.00% 0.00% 0.06%
Megasphaera_sp._UPII_135-E 0.10% 0.01% 0.00% 0.04%
Megasphaera_sp._UPII_199-6 0.04% 0.01% 0.00% 0.00%
Mobiluncus_curtisii_ATCC_43063 0.29% 0.00% 0.15% 0.02%
Mobiluncus_curtisii_ATCC_51333 0.34% 0.00% 0.14% 0.01%
Mobiluncus_curtisii_subsp._curtisii_ATCC_35241 0.01% 0.00% 0.00% 0.00%
Mobiluncus_curtisii_subsp._holmesii_ATCC_35242 0.01% 0.00% 0.00% 0.00%
Mobiluncus_mulieris_28-1 0.22% 0.00% 0.12% 0.09%
Mobiluncus_mulieris_ATCC_35239 0.01% 0.00% 0.00% 0.00%
Mobiluncus_mulieris_ATCC_35243 0.00% 0.00% 0.00% 0.00%
Mobiluncus_mulieris_FB024-16 0.00% 0.00% 0.00% 0.00%
Mycobacterium_parascrofulaceum_ATCC_BAA-614 0.00% 0.00% 0.00% 0.00%
Myroides_odoratimimus_CCUG_12901 0.00% 0.00% 0.00% 0.00%
Myroides_odoratimimus_CCUG_3837 0.00% 0.00% 0.00% 0.00%
Pasteurella_bettyae_CCUG_2042 0.00% 0.05% 0.00% 0.00%
Peptoniphilus_duerdenii_ATCC_BAA-1640 0.32% 0.04% 0.01% 0.00%
Peptoniphilus_harei_ACS-146-V-Sch2b 12.40% 0.85% 0.01% 0.01%
Peptoniphilus_lacrimalis_315-B 0.22% 0.30% 0.00% 0.01%
Porphyromonas_asaccharolytica_PR426713P-I 0.01% 0.01% 0.00% 0.00%
Porphyromonas_uenonis_60-3 0.03% 0.00% 0.00% 0.00%
Prevotella_amnii_CRIS_21A-A 0.49% 0.20% 0.04% 0.06%
Prevotella_bivia_JCVIHMP010 25.14% 1.77% 0.10% 0.03%
Prevotella_buccalis_ATCC_35310 2.44% 1.16% 0.01% 0.00%
Prevotella_denticola_CRIS_18C-A 0.28% 0.15% 0.00% 0.00%
Prevotella_disiens_FB035-09AN 18.30% 0.76% 0.01% 0.01%
Prevotella_oralis_ATCC_33269 0.08% 0.00% 0.00% 0.00%
Prevotella_timonensis_CRIS_5C-B1 32.44% 23.95% 0.03% 0.01%
Propionibacterium_sp._409-HC1 0.01% 0.00% 0.00% 0.00%
Propionibacterium_sp._434-HC2 0.00% 0.00% 0.00% 0.00%
Proteus_mirabilis_ATCC_29906 0.00% 0.00% 0.00% 0.00%
Roseomonas_cervicalis_ATCC_49957 0.00% 0.00% 0.00% 0.00%
Sphingobacterium_spiritivorum_ATCC_33300 0.00% 0.00% 0.00% 0.00%
Sphingobacterium_spiritivorum_ATCC_33861 0.00% 0.00% 0.10% 0.00%
Staphylococcus_aureus_subsp._aureus_MN8 0.00% 0.01% 0.00% 0.00%
Staphylococcus_epidermidis_BVS058A4 0.00% 0.01% 0.06% 0.01%
Staphylococcus_lugdunensis_ACS-027-V-Sch2 0.00% 0.00% 0.01% 0.00%
Staphylococcus_simulans_ACS-120-V-Sch1 0.00% 0.00% 0.02% 0.02%
Streptococcus_bovis_ATCC_700338 0.00% 0.01% 0.00% 0.00%
Streptococcus_pseudoporcinus_SPIN_20026 0.07% 0.01% 0.00% 0.00%
Streptococcus_urinalis_FB127-CNA-2 0.12% 0.01% 0.02% 0.00%
Treponema_phagedenis_F0421 0.00% 0.00% 0.00% 0.00%
Veillonella_atypica_ACS-049-V-Sch6 0.00% 0.00% 0.00% 0.00%
Veillonella_atypica_ACS-134-V-Col7a 0.00% 0.00% 0.01% 0.00%
Veillonella_parvula_ACS-068-V-Sch12 0.00% 0.00% 0.00% 0.00%
Veillonella_ratti_ACS-216-V-Col6b 0.28% 0.00% 0.00% 0.00%
Note: only reads (mapping quality > 20) were considered as correct alignment.
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Table 5. List of scaffolds whose sequencing depths were bigger than 20X in Chinese 
BV patients and which were classified by essential single copy gene.  
 
Note: Reads were independently mapped from subjects SMUB9 and SMUB27 to the 
assembled scaffolds from SMUB9 or SMUB27 to calculate sequencing depth for each 
subject. Only scaffolds (sequencing depth > 20 in both subjects) are listed in the table. 
 
 
 
 
 
 
 
 
 
 
 
 
Taxonomic ID Scaffold ID Scaffold length GC (%) Sequencing depth in subject SMUB9 Sequencing depth in subject SMUB27
Actinobacteria 11 9955 38.37 24.684X 20.748X
Actinobacteria 31 16965 37.96 25.598X 21.25X
Actinobacteria 103 19418 39.78 26.577X 25.138X
Actinobacteria 105 13609 39.38 30.149X 26.823X
Actinobacteria 3659 5170 37.81 25.955X 24.831X
Actinobacteria 3665 12617 39.72 26.426X 26.474X
Actinobacteria 12 3365 43.42 32.929X 30.281X
Actinobacteria 26 4827 39.24 33.123X 20.731X
Actinobacteria 40 21633 38.39 29.12X 23.425X
Actinobacteria 68 10933 38.93 27.66X 25.003X
Actinobacteria 81 7564 37.36 21.597X 24.519X
Actinobacteria 104 17692 39.72 27.611X 26.973X
Actinobacteria 144 9311 39.3 27.43X 24.95X
Actinobacteria 1987 10015 42.19 40.205X 27.334X
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Table 6. Sequence statistics of metagenome vaginal samples. 
 
Note: Assemblies were composed of contigs that are >= 300 bp. Contig N50 is defined as 
the contig length such that using equal or longer contigs produces 50% the bases of the 
assembly. 
Metagenome coverage is calculated as a / (b*c*d) where a = the number of bases in a 
quality-filtered metagenome, b = 3 Mb average bacterial genome size, c =  400 vaginal 
bacteria,  d = 30 X sequencing depth. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Sample ID SMUB9 SMUB27 SMUN23 SMUN25
Number of bases in raw metagenome 2,653,178,696 2,738,728,726 2,602,034,922 1,596,228,644
Number of bases in quality-filtered  metagenome 409,491,561 510,629,843 568,325,264 208,244,881
Number of contigs in assembly #1 2,031 718 101 31
Total size of contigs in assembly #1 (bp) 2,286,994 490,128 49,770 14,449
Longest contig length in assembly #1 (bp) 36,300 5,656 1,986 1,431
N50 contig length in assembly #1 (bp) 1,726 722 472 424
Number of bases aligned to assembly #1 38,693,348 5,149,222 898,779 115,612
Number of contigs in assembly #2 129 157 0 0
Total size of contigs in assembly #2 (bp) 174,885 164,866 0 0
Longest contig length in assembly #2 (bp) 15,092 14,930 0 0
N50 contig length in assembly #2 (bp) 2,128 1,669 0 0
Number of bases aligned to assembly #2 3,238,746 2,512,421 0 0
Number of contigs in assembly #3 3,793 2,010 6,067 1,856
Total size of contigs in assembly #3 (bp) 3,945,182 1,701,892 3,303,190 898,952
Longest contig length in assembly #3 (bp) 22,569 21,718 13,528 6,803
N50 contig length in assembly #3 (bp) 1,533 1,096 520 466
Number of bases aligned to assembly #3 73,659,534 87,869,836 45,221,495 26,182,733
% of unassembled reads aligned to assembly #1 and 2 8.78 1.82 0.29 0.37
Metagenome coverage 0.01 0.01 0.02 0.01
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Table 7. The relative abundances of KEGG orthologous groups that were higher in 
the vaginal microbiomes of both Chinese BV patients compared to non-BV patients 
(%).  
 
KEGG 
Orthology ID Description BV_SMUB9 BV_SMUB27 NBV_SMUN23 NBV_SMUN25
K00033 6-phosphogluconate dehydrogenase [EC:1.1.1.44] 0.13 0.15 0.05 0.08
K00048 lactaldehyde reductase [EC:1.1.1.77] 0.11 0.12 0 0.09
K00075 UDP-N-acetylmuramate dehydrogenase [EC:1.1.1.158] 0.35 0.36 0 0.28
K00131 glyceraldehyde-3-phosphate dehydrogenase (NADP) [EC:1.2.1.9] 0.15 0.25 0.08 0
K00133 aspartate-semialdehyde dehydrogenase [EC:1.2.1.11] 0.26 0.36 0.25 0.11
K00134 glyceraldehyde 3-phosphate dehydrogenase [EC:1.2.1.12] 0.09 0.05 0.02 0.03
K00239 succinate dehydrogenase flavoprotein subunit [EC:1.3.99.1] 0.54 0.18 0.04 0.05
K00297 methylenetetrahydrofolate reductase (NADPH) [EC:1.5.1.20] 0.21 0.28 0.15 0.12
K00384 thioredoxin reductase (NADPH) [EC:1.8.1.9] 0.36 0.18 0.02 0.11
K00527 ribonucleoside-triphosphate reductase [EC:1.17.4.2] 0.09 0.08 0 0.05
K00528 ferredoxin--NADP+ reductase [EC:1.18.1.2] 0.09 0.13 0 0.01
K00549 5-methyltetrahydropteroyltriglutamate--homocysteine methyltransferase [EC:2.1.1.14] 0.1 0.11 0.06 0
K00554 tRNA (guanine-N1-)-methyltransferase [EC:2.1.1.31] 0.3 0.25 0.02 0.04
K00604 methionyl-tRNA formyltransferase [EC:2.1.2.9] 0.1 0.14 0 0.02
K00616 transaldolase [EC:2.2.1.2] 0.1 0.15 0.05 0.08
K00625 phosphate acetyltransferase [EC:2.3.1.8] 0.09 0.15 0.03 0.03
K00655 1-acyl-sn-glycerol-3-phosphate acyltransferase [EC:2.3.1.51] 0.21 0.32 0.08 0.17
K00656 formate C-acetyltransferase [EC:2.3.1.54] 0.09 0.16 0.04 0.03
K00760 hypoxanthine phosphoribosyltransferase [EC:2.4.2.8] 0.1 0.1 0 0.09
K00761 uracil phosphoribosyltransferase [EC:2.4.2.9] 0.15 0.07 0 0.03
K00783 hypothetical protein 0.01 0.03 0 0
K00791 tRNA dimethylallyltransferase [EC:2.5.1.75] 0.11 0.13 0.03 0.06
K00796 dihydropteroate synthase [EC:2.5.1.15] 0.16 0.06 0 0.05
K00800 3-phosphoshikimate 1-carboxyvinyltransferase [EC:2.5.1.19] 0.2 0.86 0.06 0.17
K00858 NAD+ kinase [EC:2.7.1.23] 0.13 0.15 0 0.08
K00869 mevalonate kinase [EC:2.7.1.36] 0.21 0.06 0 0.02
K00876 uridine kinase [EC:2.7.1.48] 0.04 0.06 0.02 0.03
K00925 acetate kinase [EC:2.7.2.1] 0.19 0.8 0.08 0.15
K00927 phosphoglycerate kinase [EC:2.7.2.3] 0.14 0.24 0.05 0.13
K00928 aspartate kinase [EC:2.7.2.4] 0.18 0.28 0.02 0.13
K00931 glutamate 5-kinase [EC:2.7.2.11] 0.15 0.02 0 0.01
K00941 hydroxymethylpyrimidine/phosphomethylpyrimidine kinase [EC:2.7.1.49 2.7.4.7] 0.36 0.3 0.03 0.25
K00943 dTMP kinase [EC:2.7.4.9] 0.12 0.11 0.07 0.05
K00949 thiamine pyrophosphokinase [EC:2.7.6.2] 0.16 0.08 0.05 0.07
K00969 nicotinate-nucleotide adenylyltransferase [EC:2.7.7.18] 0.16 0.42 0.1 0.05
K00982 glutamate-ammonia-ligase adenylyltransferase [EC:2.7.7.42] 0.1 0.09 0.02 0.05
K00995 CDP-diacylglycerol--glycerol-3-phosphate 3-phosphatidyltransferase [EC:2.7.8.5] 0.15 0.05 0 0.03
K00997 holo-[acyl-carrier protein] synthase [EC:2.7.8.7] 0.06 0.14 0 0.03
K01079 phosphoserine phosphatase [EC:3.1.3.3] 0.12 0.08 0.06 0.02
K01090 protein phosphatase [EC:3.1.3.16] 0.44 0.12 0.04 0.08
K01091 phosphoglycolate phosphatase [EC:3.1.3.18] 0.24 0.45 0.01 0.13
K01092 myo-inositol-1(or 4)-monophosphatase [EC:3.1.3.25] 0.22 0.17 0.06 0.15
K01104 protein-tyrosine phosphatase [EC:3.1.3.48] 0.18 0.24 0.08 0.16
K01139 guanosine-3',5'-bis(diphosphate) 3'-pyrophosphohydrolase [EC:3.1.7.2] 0.03 0.02 0 0
K01191 alpha-mannosidase [EC:3.2.1.24] 0.05 0.17 0 0.03
K01239 purine nucleosidase [EC:3.2.2.1] 0.31 0.38 0.19 0.1
K01262 Xaa-Pro aminopeptidase [EC:3.4.11.9] 0.25 0.15 0.03 0.08
K01304 pyroglutamyl-peptidase [EC:3.4.19.3] 0.1 0.62 0.01 0.06
K01338 ATP-dependent Lon protease [EC:3.4.21.53] 0.06 0.04 0.02 0
K01356 repressor LexA [EC:3.4.21.88] 0.14 0.41 0.13 0.09
K01430 urease subunit gamma [EC:3.5.1.5] 0.02 0.01 0 0
K01462 peptide deformylase [EC:3.5.1.88] 0.09 0.08 0.03 0.03
K01516 nucleoside-triphosphatase [EC:3.6.1.15] 0.15 0.05 0.02 0.03
K01533 Cu2+-exporting ATPase [EC:3.6.3.4] 0.05 0.06 0.03 0
K01588 5-(carboxyamino)imidazole ribonucleotide mutase [EC:5.4.99.18] 0.1 0.68 0.04 0.05
K01595 phosphoenolpyruvate carboxylase [EC:4.1.1.31] 0.06 0.05 0.01 0.01
K01597 diphosphomevalonate decarboxylase [EC:4.1.1.33] 0.29 0.07 0.03 0.04
K01676 fumarate hydratase, class I [EC:4.2.1.2] 0.02 0.02 0 0
K01696 tryptophan synthase beta chain [EC:4.2.1.20] 0.17 0.11 0 0.03
K01710 dTDP-glucose 4,6-dehydratase [EC:4.2.1.46] 0.19 0.19 0 0.16
K01714 dihydrodipicolinate synthase [EC:4.2.1.52] 0.15 0.14 0.03 0.08
K01783 ribulose-phosphate 3-epimerase [EC:5.1.3.1] 0.17 0.26 0.1 0.13
K01784 UDP-glucose 4-epimerase [EC:5.1.3.2] 0.16 0.18 0.05 0
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K01786 L-ribulose-5-phosphate 4-epimerase [EC:5.1.3.4] 0.16 0.01 0 0
K01810 glucose-6-phosphate isomerase [EC:5.3.1.9] 0.13 0.1 0.07 0.05
K01823 isopentenyl-diphosphate delta-isomerase [EC:5.3.3.2] 0.33 0.14 0 0.07
K01834 phosphoglycerate mutase [EC:5.4.2.1] 0.14 0.07 0.05 0.05
K01854 UDP-galactopyranose mutase [EC:5.4.99.9] 0.13 0.2 0.01 0.03
K01858 myo-inositol-1-phosphate synthase [EC:5.5.1.4] 0.1 0.04 0.02 0.03
K01872 alanyl-tRNA synthetase [EC:6.1.1.7] 0.13 0.08 0.05 0.07
K01875 seryl-tRNA synthetase [EC:6.1.1.11] 0.09 0.11 0.03 0
K01880 glycyl-tRNA synthetase [EC:6.1.1.14] 0.11 0.24 0.03 0.08
K01892 histidyl-tRNA synthetase [EC:6.1.1.21] 0.13 0.25 0.05 0.08
K01893 asparaginyl-tRNA synthetase [EC:6.1.1.22] 0.09 0.17 0.03 0
K01915 glutamine synthetase [EC:6.3.1.2] 0.21 0.26 0.06 0.08
K01916 NAD+ synthase [EC:6.3.1.5] 0.02 0.04 0 0
K01929 UDP-N-acetylmuramoylalanyl-D-glutamyl-2,6-diaminopimelate--D-alanyl-D-alanine ligase 0.44 0.33 0.01 0.09
K01938 formate--tetrahydrofolate ligase [EC:6.3.4.3] 0.37 0.39 0.03 0.19
K01950 NAD+ synthase (glutamine-hydrolysing) [EC:6.3.5.1] 0.1 0.11 0.03 0.08
K01951 GMP synthase (glutamine-hydrolysing) [EC:6.3.5.2] 0.22 0.3 0.15 0.08
K01956 carbamoyl-phosphate synthase small subunit [EC:6.3.5.5] 0.12 0.13 0.06 0.05
K02006 cobalt/nickel transport system ATP-binding protein 0.22 0.59 0.01 0.12
K02026 multiple sugar transport system permease protein 0.22 0.21 0 0.1
K02027 multiple sugar transport system substrate-binding protein 0.52 0.98 0.01 0.34
K02031 peptide/nickel transport system ATP-binding protein 0.31 0.28 0.24 0.03
K02032 peptide/nickel transport system ATP-binding protein 0.07 0.16 0.06 0.01
K02033 peptide/nickel transport system permease protein 0.25 0.51 0.05 0.09
K02034 peptide/nickel transport system permease protein 0.21 0.18 0.02 0.03
K02035 peptide/nickel transport system substrate-binding protein 0.22 0.21 0.04 0.07
K02039 phosphate transport system protein 0.2 0.3 0.03 0.05
K02115 F-type H+-transporting ATPase subunit gamma [EC:3.6.3.14] 0.1 0.07 0.03 0.03
K02217 ferritin [EC:1.16.3.1] 0.03 0.05 0.02 0
K02283 pilus assembly protein CpaF 0.3 0.15 0 0.13
K02314 replicative DNA helicase [EC:3.6.4.12] 0.28 0.19 0.08 0.08
K02341 DNA polymerase III subunit delta' [EC:2.7.7.7] 0.26 0.18 0.02 0.16
K02342 DNA polymerase III subunit epsilon [EC:2.7.7.7] 0.12 0.04 0 0.03
K02343 DNA polymerase III subunit gamma/tau [EC:2.7.7.7] 0.57 0.16 0.12 0
K02358 elongation factor Tu 0.13 0.11 0.07 0.03
K02483 two-component system, OmpR family, response regulator 0.1 0.14 0 0.08
K02529 LacI family transcriptional regulator 0.16 0.13 0.12 0.05
K02600 N utilization substance protein A 0.06 0.07 0.02 0.03
K02622 topoisomerase IV subunit B [EC:5.99.1.-] 0.05 0.04 0.02 0
K02654 leader peptidase (prepilin peptidase) / N-methyltransferase [EC:3.4.23.43 2.1.1.-] 0.13 0.1 0 0.05
K02838 ribosome recycling factor 0.09 0.1 0.02 0
K02884 large subunit ribosomal protein L19 0.12 0.1 0.05 0.03
K02897 large subunit ribosomal protein L25 0.07 0.03 0.01 0
K02945 small subunit ribosomal protein S1 0.09 0.2 0.05 0
K02948 small subunit ribosomal protein S11 0.07 0.03 0.02 0.01
K03086 RNA polymerase primary sigma factor 0.13 0.36 0.12 0.05
K03088 RNA polymerase sigma-70 factor, ECF subfamily 0.1 0.05 0.03 0
K03148 adenylyltransferase [EC:2.7.7.-] 0.06 0.01 0 0
K03149 thiamine biosynthesis ThiG 0.12 0.02 0 0
K03151 thiamine biosynthesis protein ThiI 0.04 0.04 0 0
K03177 tRNA pseudouridine synthase B [EC:5.4.99.12] 0.22 0.22 0.03 0.02
K03188 urease accessory protein 0.04 0.03 0 0
K03190 urease accessory protein 0.06 0.03 0.02 0
K03293 amino acid transporter, AAT family 0.63 0.56 0.37 0.37
K03299 gluconate:H+ symporter, GntP family 0.49 1.41 0 0.48
K03311 branched-chain amino acid:cation transporter, LIVCS family 0.19 0.21 0.16 0.11
K03320 ammonium transporter, Amt family 0.3 0.17 0.03 0.11
K03424 TatD DNase family protein [EC:3.1.21.-] 0.15 0.07 0.03 0.05
K03469 ribonuclease HI [EC:3.1.26.4] 0.12 0.13 0.04 0.01
K03470 ribonuclease HII [EC:3.1.26.4] 0.27 0.09 0.05 0.06
K03496 chromosome partitioning protein 0.33 0.42 0.18 0.31
K03497 chromosome partitioning protein, ParB family 0.08 0.04 0.02 0
K03501 ribosomal RNA small subunit methyltransferase G [EC:2.1.1.170] 0.2 0.3 0 0.12
K03525 type III pantothenate kinase [EC:2.7.1.33] 0.2 0.37 0.03 0.16
K03531 cell division protein FtsZ 0.17 0.29 0.13 0.11
K03536 ribonuclease P protein component [EC:3.1.26.5] 0.05 0.03 0 0
K03545 trigger factor 0.15 0.21 0.03 0.04
K03550 holliday junction DNA helicase RuvA 0.12 0.11 0.09 0.01
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K03551 holliday junction DNA helicase RuvB 0.19 0.13 0.02 0.02
K03575 A/G-specific adenine glycosylase [EC:3.2.2.-] 0.13 0.28 0 0.03
K03578 ATP-dependent helicase HrpA [EC:3.6.4.13] 0.2 0.22 0.07 0.13
K03589 cell division protein FtsQ 0.09 0.09 0 0.03
K03621 glycerol-3-phosphate acyltransferase PlsX [EC:2.3.1.15] 0.04 0.05 0.02 0
K03624 transcription elongation factor GreA 0.14 0.24 0.01 0.04
K03629 DNA replication and repair protein RecF 0.14 0.11 0.04 0.06
K03631 DNA repair protein RecN (Recombination protein N) 0.24 0.05 0.03 0.01
K03648 uracil-DNA glycosylase [EC:3.2.2.-] 0.1 0.11 0.02 0.04
K03655 ATP-dependent DNA helicase RecG [EC:3.6.4.12] 0.3 0.13 0 0.03
K03684 ribonuclease D [EC:3.1.13.5] 0.1 0.14 0.02 0.08
K03686 molecular chaperone DnaJ 0.19 0.05 0.02 0
K03696 ATP-dependent Clp protease ATP-binding subunit ClpC 0.69 0.43 0.32 0.34
K03699 putative hemolysin 0.13 0.25 0.11 0.03
K03701 excinuclease ABC subunit A 0.03 0.01 0 0
K03703 excinuclease ABC subunit C 0.22 0.05 0.02 0
K03704 cold shock protein (beta-ribbon, CspA family) 0.06 0.14 0.02 0.04
K03707 thiaminase (transcriptional activator TenA) [EC:3.5.99.2] 0.14 0.29 0 0
K03734 thiamine biosynthesis lipoprotein 0.25 0.13 0 0.06
K03742 competence/damage-inducible protein CinA 0.04 0.08 0.02 0
K03743 N/A 0.13 0.04 0 0
K03744 LemA protein 0.13 0.2 0 0.07
K03786 3-dehydroquinate dehydratase II [EC:4.2.1.10] 0.09 0.09 0.01 0.04
K03789 ribosomal-protein-alanine N-acetyltransferase [EC:2.3.1.128] 0.12 0.21 0.03 0.08
K03798 cell division protease FtsH [EC:3.4.24.-] 0.25 0.12 0 0.07
K03799 heat shock protein HtpX [EC:3.4.24.-] 0.3 0.36 0 0.06
K03977 GTP-binding protein 0.07 0.12 0.04 0.05
K03980 putative peptidoglycan lipid II flippase 0.4 0.17 0.15 0
K04042 bifunctional UDP-N-acetylglucosamine pyrophosphorylase / Glucosamine-1-phosphate N-ac   0.11 0.09 0.02 0.05
K04066 primosomal protein N' (replication factor Y) (superfamily II helicase) [EC:3.6.4.-] 0.15 0.26 0.03 0.03
K04069 pyruvate formate lyase activating enzyme [EC:1.97.1.4] 0.15 0.15 0.05 0.08
K04075 tRNA(Ile)-lysidine synthase [EC:6.3.4.-] 0.24 0.17 0.03 0.05
K04092 chorismate mutase [EC:5.4.99.5] 0.08 0.04 0 0
K04095 cell filamentation protein 0.19 0.05 0 0.04
K04096 DNA processing protein 0.35 0.17 0.02 0.03
K04485 DNA repair protein RadA/Sms 0.34 0.62 0.12 0.12
K04517 prephenate dehydrogenase [EC:1.3.1.12] 0.17 0.1 0 0.08
K05364 peptidoglycan glycosyltransferase [EC:2.4.1.129] 0.4 0.59 0.36 0.19
K06024 segregation and condensation protein B 0.01 0.02 0 0
K06148 ATP-binding cassette, subfamily C, bacterial 0.04 0.06 0.02 0
K06180 ribosomal large subunit pseudouridine synthase D [EC:5.4.99.12] 0.12 0.12 0.03 0
K06187 recombination protein RecR 0.16 0.17 0.02 0.05
K06199 CrcB protein 0.21 0.11 0 0.08
K06213 magnesium transporter 0.06 0.06 0.03 0
K06215 pyridoxine biosynthesis protein [EC:4.-.-.-] 0.27 0.55 0.15 0.18
K06217 phosphate starvation-inducible protein PhoH and related proteins 0.18 0.14 0 0.08
K06881 N/A 0.05 0.05 0.02 0
K06942 N/A 0.08 0.07 0.03 0.03
K06950 uncharacterized protein 0.21 0.05 0.02 0.02
K06966 N/A 0.21 0.22 0.03 0.14
K07012 N/A 0.44 1.07 0.01 0.06
K07021 N/A 0.07 0.08 0.03 0
K07024 N/A 0.16 0.15 0.03 0.07
K07043 N/A 0.02 0.05 0.01 0
K07056 N/A 0.26 0.14 0.03 0
K07089 N/A 0.13 0.64 0 0.03
K07114 uncharacterized protein 0.27 0.04 0.01 0.02
K07133 N/A 0.14 0.3 0.08 0.01
K07183 response regulator NasT 0.24 0.32 0.13 0.07
K07230 N/A 0.16 0.19 0.08 0.07
K07243 high-affinity iron transporter 0.23 0.07 0 0.06
K07259 D-alanyl-D-alanine carboxypeptidase / D-alanyl-D-alanine-endopeptidase (penicillin-binding p    0.41 0.12 0.01 0.04
K07478 putative ATPase 0.27 0.59 0.15 0.09
K07493 putative transposase 0.05 0.05 0.02 0
K07586 hypothetical protein 0.03 0.04 0.01 0
K07862 serine/threonine transporter 0.25 0.21 0 0.1
K08289 phosphoribosylglycinamide formyltransferase 2 [EC:2.1.2.2] 0.07 0.07 0.02 0.05
K08372 putative serine protease PepD [EC:3.4.21.-] 0.08 0.07 0.04 0.04
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K08591 glycerol-3-phosphate acyltransferase PlsY [EC:2.3.1.15] 0.05 0.04 0.02 0
K08659 dipeptidase [EC:3.4.-.-] 0.23 0.12 0.08 0.07
K08681 glutamine amidotransferase [EC:2.6.-.-] 0.14 0.28 0.07 0.08
K08884 serine/threonine protein kinase, bacterial [EC:2.7.11.1] 0.35 0.15 0.03 0
K09710 ribosome-associated protein 0.1 0.05 0 0
K09761 ribosomal RNA small subunit methyltransferase E [EC:2.1.1.-] 0.1 0.11 0.03 0.09
K09772 cell division inhibitor SepF 0.1 0.16 0.03 0.05
K09903 uridylate kinase [EC:2.7.4.22] 0.09 0.08 0.01 0
K10005 glutamate transport system substrate-binding protein 0.19 0.26 0.06 0.06
K10006 glutamate transport system permease protein 0.15 0.23 0.08 0.04
K10007 glutamate transport system permease protein 0.24 0.26 0.05 0.15
K10008 glutamate transport system ATP-binding protein [EC:3.6.3.-] 0.08 0.12 0.03 0.05
K10439 ribose transport system substrate-binding protein 0.18 0.08 0 0.05
K10440 ribose transport system permease protein 0.23 0.06 0 0.03
K10975 allantoin permease 0.12 0.04 0.02 0
K11031 thiol-activated cytolysin 0.1 0.09 0.06 0.01
K11753 riboflavin kinase / FMN adenylyltransferase [EC:2.7.1.26 2.7.7.2] 0.3 0.37 0.24 0
K11754 dihydrofolate synthase / folylpolyglutamate synthase [EC:6.3.2.12 6.3.2.17] 0.32 0.24 0.19 0.05
K12257 SecD/SecF fusion protein 0.1 0.15 0.09 0
K13640 MerR family transcriptional regulator, heat shock protein HspR 0.16 0.04 0 0
K13787 geranylgeranyl diphosphate synthase, type I [EC:2.5.1.1 2.5.1.10 2.5.1.29] 0.11 0.21 0.04 0.09
K13788 phosphate acetyltransferase [EC:2.3.1.8] 0.12 0.22 0.03 0.07
K17330 N/A 0.15 0.01 0 0
K18682 N/A 0.01 0.18 0 0
Note: N/A represents there is no related information.
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Table 8. Taxonomic abundance in Chinese women with and without BV at the genus 
level (%).  
 
Note: Numbers indicate the number of reads assigned to that bacterial genus (mean ± 
standard error of the mean). 
Bacterial genera Chinese women with BV Chinese women without BV
Lactobacillus 55.9 ± 5.49 74.16 ± 10.92
Acinetobacter 0.43 ± 0.09 0.4 ± 0.35
Adhaeribacter 0.04 ± 0.03 0 ± 0.00
Aerococcus 5.68 ± 1.87 2.86 ± 2.84
Aeromonas 0.35 ± 0.20 0.83 ± 0.83
Alkanindiges 0.01 ± 0.00 0 ± 0.00
Anaerococcus 0.01 ± 0.01 0.01 ± 0.00
Atopobium 0.12 ± 0.03 0.22 ± 0.21
Bacillus 0.03 ± 0.03 0 ± 0.00
Bacteroides 0.05 ± 0.03 0 ± 0.00
Bifidobacterium 0.01 ± 0.00 0 ± 0.00
Brevundimonas 0.02 ± 0.00 0 ± 0.00
Campylobacter 0 ± 0.00 0.04 ± 0.04
Chryseobacterium 0.01 ± 0.01 0 ± 0.00
Cloacibacterium 0.37 ± 0.15 0.01 ± 0.00
Comamonas 0.07 ± 0.04 0.07 ± 0.07
Corynebacterium 0.02 ± 0.01 0.02 ± 0.02
Deinococcus 0.08 ± 0.04 0 ± 0.00
Dialister 5.57 ± 1.86 1 ± 0.50
Diaphorobacter 0.44 ± 0.19 0.02 ± 0.01
Enterococcus 2.44 ± 0.90 0.14 ± 0.07
Gardnerella 1.37 ± 0.28 1.01 ± 0.76
Gemella 0.01 ± 0.01 0.01 ± 0.01
Gp4 0.06 ± 0.03 0 ± 0.00
Hallella 0.06 ± 0.04 0.06 ± 0.06
Halomonas 0.16 ± 0.16 0 ± 0.00
Hyphomicrobium 0.01 ± 0.00 0 ± 0.00
Janthinobacterium 0.02 ± 0.02 0 ± 0.00
Jonquetella 0.18 ± 0.14 0 ± 0.00
Mycoplasma 0.01 ± 0.00 0.01 ± 0.00
Neisseria 0 ± 0.00 0.01 ± 0.00
OD1 genera incertae sedis 0.01 ± 0.01 0.03 ± 0.03
Parvimonas 0.01 ± 0.00 0 ± 0.00
Peptoniphilus 0.05 ± 0.02 0 ± 0.00
Peptostreptococcus 0.03 ± 0.02 0.09 ± 0.06
Prevotella 10.78 ± 3.04 1.31 ± 1.00
Propionibacterium 0.03 ± 0.01 0 ± 0.00
Pseudomonas 0 ± 0.00 7.83 ± 7.78
Saccharofermentans 0.92 ± 0.61 0.01 ± 0.00
Sneathia 2.15 ± 1.15 2.78 ± 2.74
Staphylococcus 2.08 ± 0.95 1.36 ± 1.32
Streptococcus 2.03 ± 1.70 3.63 ± 3.63
Ureaplasma 8.28 ± 2.93 2.08 ± 1.97
Veillonella 0.1 ± 0.06 0.01 ± 0.00
Xanthobacter 0.01 ± 0.01 0 ± 0.00
Subdivision3 genera incertae sedis 0 ± 0.00 0.01 ± 0.01
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Table 9. Taxonomic abundance in Chinese women with and without BV at the 
strain level (%). 
 
Bacterial strains Chinese women with BV Chinese women without BV
Anaerococcus hydrogenalis ACS-025-V-Sch4 0.04 ± 0.04 0 ± 0.00
Anaerococcus lactolyticus ATCC 51172 0 ± 0.00 0.01 ± 0.01
Atopobium vaginae DSM 15829 4.33 ± 4.27 0.07 ± 0.04
Atopobium vaginae PB189-T1-4 0.04 ± 0.01 0.01 ± 0.01
Bifidobacterium dentium JCVIHMP022 0.01 ± 0.00 41.43 ± 9.84
Clostridiales genomosp. BVAB3 str. UPII9-5 0.11 ± 0.01 0.04 ± 0.02
Corynebacterium glucuronolyticum ATCC 51867 0.01 ± 0.01 0.74 ± 0.71
Corynebacterium lipophiloflavum DSM 44291 0 ± 0.00 1.3 ± 0.85
Corynebacterium pseudogenitalium ATCC 33035 0.01 ± 0.01 0 ± 0.00
Dialister microaerophilus UPII 345-E 0.02 ± 0.01 0.03 ± 0.02
Enterococcus faecalis ERV85 0.06 ± 0.06 0 ± 0.00
Eremococcus coleocola ACS-139-V-Col8 0 ± 0.00 0.01 ± 0.01
Escherichia coli 83972 0 ± 0.00 7.58 ± 6.27
Finegoldia magna BVS033A4 0.01 ± 0.01 0 ± 0.00
Finegoldia magna SY403409CC001050417 0.01 ± 0.01 0 ± 0.00
Gardnerella vaginalis 315-A 16.9 ± 0.84 1.7 ± 1.33
Gardnerella vaginalis 409-05 28.12 ± 2.72 4.52 ± 1.85
Gardnerella vaginalis ATCC 14019 17.02 ± 1.79 1.61 ± 1.13
Gardnerella vaginalis HMP9231 30.88 ± 3.28 3.13 ± 2.19
Klebsiella oxytoca 10-5245 0 ± 0.00 0.01 ± 0.01
Lactobacillus gasseri 224-1 0.01 ± 0.00 29.17 ± 4.62
Lactobacillus iners ATCC 55195 0.02 ± 0.01 0.17 ± 0.16
Lactobacillus iners DSM 13335 0.01 ± 0.00 0.14 ± 0.14
Lactobacillus iners LactinV 01V1-a 0.02 ± 0.01 0.19 ± 0.19
Lactobacillus iners LactinV 03V1-b 0.05 ± 0.00 0.33 ± 0.33
Lactobacillus iners LactinV 09V1-c 0.07 ± 0.03 0.29 ± 0.29
Lactobacillus iners LactinV 11V1-d 0.02 ± 0.01 0.29 ± 0.29
Lactobacillus iners LEAF 2052A-d 0.01 ± 0.01 0.09 ± 0.09
Lactobacillus iners LEAF 2053A-b 0.01 ± 0.00 0.14 ± 0.14
Lactobacillus iners LEAF 2062A-h1 0.08 ± 0.02 0.14 ± 0.14
Lactobacillus iners LEAF 3008A-a 0.02 ± 0.01 0.31 ± 0.31
Lactobacillus iners SPIN 1401G 0.04 ± 0.01 0.51 ± 0.51
Lactobacillus iners SPIN 2503V10-D 0.05 ± 0.02 0.55 ± 0.55
Lactobacillus iners UPII 143-D 0.04 ± 0.01 0.66 ± 0.66
Lactobacillus iners UPII 60-B 0.13 ± 0.03 1.27 ± 1.27
Lactobacillus jensenii SJ-7A-US 0.08 ± 0.07 0 ± 0.00
Lactobacillus salivarius ACS-116-V-Col5a 0.01 ± 0.00 0 ± 0.00
Lactobacillus vaginalis ATCC 49540 0 ± 0.00 3.46 ± 1.35
Megasphaera genomosp type 1 str 28L 0.04 ± 0.00 0.01 ± 0.01
Megasphaera sp. UPII 135-E 0 ± 0.00 0.01 ± 0.01
Mobiluncus curtisii ATCC 43063 0.03 ± 0.03 0.01 ± 0.01
Mobiluncus curtisii ATCC 51333 0.07 ± 0.07 0.03 ± 0.00
Mobiluncus curtisii subsp curtisii ATCC 35241 0.01 ± 0.01 0.01 ± 0.01
Mobiluncus curtisii subsp holmesii ATCC 35242 0.01 ± 0.01 0.01 ± 0.01
Mobiluncus mulieris 28-1 0.02 ± 0.02 0.01 ± 0.00
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Table 9. (cont.) 
 
Note: Numbers indicate the number of reads assigned to that bacterial genus (mean ± 
standard error of the mean). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Mobiluncus mulieris ATCC 35239 0.01 ± 0.01 0 ± 0.00
Mobiluncus mulieris FB024-16 0.01 ± 0.01 0 ± 0.00
Peptoniphilus duerdenii ATCC BAA-1640 0.01 ± 0.01 0.01 ± 0.01
Peptoniphilus harei ACS-146-V-Sch2b 0.01 ± 0.01 0.02 ± 0.02
Peptoniphilus lacrimalis 315-B 0.04 ± 0.04 0 ± 0.00
Prevotella amnii CRIS 21A-A 0.01 ± 0.01 0.01 ± 0.01
Prevotella bivia JCVIHMP010 0.05 ± 0.01 0 ± 0.00
Prevotella buccalis ATCC 35310 0.06 ± 0.04 0 ± 0.00
Prevotella denticola CRIS 18C-A 0.02 ± 0.01 0 ± 0.00
Prevotella disiens FB035-09AN 0.06 ± 0.02 0 ± 0.00
Prevotella oralis ATCC 33269 0.01 ± 0.01 0 ± 0.00
Prevotella timonensis CRIS 5C-B1 1.27 ± 0.92 0.01 ± 0.01
Staphylococcus epidermidis BVS058A4 0.08 ± 0.08 0 ± 0.00
Streptococcus bovis ATCC 700338 0.01 ± 0.01 0.04 ± 0.04
Streptococcus pseudoporcinus SPIN 20026 0.04 ± 0.01 0.04 ± 0.03
Streptococcus urinalis FB127-CNA-2 0.01 ± 0.01 0 ± 0.00
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Table 10. Sample descriptions. 
 
Note: BV in the USA was determined by the Amsel or Nugent criteria. Amsel-positive 
patients are named as symptomatic BV patients. Amsel-negative patients with high 
Nugent Score (7-10) are named as asymptomatic BV patients.   Symptoms: (D)ischarge, 
(O)dor, (P)ain, (I)tching. NA represents that there are no BV symptoms observed in the 
individual. 
 
 
 
 
 
 
 
 
 
Sample ID 403 405 409 412 416
Disease Status NBV NBV Asymptomatic BV Symptomatic BV Symptomatic BV
BV Symptoms NA NA NA DPI D
Amsel Criteria Amsel-negative Amsel-negative Amsel-negative Amsel-positive Amsel-positive
Nugent Score 6 0 9 6 3
Race/Ethnicity Asian American/Indian Caucasian Caucasian African American Caucasian
Age In Years 20 36-40 22 26 22
Length Of Residence 2-5 years More than 10 years 2-5 years 5-10 years More than 10 years
Marital Status Single Divorced Single Single Single
Sexual Orientation Bisexual Heterosexual Heterosexual Not reported Heterosexual
Days Since Last Period 16 Not reported 30 15 20
Tampon Use During Periods Yes Yes Yes No Yes
Number Of Previous Pregnancies 0 0 0 2 0
Number Of Sexual Partners In 
the Past 6 Months 2 0 4-6 1 1
Gender of Sexual Partners In the 
Past 6 Months Male Not reported Male Male Male
New Sexual Partner In the Past 6 
Months Yes No Yes No No
Days Since Intercourse 0 Not reported 3 10 3
Number Of Vaginal Sex/Week 7+ 0 0-2 7+ 3-4
Number Of Oral Sex/Week 5-6 0 0-2 0 0-2
Number Of Anal Sex/Week 3-4 0 0-2 0 0
Condom Use More than half of the time Not reported Less than half of the time More than half of the time No
Number Of Bath/Week 0-2 0-2 0-2 5-6 0-2
Days Since Last Douche 90 7 6
Comorbidities Asthma
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Table 11. 16S rRNA sequence statistics of vaginal samples.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Sample 
ID
Total 
sequences 
number
Quality-
filtered 
sequences 
number
Average 
quality-
filtered 
sequence 
length (nt)
403 99,431 63,459 440
405 95,599 79,011 488
409 92,029 54,495 475
412 232,634 158,473 377
416 105,012 81,738 493
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Table 12. Summary of the percentage of bases covered for each HMP urogenital 
tract reference genome in each sample. 
 
 
Symptomatic_
BV_USA_412
Symptomatic_
BV_USA_416
Asymptomatic
_BV_USA_409
NBV_USA
_403 NBV_USA_405
Acinetobacter_baumannii_ATCC_19606_=_CIP_70.34 0.01% 0.00% 0.05% 0.15% 0.04%
Actinobaculum_massiliae_ACS-171-V-Col2 0.00% 0.00% 0.00% 0.00% 0.00%
Actinomyces_coleocanis_DSM_15436 0.00% 0.00% 0.00% 0.00% 0.00%
Actinomyces_neuii_BVS029A5 0.00% 0.02% 0.00% 0.32% 0.00%
Actinomyces_turicensis_ACS-279-V-Col4 0.00% 0.00% 0.04% 0.00% 0.00%
Actinomyces_urogenitalis_DSM_15434 0.00% 0.00% 0.00% 0.00% 0.00%
Aerococcus_urinae_ACS-120-V-Col10a 0.01% 0.00% 0.07% 0.03% 0.00%
Aerococcus_viridans_ATCC_11563 0.00% 0.00% 0.02% 0.00% 0.00%
Anaerococcus_hydrogenalis_ACS-025-V-Sch4 0.01% 0.03% 0.07% 17.86% 0.02%
Anaerococcus_lactolyticus_ATCC_51172 0.01% 0.01% 0.25% 0.41% 0.01%
Anaerococcus_prevotii_ACS-065-V-Col13 0.00% 0.00% 0.05% 0.17% 0.02%
Anaerococcus_tetradius_ATCC_35098 0.01% 0.03% 0.15% 0.07% 0.00%
Atopobium_vaginae_DSM_15829 0.36% 0.15% 92.09% 86.39% 0.47%
Atopobium_vaginae_PB189-T1-4 0.00% 0.00% 1.41% 0.23% 0.01%
Bifidobacterium_breve_ACS-071-V-Sch8b 0.00% 0.00% 0.00% 0.00% 0.00%
Bifidobacterium_dentium_ATCC_27679 0.00% 0.00% 0.00% 0.00% 0.00%
Bifidobacterium_dentium_JCVIHMP022 0.00% 0.00% 0.00% 0.00% 0.00%
Brevibacterium_mcbrellneri_ATCC_49030 0.00% 0.00% 0.00% 0.00% 0.00%
Chryseobacterium_gleum_ATCC_35910 0.00% 0.00% 0.00% 0.00% 0.00%
Clostridiales_genomosp._BVAB3_str._UPII9-5 0.17% 0.01% 1.04% 0.65% 0.00%
Corynebacterium_aurimucosum_ATCC_700975 0.00% 0.02% 0.00% 0.01% 0.00%
Corynebacterium_genitalium_ATCC_33030 0.00% 0.00% 0.00% 0.00% 0.00%
Corynebacterium_glucuronolyticum_ATCC_51866 0.00% 0.00% 0.00% 0.01% 0.00%
Corynebacterium_glucuronolyticum_ATCC_51867 0.00% 0.00% 0.00% 0.00% 0.00%
Corynebacterium_jeikeium_ATCC_43734 0.00% 0.00% 0.00% 0.00% 0.00%
Corynebacterium_lipophiloflavum_DSM_44291 0.00% 0.00% 0.00% 0.00% 0.00%
Corynebacterium_pseudogenitalium_ATCC_33035 0.01% 0.10% 0.01% 0.79% 0.09%
Corynebacterium_striatum_ATCC_6940 0.00% 0.01% 0.00% 0.02% 0.01%
Dialister_micraerophilus_DSM_19965 0.30% 0.15% 7.12% 3.22% 0.04%
Dialister_microaerophilus_UPII_345-E 0.01% 0.01% 10.51% 0.25% 0.00%
Enterococcus_durans_FB129-CNAB-4 0.00% 0.00% 0.00% 0.00% 0.00%
Enterococcus_faecalis_ATCC_29200 0.00% 0.00% 0.00% 0.00% 0.00%
Enterococcus_faecalis_ERV81 0.00% 0.00% 0.00% 0.00% 0.00%
Enterococcus_faecalis_ERV85 0.00% 0.00% 0.00% 0.00% 0.00%
Enterococcus_faecalis_ERV93 0.00% 0.00% 0.00% 0.00% 0.00%
Enterococcus_faecalis_HH22 0.00% 0.00% 0.00% 0.00% 0.00%
Enterococcus_faecalis_TX0312 0.00% 0.00% 0.00% 0.00% 0.00%
Enterococcus_faecalis_TX0635 0.00% 0.00% 0.00% 0.00% 0.00%
Enterococcus_faecalis_TX0855 0.00% 0.00% 0.00% 0.00% 0.00%
Enterococcus_faecium_E422 0.00% 0.00% 0.00% 0.00% 0.00%
Enterococcus_faecium_P1139 0.00% 0.00% 0.06% 0.02% 0.00%
Enterococcus_faecium_S447 0.00% 0.00% 0.00% 0.00% 0.00%
Eremococcus_coleocola_ACS-139-V-Col8 0.00% 0.00% 0.01% 0.00% 0.00%
Escherichia_coli_83972 0.01% 0.00% 0.00% 0.01% 0.05%
Finegoldia_magna_ACS-171-V-Col3 0.00% 0.00% 0.24% 0.12% 0.03%
Finegoldia_magna_ATCC_53516 0.00% 0.34% 0.18% 0.16% 0.02%
Finegoldia_magna_BVS033A4 0.00% 0.00% 0.35% 0.02% 0.01%
Finegoldia_magna_SY403409CC001050417 0.01% 0.04% 0.28% 1.27% 0.05%
Fusobacterium_nucleatum_subsp._nucleatum_ATCC_23726 0.04% 0.01% 0.12% 0.02% 0.00%
Gardnerella_vaginalis_315-A 0.64% 0.10% 6.83% 19.59% 0.05%
Gardnerella_vaginalis_409-05 0.95% 1.93% 99.24% 87.03% 1.53%
Gardnerella_vaginalis_ATCC_14019 0.42% 0.05% 7.18% 17.61% 0.02%
Gardnerella_vaginalis_HMP9231 0.87% 0.08% 7.11% 17.06% 0.05%
  
130 
 
Table 12. (cont.) 
 
 
 
Haemophilus_parainfluenzae_HK262 0.00% 0.00% 0.00% 3.37% 0.00%
Klebsiella_oxytoca_10-5245 0.00% 0.00% 0.00% 0.02% 0.00%
Klebsiella_oxytoca_10-5250 0.00% 0.00% 0.00% 0.00% 0.00%
Lactobacillus_coleohominis_101-4-CHN 1.32% 0.11% 0.00% 0.24% 0.35%
Lactobacillus_crispatus_125-2-CHN 0.14% 0.19% 0.00% 0.00% 1.86%
Lactobacillus_crispatus_214-1 0.04% 0.23% 0.01% 0.02% 0.90%
Lactobacillus_crispatus_CTV-05 0.46% 2.36% 0.00% 0.05% 3.23%
Lactobacillus_crispatus_FB049-03 0.67% 0.45% 0.01% 0.00% 1.38%
Lactobacillus_crispatus_FB077-07 0.48% 0.55% 0.00% 0.01% 3.79%
Lactobacillus_crispatus_JV-V01 0.09% 0.02% 0.00% 0.00% 0.08%
Lactobacillus_crispatus_MV-1A-US 0.41% 0.80% 0.00% 0.00% 0.22%
Lactobacillus_crispatus_MV-3A-US 1.22% 0.53% 0.00% 0.00% 0.32%
Lactobacillus_crispatus_SJ-3C-US 0.42% 0.23% 0.00% 0.02% 0.99%
Lactobacillus_delbrueckii_subsp._bulgaricus_PB2003/044-T3-4 0.00% 0.00% 0.00% 0.00% 0.00%
Lactobacillus_fermentum_28-3-CHN 0.00% 0.02% 0.00% 0.01% 0.02%
Lactobacillus_gasseri_202-4 0.74% 0.64% 0.02% 16.71% 0.02%
Lactobacillus_gasseri_224-1 0.05% 0.04% 0.02% 0.17% 0.03%
Lactobacillus_gasseri_JV-V03 1.63% 0.02% 0.00% 0.18% 0.02%
Lactobacillus_gasseri_MV-22 0.02% 0.04% 0.00% 0.07% 0.23%
Lactobacillus_gasseri_SJ-9E-US 0.06% 0.00% 0.00% 0.01% 0.01%
Lactobacillus_gasseri_SV-16A-US 0.02% 0.02% 0.00% 0.85% 0.00%
Lactobacillus_iners_ATCC_55195 2.79% 1.61% 1.42% 0.01% 0.71%
Lactobacillus_iners_DSM_13335 3.31% 2.09% 0.75% 0.01% 0.48%
Lactobacillus_iners_LactinV_01V1-a 1.65% 1.64% 0.86% 0.00% 0.19%
Lactobacillus_iners_LactinV_03V1-b 2.57% 1.70% 0.95% 0.04% 0.26%
Lactobacillus_iners_LactinV_09V1-c 2.74% 1.88% 0.99% 0.00% 0.27%
Lactobacillus_iners_LactinV_11V1-d 2.44% 1.35% 0.80% 0.03% 0.53%
Lactobacillus_iners_LEAF_2052A-d 2.60% 1.41% 1.38% 0.00% 0.68%
Lactobacillus_iners_LEAF_2053A-b 9.22% 8.26% 1.22% 0.23% 0.79%
Lactobacillus_iners_LEAF_2062A-h1 3.18% 1.45% 1.06% 0.04% 0.19%
Lactobacillus_iners_LEAF_3008A-a 1.55% 1.67% 0.53% 0.00% 0.33%
Lactobacillus_iners_SPIN_1401G 1.79% 1.37% 0.72% 0.91% 0.41%
Lactobacillus_iners_SPIN_2503V10-D 1.60% 3.15% 0.60% 0.00% 0.26%
Lactobacillus_iners_UPII_143-D 1.63% 1.15% 0.82% 0.00% 0.20%
Lactobacillus_iners_UPII_60-B 4.02% 3.25% 1.21% 0.13% 0.47%
Lactobacillus_jensenii_1153 0.00% 1.45% 0.00% 0.03% 0.00%
Lactobacillus_jensenii_115-3-CHN 0.00% 0.00% 0.00% 0.00% 0.02%
Lactobacillus_jensenii_269-3 0.00% 0.35% 0.00% 0.01% 0.00%
Lactobacillus_jensenii_27-2-CHN 0.00% 0.00% 0.00% 0.00% 0.02%
Lactobacillus_jensenii_JV-V16 0.12% 0.05% 0.00% 0.00% 9.02%
Lactobacillus_jensenii_SJ-7A-US 0.20% 6.46% 0.01% 0.01% 0.12%
Lactobacillus_johnsonii_ATCC_33200 0.00% 0.00% 0.00% 0.11% 0.00%
Lactobacillus_oris_PB013-T2-3 0.06% 0.02% 0.00% 0.00% 0.01%
Lactobacillus_salivarius_ACS-116-V-Col5a 0.00% 0.00% 0.00% 0.01% 0.00%
Lactobacillus_vaginalis_ATCC_49540 0.02% 1.10% 0.01% 1.51% 2.00%
Megasphaera_genomosp._type_1_str._28L 0.00% 0.00% 0.17% 0.07% 0.00%
Megasphaera_sp._UPII_135-E 0.01% 0.00% 0.46% 0.05% 0.00%
Megasphaera_sp._UPII_199-6 0.00% 0.00% 0.15% 0.04% 0.00%
Mobiluncus_curtisii_ATCC_43063 0.00% 0.00% 0.00% 0.00% 0.00%
Mobiluncus_curtisii_ATCC_51333 0.00% 0.00% 0.00% 0.00% 0.00%
Mobiluncus_curtisii_subsp._curtisii_ATCC_35241 0.00% 0.00% 0.00% 0.00% 0.00%
Mobiluncus_curtisii_subsp._holmesii_ATCC_35242 0.00% 0.00% 0.01% 0.02% 0.00%
Mobiluncus_mulieris_28-1 0.00% 0.00% 0.00% 0.00% 0.00%
Mobiluncus_mulieris_ATCC_35239 0.00% 0.00% 0.00% 0.00% 0.00%
Mobiluncus_mulieris_ATCC_35243 0.00% 0.00% 0.00% 0.00% 0.00%
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Table 12. (cont.) 
 
 
 
 
 
 
 
 
 
 
Mobiluncus_mulieris_FB024-16 0.00% 0.00% 0.00% 0.00% 0.00%
Mycobacterium_parascrofulaceum_ATCC_BAA-614 0.00% 0.00% 0.00% 0.00% 0.00%
Myroides_odoratimimus_CCUG_12901 0.00% 0.00% 0.00% 0.00% 0.00%
Myroides_odoratimimus_CCUG_3837 0.00% 0.00% 0.00% 0.00% 0.00%
Pasteurella_bettyae_CCUG_2042 0.00% 0.00% 0.02% 0.02% 0.00%
Peptoniphilus_duerdenii_ATCC_BAA-1640 0.06% 0.00% 0.25% 0.08% 0.00%
Peptoniphilus_harei_ACS-146-V-Sch2b 0.00% 0.11% 0.21% 8.29% 0.11%
Peptoniphilus_lacrimalis_315-B 0.13% 0.00% 0.28% 0.06% 0.01%
Porphyromonas_asaccharolytica_PR426713P-I 0.00% 0.00% 0.00% 0.01% 0.00%
Porphyromonas_uenonis_60-3 0.01% 0.00% 0.67% 0.00% 0.00%
Prevotella_amnii_CRIS_21A-A 0.05% 0.02% 85.27% 0.31% 0.11%
Prevotella_bivia_JCVIHMP010 0.08% 2.14% 84.10% 55.79% 0.81%
Prevotella_buccalis_ATCC_35310 0.05% 0.01% 9.99% 0.15% 0.01%
Prevotella_denticola_CRIS_18C-A 0.00% 0.01% 1.58% 0.20% 0.00%
Prevotella_disiens_FB035-09AN 0.05% 0.02% 1.80% 0.28% 0.01%
Prevotella_oralis_ATCC_33269 0.00% 0.00% 0.07% 0.01% 0.00%
Prevotella_timonensis_CRIS_5C-B1 0.14% 0.02% 1.76% 0.26% 0.15%
Propionibacterium_sp._409-HC1 0.00% 0.02% 0.00% 0.00% 0.00%
Propionibacterium_sp._434-HC2 0.00% 0.00% 0.00% 0.01% 0.00%
Proteus_mirabilis_ATCC_29906 0.00% 0.00% 0.00% 0.01% 0.00%
Roseomonas_cervicalis_ATCC_49957 0.00% 0.00% 0.00% 0.00% 0.00%
Sphingobacterium_spiritivorum_ATCC_33300 0.00% 0.00% 0.00% 0.00% 0.00%
Sphingobacterium_spiritivorum_ATCC_33861 0.00% 0.00% 0.00% 0.00% 0.00%
Staphylococcus_aureus_subsp._aureus_MN8 0.00% 0.00% 0.02% 0.02% 0.05%
Staphylococcus_epidermidis_BVS058A4 0.07% 0.41% 0.01% 0.04% 0.06%
Staphylococcus_lugdunensis_ACS-027-V-Sch2 0.00% 0.00% 0.00% 0.00% 0.00%
Staphylococcus_simulans_ACS-120-V-Sch1 0.00% 0.00% 0.00% 0.00% 0.00%
Streptococcus_bovis_ATCC_700338 0.00% 0.00% 0.02% 0.01% 0.00%
Streptococcus_pseudoporcinus_SPIN_20026 0.01% 0.01% 0.08% 0.03% 0.00%
Streptococcus_urinalis_FB127-CNA-2 0.02% 0.00% 0.07% 0.01% 0.00%
Treponema_phagedenis_F0421 0.00% 0.00% 0.01% 0.00% 0.00%
Veillonella_atypica_ACS-049-V-Sch6 0.00% 0.00% 0.00% 0.02% 0.00%
Veillonella_atypica_ACS-134-V-Col7a 0.00% 0.00% 0.03% 0.08% 0.00%
Veillonella_parvula_ACS-068-V-Sch12 0.00% 0.03% 0.06% 0.26% 0.00%
Veillonella_ratti_ACS-216-V-Col6b 0.02% 0.00% 0.02% 0.02% 0.00%
Note: only reads (mapping quality > 20) were considered as correct alignment.
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Table 13. List of scaffolds whose sequencing depths were bigger than 20X in the US 
BV patients and which were classified by essential single copy gene. 
 
Note: Reads were independently mapped from subject 412 and 416 to the assembled 
scaffolds from 412 or 416 to calculate sequencing depth for each subject. Only scaffolds 
(sequencing depth > 20 in both subjects) are listed in the table. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Taxonomic ID Scaffold ID Scaffold length GC (%) Sequencing depth in subject 412 Sequencing depth in subject 416
Firmicutes 9 96002 33.84 21.105X 29.683X
Firmicutes 44 15377 34.96 30.507X 24.649X
Firmicutes 229 9947 32.71 31.366X 25.312X
Firmicutes 1162 8425 32.45 28.363X 20.202X
Firmicutes 2886 12830 32.34 30.698X 21.666X
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Table 14. Sequence statistics of metagenome vaginal samples. 
 
Note: Assemblies were composed of contigs that are >= 300 bp. Contig N50 is defined 
as the contig length such that using equal or longer contigs produces 50% the bases of 
the assembly. 
Metagenome coverage is calculated as a / (b*c*d) where a = the number of bases in a 
quality-filtered metagenome, b = 3 Mb average bacterial genome size, c =  400 vaginal 
bacteria,  d = 30 X sequencing depth. 
 
 
Sample ID 403 405 409 412 416
Number of bases in raw 
metagenome 2,861,944,484 2,401,202,078 2,486,494,154 1,864,440,406 1,979,304,878
Number of bases in quality-
filtered  metagenome 625,577,947 466,419,347 453,049,970 198,301,156 135,032,473
Number of contigs in 
assembly #1 2,226 208 3,273 263 291
Total size of contigs in 
assembly #1 (bp) 3,238,879 121,543 6,695,385 222,561 224,266
Longest contigs length in 
assembly #1 (bp) 35,100 6,029 254,925 10,219 9,772
N50 contig length in 
assembly #1 (bp) 3,496 566 5,345 1,245 945
Number of bases aligned to 
assembly #1
122,155,741 19,488,753 164,582,366 27,486,163 2,326,934
Number of contigs in 
assembly #2 0 0 0 22 113
Total size of contigs in 
assembly #2 (bp) 0 0 0 122,100 133,316
Longest contigs length in 
assembly #2 (bp) 0 0 0 41,164 14,072
N50 contig length in 
assembly #2 (bp) 0 0 0 33,992 1,980
Number of bases aligned to 
assembly #2 0 0 0 3,369,112 2,202,156
Number of contigs in 
assembly #3 6,402 1,102 10,502 362 2,905
Total size of contigs in 
assembly #3 (bp) 7,630,506 2,843,858 9,998,666 1,530,246 2,408,033
Longest contigs length in 
assembly #3 (bp) 47,614 112,374 40,767 116,168 36,056
N50 contig length in 
assembly #3 (bp) 2,118 15,623 1,301 43,763 1,056
Number of bases aligned to 
assembly #3 236,831,991 298,666,171 136,881,145 76,585,271 28,288,767
Metagenome coverage 0.02 0.01 0.01 0.01 0
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Table 15. List of metabolites correlated with vaginal discharge in Yeoman et al. 1. 
 
 
 
 
 
1-Acetoxy-2-Propanol
1-Hydroxy-2-Propanone
1-Methyl-4-hydroxy-1H-imidazol-2-amine
1,2-Propanediol
1,2-Propanediol,_2-acetate
1,3-Dihydro_isobenzofuran
1,4-Dimethyldioxane
2-Aminoethylphosphate
2-Ethyl-4-methyl-1,3-Dioxolane
2-Hydroxy-3-methyl-2-Cyclopenten-1-one
2-Methyl-2-hydroxybutanoic_acid
2-O-Glycerol-beta-D-galactopyranoside
2,3-Hydroxypropyl_2-aminoethylphosphate
3-Phosphoglycerate
3-Pyridinecarboxamide
Acetic_acid_(Acetate)
Alanine
Arabitol
Cyclopentanol
Ethanolamine
Gluconic_acid
Gluconic_acid-1,5-lactone
Glucose
Glutamic_acid_(Glutamate)
Glycerin
Guanine
Inositol-P
Lactic_acid_(Lactate)
N-Acetyl-serine
Ornithine
Ribose
Threonine
Valine
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Table 16. Network connections among bacteria, functional genes, and metabolites. 
 
Node 1 Node 2
Spearman 
correlation 
coefficient
FDR-adjusted 
p-values
2-Hydroxy-3-methyl-2-Cyclopenten-1-one K11031 thiol-activated cytolysin 1 0
2-Ethyl-4-methyl-1,3-Dioxolane K03320 ammonium transporter, Amt family 1 0
Gluconic_acid-1,5-lactone K03320 ammonium transporter, Amt family 1 0
2-Hydroxy-3-methyl-2-Cyclopenten-1-one K01000 phospho-N-acetylmuramoyl-pentapeptide-transferase 1 0
2-Hydroxy-3-methyl-2-Cyclopenten-1-one K01736 chorismate synthase [EC:4.2.3.5] 1 0
Lactic_acid K01262 Xaa-Pro aminopeptidase [EC:3.4.11.9] -1 0
Lactic_acid K01915 glutamine synthetase [EC:6.3.1.2] -1 0
Arabitol K03431 phosphoglucosamine mutase [EC:5.4.2.10] -1 0
Arabitol K00790 UDP-N-acetylglucosamine 1-carboxyvinyltransferase -1 0
Lactic_acid K00133 aspartate-semialdehyde dehydrogenase [EC:1.2.1.11] -1 0
Arabitol K01887 arginyl-tRNA synthetase [EC:6.1.1.19] -1 0
Arabitol K03293 amino acid transporter, AAT family -1 0
Lactic_acid K00791 tRNA dimethylallyltransferase [EC:2.5.1.75] -1 0
2-Hydroxy-3-methyl-2-Cyclopenten-1-one K02483 two-component system, OmpR family, response regulator 1 0
Acetic_acid K02313 chromosomal replication initiator protein -1 0
Arabitol K01924 UDP-N-acetylmuramate--alanine ligase [EC:6.3.2.8] -1 0
Arabitol K00963 UTP--glucose-1-phosphate uridylyltransferase -1 0
2-Hydroxy-3-methyl-2-Cyclopenten-1-one K01868 threonyl-tRNA synthetase [EC:6.1.1.3] 1 0
2-Hydroxy-3-methyl-2-Cyclopenten-1-one K03531 cell division protein FtsZ 1 0
2-Ethyl-4-methyl-1,3-Dioxolane K03589 cell division protein FtsQ 1 0
Ethanolamine K03470 ribonuclease HII [EC:3.1.26.4] 1 0
Ethanolamine K07042 probable rRNA maturation factor 1 0
Gluconic_acid-1,5-lactone K03589 cell division protein FtsQ 1 0
Lactic_acid K02335 DNA polymerase I [EC:2.7.7.7] -1 0
Glutamic_acid K02810 PTS system, sucrose-specific IIC component 1 0
Glycerin K00599  [EC:2.1.1.-] 1 0
Arabitol K03553 recombination protein RecA -1 0
Arabitol K01803 triosephosphate isomerase (TIM) [EC:5.3.1.1] -1 0
Threonine K00873 pyruvate kinase [EC:2.7.1.40] -1 0
1,3-Dihydro_isobenzofuran K08483 phosphotransferase system, enzyme I, PtsI [EC:2.7.3.9] -1 0
2-Hydroxy-3-methyl-2-Cyclopenten-1-one K00655 1-acyl-sn-glycerol-3-phosphate acyltransferase 1 0
Acetic_acid
K04066 primosomal protein N' (replication factor Y) (superfamily 
II helicase) -1 0
Lactic_acid K00849 galactokinase [EC:2.7.1.6] -1 0
Ethanolamine K03584 DNA repair protein RecO (recombination protein O) 1 0
Ethanolamine K00806 undecaprenyl diphosphate synthase [EC:2.5.1.31] 1 0
Glutamic_acid K02073 D-methionine transport system substrate-binding protein 1 0
Glutamic_acid K02036 phosphate transport system ATP-binding protein 1 0
Arabitol K09013 Fe-S cluster assembly ATP-binding protein -1 0
Glycerin K03647 protein involved in ribonucleotide reduction 1 0
Ethanolamine K02503 Hit-like protein involved in cell-cycle regulation 1 0
Arabitol K00948 ribose-phosphate pyrophosphokinase [EC:2.7.6.1] -1 0
Threonine K02863 large subunit ribosomal protein L1 -1 0
Glutamic_acid K03502 DNA polymerase V 1 0
Arabitol K06180 ribosomal large subunit pseudouridine synthase D -1 0
Threonine K01689 enolase [EC:4.2.1.11] -1 0
2-Ethyl-4-methyl-1,3-Dioxolane K03536 ribonuclease P protein component [EC:3.1.26.5] 1 0
Gluconic_acid-1,5-lactone K03536 ribonuclease P protein component [EC:3.1.26.5] 1 0
Threonine K01409 O-sialoglycoprotein endopeptidase [EC:3.4.24.57] -1 0
Acetic_acid K07738 transcriptional repressor NrdR -1 0
Glutamic_acid K02687 ribosomal protein L11 methyltransferase 1 0
Glycerin K00761 uracil phosphoribosyltransferase [EC:2.4.2.9] -1 0
1,3-Dihydro_isobenzofuran K02933 large subunit ribosomal protein L6 -1 0
1,3-Dihydro_isobenzofuran K02879 large subunit ribosomal protein L17 -1 0
1,3-Dihydro_isobenzofuran K02950 small subunit ribosomal protein S12 -1 0
Glutamic_acid K06024 segregation and condensation protein B 1 0
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Glutamic_acid
K05946 N-acetylglucosaminyldiphosphoundecaprenol N-acetyl-
beta-D-mannosaminyltransferase 1 0
1,3-Dihydro_isobenzofuran K02356 elongation factor P -1 0
1,3-Dihydro_isobenzofuran K00566 tRNA-specific 2-thiouridylase [EC:2.8.1.-] -1 0
Glycerin K00625 phosphate acetyltransferase [EC:2.3.1.8] -1 0
Glycerin K06213 magnesium transporter -1 0
1,3-Dihydro_isobenzofuran
K11072 spermidine/putrescine transport system ATP-binding 
protein [EC:3.6.3.31] -1 0
Lactic_acid
K04094 methylenetetrahydrofolate--tRNA-(uracil-5-)-
methyltransferase 1 0
Lactic_acid K03978 GTP-binding protein 1 0
Lactic_acid K00926 carbamate kinase 1 0
2-Methyl-2-hydroxybutanoic_acid K11752 5-amino-6-(5-phosphoribosylamino)uracil reductase 1 0
2-Methyl-2-hydroxybutanoic_acid K00027 malate dehydrogenase (oxaloacetate-decarboxylating) 1 0
3-Pyridinecarboxamide K00690 sucrose phosphorylase 1 0
Ornithine K00690 sucrose phosphorylase 1 0
2-Methyl-2-hydroxybutanoic_acid K06153 undecaprenyl-diphosphatase 1 0
K00599  [EC:2.1.1.-] K00625 phosphate acetyltransferase [EC:2.3.1.8] -1 0
K00761 uracil phosphoribosyltransferase K00599  [EC:2.1.1.-] -1 0
K00761 uracil phosphoribosyltransferase K00625 phosphate acetyltransferase [EC:2.3.1.8] 1 0
K00791 tRNA dimethylallyltransferase K00133 aspartate-semialdehyde dehydrogenase [EC:1.2.1.11] 1 0
K00849 galactokinase [EC:2.7.1.6] K00133 aspartate-semialdehyde dehydrogenase [EC:1.2.1.11] 1 0
K00849 galactokinase [EC:2.7.1.6] K00791 tRNA dimethylallyltransferase [EC:2.5.1.75] 1 0
K00926 carbamate kinase K00133 aspartate-semialdehyde dehydrogenase [EC:1.2.1.11] -1 0
K00926 carbamate kinase K00791 tRNA dimethylallyltransferase [EC:2.5.1.75] -1 0
K00926 carbamate kinase K00849 galactokinase [EC:2.7.1.6] -1 0
K00948 ribose-phosphate pyrophosphokinase K00790 UDP-N-acetylglucosamine 1-carboxyvinyltransferase 1 0
K00963 UTP--glucose-1-phosphate 
uridylyltransferase K00790 UDP-N-acetylglucosamine 1-carboxyvinyltransferase 1 0
K00963 UTP--glucose-1-phosphate 
uridylyltransferase K00948 ribose-phosphate pyrophosphokinase [EC:2.7.6.1] 1 0
K01000 phospho-N-acetylmuramoyl-
pentapeptide-transferase K00655 1-acyl-sn-glycerol-3-phosphate acyltransferase 1 0
K01262 Xaa-Pro aminopeptidase K00133 aspartate-semialdehyde dehydrogenase [EC:1.2.1.11] 1 0
K01262 Xaa-Pro aminopeptidase K00791 tRNA dimethylallyltransferase [EC:2.5.1.75] 1 0
K01262 Xaa-Pro aminopeptidase K00849 galactokinase [EC:2.7.1.6] 1 0
K01262 Xaa-Pro aminopeptidase K00926 carbamate kinase -1 0
K01409 O-sialoglycoprotein endopeptidase K00873 pyruvate kinase [EC:2.7.1.40] 1 0
K01689 enolase [EC:4.2.1.11] K00873 pyruvate kinase [EC:2.7.1.40] 1 0
K01689 enolase [EC:4.2.1.11] K01409 O-sialoglycoprotein endopeptidase [EC:3.4.24.57] 1 0
K01736 chorismate synthase [EC:4.2.3.5] K00655 1-acyl-sn-glycerol-3-phosphate acyltransferase 1 0
K01736 chorismate synthase [EC:4.2.3.5] K01000 phospho-N-acetylmuramoyl-pentapeptide-transferase 1 0
K01803 triosephosphate isomerase (TIM) K00790 UDP-N-acetylglucosamine 1-carboxyvinyltransferase 1 0
K01803 triosephosphate isomerase (TIM) K00948 ribose-phosphate pyrophosphokinase [EC:2.7.6.1] 1 0
K01803 triosephosphate isomerase (TIM) K00963 UTP--glucose-1-phosphate uridylyltransferase 1 0
K01868 threonyl-tRNA synthetase K00655 1-acyl-sn-glycerol-3-phosphate acyltransferase 1 0
K01868 threonyl-tRNA synthetase K01000 phospho-N-acetylmuramoyl-pentapeptide-transferase 1 0
K01868 threonyl-tRNA synthetase K01736 chorismate synthase [EC:4.2.3.5] 1 0
K01887 arginyl-tRNA synthetase K00790 UDP-N-acetylglucosamine 1-carboxyvinyltransferase 1 0
K01887 arginyl-tRNA synthetase K00948 ribose-phosphate pyrophosphokinase [EC:2.7.6.1] 1 0
K01887 arginyl-tRNA synthetase K00963 UTP--glucose-1-phosphate uridylyltransferase 1 0
K01887 arginyl-tRNA synthetase K01803 triosephosphate isomerase (TIM) [EC:5.3.1.1] 1 0
K01915 glutamine synthetase [EC:6.3.1.2] K00133 aspartate-semialdehyde dehydrogenase [EC:1.2.1.11] 1 0
K01915 glutamine synthetase [EC:6.3.1.2] K00791 tRNA dimethylallyltransferase [EC:2.5.1.75] 1 0
K01915 glutamine synthetase [EC:6.3.1.2] K00849 galactokinase [EC:2.7.1.6] 1 0
K01915 glutamine synthetase [EC:6.3.1.2] K00926 carbamate kinase -1 0
K01915 glutamine synthetase [EC:6.3.1.2] K01262 Xaa-Pro aminopeptidase [EC:3.4.11.9] 1 0
K01924 UDP-N-acetylmuramate--alanine 
ligase [EC:6.3.2.8]
K00790 UDP-N-acetylglucosamine 1-carboxyvinyltransferase 
[EC:2.5.1.7] 1 0
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K01924 UDP-N-acetylmuramate--alanine 
ligase [EC:6.3.2.8] K00948 ribose-phosphate pyrophosphokinase [EC:2.7.6.1] 1 0
K01924 UDP-N-acetylmuramate--alanine 
ligase [EC:6.3.2.8] K00963 UTP--glucose-1-phosphate uridylyltransferase [EC:2.7.7.9] 1 0
K01924 UDP-N-acetylmuramate--alanine 
ligase [EC:6.3.2.8] K01803 triosephosphate isomerase (TIM) [EC:5.3.1.1] 1 0
K01924 UDP-N-acetylmuramate--alanine 
ligase [EC:6.3.2.8] K01887 arginyl-tRNA synthetase [EC:6.1.1.19] 1 0
K02073 D-methionine transport system 
substrate-binding protein
K02036 phosphate transport system ATP-binding protein 
[EC:3.6.3.27] 1 0
K00027 malate dehydrogenase (oxaloacetate-
decarboxylating) K06153 undecaprenyl-diphosphatase 1 0
K00027 malate dehydrogenase (oxaloacetate-
decarboxylating) K11752 5-amino-6-(5-phosphoribosylamino)uracil reductase 1 0
K00133 aspartate-semialdehyde 
dehydrogenase [EC:1.2.1.11] K02335 DNA polymerase I [EC:2.7.7.7] 1 0
K00133 aspartate-semialdehyde 
dehydrogenase [EC:1.2.1.11] K03978 GTP-binding protein -1 0
K00133 aspartate-semialdehyde 
dehydrogenase [EC:1.2.1.11]
K04094 methylenetetrahydrofolate--tRNA-(uracil-5-)-
methyltransferase -1 0
K00566 tRNA-specific 2-thiouridylase K02356 elongation factor P 1 0
K00566 tRNA-specific 2-thiouridylase K02879 large subunit ribosomal protein L17 1 0
K00566 tRNA-specific 2-thiouridylase K02933 large subunit ribosomal protein L6 1 0
K00566 tRNA-specific 2-thiouridylase K02950 small subunit ribosomal protein S12 1 0
K00566 tRNA-specific 2-thiouridylase K08483 phosphotransferase system, enzyme I, PtsI [EC:2.7.3.9] 1 0
K00566 tRNA-specific 2-thiouridylase K11072 spermidine/putrescine transport system ATP-binding protein 1 0
K00599  [EC:2.1.1.-] K03647 protein involved in ribonucleotide reduction 1 0
K00599  [EC:2.1.1.-] K06213 magnesium transporter -1 0
K00625 phosphate acetyltransferase K03647 protein involved in ribonucleotide reduction -1 0
K00625 phosphate acetyltransferase K06213 magnesium transporter 1 0
K00655 1-acyl-sn-glycerol-3-phosphate 
acyltransferase K02483 two-component system, OmpR family, response regulator 1 0
K00655 1-acyl-sn-glycerol-3-phosphate 
acyltransferase K03531 cell division protein FtsZ 1 0
K00655 1-acyl-sn-glycerol-3-phosphate 
acyltransferase K11031 thiol-activated cytolysin 1 0
K00761 uracil phosphoribosyltransferase K03647 protein involved in ribonucleotide reduction -1 0
K00761 uracil phosphoribosyltransferase K06213 magnesium transporter 1 0
K00790 UDP-N-acetylglucosamine 1-
carboxyvinyltransferase K03293 amino acid transporter, AAT family 1 0
K00790 UDP-N-acetylglucosamine 1-
carboxyvinyltransferase K03431 phosphoglucosamine mutase [EC:5.4.2.10] 1 0
K00790 UDP-N-acetylglucosamine 1-
carboxyvinyltransferase K03553 recombination protein RecA 1 0
K00790 UDP-N-acetylglucosamine 1-
carboxyvinyltransferase K06180 ribosomal large subunit pseudouridine synthase D 1 0
K00790 UDP-N-acetylglucosamine 1-
carboxyvinyltransferase K09013 Fe-S cluster assembly ATP-binding protein 1 0
K00791 tRNA dimethylallyltransferase K02335 DNA polymerase I [EC:2.7.7.7] 1 0
K00791 tRNA dimethylallyltransferase K03978 GTP-binding protein -1 0
K00791 tRNA dimethylallyltransferase
K04094 methylenetetrahydrofolate--tRNA-(uracil-5-)-
methyltransferase -1 0
K00806 undecaprenyl diphosphate synthase K02503 Hit-like protein involved in cell-cycle regulation 1 0
K00806 undecaprenyl diphosphate synthase K03470 ribonuclease HII [EC:3.1.26.4] 1 0
K00806 undecaprenyl diphosphate synthase K03584 DNA repair protein RecO (recombination protein O) 1 0
K00806 undecaprenyl diphosphate synthase K07042 probable rRNA maturation factor 1 0
K00849 galactokinase [EC:2.7.1.6] K02335 DNA polymerase I [EC:2.7.7.7] 1 0
K00849 galactokinase [EC:2.7.1.6] K03978 GTP-binding protein -1 0
K00849 galactokinase [EC:2.7.1.6]
K04094 methylenetetrahydrofolate--tRNA-(uracil-5-)-
methyltransferase -1 0
K00873 pyruvate kinase [EC:2.7.1.40] K02863 large subunit ribosomal protein L1 1 0
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K00926 carbamate kinase K02335 DNA polymerase I [EC:2.7.7.7] -1 0
K00926 carbamate kinase K03978 GTP-binding protein 1 0
K00926 carbamate kinase K04094 methylenetetrahydrofolate--tRNA-(uracil-5-)-methyltransferase 1 0
K00948 ribose-phosphate pyrophosphokinase K03293 amino acid transporter, AAT family 1 0
K00948 ribose-phosphate pyrophosphokinase K03431 phosphoglucosamine mutase [EC:5.4.2.10] 1 0
K00948 ribose-phosphate pyrophosphokinase K03553 recombination protein RecA 1 0
K00948 ribose-phosphate pyrophosphokinase K06180 ribosomal large subunit pseudouridine synthase D 1 0
K00948 ribose-phosphate pyrophosphokinase K09013 Fe-S cluster assembly ATP-binding protein 1 0
K00963 UTP--glucose-1-phosphate 
uridylyltransferase K03293 amino acid transporter, AAT family 1 0
K00963 UTP--glucose-1-phosphate 
uridylyltransferase K03431 phosphoglucosamine mutase [EC:5.4.2.10] 1 0
K00963 UTP--glucose-1-phosphate 
uridylyltransferase K03553 recombination protein RecA 1 0
K00963 UTP--glucose-1-phosphate 
uridylyltransferase K06180 ribosomal large subunit pseudouridine synthase D 1 0
K00963 UTP--glucose-1-phosphate 
uridylyltransferase K09013 Fe-S cluster assembly ATP-binding protein 1 0
K01000 phospho-N-acetylmuramoyl-
pentapeptide-transferase K02483 two-component system, OmpR family, response regulator 1 0
K01000 phospho-N-acetylmuramoyl-
pentapeptide-transferase K03531 cell division protein FtsZ 1 0
K01000 phospho-N-acetylmuramoyl-
pentapeptide-transferase K11031 thiol-activated cytolysin 1 0
K01262 Xaa-Pro aminopeptidase K02335 DNA polymerase I [EC:2.7.7.7] 1 0
K01262 Xaa-Pro aminopeptidase K03978 GTP-binding protein -1 0
K01262 Xaa-Pro aminopeptidase K04094 methylenetetrahydrofolate--tRNA-(uracil-5-)-methyltransferase -1 0
K01409 O-sialoglycoprotein endopeptidase K02863 large subunit ribosomal protein L1 1 0
K01689 enolase [EC:4.2.1.11] K02863 large subunit ribosomal protein L1 1 0
K01736 chorismate synthase [EC:4.2.3.5] K02483 two-component system, OmpR family, response regulator 1 0
K01736 chorismate synthase [EC:4.2.3.5] K03531 cell division protein FtsZ 1 0
K01736 chorismate synthase [EC:4.2.3.5] K11031 thiol-activated cytolysin 1 0
K01803 triosephosphate isomerase (TIM) K03293 amino acid transporter, AAT family 1 0
K01803 triosephosphate isomerase (TIM) K03431 phosphoglucosamine mutase [EC:5.4.2.10] 1 0
K01803 triosephosphate isomerase (TIM) K03553 recombination protein RecA 1 0
K01803 triosephosphate isomerase (TIM) K06180 ribosomal large subunit pseudouridine synthase D 1 0
K01803 triosephosphate isomerase (TIM) K09013 Fe-S cluster assembly ATP-binding protein 1 0
K01868 threonyl-tRNA synthetase K02483 two-component system, OmpR family, response regulator 1 0
K01868 threonyl-tRNA synthetase K03531 cell division protein FtsZ 1 0
K01868 threonyl-tRNA synthetase K11031 thiol-activated cytolysin 1 0
K01887 arginyl-tRNA synthetase K03293 amino acid transporter, AAT family 1 0
K01887 arginyl-tRNA synthetase K03431 phosphoglucosamine mutase [EC:5.4.2.10] 1 0
K01887 arginyl-tRNA synthetase K03553 recombination protein RecA 1 0
K01887 arginyl-tRNA synthetase K06180 ribosomal large subunit pseudouridine synthase D 1 0
K01887 arginyl-tRNA synthetase K09013 Fe-S cluster assembly ATP-binding protein 1 0
K01915 glutamine synthetase [EC:6.3.1.2] K02335 DNA polymerase I [EC:2.7.7.7] 1 0
K01915 glutamine synthetase [EC:6.3.1.2] K03978 GTP-binding protein -1 0
K01915 glutamine synthetase [EC:6.3.1.2] K04094 methylenetetrahydrofolate--tRNA-(uracil-5-)-methyltransferase -1 0
K01924 UDP-N-acetylmuramate--alanine 
ligase [EC:6.3.2.8] K03293 amino acid transporter, AAT family 1 0
K01924 UDP-N-acetylmuramate--alanine 
ligase [EC:6.3.2.8] K03431 phosphoglucosamine mutase [EC:5.4.2.10] 1 0
K01924 UDP-N-acetylmuramate--alanine 
ligase [EC:6.3.2.8] K03553 recombination protein RecA 1 0
K01924 UDP-N-acetylmuramate--alanine 
ligase [EC:6.3.2.8] K06180 ribosomal large subunit pseudouridine synthase D 1 0
K01924 UDP-N-acetylmuramate--alanine 
ligase [EC:6.3.2.8] K09013 Fe-S cluster assembly ATP-binding protein 1 0
K02036 phosphate transport system ATP-
binding protein K02687 ribosomal protein L11 methyltransferase 1 0
K02036 phosphate transport system ATP-
binding protein K02810 PTS system, sucrose-specific IIC component 1 0
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K02036 phosphate transport system ATP-
binding protein K03502 DNA polymerase V 1 0
K02036 phosphate transport system ATP-
binding protein
K05946 N-acetylglucosaminyldiphosphoundecaprenol N-acetyl-beta-D-
mannosaminyltransferase 1 0
K02036 phosphate transport system ATP-
binding protein K06024 segregation and condensation protein B 1 0
K02073 D-methionine transport system 
substrate-binding protein K02687 ribosomal protein L11 methyltransferase 1 0
K02073 D-methionine transport system 
substrate-binding protein K02810 PTS system, sucrose-specific IIC component 1 0
K02073 D-methionine transport system 
substrate-binding protein K03502 DNA polymerase V 1 0
K02073 D-methionine transport system 
substrate-binding protein
K05946 N-acetylglucosaminyldiphosphoundecaprenol N-acetyl-beta-D-
mannosaminyltransferase 1 0
K02073 D-methionine transport system 
substrate-binding protein K06024 segregation and condensation protein B 1 0
K02313 chromosomal replication initiator 
protein
K04066 primosomal protein N' (replication factor Y) (superfamily II 
helicase) [EC:3.6.4.-] 1 0
K02313 chromosomal replication initiator 
protein K07738 transcriptional repressor NrdR 1 0
K02335 DNA polymerase I [EC:2.7.7.7] K03978 GTP-binding protein -1 0
K02335 DNA polymerase I [EC:2.7.7.7] K04094 methylenetetrahydrofolate--tRNA-(uracil-5-)-methyltransferase -1 0
K02356 elongation factor P K02879 large subunit ribosomal protein L17 1 0
K02356 elongation factor P K02933 large subunit ribosomal protein L6 1 0
K02356 elongation factor P K02950 small subunit ribosomal protein S12 1 0
K02356 elongation factor P K08483 phosphotransferase system, enzyme I, PtsI [EC:2.7.3.9] 1 0
K02356 elongation factor P K11072 spermidine/putrescine transport system ATP-binding protein 1 0
K02483 two-component system, OmpR family, 
response regulator K03531 cell division protein FtsZ 1 0
K02483 two-component system, OmpR family, 
response regulator K11031 thiol-activated cytolysin 1 0
K02503 Hit-like protein involved in cell-cycle 
regulation K03470 ribonuclease HII [EC:3.1.26.4] 1 0
K02503 Hit-like protein involved in cell-cycle 
regulation K03584 DNA repair protein RecO (recombination protein O) 1 0
K02503 Hit-like protein involved in cell-cycle 
regulation K07042 probable rRNA maturation factor 1 0
K02687 ribosomal protein L11 
methyltransferase K02810 PTS system, sucrose-specific IIC component 1 0
K02687 ribosomal protein L11 
methyltransferase K03502 DNA polymerase V 1 0
K02687 ribosomal protein L11 
methyltransferase
K05946 N-acetylglucosaminyldiphosphoundecaprenol N-acetyl-beta-D-
mannosaminyltransferase 1 0
K02687 ribosomal protein L11 
methyltransferase K06024 segregation and condensation protein B 1 0
K02810 PTS system, sucrose-specific IIC 
component K03502 DNA polymerase V 1 0
K02810 PTS system, sucrose-specific IIC 
component
K05946 N-acetylglucosaminyldiphosphoundecaprenol N-acetyl-beta-D-
mannosaminyltransferase 1 0
K02810 PTS system, sucrose-specific IIC 
component K06024 segregation and condensation protein B 1 0
K02879 large subunit ribosomal protein L17 K02933 large subunit ribosomal protein L6 1 0
K02879 large subunit ribosomal protein L17 K02950 small subunit ribosomal protein S12 1 0
K02879 large subunit ribosomal protein L17 K08483 phosphotransferase system, enzyme I, PtsI [EC:2.7.3.9] 1 0
K02879 large subunit ribosomal protein L17 K11072 spermidine/putrescine transport system ATP-binding protein 1 0
K02933 large subunit ribosomal protein L6 K02950 small subunit ribosomal protein S12 1 0
K02933 large subunit ribosomal protein L6 K08483 phosphotransferase system, enzyme I, PtsI [EC:2.7.3.9] 1 0
K02933 large subunit ribosomal protein L6 K11072 spermidine/putrescine transport system ATP-binding protein 1 0
K02950 small subunit ribosomal protein S12 K08483 phosphotransferase system, enzyme I, PtsI [EC:2.7.3.9] 1 0
K02950 small subunit ribosomal protein S12 K11072 spermidine/putrescine transport system ATP-binding protein 1 0
K03293 amino acid transporter, AAT family K03431 phosphoglucosamine mutase [EC:5.4.2.10] 1 0
K03293 amino acid transporter, AAT family K03553 recombination protein RecA 1 0
K03293 amino acid transporter, AAT family K06180 ribosomal large subunit pseudouridine synthase D 1 0
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K03293 amino acid transporter, AAT family K09013 Fe-S cluster assembly ATP-binding protein 1 0
K03320 ammonium transporter, Amt family K03536 ribonuclease P protein component [EC:3.1.26.5] 1 0
K03320 ammonium transporter, Amt family K03589 cell division protein FtsQ 1 0
K03431 phosphoglucosamine mutase K03553 recombination protein RecA 1 0
K03431 phosphoglucosamine mutase K06180 ribosomal large subunit pseudouridine synthase D 1 0
K03431 phosphoglucosamine mutase K09013 Fe-S cluster assembly ATP-binding protein 1 0
K03470 ribonuclease HII [EC:3.1.26.4] K03584 DNA repair protein RecO (recombination protein O) 1 0
K03470 ribonuclease HII [EC:3.1.26.4] K07042 probable rRNA maturation factor 1 0
K03502 DNA polymerase V
K05946 N-acetylglucosaminyldiphosphoundecaprenol N-acetyl-beta-D-
mannosaminyltransferase 1 0
K03502 DNA polymerase V K06024 segregation and condensation protein B 1 0
K11031 thiol-activated cytolysin K03531 cell division protein FtsZ 1 0
K03589 cell division protein FtsQ K03536 ribonuclease P protein component [EC:3.1.26.5] 1 0
K03553 recombination protein RecA K06180 ribosomal large subunit pseudouridine synthase D 1 0
K03553 recombination protein RecA K09013 Fe-S cluster assembly ATP-binding protein 1 0
K07042 probable rRNA maturation factor K03584 DNA repair protein RecO (recombination protein O) 1 0
K06213 magnesium transporter K03647 protein involved in ribonucleotide reduction -1 0
K04094 methylenetetrahydrofolate--tRNA-
(uracil-5-)-methyltransferase K03978 GTP-binding protein 1 0
K07738 transcriptional repressor NrdR
K04066 primosomal protein N' (replication factor Y) (superfamily II 
helicase) [EC:3.6.4.-] 1 0
K06024 segregation and condensation protein 
B
K05946 N-acetylglucosaminyldiphosphoundecaprenol N-acetyl-beta-D-
mannosaminyltransferase 1 0
K11752 5-amino-6-(5-
phosphoribosylamino)uracil reductase K06153 undecaprenyl-diphosphatase 1 0
K09013 Fe-S cluster assembly ATP-binding 
protein K06180 ribosomal large subunit pseudouridine synthase D 1 0
K11072 spermidine/putrescine transport system 
ATP-binding protein K08483 phosphotransferase system, enzyme I, PtsI [EC:2.7.3.9] 1 0
2-Methyl-2-hydroxybutanoic_acid Aquabacterium 1 0
2-Methyl-2-hydroxybutanoic_acid Chryseobacterium 1 0
2-Methyl-2-hydroxybutanoic_acid Elizabethkingia 1 0
2-Methyl-2-hydroxybutanoic_acid Finegoldia 1 0
2-Methyl-2-hydroxybutanoic_acid Morganella 1 0
2-Methyl-2-hydroxybutanoic_acid Negativicoccus 1 0
2-Methyl-2-hydroxybutanoic_acid Phenylobacterium 1 0
2-Methyl-2-hydroxybutanoic_acid Propionibacterium 1 0
2-Methyl-2-hydroxybutanoic_acid Serratia 1 0
2-Methyl-2-hydroxybutanoic_acid Siphonobacter 1 0
2-Hydroxy-3-methyl-2-Cyclopenten-1-one Bulleidia 1 0
1,2-Propanediol Peptoniphilus 1 0
3-Pyridinecarboxamide Chlorophyta 1 0
Glucose Janthinobacterium -1 0
Ornithine Chlorophyta 1 0
Ribose Acinetobacter 1 0
Valine Ureaplasma -1 0
K00027 malate dehydrogenase (oxaloacetate-
decarboxylating) Aquabacterium 1 0
K00027 malate dehydrogenase (oxaloacetate-
decarboxylating) Chryseobacterium 1 0
K00027 malate dehydrogenase (oxaloacetate-
decarboxylating) Elizabethkingia 1 0
K00027 malate dehydrogenase (oxaloacetate-
decarboxylating) Finegoldia 1 0
K00027 malate dehydrogenase (oxaloacetate-
decarboxylating) Morganella 1 0
K00027 malate dehydrogenase (oxaloacetate-
decarboxylating) Negativicoccus 1 0
K00027 malate dehydrogenase (oxaloacetate-
decarboxylating) Phenylobacterium 1 0
K00027 malate dehydrogenase (oxaloacetate-
decarboxylating) Propionibacterium 1 0
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K00027 malate dehydrogenase (oxaloacetate-
decarboxylating) Serratia 1 0
K00027 malate dehydrogenase (oxaloacetate-
decarboxylating) Siphonobacter 1 0
K00655 1-acyl-sn-glycerol-3-phosphate 
acyltransferase [EC:2.3.1.51] Bulleidia 1 0
K00690 sucrose phosphorylase Chlorophyta 1 0
K01000 phospho-N-acetylmuramoyl-
pentapeptide-transferase Bulleidia 1 0
K01736 chorismate synthase [EC:4.2.3.5] Bulleidia 1 0
K01868 threonyl-tRNA synthetase Bulleidia 1 0
K02483 two-component system, OmpR family, 
response regulator Bulleidia 1 0
K03531 cell division protein FtsZ Bulleidia 1 0
K06153 undecaprenyl-diphosphatase Aquabacterium 1 0
K06153 undecaprenyl-diphosphatase Chryseobacterium 1 0
K06153 undecaprenyl-diphosphatase Elizabethkingia 1 0
K06153 undecaprenyl-diphosphatase Finegoldia 1 0
K06153 undecaprenyl-diphosphatase Morganella 1 0
K06153 undecaprenyl-diphosphatase Negativicoccus 1 0
K06153 undecaprenyl-diphosphatase Phenylobacterium 1 0
K06153 undecaprenyl-diphosphatase Propionibacterium 1 0
K06153 undecaprenyl-diphosphatase Serratia 1 0
K06153 undecaprenyl-diphosphatase Siphonobacter 1 0
K11752 5-amino-6-(5-
phosphoribosylamino)uracil reductase Aquabacterium 1 0
K11752 5-amino-6-(5-
phosphoribosylamino)uracil reductase Chryseobacterium 1 0
K11752 5-amino-6-(5-
phosphoribosylamino)uracil reductase Elizabethkingia 1 0
K11752 5-amino-6-(5-
phosphoribosylamino)uracil reductase Finegoldia 1 0
K11752 5-amino-6-(5-
phosphoribosylamino)uracil reductase Morganella 1 0
K11752 5-amino-6-(5-
phosphoribosylamino)uracil reductase Negativicoccus 1 0
K11752 5-amino-6-(5-
phosphoribosylamino)uracil reductase Phenylobacterium 1 0
K11752 5-amino-6-(5-
phosphoribosylamino)uracil reductase Propionibacterium 1 0
K11752 5-amino-6-(5-
phosphoribosylamino)uracil reductase Serratia 1 0
K11752 5-amino-6-(5-
phosphoribosylamino)uracil reductase Siphonobacter 1 0
K11031 thiol-activated cytolysin Bulleidia 1 0
Chryseobacterium Aquabacterium 1 0
Elizabethkingia Aquabacterium 1 0
Elizabethkingia Chryseobacterium 1 0
Finegoldia Aquabacterium 1 0
Finegoldia Chryseobacterium 1 0
Finegoldia Elizabethkingia 1 0
Morganella Aquabacterium 1 0
Negativicoccus Aquabacterium 1 0
Phenylobacterium Aquabacterium 1 0
Propionibacterium Aquabacterium 1 0
Serratia Aquabacterium 1 0
Siphonobacter Aquabacterium 1 0
Morganella Chryseobacterium 1 0
Negativicoccus Chryseobacterium 1 0
Phenylobacterium Chryseobacterium 1 0
Propionibacterium Chryseobacterium 1 0
Serratia Chryseobacterium 1 0
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Siphonobacter Chryseobacterium 1 0
Morganella Elizabethkingia 1 0
Negativicoccus Elizabethkingia 1 0
Phenylobacterium Elizabethkingia 1 0
Propionibacterium Elizabethkingia 1 0
Serratia Elizabethkingia 1 0
Siphonobacter Elizabethkingia 1 0
Morganella Finegoldia 1 0
Negativicoccus Finegoldia 1 0
Phenylobacterium Finegoldia 1 0
Propionibacterium Finegoldia 1 0
Serratia Finegoldia 1 0
Siphonobacter Finegoldia 1 0
Negativicoccus Morganella 1 0
Phenylobacterium Morganella 1 0
Propionibacterium Morganella 1 0
Serratia Morganella 1 0
Siphonobacter Morganella 1 0
Phenylobacterium Negativicoccus 1 0
Propionibacterium Negativicoccus 1 0
Serratia Negativicoccus 1 0
Siphonobacter Negativicoccus 1 0
Propionibacterium Phenylobacterium 1 0
Serratia Phenylobacterium 1 0
Siphonobacter Phenylobacterium 1 0
Serratia Propionibacterium 1 0
Siphonobacter Propionibacterium 1 0
Siphonobacter Serratia 1 0
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Table 17. Taxonomic annotations of functional genes correlated with discharge- 
associated metabolites. 
 
KO ID KO Description Open reading frames ID Name of bacterial strain
K00027 malate dehydrogenase (oxaloacetate-decarboxylating) 416_2237_2237_1 Gardnerella vaginalis 409-05
K00133 aspartate-semialdehyde dehydrogenase 403_976_976_21 Gardnerella vaginalis 409-05
K00133 aspartate-semialdehyde dehydrogenase 403_2578_2578_3 Gardnerella vaginalis 409-05
K00133 aspartate-semialdehyde dehydrogenase 403_7327_7327_11 Gardnerella vaginalis ATCC 14018 = JCM 11026
K00133 aspartate-semialdehyde dehydrogenase 403_2588_2588_4 Gardnerella vaginalis ATCC 14018 = JCM 11026
K00133 aspartate-semialdehyde dehydrogenase 405_252_252_33 Gardnerella vaginalis ATCC 14018 = JCM 11026
K00133 aspartate-semialdehyde dehydrogenase 409_1955_1955_1 Gardnerella vaginalis ATCC 14018 = JCM 11026
K00133 aspartate-semialdehyde dehydrogenase 409_2728_2728_1 Gardnerella vaginalis ATCC 14018 = JCM 11026
K00566 tRNA-specific 2-thiouridylase 409_12116_12116_1 Gardnerella vaginalis ATCC 14018 = JCM 11026
K00566 tRNA-specific 2-thiouridylase 416_2369_2369_1 Gardnerella vaginalis HMP9231
K00566 tRNA-specific 2-thiouridylase 403_2996_2996_1 Lactobacillus acetotolerans
K00566 tRNA-specific 2-thiouridylase 405_375_375_24 Lactobacillus acidophilus strain FSI4
K00566 tRNA-specific 2-thiouridylase 409_8276_8276_1 Lactobacillus acidophilus strain FSI4
K00566 tRNA-specific 2-thiouridylase 409_8138_8138_1 Lactobacillus acidophilus strain FSI4
K00599  [EC:2.1.1.-] 403_797_797_1 Lactobacillus acidophilus strain FSI4
K00599  [EC:2.1.1.-] 403_1632_1632_2 Lactobacillus acidophilus strain FSI4
K00599  [EC:2.1.1.-] 409_581_581_199 Lactobacillus delbrueckii subsp. bulgaricus ND02
K00599  [EC:2.1.1.-] 405_386_386_8 Lactobacillus delbrueckii subsp. bulgaricus ND02
K00599  [EC:2.1.1.-] 403_2626_2626_4 Lactobacillus gasseri 130918
K00599  [EC:2.1.1.-] 403_2833_2833_3 Lactobacillus gasseri 130918
K00599  [EC:2.1.1.-] 405_247_247_29 Lactobacillus gasseri 130918
K00599  [EC:2.1.1.-] 409_3006_3006_1 Lactobacillus gasseri 130918
K00625 phosphate acetyltransferase 405_271_271_5 Lactobacillus gasseri ATCC 33323
K00625 phosphate acetyltransferase 403_3042_3042_2 Lactobacillus gasseri ATCC 33323
K00625 phosphate acetyltransferase 409_1889_1889_1 Lactobacillus gasseri ATCC 33323
K00625 phosphate acetyltransferase 409_2609_2609_2 Lactobacillus gasseri ATCC 33323
K00625 phosphate acetyltransferase 403_5931_5931_1 Lactobacillus gasseri ATCC 33323
K00625 phosphate acetyltransferase 403_6927_6927_1 Lactobacillus helveticus H9
K00625 phosphate acetyltransferase 409_6597_6597_1 Lactobacillus helveticus strain MB2-1
K00655 1-acyl-sn-glycerol-3-phosphate acyltransferase 403_1130_1130_11 Lactobacillus helveticus strain MB2-1
K00655 1-acyl-sn-glycerol-3-phosphate acyltransferase 403_2285_2285_7 Lactobacillus helveticus strain MB2-1
K00655 1-acyl-sn-glycerol-3-phosphate acyltransferase 403_3322_3322_3 Lactobacillus johnsonii FI9785
K00655 1-acyl-sn-glycerol-3-phosphate acyltransferase 403_2640_2640_3 Lactobacillus johnsonii FI9785
K00655 1-acyl-sn-glycerol-3-phosphate acyltransferase 405_1310_1310_105 Lactobacillus johnsonii N6.2
K00655 1-acyl-sn-glycerol-3-phosphate acyltransferase 409_2324_2324_7 Lactobacillus johnsonii N6.2
K00690 sucrose phosphorylase 405_430_430_1 Lactobacillus johnsonii N6.2
K00761 uracil phosphoribosyltransferase 403_957_957_14 Lactobacillus johnsonii N6.2
K00761 uracil phosphoribosyltransferase 403_3712_3712_1 Lactobacillus johnsonii N6.2
K00761 uracil phosphoribosyltransferase 412_379_379_20 Lactobacillus johnsonii N6.2
K00761 uracil phosphoribosyltransferase 405_1299_1299_27 Lactobacillus kefiranofaciens ZW3
K00761 uracil phosphoribosyltransferase 403_126_126_1 Lactobacillus kefiranofaciens ZW3
K00761 uracil phosphoribosyltransferase 409_2503_2503_2 Lactobacillus kimbladii strain Hma2N
K00761 uracil phosphoribosyltransferase 409_4777_4777_1 Lactobacillus sp. wkB8
K00761 uracil phosphoribosyltransferase 409_3706_3706_2 Mycoplasma hominis strain Sprott
K11031 thiol-activated cytolysin 403_8310_8310_4 Prevotella intermedia 17
K11031 thiol-activated cytolysin 409_574_574_8 Prevotella melaninogenica ATCC 25845
K11072 spermidine/putrescine transport system ATP-binding protein 405_250_250_17 Pseudomonas chlororaphis strain PA23
K11072 spermidine/putrescine transport system ATP-binding protein 416_1729_1729_1 Pseudomonas chlororaphis strain PA23
K11072 spermidine/putrescine transport system ATP-binding protein 403_1946_1946_1 Pseudomonas fluorescens SBW25
K11072 spermidine/putrescine transport system ATP-binding protein 403_6499_6499_1 Pseudomonas rhizosphaerae strain DSM 16299
K11072 spermidine/putrescine transport system ATP-binding protein 409_3876_3876_2 Streptobacillus moniliformis DSM 12112
K11072 spermidine/putrescine transport system ATP-binding protein 416_2437_2437_1 Ureaplasma parvum serovar 3
K11072 spermidine/putrescine transport system ATP-binding protein 409_10674_10674_1 Ureaplasma urealyticum serovar 10
K11072 spermidine/putrescine transport system ATP-binding protein 409_11047_11047_1 Ureaplasma urealyticum serovar 10
K11072 spermidine/putrescine transport system ATP-binding protein 409_8054_8054_1 Ureaplasma urealyticum serovar 10 str. ATCC 33699
K11752 5-amino-6-(5-phosphoribosylamino)uracil reductase 416_2289_2289_1 Veillonella parvula DSM 2008
K00790 UDP-N-acetylglucosamine 1-carboxyvinyltransferase 403_995_995_3 NA
K00790 UDP-N-acetylglucosamine 1-carboxyvinyltransferase 403_2949_2949_4 NA
K00790 UDP-N-acetylglucosamine 1-carboxyvinyltransferase 403_3001_3001_2 NA
K00790 UDP-N-acetylglucosamine 1-carboxyvinyltransferase 403_2774_2774_2 NA
K00790 UDP-N-acetylglucosamine 1-carboxyvinyltransferase 405_862_862_11 NA
K00790 UDP-N-acetylglucosamine 1-carboxyvinyltransferase 416_917_917_1 NA
K00790 UDP-N-acetylglucosamine 1-carboxyvinyltransferase 409_824_824_2 NA
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K00790 UDP-N-acetylglucosamine 1-carboxyvinyltransferase 409_2088_2088_1 NA
K00790 UDP-N-acetylglucosamine 1-carboxyvinyltransferase 409_10581_10581_1 NA
K00791 tRNA dimethylallyltransferase 403_1238_1238_1 NA
K00791 tRNA dimethylallyltransferase 403_2374_2374_5 NA
K00791 tRNA dimethylallyltransferase 403_2414_2414_2 NA
K00791 tRNA dimethylallyltransferase 405_267_267_24 NA
K00791 tRNA dimethylallyltransferase 403_5148_5148_1 NA
K00806 undecaprenyl diphosphate synthase 403_1063_1063_8 NA
K00806 undecaprenyl diphosphate synthase 405_1310_1310_99 NA
K00806 undecaprenyl diphosphate synthase 403_2604_2604_5 NA
K00806 undecaprenyl diphosphate synthase 403_3010_3010_1 NA
K00849 galactokinase 403_2598_2598_8 NA
K00849 galactokinase 403_2726_2726_3 NA
K00849 galactokinase 409_1442_1442_1 NA
K00849 galactokinase 409_2898_2898_2 NA
K00873 pyruvate kinase 403_1110_1110_2 NA
K00873 pyruvate kinase 403_8044_8044_2 NA
K00873 pyruvate kinase 405_242_242_12 NA
K00873 pyruvate kinase 403_2952_2952_2 NA
K00873 pyruvate kinase 403_3177_3177_2 NA
K00873 pyruvate kinase 412_331_331_56 NA
K00873 pyruvate kinase 403_38_38_1 NA
K00873 pyruvate kinase 409_2359_2359_1 NA
K00926 carbamate kinase 405_258_258_6 NA
K00926 carbamate kinase 409_8028_8028_1 NA
K00948 ribose-phosphate pyrophosphokinase 403_2270_2270_1 NA
K00948 ribose-phosphate pyrophosphokinase 403_4073_4073_3 NA
K00948 ribose-phosphate pyrophosphokinase 409_609_609_6 NA
K00948 ribose-phosphate pyrophosphokinase 403_1260_1260_1 NA
K00948 ribose-phosphate pyrophosphokinase 403_2575_2575_5 NA
K00948 ribose-phosphate pyrophosphokinase 403_8210_8210_1 NA
K00948 ribose-phosphate pyrophosphokinase 405_282_282_2 NA
K00948 ribose-phosphate pyrophosphokinase 416_744_744_1 NA
K00948 ribose-phosphate pyrophosphokinase 405_627_627_1 NA
K00948 ribose-phosphate pyrophosphokinase 405_1240_1240_1 NA
K00948 ribose-phosphate pyrophosphokinase 416_1595_1595_1 NA
K00948 ribose-phosphate pyrophosphokinase 403_8623_8623_13 NA
K00948 ribose-phosphate pyrophosphokinase 409_3696_3696_3 NA
K00948 ribose-phosphate pyrophosphokinase 403_2254_2254_11 NA
K00948 ribose-phosphate pyrophosphokinase 405_1242_1242_1 NA
K00948 ribose-phosphate pyrophosphokinase 412_341_341_36 NA
K00948 ribose-phosphate pyrophosphokinase 416_3135_3135_1 NA
K00948 ribose-phosphate pyrophosphokinase 403_367_367_4 NA
K00948 ribose-phosphate pyrophosphokinase 409_1604_1604_1 NA
K00948 ribose-phosphate pyrophosphokinase 409_2874_2874_3 NA
K00948 ribose-phosphate pyrophosphokinase 409_11574_11574_1 NA
K00948 ribose-phosphate pyrophosphokinase 409_11799_11799_1 NA
K00963 UTP--glucose-1-phosphate uridylyltransferase 403_1150_1150_10 NA
K00963 UTP--glucose-1-phosphate uridylyltransferase 403_2291_2291_3 NA
K00963 UTP--glucose-1-phosphate uridylyltransferase 403_8618_8618_6 NA
K00963 UTP--glucose-1-phosphate uridylyltransferase 416_545_545_1 NA
K00963 UTP--glucose-1-phosphate uridylyltransferase 403_3482_3482_1 NA
K00963 UTP--glucose-1-phosphate uridylyltransferase 403_4795_4795_1 NA
K00963 UTP--glucose-1-phosphate uridylyltransferase 405_318_318_5 NA
K00963 UTP--glucose-1-phosphate uridylyltransferase 412_303_303_36 NA
K01000 phospho-N-acetylmuramoyl-pentapeptide-transferase 403_1239_1239_10 NA
K01000 phospho-N-acetylmuramoyl-pentapeptide-transferase 403_2363_2363_6 NA
K01000 phospho-N-acetylmuramoyl-pentapeptide-transferase 403_2908_2908_21 NA
K01000 phospho-N-acetylmuramoyl-pentapeptide-transferase 405_375_375_7 NA
K01000 phospho-N-acetylmuramoyl-pentapeptide-transferase 403_2615_2615_5 NA
K01262 Xaa-Pro aminopeptidase 403_1064_1064_10 NA
K01262 Xaa-Pro aminopeptidase 403_2368_2368_4 NA
K01262 Xaa-Pro aminopeptidase 403_8346_8346_2 NA
K01262 Xaa-Pro aminopeptidase 405_264_264_33 NA
K01262 Xaa-Pro aminopeptidase 403_3998_3998_1 NA
K01262 Xaa-Pro aminopeptidase 409_1819_1819_2 NA
K01262 Xaa-Pro aminopeptidase 409_2801_2801_1 NA
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K01409 O-sialoglycoprotein endopeptidase 403_1189_1189_1 NA
K01409 O-sialoglycoprotein endopeptidase 403_8369_8369_3 NA
K01409 O-sialoglycoprotein endopeptidase 403_2606_2606_7 NA
K01409 O-sialoglycoprotein endopeptidase 405_263_263_23 NA
K01409 O-sialoglycoprotein endopeptidase 416_722_722_5 NA
K01409 O-sialoglycoprotein endopeptidase 416_2554_2554_1 NA
K01409 O-sialoglycoprotein endopeptidase 409_835_835_2 NA
K01409 O-sialoglycoprotein endopeptidase 409_2470_2470_2 NA
K01409 O-sialoglycoprotein endopeptidase 409_2471_2471_1 NA
K01689 enolase 403_2984_2984_1 NA
K01689 enolase 403_3327_3327_1 NA
K01689 enolase 409_586_586_108 NA
K01689 enolase 403_3442_3442_2 NA
K01689 enolase 403_4869_4869_1 NA
K01689 enolase 412_287_287_8 NA
K01689 enolase 416_1285_1285_1 NA
K01689 enolase 403_2586_2586_14 NA
K01689 enolase 403_2586_2586_15 NA
K01689 enolase 403_2584_2584_8 NA
K01689 enolase 405_290_290_3 NA
K01689 enolase 412_430_430_27 NA
K01689 enolase 409_54_54_2 NA
K01689 enolase 409_1226_1226_6 NA
K01689 enolase 409_2124_2124_1 NA
K01689 enolase 409_2125_2125_1 NA
K01689 enolase 409_3565_3565_1 NA
K01736 chorismate synthase 403_1025_1025_5 NA
K01736 chorismate synthase 403_7606_7606_1 NA
K01736 chorismate synthase 403_8205_8205_1 NA
K01803 triosephosphate isomerase (TIM) 403_1177_1177_2 NA
K01803 triosephosphate isomerase (TIM) 403_2344_2344_8 NA
K01803 triosephosphate isomerase (TIM) 403_7853_7853_1 NA
K01803 triosephosphate isomerase (TIM) 403_3442_3442_1 NA
K01803 triosephosphate isomerase (TIM) 405_331_331_2 NA
K01803 triosephosphate isomerase (TIM) 412_287_287_9 NA
K01803 triosephosphate isomerase (TIM) 409_2232_2232_7 NA
K01868 threonyl-tRNA synthetase 403_1161_1161_10 NA
K01868 threonyl-tRNA synthetase 403_8268_8268_1 NA
K01868 threonyl-tRNA synthetase 403_1429_1429_1 NA
K01868 threonyl-tRNA synthetase 403_8075_8075_1 NA
K01868 threonyl-tRNA synthetase 403_2636_2636_4 NA
K01868 threonyl-tRNA synthetase 405_278_278_34 NA
K01868 threonyl-tRNA synthetase 409_1389_1389_7 NA
K01868 threonyl-tRNA synthetase 409_1390_1390_1 NA
K01868 threonyl-tRNA synthetase 409_1391_1391_1 NA
K01868 threonyl-tRNA synthetase 409_2180_2180_3 NA
K01868 threonyl-tRNA synthetase 409_13227_13227_1 NA
K01868 threonyl-tRNA synthetase 409_4102_4102_1 NA
K01887 arginyl-tRNA synthetase 403_2572_2572_2 NA
K01887 arginyl-tRNA synthetase 403_8409_8409_2 NA
K01887 arginyl-tRNA synthetase 405_337_337_7 NA
K01887 arginyl-tRNA synthetase 403_2939_2939_1 NA
K01887 arginyl-tRNA synthetase 412_299_299_7 NA
K01887 arginyl-tRNA synthetase 409_1247_1247_2 NA
K01887 arginyl-tRNA synthetase 409_2609_2609_7 NA
K01915 glutamine synthetase 403_1241_1241_1 NA
K01915 glutamine synthetase 403_2320_2320_1 NA
K01915 glutamine synthetase 403_8225_8225_10 NA
K01915 glutamine synthetase 409_4805_4805_2 NA
K01915 glutamine synthetase 409_11332_11332_1 NA
K01915 glutamine synthetase 403_1248_1248_3 NA
K01915 glutamine synthetase 403_2421_2421_1 NA
K01915 glutamine synthetase 403_8200_8200_3 NA
K01915 glutamine synthetase 405_267_267_22 NA
K01915 glutamine synthetase 403_3164_3164_2 NA
K01915 glutamine synthetase 405_1259_1259_1 NA
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K01915 glutamine synthetase 412_430_430_20 NA
K01915 glutamine synthetase 416_1346_1346_1 NA
K01915 glutamine synthetase 409_6530_6530_2 NA
K01915 glutamine synthetase 403_5453_5453_1 NA
K01915 glutamine synthetase 403_5091_5091_1 NA
K01915 glutamine synthetase 409_8789_8789_1 NA
K01924 UDP-N-acetylmuramate--alanine ligase 403_1239_1239_6 NA
K01924 UDP-N-acetylmuramate--alanine ligase 403_2363_2363_2 NA
K01924 UDP-N-acetylmuramate--alanine ligase 403_3421_3421_1 NA
K01924 UDP-N-acetylmuramate--alanine ligase 405_278_278_20 NA
K01924 UDP-N-acetylmuramate--alanine ligase 416_1590_1590_1 NA
K02036 phosphate transport system ATP-binding protein 403_999_999_1 NA
K02036 phosphate transport system ATP-binding protein 403_2472_2472_2 NA
K02036 phosphate transport system ATP-binding protein 405_262_262_2 NA
K02036 phosphate transport system ATP-binding protein 405_215_215_11 NA
K02036 phosphate transport system ATP-binding protein 405_262_262_3 NA
K02036 phosphate transport system ATP-binding protein 403_2597_2597_4 NA
K02036 phosphate transport system ATP-binding protein 403_2597_2597_3 NA
K02036 phosphate transport system ATP-binding protein 403_4830_4830_3 NA
K02073 D-methionine transport system substrate-binding protein 403_1168_1168_4 NA
K02073 D-methionine transport system substrate-binding protein 403_4044_4044_1 NA
K02073 D-methionine transport system substrate-binding protein 405_673_673_7 NA
K02073 D-methionine transport system substrate-binding protein 405_236_236_10 NA
K02073 D-methionine transport system substrate-binding protein 403_2584_2584_2 NA
K02073 D-methionine transport system substrate-binding protein 403_5136_5136_1 NA
K02313 chromosomal replication initiator protein 403_954_954_20 NA
K02313 chromosomal replication initiator protein 403_8591_8591_3 NA
K02313 chromosomal replication initiator protein 405_211_211_9 NA
K02313 chromosomal replication initiator protein 403_8598_8598_9 NA
K02313 chromosomal replication initiator protein 412_344_344_23 NA
K02313 chromosomal replication initiator protein 409_2128_2128_1 NA
K02335 DNA polymerase I 403_1115_1115_3 NA
K02335 DNA polymerase I 403_2620_2620_3 NA
K02335 DNA polymerase I 405_278_278_28 NA
K02335 DNA polymerase I 409_3313_3313_1 NA
K02335 DNA polymerase I 403_4490_4490_1 NA
K02356 elongation factor P 403_2947_2947_5 NA
K02356 elongation factor P 405_427_427_10 NA
K02356 elongation factor P 405_264_264_32 NA
K02356 elongation factor P 403_3998_3998_2 NA
K02356 elongation factor P 403_1852_1852_1 NA
K02356 elongation factor P 403_2966_2966_1 NA
K02356 elongation factor P 409_3661_3661_2 NA
K02356 elongation factor P 403_449_449_6 NA
K02356 elongation factor P 409_1435_1435_2 NA
K02483 two-component system, OmpR family, response regulator 403_1134_1134_24 NA
K02483 two-component system, OmpR family, response regulator 403_2923_2923_5 NA
K02483 two-component system, OmpR family, response regulator 403_3017_3017_1 NA
K02503 Hit-like protein involved in cell-cycle regulation 403_1165_1165_14 NA
K02503 Hit-like protein involved in cell-cycle regulation 403_2540_2540_7 NA
K02503 Hit-like protein involved in cell-cycle regulation 405_278_278_13 NA
K02503 Hit-like protein involved in cell-cycle regulation 409_2564_2564_3 NA
K02687 ribosomal protein L11 methyltransferase 403_2659_2659_3 NA
K02687 ribosomal protein L11 methyltransferase 405_238_238_19 NA
K02810 PTS system, sucrose-specific IIC component 405_738_738_7 NA
K02810 PTS system, sucrose-specific IIC component 403_2651_2651_6 NA
K02810 PTS system, sucrose-specific IIC component 403_1878_1878_1 NA
K02863 large subunit ribosomal protein L1 403_1286_1286_2 NA
K02863 large subunit ribosomal protein L1 403_2249_2249_3 NA
K02863 large subunit ribosomal protein L1 405_262_262_7 NA
K02863 large subunit ribosomal protein L1 403_3250_3250_1 NA
K02863 large subunit ribosomal protein L1 403_337_337_4 NA
K02879 large subunit ribosomal protein L17 403_1001_1001_27 NA
K02879 large subunit ribosomal protein L17 409_3783_3783_2 NA
K02879 large subunit ribosomal protein L17 403_2600_2600_7 NA
K02879 large subunit ribosomal protein L17 405_235_235_8 NA
K02879 large subunit ribosomal protein L17 412_341_341_8 NA
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K02879 large subunit ribosomal protein L17 403_359_359_6 NA
K02933 large subunit ribosomal protein L6 403_1001_1001_16 NA
K02933 large subunit ribosomal protein L6 403_2406_2406_6 NA
K02933 large subunit ribosomal protein L6 403_5114_5114_2 NA
K02933 large subunit ribosomal protein L6 412_341_341_19 NA
K02933 large subunit ribosomal protein L6 405_235_235_20 NA
K02933 large subunit ribosomal protein L6 403_356_356_3 NA
K02933 large subunit ribosomal protein L6 409_2049_2049_1 NA
K02950 small subunit ribosomal protein S12 403_342_342_1 NA
K02950 small subunit ribosomal protein S12 403_1239_1239_4 NA
K02950 small subunit ribosomal protein S12 403_2431_2431_3 NA
K02950 small subunit ribosomal protein S12 409_4214_4214_2 NA
K02950 small subunit ribosomal protein S12 403_5044_5044_1 NA
K02950 small subunit ribosomal protein S12 405_369_369_6 NA
K02950 small subunit ribosomal protein S12 412_275_275_29 NA
K02950 small subunit ribosomal protein S12 403_3947_3947_1 NA
K02950 small subunit ribosomal protein S12 409_3275_3275_1 NA
K03293 amino acid transporter, AAT family 403_976_976_25 NA
K03293 amino acid transporter, AAT family 403_2554_2554_1 NA
K03293 amino acid transporter, AAT family 403_1197_1197_1 NA
K03293 amino acid transporter, AAT family 409_9710_9710_1 NA
K03293 amino acid transporter, AAT family 403_1713_1713_1 NA
K03293 amino acid transporter, AAT family 403_8280_8280_2 NA
K03293 amino acid transporter, AAT family 405_1070_1070_13 NA
K03293 amino acid transporter, AAT family 405_673_673_12 NA
K03293 amino acid transporter, AAT family 405_279_279_7 NA
K03293 amino acid transporter, AAT family 405_1070_1070_14 NA
K03293 amino acid transporter, AAT family 403_2633_2633_2 NA
K03293 amino acid transporter, AAT family 416_1314_1314_1 NA
K03293 amino acid transporter, AAT family 403_8623_8623_15 NA
K03293 amino acid transporter, AAT family 403_2633_2633_3 NA
K03293 amino acid transporter, AAT family 403_2647_2647_1 NA
K03293 amino acid transporter, AAT family 409_13751_13751_2 NA
K03293 amino acid transporter, AAT family 409_8541_8541_1 NA
K03320 ammonium transporter, Amt family 403_957_957_6 NA
K03320 ammonium transporter, Amt family 403_8625_8625_9 NA
K03320 ammonium transporter, Amt family 405_260_260_5 NA
K03431 phosphoglucosamine mutase 403_1250_1250_3 NA
K03431 phosphoglucosamine mutase 403_3536_3536_2 NA
K03431 phosphoglucosamine mutase 403_3564_3564_1 NA
K03431 phosphoglucosamine mutase 405_250_250_11 NA
K03431 phosphoglucosamine mutase 403_3283_3283_2 NA
K03431 phosphoglucosamine mutase 412_380_380_21 NA
K03431 phosphoglucosamine mutase 403_3140_3140_1 NA
K03431 phosphoglucosamine mutase 409_141_141_14 NA
K03470 ribonuclease HII 403_1020_1020_1 NA
K03470 ribonuclease HII 403_2391_2391_4 NA
K03470 ribonuclease HII 405_279_279_24 NA
K03470 ribonuclease HII 403_5071_5071_1 NA
K03502 DNA polymerase V 405_234_234_12 NA
K03502 DNA polymerase V 416_639_639_1 NA
K03502 DNA polymerase V 403_8630_8630_5 NA
K03531 cell division protein FtsZ 403_8225_8225_3 NA
K03531 cell division protein FtsZ 403_8604_8604_5 NA
K03531 cell division protein FtsZ 409_581_581_166 NA
K03531 cell division protein FtsZ 405_375_375_12 NA
K03531 cell division protein FtsZ 403_4463_4463_1 NA
K03531 cell division protein FtsZ 409_10667_10667_1 NA
K03531 cell division protein FtsZ 409_8560_8560_1 NA
K03536 ribonuclease P protein component 403_954_954_22 NA
K03536 ribonuclease P protein component 403_8591_8591_2 NA
K03536 ribonuclease P protein component 405_211_211_7 NA
K03553 recombination protein RecA 403_1203_1203_4 NA
K03553 recombination protein RecA 403_2258_2258_1 NA
K03553 recombination protein RecA 403_2342_2342_3 NA
K03553 recombination protein RecA 405_240_240_19 NA
K03553 recombination protein RecA 403_2599_2599_9 NA
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Table 17. (cont.) 
 
K03553 recombination protein RecA 405_771_771_1 NA
K03553 recombination protein RecA 412_273_273_6 NA
K03553 recombination protein RecA 409_4643_4643_2 NA
K03553 recombination protein RecA 409_5950_5950_1 NA
K03553 recombination protein RecA 409_11841_11841_1 NA
K03584 DNA repair protein RecO (recombination protein O) 403_1063_1063_7 NA
K03584 DNA repair protein RecO (recombination protein O) 403_2262_2262_1 NA
K03584 DNA repair protein RecO (recombination protein O) 405_244_244_41 NA
K03584 DNA repair protein RecO (recombination protein O) 403_4774_4774_1 NA
K03589 cell division protein FtsQ 403_1239_1239_5 NA
K03589 cell division protein FtsQ 403_2363_2363_1 NA
K03589 cell division protein FtsQ 405_375_375_10 NA
K03647 protein involved in ribonucleotide reduction 403_989_989_2 NA
K03647 protein involved in ribonucleotide reduction 403_2457_2457_2 NA
K03647 protein involved in ribonucleotide reduction 403_8080_8080_3 NA
K03647 protein involved in ribonucleotide reduction 405_302_302_20 NA
K03647 protein involved in ribonucleotide reduction 403_2876_2876_2 NA
K03647 protein involved in ribonucleotide reduction 403_2852_2852_3 NA
K03978 GTP-binding protein 405_252_252_22 NA
K03978 GTP-binding protein 403_5363_5363_1 NA
K03978 GTP-binding protein 409_1972_1972_1 NA
K03978 GTP-binding protein 409_2804_2804_1 NA
K04066 primosomal protein N' (replication factor Y) (superfamily II helicase) 403_1178_1178_4 NA
K04066 primosomal protein N' (replication factor Y) (superfamily II helicase) 403_4515_4515_3 NA
K04066 primosomal protein N' (replication factor Y) (superfamily II helicase) 405_264_264_20 NA
K04066 primosomal protein N' (replication factor Y) (superfamily II helicase) 416_2340_2340_1 NA
K04066 primosomal protein N' (replication factor Y) (superfamily II helicase) 403_2637_2637_1 NA
K04066 primosomal protein N' (replication factor Y) (superfamily II helicase) 403_3196_3196_2 NA
K04066 primosomal protein N' (replication factor Y) (superfamily II helicase) 416_1379_1379_1 NA
K04066 primosomal protein N' (replication factor Y) (superfamily II helicase) 409_2389_2389_1 NA
K04094 glucose inhibited division protein Gid 405_279_279_21 NA
K04094 glucose inhibited division protein Gid 403_6286_6286_1 NA
K04094 glucose inhibited division protein Gid 409_6168_6168_1 NA
K05946 N-acetylglucosaminyldiphosphoundecaprenol 403_3127_3127_2 NA
K05946 N-acetylglucosaminyldiphosphoundecaprenol 405_247_247_6 NA
K06024 segregation and condensation protein B 405_242_242_7 NA
K06024 segregation and condensation protein B 403_2746_2746_3 NA
K06153 undecaprenyl-diphosphatase 416_2166_2166_1 NA
K06180 ribosomal large subunit pseudouridine synthase D 403_1241_1241_4 NA
K06180 ribosomal large subunit pseudouridine synthase D 403_8137_8137_2 NA
K06180 ribosomal large subunit pseudouridine synthase D 405_209_209_4 NA
K06180 ribosomal large subunit pseudouridine synthase D 405_356_356_6 NA
K06180 ribosomal large subunit pseudouridine synthase D 405_278_278_1 NA
K06180 ribosomal large subunit pseudouridine synthase D 403_3315_3315_3 NA
K06180 ribosomal large subunit pseudouridine synthase D 403_8593_8593_3 NA
K06180 ribosomal large subunit pseudouridine synthase D 403_8630_8630_16 NA
K06180 ribosomal large subunit pseudouridine synthase D 409_1434_1434_9 NA
K06180 ribosomal large subunit pseudouridine synthase D 409_2287_2287_4 NA
K06180 ribosomal large subunit pseudouridine synthase D 403_2088_2088_1 NA
K06180 ribosomal large subunit pseudouridine synthase D 409_1156_1156_1 NA
K06180 ribosomal large subunit pseudouridine synthase D 409_2372_2372_3 NA
K06213 magnesium transporter 403_5877_5877_1 NA
K06213 magnesium transporter 403_6549_6549_1 NA
K06213 magnesium transporter 409_4316_4316_2 NA
K07042 probable rRNA maturation factor 403_1165_1165_12 NA
K07042 probable rRNA maturation factor 403_2540_2540_9 NA
K07042 probable rRNA maturation factor 405_244_244_43 NA
K07738 transcriptional repressor NrdR 403_1100_1100_8 NA
K07738 transcriptional repressor NrdR 403_2770_2770_1 NA
K07738 transcriptional repressor NrdR 403_2908_2908_13 NA
K07738 transcriptional repressor NrdR 405_278_278_31 NA
K07738 transcriptional repressor NrdR 403_2636_2636_1 NA
K07738 transcriptional repressor NrdR 412_303_303_24 NA
K08483 phosphotransferase system, enzyme I, PtsI 403_1305_1305_5 NA
K08483 phosphotransferase system, enzyme I, PtsI 409_11932_11932_1 NA
K08483 phosphotransferase system, enzyme I, PtsI 405_209_209_12 NA
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K08483 phosphotransferase system, enzyme I, PtsI 405_209_209_12 NA
K08483 phosphotransferase system, enzyme I, PtsI 403_5076_5076_1 NA
K08483 phosphotransferase system, enzyme I, PtsI 403_8593_8593_11 NA
K08483 phosphotransferase system, enzyme I, PtsI 412_300_300_8 NA
K08483 phosphotransferase system, enzyme I, PtsI 403_438_438_3 NA
K09013 Fe-S cluster assembly ATP-binding protein 403_1025_1025_11 NA
K09013 Fe-S cluster assembly ATP-binding protein 403_8518_8518_3 NA
K09013 Fe-S cluster assembly ATP-binding protein 412_379_379_97 NA
K09013 Fe-S cluster assembly ATP-binding protein 416_2282_2282_1 NA
K09013 Fe-S cluster assembly ATP-binding protein 409_1730_1730_5 NA
K09013 Fe-S cluster assembly ATP-binding protein 409_2279_2279_4 NA
K09013 Fe-S cluster assembly ATP-binding protein 409_3666_3666_1 NA
K11031 thiol-activated cytolysin 403_2473_2473_1 NA
Note: NA represents that no information is provided.
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Table 18. Sample descriptions. 
 
Note: NA represents no information is provided. Subject 201 did not turn in the 
questionnaire. 
 
 
 
 
 
 
 
 
Sample ID 110 117 119 120 125 202 203 205 206
Race/Ethnicity Caucasian Caucasian Caucasian Caucasian Caucasian Caucasian Caucasian Caucasian Caucasian
Age 34 43 31 33 23 30 35 33 29
Marital status NA Married Married Married Married Married Married Married Married
Length of residence 
more than 10 
years
more than 10 
years
more than 10 
years
more than 10 
years 1-2 years 2-5 years 1-2 years 2-5 years 2-5 years
Regular periods Yes Yes Yes Yes Yes Yes Yes Yes Yes
Length of menstrual cycle 29 30 28 29 27 28 30 30 32
Tampon use during periods Yes Yes Yes Yes Yes Yes Yes Yes Yes
Number of previous 
pregnancies 3 3 1 3 3 5 6 4 2
Number of children 1 0 0 2 1 2 4 2 1
Problems with the birth of 
any of your children
Failure to 
progress NA NA NA NA
PPROM, 
preterm Preterm birth
PPROM, 
preterm Preterm birth
Sexual orientation Heterosexual Heterosexual Heterosexual Heterosexual Heterosexual Heterosexual Heterosexual Heterosexual Heterosexual
Sexual intercourse in the 
past 6 months Yes Yes Yes Yes Yes Yes Yes Yes Yes
Number of sexual partners 
in the past 6 months 1 1 1 1 1 1 1 1 1
New sexual partner in the 
past 6 months No No No No No No No No No
New sexual partner in the 
past 2 months No No No No No No No No No
Days since intercourse 7 0 7 4 2 3 6 7--14 60--180
Frequency of vaginal 
intercourse per month on 
average Occasionally
Very 
Frequently Occasionally
Very 
Frequently Frequently Occasionally Occasionally Rarely Occasionally
Birth control methods None None None
Birth control 
pill Condom None None None
Birth control 
pill
Douche No No No No No No No No No
Diagnose with a vaginal 
bacterial infection NA NA No No No Yes No Yes No
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Table 19. Sequence statistics of metagenome vaginal samples. 
 
Sample ID Time point
Number of bases in 
raw metagenome
Absolute number of short 
reads in raw metagenome
Number of bases in quality-
filtered  metagenome
Absolute number of  short reads 
in quality-filtered  metagenome
110 8-12 wks 6,222,521,000 62,225,210 1,012,674,130 10,962,510
110 17-21 wks 3,419,244,400 34,192,444 548,610,851 5,967,898
110 26-30 wks 8,422,921,600 84,229,216 816,016,476 8,889,386
110 35-38 wks 6,153,614,600 61,536,146 1,449,913,587 15,725,802
110 Labor 6,521,101,000 65,211,010 808,972,001 8,784,180
110 6-wk post-partum 6,420,355,200 64,203,552 709,894,660 7,741,828
110 Total 37,159,757,800 371,597,578 5,346,081,705 58,071,604
117 8-12 wks 3,463,671,000 34,636,710 490,589,486 5,309,444
117 17-21 wks 2,769,467,800 27,694,678 802,458,979 8,697,176
117 26-30 wks 6,657,783,800 66,577,838 1,045,180,358 11,364,190
117 35-38 wks 6,033,391,800 60,333,918 1,010,236,534 10,977,160
117 Labor 6,532,720,200 65,327,202 919,926,088 10,016,428
117 6-wk post-partum 6,798,045,200 67,980,452 505,872,266 5,744,540
117 Total 32,255,079,800 322,550,798 4,774,263,711 52,108,938
119 8-12 wks 5,559,815,200 55,598,152 548,883,316 5,991,524
119 17-21 wks 6,532,671,400 65,326,714 808,238,308 8,733,978
119 26-30 wks 6,295,553,800 62,955,538 599,938,618 6,493,916
119 35-38 wks 5,682,729,000 56,827,290 693,469,800 7,329,562
119 6-wk post-partum 7,640,346,600 76,403,466 630,436,700 7,031,000
119 Total 31,711,116,000 317,111,160 3,280,966,742 35,579,980
120 8-12 wks 5,903,900,600 59,039,006 520,268,491 5,675,170
120 17-21 wks 6,788,770,400 67,887,704 650,151,325 7,248,860
120 26-30 wks 5,121,966,600 51,219,666 611,397,393 6,802,736
120 35-38 wks 5,662,146,400 56,621,464 707,210,925 7,699,112
120 6-wk post-partum 6,608,064,400 66,080,644 940,578,127 10,452,266
120 Total 30,084,848,400 300,848,484 3,429,606,261 37,878,144
125 8-12 wks 6,284,699,600 62,846,996 561,375,915 6,231,180
125 17-21 wks 5,341,225,600 53,412,256 489,532,965 5,445,938
125 26-30 wks 6,462,088,000 64,620,880 559,558,063 6,224,308
125 35-38 wks 5,670,923,200 56,709,232 501,003,132 5,446,978
125 6-wk post-partum 5,979,844,000 59,798,440 691,906,437 7,694,732
125 Total 29,738,780,400 297,387,804 2,803,376,512 31,043,136
201 8-12 wks 7,047,922,200 70,479,222 666,568,719 7,262,476
201 17-21 wks 6,189,886,000 61,898,860 677,123,851 7,370,600
201 26-30 wks 6,221,771,600 62,217,716 629,091,925 6,857,022
201 Labor 6,761,517,800 67,615,178 712,571,709 7,767,520
201 Total 26,221,097,600 262,210,976 2,685,356,204 29,257,618
202 8-12 wks 4,228,467,800 42,284,678 852,146,512 9,330,524
202 17-21 wks 6,497,271,000 64,972,710 866,593,791 9,641,248
202 26-30 wks 4,763,378,600 47,633,786 687,405,805 7,369,400
202 35-38 wks 5,922,797,600 59,227,976 751,314,007 8,033,618
202 6-wk post-partum 6,940,536,800 69,405,368 563,051,755 6,285,406
202 Total 28,352,451,800 283,524,518 3,720,511,870 40,660,196
203 8-12 wks 8,642,214,000 86,422,140 677,845,665 7,556,132
203 17-21 wks 6,585,760,800 65,857,608 739,270,944 7,760,692
203 26-30 wks 7,247,407,000 72,474,070 840,431,096 9,194,186
203 35-38 wks 6,312,381,600 63,123,816 674,927,563 7,351,998
203 Labor 8,013,985,600 80,139,856 968,043,839 10,734,354
203 6-wk post-partum 6,921,498,600 69,214,986 1,471,664,421 16,297,512
203 Total 43,723,247,600 437,232,476 5,372,183,528 58,894,874
205 8-12 wks 6,309,148,800 63,091,488 811,181,657 8,812,836
205 17-21 wks 8,844,356,800 88,443,568 1,283,524,268 13,953,034
205 26-30 wks 7,221,303,600 72,213,036 1,029,667,256 10,892,346
205 Labor 6,087,839,200 60,878,392 707,826,237 7,895,806
205 6-wk post-partum 8,321,430,600 83,214,306 1,426,745,772 15,501,576
205 Total 36,784,079,000 367,840,790 5,258,945,190 57,055,598
206 8-12 wks 7,745,705,400 77,457,054 641,737,529 7,156,076
206 17-21 wks 8,170,139,800 81,701,398 851,183,709 9,134,556
206 26-30 wks 8,335,937,400 83,359,374 958,816,544 10,158,590
206 35-38 wks 8,050,282,200 80,502,822 623,101,343 6,912,862
206 Labor 4,973,220,200 49,732,202 2,511,961,781 27,233,350
206 6-wk post-partum 7,366,342,400 73,663,424 733,724,833 8,169,590
206 Total 44,641,627,400 446,416,274 6,320,525,739 68,765,024
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Table 19. (cont.) 
 
Sample ID Time point
Absolute number of  short reads used in the recovery 
of the Lactobacillus  population genomes
Number of  short reads (normalized) used in the recovery 
of the Lactobacillus  population genomes
110 8-12 wks 5,276,125 481,288
110 17-21 wks 1,491,031 249,842
110 26-30 wks 1,114,764 125,404
110 35-38 wks 10,911,413 693,854
110 Labor 2,547,933 290,059
110 6-wk post-partum 56,485 7,296
110 Total 21,397,751 1,847,743
117 8-12 wks 757,741 142,716
117 17-21 wks 6,277,029 721,732
117 26-30 wks 5,287,084 465,241
117 35-38 wks 5,523,602 503,190
117 Labor 3,865,682 385,934
117 6-wk post-partum 1,155 201
117 Total 21,712,293 2,219,014
119 8-12 wks 533,844 89,100
119 17-21 wks 1,430,332 163,766
119 26-30 wks 215,377 33,166
119 35-38 wks 287,509 39,226
119 6-wk post-partum 1,542 219
119 Total 2,468,604 325,477
120 8-12 wks 287 51
120 17-21 wks 1,659 229
120 26-30 wks 1,301 191
120 35-38 wks 2,113,355 274,493
120 6-wk post-partum 761 73
120 Total 2,117,363 275,037
125 8-12 wks 1,153,618 185,136
125 17-21 wks 748,341 137,413
125 26-30 wks 622,231 99,968
125 35-38 wks 580,446 106,563
125 6-wk post-partum 1,561 203
125 Total 3,106,197 529,283
201 8-12 wks 1,092,089 150,374
201 17-21 wks 824,061 111,804
201 26-30 wks 1,044,087 152,265
201 Labor 1,269,274 163,408
201 Total 4,229,511 577,851
202 8-12 wks 1,793,107 192,176
202 17-21 wks 738,746 76,623
202 26-30 wks 5,119,354 694,677
202 35-38 wks 486,455 60,552
202 6-wk post-partum 306 49
202 Total 8,137,968 1,024,078
203 8-12 wks 713 94
203 17-21 wks 401 52
203 26-30 wks 830,752 90,356
203 35-38 wks 698,779 95,046
203 Labor 253,340 23,601
203 6-wk post-partum 1,136 70
203 Total 1,785,121 209,219
205 8-12 wks 1,989,548 225,756
205 17-21 wks 6,534,130 468,295
205 26-30 wks 4,079,190 374,501
205 Labor 218,257 27,642
205 6-wk post-partum 9,045,875 583,546
205 Total 21,867,000 1,679,739
206 8-12 wks 713 100
206 17-21 wks 1,592 174
206 26-30 wks 1,907,960 187,817
206 35-38 wks 73,587 10,645
206 Labor 824,494 30,275
206 6-wk post-partum 1,208 148
206 Total 2,809,554 229,159
  
153 
 
Table 19. (cont.) 
 
Sample ID Time point
Absolute number of short reads 
participated in the prediction of 
metabolism pathway in the 
Lactobacillus  population genome
Number of short reads (normalized) 
participated in the prediction of 
metabolism pathway in the 
Lactobacillus  population genome
Absolute number of 
bases aligned to 
assembly #1 and 2 (>= 
500 bp)
110 8-12 wks 6,672 60,862 662,454,301
110 17-21 wks 3,254 54,525 185,311,020
110 26-30 wks 1,676 18,854 164,822,120
110 35-38 wks 5,563 35,375 1,060,057,727
110 Labor 2,242 25,523 270,937,143
110 6-wk post-partum 97 1,253 41,480,454
110 Total 19,504 196,392 2,385,062,765
117 8-12 wks 1,192 22,451 89,430,036
117 17-21 wks 6,067 69,758 593,656,074
117 26-30 wks 3,923 34,521 513,101,161
117 35-38 wks 4,155 37,851 533,456,698
117 Labor 3,222 32,167 386,358,559
117 6-wk post-partum 0 0 66,556,987
117 Total 18,559 196,748 2,182,559,515
119 8-12 wks 712 11,883 71,292,101
119 17-21 wks 1,281 14,667 163,230,890
119 26-30 wks 263 4,050 44,797,528
119 35-38 wks 302 4,120 54,964,775
119 6-wk post-partum 0 0 31,138,980
119 Total 2,558 34,721 365,424,274
120 8-12 wks 0 0 31,217,350
120 17-21 wks 0 0 139,004,233
120 26-30 wks 0 0 178,606,156
120 35-38 wks 2,406 31,250 229,096,007
120 6-wk post-partum 0 0 523,555,998
120 Total 2,406 31,250 1,101,479,744
125 8-12 wks 2,122 34,055 158,360,061
125 17-21 wks 1,569 28,810 94,199,754
125 26-30 wks 1,145 18,396 85,599,898
125 35-38 wks 1,231 22,600 90,320,915
125 6-wk post-partum 1 13 320,181,576
125 Total 6,068 103,873 748,662,204
201 8-12 wks 2,371 32,647 173,024,382
201 17-21 wks 1,723 23,377 132,615,712
201 26-30 wks 2,365 34,490 160,300,236
201 Labor 2,510 32,314 188,866,362
201 Total 8,969 122,828 654,806,692
202 8-12 wks 2,080 22,292 260,673,767
202 17-21 wks 839 8,702 241,340,670
202 26-30 wks 179 2,429 528,676,059
202 35-38 wks 664 8,265 213,756,723
202 6-wk post-partum 0 0 33,654,931
202 Total 3,762 41,689 1,278,102,150
203 8-12 wks 0 0 98,601,592
203 17-21 wks 0 0 108,616,190
203 26-30 wks 873 9,495 136,155,283
203 35-38 wks 938 12,758 112,201,721
203 Labor 230 2,143 125,966,244
203 6-wk post-partum 0 0 62,392,928
203 Total 2,041 24,396 643,933,958
205 8-12 wks 1,748 19,835 213,816,916
205 17-21 wks 3,593 25,751 638,504,441
205 26-30 wks 2,826 25,945 425,544,582
205 Labor 221 2,799 52,763,657
205 6-wk post-partum 4,441 28,649 874,736,344
205 Total 12,829 102,978 2,205,365,940
206 8-12 wks 0 0 175,667,171
206 17-21 wks 0 0 163,946,678
206 26-30 wks 2,188 21,538 297,809,016
206 35-38 wks 126 1,823 96,626,772
206 Labor 369 1,355 2,225,820,070
206 6-wk post-partum 0 0 93,301,014
206 Total 2,683 24,716 3,053,170,721
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Table 20. Summary of the percentage of bases covered for each HMP urogenital 
tract reference genome in each sample. 
 
110 117 119 120 125 201 202 203 205 206
Acinetobacter_baumannii_ATCC_19606_=_CIP_70.34 0.01% 0.00% 0.00% 0.08% 0.01% 0.00% 0.01% 0.01% 0.01% 0.03%
Actinobaculum_massiliae_ACS-171-V-Col2 0.01% 0.01% 0.04% 0.03% 0.01% 0.00% 0.02% 0.48% 4.10% 0.01%
Actinomyces_coleocanis_DSM_15436 0.00% 0.02% 0.01% 0.02% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Actinomyces_neuii_BVS029A5 0.15% 0.00% 0.16% 0.46% 0.01% 0.04% 0.01% 0.59% 1.03% 0.17%
Actinomyces_turicensis_ACS-279-V-Col4 0.92% 0.00% 0.02% 0.35% 0.13% 0.01% 19.67% 5.56% 0.49% 0.55%
Actinomyces_urogenitalis_DSM_15434 0.00% 0.00% 0.00% 0.02% 0.04% 0.00% 0.06% 0.03% 0.29% 0.01%
Aerococcus_urinae_ACS-120-V-Col10a 0.01% 0.00% 0.00% 0.01% 0.00% 0.00% 0.02% 0.07% 0.12% 0.00%
Aerococcus_viridans_ATCC_11563 0.00% 0.01% 0.00% 0.03% 0.00% 0.00% 0.00% 0.01% 0.01% 0.01%
Anaerococcus_hydrogenalis_ACS-025-V-Sch4 1.49% 0.96% 0.25% 7.75% 2.61% 0.04% 1.79% 15.49% 1.22% 0.78%
Anaerococcus_lactolyticus_ATCC_51172 1.01% 0.05% 0.71% 0.37% 12.02% 0.02% 5.08% 49.06% 0.30% 0.38%
Anaerococcus_prevotii_ACS-065-V-Col13 0.37% 0.31% 0.66% 1.06% 0.35% 0.07% 1.31% 2.33% 0.02% 0.60%
Anaerococcus_tetradius_ATCC_35098 0.08% 0.02% 2.34% 0.23% 4.86% 0.01% 0.64% 0.39% 0.06% 0.09%
Atopobium_vaginae_DSM_15829 0.01% 0.02% 0.04% 0.08% 91.93% 10.64% 4.69% 0.00% 0.05% 0.12%
Atopobium_vaginae_PB189-T1-4 0.00% 0.00% 0.00% 0.00% 1.04% 0.09% 0.05% 0.09% 0.00% 0.08%
Bifidobacterium_breve_ACS-071-V-Sch8b 0.00% 20.26% 15.00% 0.07% 5.59% 0.01% 0.08% 5.43% 0.11% 0.55%
Bifidobacterium_dentium_ATCC_27679 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Bifidobacterium_dentium_JCVIHMP022 0.00% 0.01% 0.00% 0.01% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Brevibacterium_mcbrellneri_ATCC_49030 0.00% 0.02% 0.01% 0.28% 0.00% 0.00% 0.00% 0.04% 0.16% 0.01%
Chryseobacterium_gleum_ATCC_35910 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.02% 0.00% 0.01%
Clostridiales_genomosp._BVAB3_str._UPII9-5 0.13% 0.04% 0.09% 0.18% 0.73% 0.08% 0.32% 0.39% 0.03% 0.02%
Corynebacterium_aurimucosum_ATCC_700975 0.00% 0.01% 0.03% 1.27% 0.21% 0.01% 0.02% 0.41% 1.11% 0.04%
Corynebacterium_genitalium_ATCC_33030 0.00% 0.34% 0.00% 0.02% 0.00% 0.00% 0.01% 0.12% 0.44% 0.01%
Corynebacterium_glucuronolyticum_ATCC_51866 0.00% 0.01% 0.00% 0.38% 0.00% 0.01% 0.02% 0.10% 0.06% 0.01%
Corynebacterium_glucuronolyticum_ATCC_51867 0.00% 0.00% 0.00% 0.25% 0.00% 0.00% 0.01% 0.09% 0.01% 0.00%
Corynebacterium_jeikeium_ATCC_43734 0.00% 0.52% 0.09% 0.94% 0.01% 0.00% 0.01% 2.76% 1.08% 0.37%
Corynebacterium_lipophiloflavum_DSM_44291 0.00% 0.01% 0.01% 0.01% 0.00% 0.00% 0.01% 0.01% 0.07% 0.00%
Corynebacterium_pseudogenitalium_ATCC_33035 0.25% 0.92% 0.20% 3.14% 1.50% 0.08% 0.58% 5.41% 3.61% 1.83%
Corynebacterium_striatum_ATCC_6940 0.00% 0.00% 0.00% 0.27% 0.03% 0.00% 0.04% 0.04% 0.45% 0.30%
Dialister_micraerophilus_DSM_19965 0.09% 0.49% 1.88% 0.71% 1.45% 0.00% 0.78% 0.95% 0.05% 0.20%
Dialister_microaerophilus_UPII_345-E 0.00% 0.04% 0.23% 0.20% 0.06% 0.07% 0.25% 0.07% 0.04% 0.00%
Enterococcus_durans_FB129-CNAB-4 0.00% 0.00% 0.00% 0.01% 0.00% 0.00% 0.00% 0.01% 0.00% 0.00%
Enterococcus_faecalis_ATCC_29200 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterococcus_faecalis_ERV81 0.00% 0.00% 0.00% 0.01% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterococcus_faecalis_ERV85 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterococcus_faecalis_ERV93 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterococcus_faecalis_HH22 0.00% 0.03% 0.00% 0.01% 0.00% 0.00% 0.00% 0.03% 0.01% 0.01%
Enterococcus_faecalis_TX0312 0.00% 0.00% 0.00% 0.01% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterococcus_faecalis_TX0635 0.00% 0.01% 0.00% 0.01% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterococcus_faecalis_TX0855 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterococcus_faecium_E422 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.01%
Enterococcus_faecium_P1139 0.00% 0.00% 0.21% 0.00% 0.00% 0.01% 0.03% 0.00% 0.01% 0.00%
Enterococcus_faecium_S447 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Eremococcus_coleocola_ACS-139-V-Col8 0.03% 0.09% 0.00% 0.22% 0.01% 0.03% 0.03% 0.19% 0.02% 0.01%
Escherichia_coli_83972 4.46% 2.74% 3.19% 67.29% 19.74% 3.40% 2.59% 4.73% 6.59% 5.73%
Finegoldia_magna_ACS-171-V-Col3 0.34% 0.14% 0.28% 1.77% 0.52% 0.03% 0.69% 2.99% 0.41% 0.16%
Finegoldia_magna_ATCC_53516 0.33% 1.47% 0.03% 2.01% 0.32% 0.09% 0.42% 1.14% 0.68% 1.08%
Finegoldia_magna_BVS033A4 0.30% 0.02% 0.30% 2.02% 0.55% 0.03% 0.75% 2.95% 0.31% 0.22%
Finegoldia_magna_SY403409CC001050417 0.37% 0.08% 0.32% 1.73% 0.45% 0.04% 0.94% 2.59% 0.20% 0.17%
Fusobacterium_nucleatum_subsp._nucleatum_ATCC_23726 0.02% 5.16% 0.10% 0.19% 0.02% 0.00% 0.31% 0.08% 0.58% 0.03%
Gardnerella_vaginalis_315-A 0.05% 0.10% 0.09% 18.75% 8.91% 0.03% 0.30% 18.50% 0.59% 1.89%
Gardnerella_vaginalis_409-05 18.59% 0.03% 2.61% 19.03% 4.95% 13.00% 94.37% 4.56% 23.29% 9.25%
Gardnerella_vaginalis_ATCC_14019 0.03% 0.16% 0.08% 19.47% 8.40% 0.02% 0.34% 17.12% 0.55% 1.31%
Gardnerella_vaginalis_HMP9231 0.23% 0.14% 0.14% 20.73% 8.15% 0.41% 2.92% 17.15% 0.79% 1.46%
Haemophilus_parainfluenzae_HK262 0.00% 0.00% 0.00% 0.08% 0.00% 0.00% 0.13% 23.41% 0.08% 0.06%
Klebsiella_oxytoca_10-5245 0.07% 0.03% 0.04% 0.21% 0.04% 0.04% 0.03% 0.05% 0.06% 0.08%
Klebsiella_oxytoca_10-5250 0.00% 0.00% 0.00% 0.12% 0.01% 0.00% 0.00% 0.00% 0.00% 0.00%
Lactobacillus_coleohominis_101-4-CHN 5.54% 0.04% 0.00% 0.40% 1.79% 0.06% 0.00% 0.47% 0.79% 0.00%
Lactobacillus_crispatus_125-2-CHN 1.77% 4.76% 0.53% 3.24% 0.14% 0.00% 0.02% 0.11% 1.65% 0.03%
Lactobacillus_crispatus_214-1 1.93% 2.65% 0.87% 0.91% 0.02% 0.00% 0.02% 0.05% 2.00% 0.10%
Lactobacillus_crispatus_CTV-05 5.48% 4.28% 5.94% 2.14% 0.04% 0.02% 0.02% 0.09% 7.80% 0.83%
Lactobacillus_crispatus_FB049-03 3.71% 2.89% 0.88% 1.62% 0.02% 0.01% 0.02% 0.02% 4.24% 0.51%
Lactobacillus_crispatus_FB077-07 4.34% 1.77% 4.45% 0.73% 0.01% 0.04% 0.16% 0.06% 6.22% 0.73%
Lactobacillus_crispatus_JV-V01 0.60% 1.52% 0.14% 1.34% 0.08% 0.00% 0.00% 0.02% 0.81% 0.01%
Lactobacillus_crispatus_MV-1A-US 0.75% 1.19% 0.48% 0.92% 0.00% 0.00% 0.01% 0.00% 1.07% 0.04%
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Lactobacillus_crispatus_MV-3A-US 1.25% 2.63% 0.63% 2.03% 0.06% 0.00% 0.06% 0.01% 1.73% 0.03%
Lactobacillus_crispatus_SJ-3C-US 1.84% 2.53% 1.32% 1.36% 0.05% 0.00% 0.01% 0.11% 2.19% 0.09%
Lactobacillus_delbrueckii_subsp._bulgaricus_PB2003/044-T3-4 0.02% 0.06% 0.01% 0.00% 0.00% 0.00% 0.00% 0.02% 0.01% 0.04%
Lactobacillus_fermentum_28-3-CHN 0.02% 0.03% 0.01% 5.81% 0.15% 0.02% 0.02% 49.24% 0.08% 0.08%
Lactobacillus_gasseri_202-4 0.86% 0.06% 0.14% 0.65% 19.75% 2.17% 29.74% 0.26% 5.84% 0.87%
Lactobacillus_gasseri_224-1 0.09% 0.07% 0.00% 1.00% 0.31% 0.06% 3.47% 0.02% 0.04% 1.61%
Lactobacillus_gasseri_JV-V03 0.05% 0.03% 0.04% 0.37% 0.30% 0.04% 1.85% 0.61% 0.15% 0.66%
Lactobacillus_gasseri_MV-22 0.40% 0.15% 0.07% 1.91% 0.11% 0.04% 2.00% 0.00% 0.43% 2.89%
Lactobacillus_gasseri_SJ-9E-US 0.05% 0.09% 0.05% 2.70% 0.17% 0.00% 0.16% 0.01% 0.19% 3.08%
Lactobacillus_gasseri_SV-16A-US 0.06% 0.01% 0.01% 0.09% 0.88% 0.16% 1.70% 0.00% 0.19% 0.12%
Lactobacillus_iners_ATCC_55195 5.31% 0.01% 0.00% 0.03% 4.90% 5.05% 0.07% 0.03% 0.05% 0.05%
Lactobacillus_iners_DSM_13335 4.13% 0.00% 0.00% 0.03% 4.49% 4.94% 0.06% 0.00% 0.05% 0.09%
Lactobacillus_iners_LactinV_01V1-a 3.34% 0.01% 0.04% 0.24% 4.73% 6.30% 0.27% 0.01% 0.01% 0.04%
Lactobacillus_iners_LactinV_03V1-b 5.39% 0.03% 0.12% 0.01% 3.12% 4.18% 0.10% 0.00% 0.01% 0.07%
Lactobacillus_iners_LactinV_09V1-c 4.12% 0.01% 0.01% 0.03% 2.67% 4.21% 0.07% 0.05% 0.04% 0.05%
Lactobacillus_iners_LactinV_11V1-d 3.34% 0.01% 0.03% 0.06% 2.88% 4.24% 0.08% 0.00% 0.03% 0.09%
Lactobacillus_iners_LEAF_2052A-d 5.08% 0.00% 0.03% 0.07% 3.31% 4.32% 0.05% 0.00% 0.04% 0.00%
Lactobacillus_iners_LEAF_2053A-b 4.68% 0.00% 0.02% 0.07% 3.88% 5.00% 0.04% 0.01% 0.04% 0.06%
Lactobacillus_iners_LEAF_2062A-h1 4.86% 0.01% 0.03% 0.00% 2.84% 4.20% 0.04% 0.14% 0.00% 0.01%
Lactobacillus_iners_LEAF_3008A-a 3.60% 0.00% 0.00% 0.00% 2.40% 3.55% 0.07% 0.01% 0.03% 0.00%
Lactobacillus_iners_SPIN_1401G 5.08% 0.01% 0.01% 0.07% 3.71% 3.55% 0.05% 0.01% 0.05% 0.04%
Lactobacillus_iners_SPIN_2503V10-D 5.62% 0.00% 0.01% 0.06% 2.44% 4.89% 0.06% 0.03% 0.04% 0.09%
Lactobacillus_iners_UPII_143-D 2.84% 0.00% 0.02% 0.03% 1.79% 2.96% 0.12% 0.02% 0.01% 0.01%
Lactobacillus_iners_UPII_60-B 6.18% 0.04% 0.03% 0.13% 5.80% 5.53% 0.43% 0.04% 0.06% 0.10%
Lactobacillus_jensenii_1153 0.00% 0.23% 0.00% 0.01% 0.00% 0.00% 0.03% 0.00% 0.02% 0.00%
Lactobacillus_jensenii_115-3-CHN 0.05% 0.19% 0.00% 0.06% 4.06% 0.00% 0.52% 0.00% 0.00% 0.02%
Lactobacillus_jensenii_269-3 0.00% 0.04% 0.00% 0.02% 0.93% 0.01% 0.08% 0.00% 0.01% 0.00%
Lactobacillus_jensenii_27-2-CHN 0.00% 0.13% 0.00% 0.00% 0.01% 0.00% 0.00% 0.00% 0.03% 0.00%
Lactobacillus_jensenii_JV-V16 0.06% 1.75% 0.07% 0.06% 0.13% 0.00% 0.11% 0.00% 0.05% 0.00%
Lactobacillus_jensenii_SJ-7A-US 0.22% 0.64% 0.02% 0.05% 2.22% 0.06% 0.02% 0.00% 0.06% 0.00%
Lactobacillus_johnsonii_ATCC_33200 0.04% 0.11% 0.01% 0.12% 0.06% 0.00% 0.25% 0.01% 0.03% 0.15%
Lactobacillus_oris_PB013-T2-3 0.01% 0.01% 0.00% 1.68% 0.11% 0.25% 0.00% 1.00% 0.10% 0.13%
Lactobacillus_salivarius_ACS-116-V-Col5a 0.00% 0.00% 0.04% 0.03% 0.00% 0.00% 0.02% 0.05% 0.01% 0.03%
Lactobacillus_vaginalis_ATCC_49540 0.11% 48.98% 0.10% 82.81% 24.70% 0.04% 0.00% 0.20% 33.63% 0.16%
Megasphaera_genomosp._type_1_str._28L 0.02% 0.01% 0.09% 0.10% 0.32% 0.01% 0.13% 0.46% 0.00% 0.05%
Megasphaera_sp._UPII_135-E 0.03% 0.02% 0.04% 0.12% 0.18% 0.01% 0.19% 0.65% 0.02% 0.07%
Megasphaera_sp._UPII_199-6 0.02% 0.00% 0.96% 0.55% 0.08% 0.02% 0.04% 0.24% 0.00% 0.02%
Mobiluncus_curtisii_ATCC_43063 0.00% 0.00% 0.00% 0.07% 0.06% 0.00% 0.08% 0.03% 0.02% 0.01%
Mobiluncus_curtisii_ATCC_51333 0.00% 0.00% 0.00% 0.66% 0.03% 0.00% 0.15% 0.04% 0.03% 0.07%
Mobiluncus_curtisii_subsp._curtisii_ATCC_35241 0.00% 0.00% 0.00% 0.01% 0.01% 0.00% 0.02% 0.00% 0.00% 0.03%
Mobiluncus_curtisii_subsp._holmesii_ATCC_35242 0.00% 0.00% 0.00% 0.04% 0.03% 0.00% 0.10% 0.02% 0.02% 0.19%
Mobiluncus_mulieris_28-1 0.00% 0.00% 0.00% 0.01% 0.01% 0.00% 0.00% 0.01% 0.00% 0.01%
Mobiluncus_mulieris_ATCC_35239 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Mobiluncus_mulieris_ATCC_35243 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.01% 0.00% 0.01% 0.00%
Mobiluncus_mulieris_FB024-16 0.00% 0.01% 0.00% 0.01% 0.01% 0.00% 0.00% 0.00% 0.00% 0.00%
Mycobacterium_parascrofulaceum_ATCC_BAA-614 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Myroides_odoratimimus_CCUG_12901 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Myroides_odoratimimus_CCUG_3837 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Pasteurella_bettyae_CCUG_2042 0.00% 0.00% 0.01% 0.02% 0.07% 0.00% 0.03% 0.14% 0.00% 0.01%
Peptoniphilus_duerdenii_ATCC_BAA-1640 0.13% 0.12% 0.81% 2.48% 1.26% 0.07% 6.09% 14.20% 0.73% 0.35%
Peptoniphilus_harei_ACS-146-V-Sch2b 2.35% 1.02% 1.33% 7.59% 2.23% 0.12% 11.15% 19.48% 5.63% 0.35%
Peptoniphilus_lacrimalis_315-B 0.09% 0.08% 0.88% 0.53% 2.45% 0.04% 3.31% 13.76% 1.08% 0.30%
Porphyromonas_asaccharolytica_PR426713P-I 0.01% 0.04% 0.34% 0.05% 0.33% 0.00% 3.85% 1.31% 0.00% 0.39%
Porphyromonas_uenonis_60-3 0.03% 0.20% 0.06% 0.66% 1.91% 0.00% 17.33% 0.61% 0.10% 1.90%
Prevotella_amnii_CRIS_21A-A 0.02% 0.05% 0.06% 0.05% 0.34% 0.01% 0.25% 0.28% 0.02% 1.91%
Prevotella_bivia_JCVIHMP010 0.39% 0.11% 3.80% 1.26% 15.06% 0.17% 0.61% 0.36% 0.71% 85.42%
Prevotella_buccalis_ATCC_35310 0.44% 1.00% 0.41% 1.75% 5.48% 0.04% 12.07% 2.56% 0.26% 4.99%
Prevotella_denticola_CRIS_18C-A 0.02% 0.02% 0.02% 0.01% 0.29% 0.01% 0.10% 0.19% 0.03% 0.70%
Prevotella_disiens_FB035-09AN 0.41% 0.49% 1.80% 1.13% 1.90% 0.10% 1.10% 2.47% 1.13% 2.94%
Prevotella_oralis_ATCC_33269 0.00% 0.00% 0.00% 0.00% 0.08% 0.00% 0.00% 0.00% 0.00% 0.03%
Prevotella_timonensis_CRIS_5C-B1 3.75% 8.68% 4.04% 20.36% 49.66% 0.18% 6.42% 22.31% 2.60% 23.47%
Propionibacterium_sp._409-HC1 0.24% 0.07% 0.06% 0.13% 0.01% 0.03% 0.07% 0.08% 0.41% 1.28%
Propionibacterium_sp._434-HC2 0.07% 0.10% 0.02% 0.07% 0.01% 0.02% 0.02% 0.04% 0.35% 0.64%
Proteus_mirabilis_ATCC_29906 0.00% 0.00% 0.00% 0.04% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Roseomonas_cervicalis_ATCC_49957 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Sphingobacterium_spiritivorum_ATCC_33300 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.01% 0.00% 0.00% 0.00%
Sphingobacterium_spiritivorum_ATCC_33861 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Staphylococcus_aureus_subsp._aureus_MN8 0.00% 1.71% 0.00% 0.03% 0.01% 0.00% 0.01% 0.02% 0.01% 0.00%
Staphylococcus_epidermidis_BVS058A4 0.15% 0.75% 0.06% 9.33% 0.67% 0.11% 0.70% 4.95% 3.77% 0.44%
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Staphylococcus_lugdunensis_ACS-027-V-Sch2 0.00% 0.01% 0.01% 0.23% 0.01% 0.02% 0.00% 0.01% 0.03% 0.00%
Staphylococcus_simulans_ACS-120-V-Sch1 0.00% 0.00% 0.00% 0.01% 0.00% 0.00% 0.00% 0.01% 0.03% 0.00%
Streptococcus_bovis_ATCC_700338 0.03% 0.02% 0.73% 0.38% 0.01% 0.01% 0.11% 0.84% 0.02% 0.40%
Streptococcus_pseudoporcinus_SPIN_20026 0.11% 0.05% 0.43% 0.38% 0.13% 0.00% 0.52% 1.23% 0.04% 0.34%
Streptococcus_urinalis_FB127-CNA-2 0.17% 0.01% 1.53% 0.68% 0.02% 0.01% 0.17% 2.04% 0.04% 0.20%
Treponema_phagedenis_F0421 0.00% 0.00% 0.00% 0.01% 0.01% 0.00% 0.00% 0.01% 0.01% 0.00%
Veillonella_atypica_ACS-049-V-Sch6 0.00% 0.05% 0.00% 0.21% 0.00% 0.00% 0.00% 0.16% 0.00% 0.00%
Veillonella_atypica_ACS-134-V-Col7a 0.01% 0.03% 0.00% 0.23% 0.01% 0.00% 0.00% 0.27% 0.00% 0.00%
Veillonella_parvula_ACS-068-V-Sch12 0.04% 0.73% 0.00% 0.50% 0.01% 0.01% 0.03% 22.27% 0.02% 0.01%
Veillonella_ratti_ACS-216-V-Col6b 0.01% 0.01% 0.01% 0.12% 0.00% 0.00% 0.10% 0.05% 0.00% 0.02%
Note: only reads (mapping quality > 20) were considered as correct alignment.
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Table 21. Assembly statistics of metagenome vaginal samples. 
 
Note: Assemblies were composed of contigs that are >= 500 bp. Contig N50 is defined as 
the contig length such that using equal or longer contigs produces 50% the bases of the 
assembly. 
 
Sample ID 110 117 119 120 125 201 202 203 205 206
Number of 
contigs in 
assembly #1 383 307 136 1,895 704 267 372 444 246 767
Total size of 
contigs in 
assembly #1 342,412 311,577 189,805 4,891,172 1,704,923 237,337 1,982,114 405,458 236,882 3,306,810
Longest 
contig length 
in assembly 
#1 (bp) 9,730 6,599 41,629 42,826 54,768 6,876 199,022 10,517 6,900 48,481
N50 contig 
length in 
assembly #1 
(bp) 898 1,000 1,660 6,391 6,790 873 59,497 921 942 9,956
Number of 
contigs in 
assembly #2 2,090 3,079 2,573 3,840 3,905 1,306 1,509 4,137 2,174 2,959
Total size of 
contigs in 
assembly #2 
(bp) 5,560,865 6,612,830 4,464,242 10,122,789 7,001,139 2,577,370 5,118,034 7,562,140 4,309,859 9,125,125
Longest 
contig length 
in assembly 
#2 (bp) 152,421 60,015 137,548 535,652 86,365 192,112 343,435 120,010 104,053 375,197
N50 contig 
length in 
assembly #2 
(bp) 13,320 6,377 4,859 10,027 2,908 21,712 40,086 5,341 5,341 46,037
Number of 
contigs in 
assembly #1 
and #2 2,473 3,386 2,709 5,735 4,609 1,573 1,881 4,581 2,420 3,726
Total size of 
contigs in 
assembly #1 
and #2 (bp) 5,903,277 6,924,407 4,654,047 15,013,961 8,706,062 2,814,707 7,100,148 7,967,598 4,546,741 12,431,935
Longest 
contig length 
in assembly 
#1 and #2 (bp) 152,421 60,015 137,548 535,652 86,365 192,112 343,435 120,010 104,053 375,197
N50 contig 
length in 
assembly #1 
and #2 (bp) 11,653 5,803 4,609 7,815 3,836 6,490 41,768 3,874 4,438 17,469
Number of 
population 
genome bins 9 8 7 12 12 23 12 8 2 18
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Table 22. Summary statistics for high-quality population genomes. 
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Table 23. Taxonomic abundance determined from the metagenomic short reads in 
women with and without a previous preterm birth history (%). 
 
 
Bacterial species 110_1 110_2 110_3 110_4 110_5 110_6 117_1 117_2 117_3 117_4 117_5
[Bacteroides]_pectinophilus 0 0 0 0 0 0 0 0 0 0 0
[Clostridium]_bartlettii 0 0 0 0 0 0 0 0 0 0 0
[Clostridium]_sticklandii 0 0 0 0 0 0 0 0 0 0 0
[Ruminococcus]_gnavus 0 0 0 0 0 0 0 0 0 0 0
[Ruminococcus]_obeum 0 0 0 0 0 0 0 0 0 0 0
[Ruminococcus]_torques 0 0 0 0 0 0 0 0 0 0 0
Acetobacterium_woodii 0 0 0 0 0 0 0 0 0 0 0
Acholeplasma_laidlawii 0 0 0 0 0 0 0 0 0 0 0
Acidimicrobium_ferrooxidans 0 0 0 0 0 0 0 0 0 0 0
Acidothermus_cellulolyticus 0 0 0 0 0 0 0 0 0 0 0
Aciduliprofundum_boonei 0 0 0 0 0 0 0 0 0 0 0
Acinetobacter_baumannii 0 0 0 0 0 0 0 0 0 0 0
Acinetobacter_junii 0 0 0 0 0 0 0 0 0 0 0
Acinetobacter_lwoffii 0 0 0 0 0 0 0 0 0 0 0
Actinobacillus_succinogenes 0 0 0 0 0 0 2.00E-02 0 1.00E-02 1.00E-02 0
Actinomyces_coleocanis 0 0 0 0 0 0 0 0 0 0 0
Actinomyces_urogenitalis 0 0 0 0 0 0 0 0 0 0 0
Aggregatibacter_aphrophilus 0 0 0 0 0 0 0 0 0 0 0
Alistipes_finegoldii 0 0 0 0 0 0 0 0 0 0 0
Alistipes_shahii 0 0 0 0 0 0 0 0 0 0 0
Alkaliphilus_metalliredigens 0 0 0 0 0 0 0 0 0 0 0
Allochromatium_vinosum 0 0 0 0 0 0 0 0 0 0 0
Alteromonas_macleodii 0 0 0 0 0 0 0 0 0 0 0
Alteromonas_sp._sn2 0 0 0 0 0 0 0 0 0 0 0
Amycolatopsis_mediterranei 0 0 0 0 0 0 0 0 0 0 0
Amycolicicoccus_subflavus 0 0 0 0 0 0 0 0 0 0 0
Anaerococcus_hydrogenalis 0 0 0 0 0 0.87 0 0 0 0 0
Anaerococcus_lactolyticus 0 0 0 0 1.00E-02 2.7 0 0 0 0 0
Anaerococcus_prevotii 0 0 1.00E-02 0 0 0 0 0 0 0 0
Anaerococcus_tetradius 0 0 0 0 0 0 0 0 0 0 0
Anaerococcus_vaginalis 0 0 0 0 0 1.06 2.00E-02 0 0 0 1.00E-02
Anaerotruncus_colihominis 0 0 0 0 0 0 0 0 0 0 0
Arcobacter_nitrofigilis 0 0 0 0 0 0 0 0 0 0 0
Atopobium_parvulum 0 0 0 0 0 0 0 0 0 0 0
Atopobium_vaginae 0 0 0 0 0 0 0 0 0 0 0
Azospira_oryzae 0 0 0 0 0 0 0 0 0 0 0
Bacillus_cereus 0 0 0 0 0 0 0 0 0 0 0
Bacillus_clausii 0 0 0 0 0 0 0 0 0 0 0
Bacillus_pseudofirmus 0 0 0 0 0 0 0 0 0 0 0
Bacillus_thuringiensis 0 0 0 0 0 0 0 0 0 0 0
Bacteriovorax_marinus 0 0 0 0 0 0 0 0 0 0 0
Bacteroides_caccae 0 0 0 0 0 0 0 0 0 0 0
Bacteroides_cellulosilyticus 0 0 0 0 0 0 0 0 0 0 0
Bacteroides_dorei 0 0 0 0 0 0 0 0 0 0 0
Bacteroides_fragilis 0 0 0 0 0 0.1 0 0 0 0 0
Bacteroides_ovatus 0 0 0 0 0 0 0 0 0 0 0
Bacteroides_stercoris 0 0 0 0 0 0 0 0 0 0 0
Bacteroides_thetaiotaomicron 0 0 0 0 0 0 0 0 0 0 0
Bacteroides_uniformis 0 0 0 0 0 0 0 0 0 0 0
Bacteroides_vulgatus 0 0 0 0 0 0 0 0 0 0 0
Bifidobacterium_adolescentis 0 0 0 0 0 0 0 0 0 0 0
Bifidobacterium_angulatum 0 0 0 0 0 0 0 0 0 0 0
Bifidobacterium_animalis 0 0 0 0 0 0 0 0 0 0 0
Bifidobacterium_bifidum 0 0 0 0 0 0 0 0 0 0 0
Bifidobacterium_breve 0 0 0 0 0 0 0 0 0 0 0
Bifidobacterium_catenulatum 0 0 0 0 0 0 0 0 0 0 0
Bifidobacterium_dentium 0 0 0 0 0 0 0 0 0 0 0
Bifidobacterium_gallicum 0 0 0 0 0 0 0 0 0 0 0
Bifidobacterium_longum 0 0 0 0 0 0 0 0 0 0 1.00E-02
Bifidobacterium_pseudocatenulatum 0 0 0 0 0 0 0 0 0 0 0
Bilophila_wadsworthia 0 0 0 0 0 0 0 0 0 0 0
Blautia_hydrogenotrophica 0 0 0 0 0 0 0 0 0 0 0
Brevibacterium_mcbrellneri 0 0 0 0 0 0 0 0 0 0 1.00E-02
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Buchnera_aphidicola 0 0 0 0 0 0 0 0 0 0 0
Burkholderia_glumae 0 0 0 0 0 0 0 0 0 0 0
Burkholderia_phytofirmans 0 0 0 0 0 0 0 0 0 0 0
Burkholderia_pseudomallei 0 0 0 0 0 0 0 2.00E-02 1.00E-02 1.00E-02 1.00E-02
Butyrivibrio_crossotus 0 0 0 0 0 0 0 0 0 0 0
Butyrivibrio_fibrisolvens 0 0 0 0 0 0 0 0 0 0 0
Butyrivibrio_proteoclasticus 0 0 0 0 0 0 0 0 0 0 0
Caldicellulosiruptor_bescii 0 0 0 0 0 0 0 0 0 0 0
Campylobacter_fetus 0 0 0 0 0 0 0 0 0 0 0
Campylobacter_gracilis 0 0 0 0 0 0 0 0 0 0 0
Campylobacter_hominis 0 0 0 0 0 0 0 0 0 0 0
Campylobacter_lari 0 0 0 0 0 0 0 0 0 0 0
Campylobacter_upsaliensis 0 0 0 0 0 0.1 0 0 0 0 0
Candidatus_accumulibacter_phosphatis 0 0 0 0 0 0 0 0 0 0 0
Candidatus_azobacteroides_pseudotrichonymphae 0 0 0 0 0 0 0 0 0 0 0
Candidatus_baumannia_cicadellinicola 0 0 0 2.00E-02 1.00E-02 0 4.00E-02 2.00E-02 2.00E-02 2.00E-02 1.00E-02
Candidatus_carsonella_ruddii 0 0 0 0 0 0 0 0 0 0 0
Candidatus_nitrospira_defluvii 0 0 0 3.00E-02 2.00E-02 0 0 2.00E-02 2.00E-02 1.00E-02 1.00E-02
Candidatus_portiera_aleyrodidarum 3.00E-02 2.00E-02 1.00E-02 0 0 0.1 0 0 0 0 0
Candidatus_puniceispirillum_marinum 0 0 0 0 0 0 0 0 0 0 0
Candidatus_riesia_pediculicola 0 0 0 0 0 0 0 0 0 0 0
Candidatus_zinderia_insecticola 5.00E-02 9.00E-02 7.00E-02 0 0 0 0 0 0 0 0
Carboxydothermus_hydrogenoformans 0 0 0 0 0 0 0 0 0 0 0
Catenibacterium_mitsuokai 0 0 0 0 0 0 0 0 0 0 0
Cellulophaga_algicola 0 0 0 0 0 0 0 0 0 0 0
Cellulosilyticum_lentocellum 0 0 0 0 0 0 0 0 0 0 0
Chitinophaga_pinensis 0 0 0 0 0 0 0 0 0 0 0
Chlamydia_trachomatis 0 0 0 0 0 0 0 0 0 0 0
Chlamydophila_felis 0 0 0 0 0 0 0 0 0 0 0
Chryseobacterium_gleum 0 0 0 0 0 0 0 0 0 0 0
Clostridiales_genomosp._bvab3 0 0 0 0 1.00E-02 0 2.00E-02 1.00E-02 1.00E-02 2.00E-02 1.00E-02
Clostridium_acidurici 0 0 0 0 0 0 0 0 0 0 0
Clostridium_botulinum 0 0 0 0 0 0 2.00E-02 0 2.00E-02 0 0
Clostridium_cellulovorans 0 0 0 0 0 0 0 0 0 0 0
Clostridium_leptum 0 0 0 0 0 0 0 0 0 0 0
Clostridium_novyi 0 0 0 0 0 0 0 0 0 0 0
Clostridium_perfringens 0 0 0 0 0 0 7.00E-02 0 4.00E-02 0 1.00E-02
Clostridium_sp._sy8519 0 0 0 0 0 0 0 0 0 0 0
Collinsella_aerofaciens 0 0 0 0 0 0 0 0 0 0 0
Comamonas_testosteroni 0 0 0 0 0 0 0 0 0 0 0
Coprococcus_catus 0 0 0 0 0 0 0 0 0 0 0
Coprococcus_comes 0 0 0 0 0 0 0 0 0 0 0
Coprococcus_eutactus 0 0 0 0 0 0 0 0 0 0 0
Coprothermobacter_proteolyticus 1.00E-02 2.00E-02 3.00E-02 0 0 0 0 0 0 0 0
Corynebacterium_accolens 0 0 0 0 0 0 0 0 0 0 0
Corynebacterium_ammoniagenes 0 0 0 0 0 0 0 0 0 0 0
Corynebacterium_amycolatum 0 0 0 0 0 0 0 0 0 0 0
Corynebacterium_aurimucosum 0 0 0 0 0 0 0 0 0 0 0
Corynebacterium_glucuronolyticum 0 0 0 0 0 0 2.00E-02 0 0 0 0
Corynebacterium_glutamicum 0 0 0 0 0 0 0 0 0 0 0
Corynebacterium_jeikeium 0 0 0 0 0 0 0 0 0 0 0
Corynebacterium_kroppenstedtii 0 0 0 0 0 0 0 0 0 0 0
Corynebacterium_lipophiloflavum 0 0 0 0 0 0 0 0 0 0 0
Corynebacterium_matruchotii 0 0 0 0 0 0 0 0 0 0 0
Corynebacterium_pseudogenitalium 0 0 0 0 0 0 0 0 0 0 0
Corynebacterium_striatum 0 0 0 0 0 0 0 0 0 0 0
Corynebacterium_tuberculostearicum 0 0 0 0 0 0 0 0 0 0 0
Corynebacterium_ulcerans 0 0 0 0 0 0 0 0 0 0 0
Corynebacterium_urealyticum 0 0 0 0 0 0 0 0 0 0 0
Cronobacter_sakazakii 0 0 0 0 0 0 0 0 0 0 0
Cupriavidus_necator 0 0 0 0 0 0 0 0 0 0 0
Cytophaga_hutchinsonii 0 0 0 0 0 0 0 0 0 0 0
Deinococcus_proteolyticus 0 0 0 0 0 0 0 0 0 0 0
Delftia_acidovorans 0 0 0 0 0 0 0 0 0 0 0
Desulfitobacterium_hafniense 0 0 0 0 0 0 0 0 0 0 0
  
161 
 
Table 23. (cont.)  
 
 
 
Desulfomonile_tiedjei 0 0 0 0 0 0 0 0 0 0 0
Dialister_invisus 0 0 0 0 0 0 0 0 0 0 0
Dichelobacter_nodosus 0 0 0 0 0 0 0 0 0 0 0
Dickeya_dadantii 0 0 0 0 0 0 0 0 0 0 0
Dorea_longicatena 0 0 0 0 0 0 0 0 0 0 0
Enterobacter_asburiae 0 0 0 0 0 0 0 0 0 0 0
Enterobacter_cloacae 0 0 0 0 0 0 0 0 0 0 0
Enterobacter_sp._638 0 0 0 0 0 0 0 0 0 0 0
Enterococcus_faecalis 0 0 0 0 0 0 0 0 0 0 0
Enterococcus_faecium 0 0 0 0 0 0 0 0 0 0 0
Erysipelothrix_rhusiopathiae 0 0 0 0 0 0 0 0 0 0 0
Erythrobacter_litoralis 0 0 0 0 0 0 2.00E-02 0 0 0 0
Escherichia_coli 2.00E-02 1.00E-02 4.00E-02 0 3.00E-02 0.1 4.00E-02 0 0 0 0
Escherichia_fergusonii 0 0 0 0 0 0 0 0 0 0 0
Eubacterium_eligens 0 0 0 0 0 0 0 0 0 0 0
Eubacterium_hallii 0 0 0 0 0 0 0 0 0 0 0
Eubacterium_limosum 0 0 0 0 0 0 0 0 0 0 0
Eubacterium_rectale 0 0 0 0 0 0 0 0 0 0 0
Eubacterium_siraeum 0 0 0 0 0 0 0 0 0 0 0
Faecalibacterium_prausnitzii 0 0 0 0 0 0 0 0 0 0 0
Ferroglobus_placidus 0 0 0 0 0 0 0 0 0 0 0
Fervidobacterium_pennivorans 0 0 0 0 0 0 0 0 0 0 0
Filifactor_alocis 6.00E-02 7.00E-02 0.11 0 0 0 0 0 0 0 0
Finegoldia_magna 0 0 0 0 1.00E-02 1.25 0 0 1.00E-02 0 1.00E-02
Flavobacterium_johnsoniae 0 0 0 0 0 0 0 0 0 0 0
Fusobacterium_mortiferum 0 0 0 0 0 0 0 0 0 0 0
Fusobacterium_nucleatum 0 0 0 0 0 0 0 0 0 0 1.00E-02
Fusobacterium_periodonticum 0 0 0 0 0 0 0 0 0 0 0
Gardnerella_vaginalis 9.00E-02 1.00E-02 0 0 0 0.29 0 0 0 0 3.00E-02
Gemella_haemolysans 0 0 0 0 0 0 0 0 0 0 0
Gemella_morbillorum 0 0 0 0 0 0 0 0 0 0 0
Gemmatimonas_aurantiaca 0 0 0 0 0 0 0 0 0 0 0
Geobacter_uraniireducens 0 0 0 0 0 0 0 0 0 0 0
Haemophilus_influenzae 0 0 0 1.00E-02 1.00E-02 0 0 0 0 0 0
Haemophilus_parainfluenzae 0 0 0 0 0 0 0 0 0 0 0
Halothermothrix_orenii 0 0 0 0 0 0 0 0 0 0 0
Helicobacter_bilis 0 0 0 0 0 0 0 0 0 0 0
Helicobacter_cetorum 0 0 0 0 1.00E-02 0 0 0 0 0 0
Helicobacter_mustelae 0 0 0 0 0 0 0 0 0 0 0
Helicobacter_pylori 0 0 0 1.00E-02 1.00E-02 0.1 0 1.00E-02 1.00E-02 0 0
Hippea_maritima 0 0 0 0 0 0 0 0 0 0 0
Holdemania_filiformis 0 0 0 0 0 0 0 0 0 0 0
Ignavibacterium_album 0 0 0 0 0 0 0 0 0 0 0
Isoptericola_variabilis 0 0 0 0 0 0 0 0 0 0 0
Jannaschia_sp._ccs1 0 0 0 0 0 0 0 0 0 0 0
Jonquetella_anthropi 0 0 0 0 0 0 0 0 0 0 0
Kangiella_koreensis 0 0 0 0 0 0 0 0 0 0 0
Kineococcus_radiotolerans 0 0 0 0 0 0 0 0 0 0 0
Kitasatospora_setae 0 0 0 0 0 0 0 0 0 0 0
Klebsiella_oxytoca 0 0 0 0 0 0 0 0 0 0 0
Klebsiella_pneumoniae 0 0 0 0 0 0 0 0 0 0 0
Kribbella_flavida 0 0 0 0 0 0 0 0 0 0 0
Lactobacillus_acidophilus 0 0 1.00E-02 0.14 0.13 0 4.00E-02 5.00E-02 4.00E-02 5.00E-02 6.00E-02
Lactobacillus_amylolyticus 0 0 0 0 0 0 0 0 0 0 0
Lactobacillus_amylovorus 0 0 0 0 0 0 0 0 0 0 0
Lactobacillus_antri 0 0 0 0 0 0 0 0 0 0 0
Lactobacillus_casei 0 0 0 0 0 0 0 0 0 0 0
Lactobacillus_coleohominis 0 0 0 2.00E-02 7.00E-02 0 2.00E-02 1.00E-02 2.00E-02 1.00E-02 3.00E-02
Lactobacillus_crispatus 0 1.00E-02 0.47 86.66 86.62 0.29 80.55 86.78 86.93 86.68 84.71
Lactobacillus_delbrueckii 1.00E-02 0 0 3.00E-02 3.00E-02 0 4.00E-02 3.00E-02 6.00E-02 5.00E-02 3.00E-02
Lactobacillus_fermentum 0 0 0 0 0 0 0 0 0 0 0
Lactobacillus_gasseri 2.00E-02 3.00E-02 2.00E-02 1.00E-02 4.00E-02 0.39 0 0 0 0 3.00E-02
Lactobacillus_helveticus 0 1.00E-02 1.00E-02 1.7 1.82 0.1 1.83 1.86 1.89 1.79 1.77
Lactobacillus_iners 89.1 88.72 88.78 0.14 0.39 77.82 4.00E-02 6.00E-02 6.00E-02 5.00E-02 6.00E-02
Lactobacillus_jensenii 0 0 1.00E-02 4.00E-02 4.00E-02 0 7.5 0.1 5.00E-02 0.37 2.28
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Lactobacillus_johnsonii 0 0 0 0 0 0.1 0 0 0 0 0
Lactobacillus_kefiranofaciens 0 0 0 0 1.00E-02 0 0 0 0 0 0
Lactobacillus_plantarum 0 0 0 0 0 0 0 0 0 0 0
Lactobacillus_reuteri 0 0 0 0 0 0 0 0 0 0 0
Lactobacillus_rhamnosus 0 0 0 0 0 0 0 0 0 0 0
Lactobacillus_sakei 0 0 0 0 0 0 0 0 0 0 0
Lactobacillus_ultunensis 0 0 0 0 0 0 0 0 0 0 0
Lactobacillus_vaginalis 0 0 0 0 0 0 5.00E-02 7.00E-02 0.11 5.00E-02 0.12
Lactococcus_garvieae 0 0 0 0 0 0 0 0 0 0 0
Lactococcus_lactis 0 0 0 1.00E-02 1.00E-02 0 0 0 0 0 0
Lawsonia_intracellularis 0 0 0 0 0 0 0 0 0 0 0
Leadbetterella_byssophila 0 0 0 0 0 0 0 0 0 0 0
Lysinibacillus_sphaericus 0 0 0 4.00E-02 4.00E-02 0 2.00E-02 6.00E-02 4.00E-02 4.00E-02 4.00E-02
Mahella_australiensis 0 0 0 0 0 0 0 0 0 0 0
Mannheimia_haemolytica 0 0 0 0 0 0 0 0 0 0 0
Marvinbryantia_formatexigens 0 0 0 0 0 0 0 0 0 0 0
Mesoplasma_florum 0 0 0 0 0 0 0 0 0 0 0
Methanobrevibacter_ruminantium 0 0 0 0 0 0 0 0 0 0 0
Methylacidiphilum_infernorum 0 0 0 0 0 0 0 0 0 0 0
Methylomicrobium_alcaliphilum 0 0 0 0 0 0 0 0 0 0 0
Micrococcus_luteus 0 0 0 0 0 0 0 0 0 0 0
Microlunatus_phosphovorus 0 0 0 0 0 0 0 0 0 0 0
Micromonospora_sp._l5 0 0 0 0 0 0 0 0 0 0 0
Mobiluncus_curtisii 0 0 0 0 0 0 0 0 0 0 0
Mycobacterium_abscessus 0 0 0 0 0 0 0 0 0 0 0
Mycobacterium_chubuense 0 0 0 0 0 0 0 0 0 0 0
Mycobacterium_smegmatis 0 0 0 0 0 0 0 0 0 0 0
Mycobacterium_vanbaalenii 0 0 0 0 0 0 0 0 0 0 0
Mycoplasma_arthritidis 0 0 0 0 0 0 0 0 0 0 0
Mycoplasma_crocodyli 0 1.00E-02 1.00E-02 0 0 0 0 0 0 0 0
Mycoplasma_gallisepticum 0 0 0 3.00E-02 1.00E-02 0 0 1.00E-02 2.00E-02 2.00E-02 1.00E-02
Mycoplasma_haemofelis 0 0 0 0 0 0 0 0 0 0 0
Mycoplasma_hominis 0 2.00E-02 1.00E-02 0 0 0 0 0 0 0 0
Mycoplasma_hyopneumoniae 0.17 0.11 0.16 0 0 0.19 0 0 0 0 0
Mycoplasma_synoviae 0 0 0 0 0 0 0 0 0 0 0
Nanoarchaeum_equitans 0 0 0 0 0 0 0 0 0 0 0
Oenococcus_oeni 0 0 0 0 0 0 0 0 0 0 0
Opitutus_terrae 0 0 0 0 0 0 0 0 0 0 0
Orientia_tsutsugamushi 0 0 0 0 0 0 0 0 0 0 0
Oscillibacter_valericigenes 0 0 0 0 0 0 0 0 0 0 0
Owenweeksia_hongkongensis 0 0 0 0 0 0 0 0 0 0 0
Pantoea_ananatis 0 0 0 0 0 0 0 0 0 0 0
Parabacteroides_distasonis 0 0 0 0 0 0 0 0 0 0 0
Parabacteroides_johnsonii 0 0 0 0 0 0 0 0 0 0 0
Parabacteroides_merdae 0 0 0 0 0 0 0 0 0 0 0
Parascardovia_denticolens 0 0 0 0 0 0 0 0 0 0 0
Parvimonas_micra 0 0 0 0 0 0 0 0 0 0 0
Pasteurella_multocida 0 0 0 0 0 0 0 0 0 0 0
Peptoniphilus_lacrimalis 0 0 0 0 0 0 0 0 0 0 0
Peptoniphilus_sp._oral_taxon_386 0 0 0 0 0 0 0 0 0 0 0
Peptostreptococcus_anaerobius 0 0 0 0 0 0 0 0 0 0 0
Peptostreptococcus_stomatis 0 0 0 0 0 0 0 0 0 0 0
Phycisphaera_mikurensis 0 0 0 0 0 0 0 0 0 0 0
Polynucleobacter_necessarius 0 0 0 0 0 0 0 0 0 0 0
Porphyromonas_asaccharolytica 0 0 0 0 0 0 0 0 0 0 0
Porphyromonas_uenonis 0 0 0 0 0 0 0 0 0 0 0
Prevotella_amnii 0 0 0 0 0 0 0 0 0 0 0
Prevotella_bergensis 0 0 0 0 0 0 0 0 0 0 0
Prevotella_bivia 0 0 0 0 0 0 0 0 0 0 0
Prevotella_buccalis 0 0 0 0 0 0 0 0 0 0 0
Prevotella_copri 0 0 0 0 0 0 0 0 0 0 0
Prevotella_melaninogenica 0 0 0 0 0 0 0 0 0 0 0
Prevotella_ruminicola 0 0 0 0 0 0 0 0 0 0 0
Prevotella_sp._oral_taxon_299 0 0 0 0 0 0 0 0 0 0 0
Prevotella_timonensis 0 0 0 0 0 0.96 0 0 0 0 0
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Prochlorococcus_marinus 0 0 0 1.00E-02 1.00E-02 0 0 1.00E-02 1.00E-02 2.00E-02 1.00E-02
Propionibacterium_acnes 0 0 0 0 0 0 0 0 0 0 1.00E-02
Propionibacterium_freudenreichii 0 0 0 0 0 0 0 0 0 0 0
Pseudoalteromonas_haloplanktis 0 0 0 0 0 0 0 0 0 0 0
Pseudomonas_aeruginosa 0 0 0 0 0 0 0 0 0 0 0
Pseudomonas_fluorescens 0 0 0 0 0 0 0 0 0 0 0
Pseudomonas_mendocina 0 0 0 0 0 0.1 0 0 0 0 0
Pseudomonas_putida 0 0 0 0 0 0 0 0 0 0 0
Pseudomonas_stutzeri 0 0 0 0 0 0 0 0 0 0 0
Psychromonas_ingrahamii 0 0 0 0 0 0 0 0 0 0 0
Pyramidobacter_piscolens 0 0 0 0 0 0 0 0 0 0 0
Rhizobium_leguminosarum 0 0 0 0 0 0 0 0 0 0 0
Rhodococcus_equi 0 0 0 0 0 0 0 0 0 0 0
Rhodococcus_erythropolis 0 0 0 0 0 0 0 0 0 0 0
Rhodopseudomonas_palustris 0 0 0 0 0 0 0 0 0 0 0
Roseburia_hominis 0 0 0 0 0 0 0 0 0 0 0
Roseburia_intestinalis 0 0 0 0 0 0 0 0 0 0 0
Roseburia_inulinivorans 0 0 0 0 0 0 0 0 0 0 0
Rothia_mucilaginosa 0 0 0 0 0 0 0 0 0 0 0
Ruminococcus_albus 0 0 0 0 0 0 0 0 0 0 0
Ruminococcus_champanellensis 0 0 0 0 0 0 0 0 0 0 0
Ruminococcus_lactaris 0 0 0 0 0 0 0 0 0 0 0
Ruminococcus_sp._sr1/5 0 0 0 0 0 0 0 0 0 0 0
Salinibacter_ruber 0 0 0 0 0 0 0 0 0 0 0
Salmonella_enterica 0 0 0 0 0 0 0 0 0 0 0
Scardovia_inopinata 0 0 0 0 0 0 0 0 0 0 0
Selenomonas_ruminantium 0 0 0 0 0 0 0 0 0 0 0
Serratia_symbiotica 0 0 0 0 0 0 0 0 0 0 0
Shewanella_baltica 0 0 0 0 0 0 0 0 0 0 0
Shigella_boydii 0 0 0 0 0 0 0 0 0 0 0
Shigella_dysenteriae 0 0 0 0 0 0 0 0 0 0 0
Shigella_flexneri 0 0 0 0 0 0 0 0 0 0 0
Shigella_sonnei 0 0 0 0 0 0 0 0 0 0 0
Shuttleworthia_satelles 0 0 0 0 0 0 0 0 0 0 0
Simkania_negevensis 0 0 0 0 0 0.1 0 0 0 0 0
Slackia_heliotrinireducens 0 0 0 0 0 0 0 0 0 0 0
Sorangium_cellulosum 0 0 0 0 0 0 0 0 0 0 0
Sphingomonas_wittichii 0 0 0 0 0 0 0 0 0 0 0
Sphingopyxis_alaskensis 0 0 0 0 0 0 0 0 0 0 0
Spirochaeta_africana 0 0 0 0 0 0 0 0 0 0 0
Stackebrandtia_nassauensis 0 0 0 0 0 0 0 0 0 0 0
Staphylococcus_aureus 0 0 0 0 0 0 0 0 1.00E-02 0 0
Staphylococcus_epidermidis 0 0 0 1.00E-02 1.00E-02 0 0 2.00E-02 2.00E-02 1.00E-02 0
Staphylococcus_haemolyticus 0 0 0 0 0 0 0 0 0 0 0
Staphylococcus_hominis 0 0 0 0 0 0 0 0 0 0 0
Staphylococcus_lugdunensis 0 0 0 0 0 0 0 0 0 0 0
Staphylococcus_pseudintermedius 0 0 0 0 0 0 0 0 0 0 0
Staphylococcus_saprophyticus 0 0 0 0 0 0 0 0 0 0 0
Staphylococcus_warneri 0 0 0 0 0 0 0 0 0 0 0
Streptobacillus_moniliformis 0 0 0 0 0 0 0 0 0 0 0
Streptococcus_agalactiae 0 0 0 0 0 0.1 0 0 0 0 0
Streptococcus_anginosus 0 0 0 0 0 1.25 0 0 0 0 1.00E-02
Streptococcus_dysgalactiae 0 0 0 0 0 0 0 0 0 0 0
Streptococcus_equi 0 0 0 0 0 0 0 0 0 0 0
Streptococcus_equinus 0 0 0 0 0 0 0 0 0 0 0
Streptococcus_gallolyticus 0 0 0 0 0 0 0 0 0 0 0
Streptococcus_infantarius 0 0 0 0 0 0 0 0 0 0 0
Streptococcus_intermedius 0 0 0 0 0 0.1 0 0 0 0 0
Streptococcus_mitis 0 0 0 0 0 0 0 1.00E-02 0 0 0
Streptococcus_mutans 0 0 0 0 0 0.1 0 0 0 0 0
Streptococcus_oralis 0 0 0 0 0 0.1 0 0 0 0 0
Streptococcus_parasanguinis 0 0 0 0 0 0 0 0 0 0 0
Streptococcus_parauberis 0 1.00E-02 1.00E-02 0 0 0 0 0 0 0 0
Streptococcus_pneumoniae 0 0 0 0 0 0 0 1.00E-02 0 0 0
Streptococcus_pseudopneumoniae 0 0 0 0 0 0 0 0 0 0 0
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Streptococcus_pyogenes 0 0 0 0 0 0 0 0 0 0 0
Streptococcus_salivarius 0 0 0 0 0 0 0 0 0 0 0
Streptococcus_sanguinis 0 0 0 0 0 0 0 0 0 0 0
Streptococcus_suis 0 0 1.00E-02 2.00E-02 1.00E-02 0 2.00E-02 3.00E-02 2.00E-02 2.00E-02 1.00E-02
Streptococcus_thermophilus 0 0 0 0 0 0 0 0 0 0 0
Streptococcus_uberis 0 0 0 0 0 0 0 0 0 0 0
Subdoligranulum_variabile 0 0 0 0 0 0 0 0 0 0 0
Sulfolobus_acidocaldarius 0 0 0 0 0 0 0 0 0 0 0
Sulfolobus_islandicus 0 0 0 0 0 0 0 0 0 0 0
Sulfolobus_solfataricus 0 0 0 0 0 0 2.00E-02 0 0 0 0
Sulfolobus_tokodaii 0 0 0 0 0 0 0 0 0 0 0
Sutterella_wadsworthensis 0 0 0 0 0 0 0 0 0 0 0
Synechocystis_sp._pcc_6803 0 0 0 0 0 0 0 0 0 0 0
Teredinibacter_turnerae 0 0 0 0 0 0 0 0 0 0 0
Tetragenococcus_halophilus 0 0 0 0 0 0 0 0 0 0 0
Thermoanaerobacterium_thermosaccharolyticum 0 0 0 0 0 0 0 0 0 0 0
Thermobispora_bispora 0 0 0 0 0 0 0 0 0 0 0
Thermosediminibacter_oceani 0 0 0 0 0 0 0 0 0 0 0
Thermovirga_lienii 0 0 0 0 0 0 0 0 0 0 0
Turicella_otitidis 0 0 0 0 0 0 0 0 0 0 0
Ureaplasma_parvum 0 0 0 0 0 0 0 0 1.00E-02 0 7.00E-02
Ureaplasma_urealyticum 0 0 0 0 0 0 0 0 0 0 0
Variovorax_paradoxus 0 0 0 2.00E-02 2.00E-02 0 0 2.00E-02 1.00E-02 1.00E-02 1.00E-02
Veillonella_parvula 0 0 0 0 0 0 0 0 0 0 0
Weeksella_virosa 0 0 0 0 0 0 0 0 0 0 0
Wolinella_succinogenes 0 0 0 0 0 0 0 0 0 0 0
Xanthomonas_campestris 0 0 0 0 0 0 0 0 0 0 0
Zymomonas_mobilis 0 0 0 2.00E-02 2.00E-02 0 2.00E-02 2.00E-02 3.00E-02 4.00E-02 5.00E-02
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Bacterial species 117_6 119_1 119_2 119_3 119_4 119_6 120_1 120_2 120_3 120_4 120_6
[Bacteroides]_pectinophilus 0 0 0 0 0 0.11 0 0 0 0 0
[Clostridium]_bartlettii 0 0 0 0 0 0 0 0 0 0 0
[Clostridium]_sticklandii 0 0 0 0 0 0 0 0 0 0 0
[Ruminococcus]_gnavus 0 0 0 0 0 0 0 0 0 0 0
[Ruminococcus]_obeum 0 0 0 0 0 0 0 0 0 0 0
[Ruminococcus]_torques 0 0 0 0 0 0 0 0 0 0 1.00E-02
Acetobacterium_woodii 0 0 0 0 0 0 0 0 0 0 0
Acholeplasma_laidlawii 0 0 0 0 0 0 0 0 0 0 0
Acidimicrobium_ferrooxidans 0 0 0 0 0 0 0 0 0 0 0
Acidothermus_cellulolyticus 2.00E-02 0 0 0 0 0 0 0 0 0 0
Aciduliprofundum_boonei 0 0 0 0 0 0 0 0 0 0 0
Acinetobacter_baumannii 0 0 0 0 0 0 0 0 0 0 0
Acinetobacter_junii 0 0 0 0 0 0 0 0 0 0 0
Acinetobacter_lwoffii 0 0 0 0 0 0 0 0 0 0 0
Actinobacillus_succinogenes 0 0 0 0 0 0 0 0 0 0 0
Actinomyces_coleocanis 0 0 0 0 0 0 0 0 0 0 0
Actinomyces_urogenitalis 0 0 0 0 0 0 0 0 0 0 0
Aggregatibacter_aphrophilus 0 0 0 0 0 0 0 0 0 0 0
Alistipes_finegoldii 0 0 0 0 0 0 0 0 0 0 0
Alistipes_shahii 0 0 0 0 0 0 0 0 0 0 0
Alkaliphilus_metalliredigens 0 0 0 0 0 0 0 0 0 0 0
Allochromatium_vinosum 0 0 0 0 0 0 0 0 0 0 0
Alteromonas_macleodii 0 0 0 0 0 0 0 0 0 0 0
Alteromonas_sp._sn2 0 0 0 0 0 0 0 0 0 0 0
Amycolatopsis_mediterranei 0 0 0 0 0 0 0 0 0 0 0
Amycolicicoccus_subflavus 0 0 0 0 0 0 0 0 0 0 0
Anaerococcus_hydrogenalis 7.00E-02 0 0 0 0 0 0 0 1.00E-02 2.00E-02 5.00E-02
Anaerococcus_lactolyticus 2.00E-02 0 0 0 0 0.22 0 0 0 1.00E-02 6.00E-02
Anaerococcus_prevotii 2.00E-02 0 0 0 0 8.41 0 0 1.00E-02 1.00E-02 3.00E-02
Anaerococcus_tetradius 0 0 0 0 0 2.82 0 0 0 0 1.00E-02
Anaerococcus_vaginalis 2.00E-02 0 0 0 0 0 0 0 5.00E-02 1.00E-02 5.00E-02
Anaerotruncus_colihominis 0 0 0 0 0 0 0 0 0 0 1.00E-02
Arcobacter_nitrofigilis 0 0 0 0 0 0 0 0 0 0 0
Atopobium_parvulum 2.8 0 1.00E-02 0 0 0 0 0 0 0 0
Atopobium_vaginae 0 0 0 0 0 0 0 0 0 0 0
Azospira_oryzae 0 0 0 0 0 0 0.11 0 0 0 0
Bacillus_cereus 0 0 0 0 0 0 0 2.00E-02 1.00E-02 0 0
Bacillus_clausii 0 0 0 0 0 0 0 0 0 0 0
Bacillus_pseudofirmus 0 0 0 0 0 0 0 0 0 0 0
Bacillus_thuringiensis 0 0 0 0 0 0 0 0 0 0 0
Bacteriovorax_marinus 0 0 0 0 0 0 0 2.00E-02 1.00E-02 0 0
Bacteroides_caccae 0 0 0 0 0 0 0 0 0 0 0
Bacteroides_cellulosilyticus 0 0 0 0 0 0 0 0 0 0 0
Bacteroides_dorei 0 0 0 0 0 0 0.11 0 0 0 0
Bacteroides_fragilis 0 0 0 0 0 0 0 0 0 0 0
Bacteroides_ovatus 0 0 0 0 0 0 0 0 0 0 0
Bacteroides_stercoris 0 0 0 0 0 0 0 0 0 0 0
Bacteroides_thetaiotaomicron 0 0 0 0 0 0 0 0 0 0 0
Bacteroides_uniformis 0 0 0 0 0 0 0 0 0 0 0
Bacteroides_vulgatus 0 0 0 0 0 0 0 0 0 0 0
Bifidobacterium_adolescentis 0 0 0 0 0 0 0 0 0 0 0
Bifidobacterium_angulatum 5.00E-02 0 0 0 0 6.00E-02 0 0 0 0 0
Bifidobacterium_animalis 0 0 0 0 0 0.17 0 1.00E-02 0 0 1.00E-02
Bifidobacterium_bifidum 1.34 0 0 0 0 6.00E-02 0 5.00E-02 4.00E-02 0 1.00E-02
Bifidobacterium_breve 1.15 0 0 0 0 0.66 0 0 0 0 0
Bifidobacterium_catenulatum 0 0 0 0 0 0 0 0 0 0 0
Bifidobacterium_dentium 2.00E-02 0 0 0 0 6.00E-02 0 0 0 0 0
Bifidobacterium_gallicum 0 0 0 0 0 0 0 0 0 0 0
Bifidobacterium_longum 78.26 0 0.51 0 0 35.36 0 1.00E-02 0 0 0
Bifidobacterium_pseudocatenulatum 5.00E-02 0 1.00E-02 0 0 0 0 0 0 0 0
Bilophila_wadsworthia 2.00E-02 0 0 0 0 0 0 0 0 0 0
Blautia_hydrogenotrophica 0 0 0 0 0 6.00E-02 0 0 0 0 0
Brevibacterium_mcbrellneri 0 0 0 0 0 0 0 0 1.00E-02 0 1.00E-02
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Buchnera_aphidicola 0 0 0 0 0 0 0 0 1.00E-02 0 0
Burkholderia_glumae 0 0 0 0 0 0 0 0 1.00E-02 0 0
Burkholderia_phytofirmans 0 0 0 0 0 0 0 1.00E-02 1.00E-02 1.00E-02 1.00E-02
Burkholderia_pseudomallei 0 0 0 0 0 0 0 0 0 1.00E-02 3.00E-02
Butyrivibrio_crossotus 0 0 0 0 0 6.00E-02 0 0 0 0 0
Butyrivibrio_fibrisolvens 0 0 0 0 0 6.00E-02 0 0 0 0 0
Butyrivibrio_proteoclasticus 0 0 0 0 0 6.00E-02 0 0 0 0 0
Caldicellulosiruptor_bescii 0 0 0 0 0 6.00E-02 0 0 0 0 0
Campylobacter_fetus 0 0 0 7.00E-02 0 6.00E-02 0 0 0 0 0
Campylobacter_gracilis 2.00E-02 0 0 0 0 0 0 0 0 0 0
Campylobacter_hominis 5.00E-02 0 0 0 0 6.00E-02 0 0 0 0 1.00E-02
Campylobacter_lari 0 0 0 0 0 0 0 0 0 0 0
Campylobacter_upsaliensis 0 0 0 0 0 0 0 0 0 0 0
Candidatus_accumulibacter_phosphatis 5.00E-02 0 0 0 0 6.00E-02 0 0 0 0 0
Candidatus_azobacteroides_pseudotrichonymphae 0 0 0 0 0 0 0 0 1.00E-02 0 0
Candidatus_baumannia_cicadellinicola 0 0 1.00E-02 0 5.00E-02 0 0 0 0 1.00E-02 0
Candidatus_carsonella_ruddii 0 0 0 0 0 0 0 0 0 0 0
Candidatus_nitrospira_defluvii 0 3.00E-02 1.00E-02 7.00E-02 0 0 0 0 0 2.00E-02 0
Candidatus_portiera_aleyrodidarum 0 0 0 0 0 0 0 0 0 0 0
Candidatus_puniceispirillum_marinum 0 0 0 0 0 0 0 0 0 0 0
Candidatus_riesia_pediculicola 0 0 1.00E-02 0 0 0 0 1.00E-02 1.00E-02 0 0
Candidatus_zinderia_insecticola 0 0 0 0 0 0 0 0 0 0 0
Carboxydothermus_hydrogenoformans 0 0 0 0 0 0 0 0 0 0 0
Catenibacterium_mitsuokai 0 0 0 0 0 0 0 0 0 0 0
Cellulophaga_algicola 0 0 0 0 0 6.00E-02 0 0 0 0 0
Cellulosilyticum_lentocellum 0 0 0 0 0 0 0 0 0 0 0
Chitinophaga_pinensis 0 0 0 0 0 0 0 1.00E-02 0 0 0
Chlamydia_trachomatis 0 0 0 0 0 0 0 0 0 0 0
Chlamydophila_felis 0 0 0 0 0 0 0 0 0 0 0
Chryseobacterium_gleum 0 0 0 0 0 0 0 0 0 0 0
Clostridiales_genomosp._bvab3 0 0 0 0 0 0 0 0 0 0 0
Clostridium_acidurici 0 0 0 0 0 6.00E-02 0 0 0 0 0
Clostridium_botulinum 0 0 0 0 0 0 0 0 1.00E-02 0 0
Clostridium_cellulovorans 0 0 0 0 0 0 0 0 0 0 0
Clostridium_leptum 0 0 0 0 0 0 0 0 0 0 0
Clostridium_novyi 0 0 0 0 0 0 0 0 0 0 0
Clostridium_perfringens 0 0 0 0 0 0 0 0 0 0 0
Clostridium_sp._sy8519 0 0 0 0 0 6.00E-02 0 0 0 0 0
Collinsella_aerofaciens 0 0 0 0 0 0 0 0 0 0 0
Comamonas_testosteroni 0 0 0 0 0 0 0 0 0 0 0
Coprococcus_catus 0 0 0 0 0 0 0 0 0 0 0
Coprococcus_comes 0 0 0 0 0 0 0 0 0 0 0
Coprococcus_eutactus 0 0 0 0 0 0 0 0 0 0 0
Coprothermobacter_proteolyticus 0 0 0 0 0 0 0 0 0 0 0
Corynebacterium_accolens 0 0 0 0 0 0 0.11 0 0 0 0
Corynebacterium_ammoniagenes 0 0 0 0 0 0 0 0 0 0 1.00E-02
Corynebacterium_amycolatum 2.00E-02 0 0 0 0 0 0 0 1.00E-02 1.00E-02 0.11
Corynebacterium_aurimucosum 0 0 0 0 0 0 0.32 0 0 0 3.00E-02
Corynebacterium_glucuronolyticum 0 0 0 0 0 0 0.11 0 0 0 0.11
Corynebacterium_glutamicum 2.00E-02 0 0 0 0 0 0 0 0 0 0
Corynebacterium_jeikeium 0 0 0 0 0.1 0 0.43 0 1.00E-02 1.00E-02 1.00E-02
Corynebacterium_kroppenstedtii 0 0 0 0 0 0 0 0 0 0 0
Corynebacterium_lipophiloflavum 0 0 0 0 0 0 0 0 0 0 1.00E-02
Corynebacterium_matruchotii 0 0 0 0 0 0 0 0 0 0 0
Corynebacterium_pseudogenitalium 0 0 0 0 0 0 0 0 0 0 2.00E-02
Corynebacterium_striatum 0 0 0 0 0 0 0.11 0 0 0 1.00E-02
Corynebacterium_tuberculostearicum 0 0 0 0 0 0 0 0 0 1.00E-02 1.00E-02
Corynebacterium_ulcerans 0 0 0 0 0 0 0 1.00E-02 0 0 0
Corynebacterium_urealyticum 0 0 0 0 0 0 0 0 0 0 2.00E-02
Cronobacter_sakazakii 0 0 0 0 0 0 0 0 0 0 4.00E-02
Cupriavidus_necator 0 0 0 0 0 0 0 0 0 0 0
Cytophaga_hutchinsonii 0 0 0 0 0 0 0 3.00E-02 1.00E-02 0 0
Deinococcus_proteolyticus 0 0 0 0 0 0 0 0 0 0 0
Delftia_acidovorans 0 0 0 0 0 0 0 0 0 0 0
Desulfitobacterium_hafniense 0 0 0 0 0 0 0 0 0 0 0
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Desulfomonile_tiedjei 0 0 0 0 0 0 0 0 0 0 1.00E-02
Dialister_invisus 0 0 1.00E-02 0 0 6.00E-02 0 0 1.00E-02 0 0
Dichelobacter_nodosus 0 0 0 0 0 0 0 0 0 0 0
Dickeya_dadantii 0 0 0 0 0 0 0 0 0 0 3.00E-02
Dorea_longicatena 0 0 0 0 0 0 0 0 0 0 1.00E-02
Enterobacter_asburiae 0 0 0 0 0 0 0 0 0 0 1.00E-02
Enterobacter_cloacae 0 0 0 0 0 0 0 0 0 0 0.19
Enterobacter_sp._638 0 0 0 0 0 0 0 0 0 0 4.00E-02
Enterococcus_faecalis 0 0 0 0 0 0 0 0 0 0 0
Enterococcus_faecium 0 0 0 0 0 0 0 5.00E-02 1.00E-02 0 0
Erysipelothrix_rhusiopathiae 0 0 0 0 0 0 0 0 0 0 0
Erythrobacter_litoralis 0 0 0 0 0 0 0.11 0 0 0 0
Escherichia_coli 2.00E-02 6.00E-02 1.00E-02 0.14 0 0.11 0.43 0 4.00E-02 2.00E-02 58.47
Escherichia_fergusonii 0 0 0 0 0 0 0 0 1.00E-02 0 0.36
Eubacterium_eligens 5.00E-02 0 0 0 0 0.17 0 0 0 0 1.00E-02
Eubacterium_hallii 0 0 0 0 0 0 0 0 0 0 0
Eubacterium_limosum 0 0 0 0 0 0 0 0 0 0 0
Eubacterium_rectale 0 0 0 0 0 0 0 0 0 0 0
Eubacterium_siraeum 0 0 0 0 0 0 0 0 0 0 0
Faecalibacterium_prausnitzii 0 0 0 0 0 0 0 0 0 0 0
Ferroglobus_placidus 0 0 0 0 0 0 0 0 0 0 0
Fervidobacterium_pennivorans 0 0 0 0 0 0 0 0 0 0 0
Filifactor_alocis 0 0 0 0 0 0 0 0 0 0 0
Finegoldia_magna 5.00E-02 0 0 0 0 0 0.32 0 4.00E-02 3.00E-02 0.41
Flavobacterium_johnsoniae 0 0 0 0 0 0 0 0 0 0 0
Fusobacterium_mortiferum 0 0 0 0 0 0 0 0 0 0 0
Fusobacterium_nucleatum 0.97 0 0 0 0 0 0 0 0 0 1.00E-02
Fusobacterium_periodonticum 0 0 0 0 0 0 0 0 0 0 0
Gardnerella_vaginalis 2.00E-02 0 0 7.00E-02 0.55 1 61.28 39.81 53.88 3.59 9.92
Gemella_haemolysans 0 0 0 0 0 0 0 0 0 0 0
Gemella_morbillorum 5.00E-02 0 0 0 0 0 0 0 0 0 0
Gemmatimonas_aurantiaca 7.00E-02 0 0 0 0 0 0 0 0 0 0
Geobacter_uraniireducens 0 0 0 0 0 0 0 0 0 0 0
Haemophilus_influenzae 0 0 0 0 0 0 0 0 0 0 0
Haemophilus_parainfluenzae 0 0 0 0 0 0 0 0 0 0 0
Halothermothrix_orenii 0 0 0 0 0 0 0 0 0 0 0
Helicobacter_bilis 0 0 0 0 0 0 0 0 0 0 0
Helicobacter_cetorum 0 0 0 0 0 0 0 0 0 0 0
Helicobacter_mustelae 0 0 0 0 0 0 0 0 0 0 0
Helicobacter_pylori 0 0 0 0 0 0 0 0 0 0 1.00E-02
Hippea_maritima 0 0 0 0 0 0 0 0 0 0 0
Holdemania_filiformis 0 0 0 0 0 0 0 0 0 0 0
Ignavibacterium_album 0 0 0 0 0 0 0 0 0 0 0
Isoptericola_variabilis 0 0 0 0 0 0 0 0 0 0 0
Jannaschia_sp._ccs1 0 0 0 0 0 0 0 0 0 0 0
Jonquetella_anthropi 0 0 0 0 0 0 0 0 0 0 1.00E-02
Kangiella_koreensis 0 0 0 0 0 0 0 0 0 0 0
Kineococcus_radiotolerans 2.00E-02 0 0 0 0 0 0 0 0 0 0
Kitasatospora_setae 0 0 0 0 0 0 0 0 2.00E-02 0 1.00E-02
Klebsiella_oxytoca 0 0 0 0 0 0 0 0 0 0 0.14
Klebsiella_pneumoniae 0 0 0 0 0 0 0 0 0 0 7.00E-02
Kribbella_flavida 0 0 0 0 0 0 0 0 0 0 1.00E-02
Lactobacillus_acidophilus 0 0 0 7.00E-02 0 0 0 0 0 1.00E-02 0
Lactobacillus_amylolyticus 0 0 0 0 0 0 0 0 0 0 0
Lactobacillus_amylovorus 0 0 0 0 0 0 0 0 0 1.00E-02 0
Lactobacillus_antri 0 0 0 0 0 0 0 0 0 0 0
Lactobacillus_casei 5.00E-02 0 0 0 0 0 0 0 0 0 0
Lactobacillus_coleohominis 0 0 0 0 0 0 0 0 0 1.00E-02 0
Lactobacillus_crispatus 0.19 85.55 86.75 88.62 81.11 0.33 0.11 7.00E-02 4.00E-02 82.12 3.00E-02
Lactobacillus_delbrueckii 2.00E-02 9.00E-02 4.00E-02 7.00E-02 0 0 0 0 1.00E-02 5.00E-02 0
Lactobacillus_fermentum 0 0 0 0 0 0 0 1.00E-02 0 0 5.00E-02
Lactobacillus_gasseri 5.00E-02 9.00E-02 1.00E-02 0 0.25 0.17 23.1 46.98 33.92 0.41 0.19
Lactobacillus_helveticus 0 1.77 1.87 1.86 1.25 0 0 0 1.00E-02 1.51 0
Lactobacillus_iners 2.00E-02 3.00E-02 8.00E-02 0 0.25 0 0.32 0 4.00E-02 7.00E-02 1.00E-02
Lactobacillus_jensenii 0 9.00E-02 2.00E-02 0 5.00E-02 0 0 0 1.00E-02 3.00E-02 2.00E-02
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Lactobacillus_johnsonii 0 0 0 0 0 0 2.57 3.59 2.62 3.00E-02 2.00E-02
Lactobacillus_kefiranofaciens 0 0 0 0 0 0 0 0 0 0 0
Lactobacillus_plantarum 0 0 0 0 0 0 0 0 0 0 0
Lactobacillus_reuteri 0 0 0 0 0 0 0 0 0 1.00E-02 0
Lactobacillus_rhamnosus 0 0 0 0 0 0 0 0 0 0 0
Lactobacillus_sakei 0 0 0 0 0 0 0 0 1.00E-02 0 0
Lactobacillus_ultunensis 0 0 0 0 0 0 0 0 0 1.00E-02 0
Lactobacillus_vaginalis 0 0 0 0 0 0 0.11 1.05 1.15 1.36 1.00E-02
Lactococcus_garvieae 0 0 0 0 0 0 0 0 0 0 0
Lactococcus_lactis 0 0 0 0 0 0 0 0 0 3.00E-02 0
Lawsonia_intracellularis 0 0 0 0 0 0 0 0 0 0 0
Leadbetterella_byssophila 0 0 0 0 0 0 0 1.00E-02 3.00E-02 0 0
Lysinibacillus_sphaericus 0 3.00E-02 3.00E-02 0 0 0 0 0 0 9.00E-02 0
Mahella_australiensis 0 0 0 0 0 0 0 0 0 0 0
Mannheimia_haemolytica 0 0 0 0 0 0 0 0 0 0 0
Marvinbryantia_formatexigens 0 0 0 0 0 0 0 0 0 0 0
Mesoplasma_florum 0 0 0 0 0 0 0 0 0 0 0
Methanobrevibacter_ruminantium 0 0 0 0 0 0 0 0 1.00E-02 0 0
Methylacidiphilum_infernorum 0 0 0 0 0 0 0 0 0 0 0
Methylomicrobium_alcaliphilum 0 0 0 0 0 0 0 1.00E-02 3.00E-02 1.00E-02 1.00E-02
Micrococcus_luteus 0 3.00E-02 0 0 0 0 0 0 0 0 0
Microlunatus_phosphovorus 0 0 0 0 0 6.00E-02 0 0 0 0 0
Micromonospora_sp._l5 0 0 0 0 0 0 0 0 0 0 0
Mobiluncus_curtisii 2.00E-02 0 0 0 0 0 0 0 0 1.00E-02 3.00E-02
Mycobacterium_abscessus 0 0 0 0 0 6.00E-02 0 0 0 0 0
Mycobacterium_chubuense 0 0 0 0 0 0 0 0 0 0 0
Mycobacterium_smegmatis 0 0 0 0 0 0 0 0 0 0 0
Mycobacterium_vanbaalenii 0 0 0 0 0 0 0 0 0 0 0
Mycoplasma_arthritidis 0 0 0 0 0 0 0 0 0 0 0
Mycoplasma_crocodyli 0 0 0 0 0 0 0 0 0 0 0
Mycoplasma_gallisepticum 0 3.00E-02 3.00E-02 0 5.00E-02 0 0 1.00E-02 1.00E-02 1.00E-02 1.00E-02
Mycoplasma_haemofelis 0 0 0 0 0 6.00E-02 0 0 0 0 0
Mycoplasma_hominis 0 0 0 0 0 0 0 0 0 0 0
Mycoplasma_hyopneumoniae 0 0 0 0 0 0 0 0 1.00E-02 0 0
Mycoplasma_synoviae 0 0 0 0 0 0 0 0 1.00E-02 0 0
Nanoarchaeum_equitans 0 0 0 0 0 0 0 0 0 0 0
Oenococcus_oeni 0 0 0 0 0 0 0 0 0 0 0
Opitutus_terrae 0 0 0 0 0 0 0 0 0 0 0
Orientia_tsutsugamushi 0 0 0 0 0 0 0 1.00E-02 0 0 0
Oscillibacter_valericigenes 0 0 0 0 0 0 0 0 0 0 0
Owenweeksia_hongkongensis 0 0 0 0 0 0 0 3.00E-02 1.00E-02 0 0
Pantoea_ananatis 0 0 0 0 0 0 0 0 0 0 0
Parabacteroides_distasonis 0 0 0 0 0 0 0 0 0 0 0
Parabacteroides_johnsonii 0 0 0 0 0 0 0 0 0 0 0
Parabacteroides_merdae 0 0 0 0 0 0 0 0 0 0 0
Parascardovia_denticolens 0 0 0 0 0 0 0 0 0 0 0
Parvimonas_micra 5.00E-02 0 0 0 0 0 0 0 0 0 0
Pasteurella_multocida 0 0 0 0 0 0 0 0 0 0 0
Peptoniphilus_lacrimalis 0 0 0 0 0 0 0 0 0 0 0
Peptoniphilus_sp._oral_taxon_386 0 0 0 0 0 0 0 0 0 0 0
Peptostreptococcus_anaerobius 0 0 0 0 5.00E-02 3.49 0 0 0 0 0.11
Peptostreptococcus_stomatis 0 0 0 0 0 0 0 0 0 0 0
Phycisphaera_mikurensis 0 0 0 0 0 0 0 0 0 0 0
Polynucleobacter_necessarius 0 0 0 0 0 0 0 1.00E-02 0 0 0
Porphyromonas_asaccharolytica 0 0 0 0 0 6.00E-02 0 0 0 0 0
Porphyromonas_uenonis 0 0 0 0 0 0 0 0 0 0 1.00E-02
Prevotella_amnii 0 0 0 0 0 6.00E-02 0 0 0 0 0
Prevotella_bergensis 0 0 0 0 0 6.00E-02 0 0 1.00E-02 0 0
Prevotella_bivia 0 3.00E-02 2.00E-02 0 0 0.17 0 0 1.00E-02 0 0
Prevotella_buccalis 0 0 0 7.00E-02 0 0 0 0 1.00E-02 1.00E-02 2.00E-02
Prevotella_copri 0 0 0 0 0 0 0 0 0 0 1.00E-02
Prevotella_melaninogenica 0 0 0 0 0 0 0 0 0 0 0
Prevotella_ruminicola 0 0 0 0 0 0 0 0 0 0 0
Prevotella_sp._oral_taxon_299 0 0 0 0 0 0 0 0 0 0 0
Prevotella_timonensis 0.71 0 4.00E-02 0 0 0.5 0 0 0.13 6.00E-02 0.25
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Prochlorococcus_marinus 0 0 2.00E-02 0 0 0 0 0 0 1.00E-02 0
Propionibacterium_acnes 0 0 0 0 0 0 0.21 0 1.00E-02 0 1.00E-02
Propionibacterium_freudenreichii 0 0 0 0 0 0 0 0 0 0 0
Pseudoalteromonas_haloplanktis 0 0 0 0 0 0 0 0 0 0 0
Pseudomonas_aeruginosa 0 0 0 0 0 0 0 0 0 0 0
Pseudomonas_fluorescens 0 0 0 0 0 0 0 0 0 0 1.00E-02
Pseudomonas_mendocina 0 0 0 0 0 0 0 0 0 0 0
Pseudomonas_putida 0 0 0 0 0 0 0 0 0 0 0
Pseudomonas_stutzeri 0 0 0 0 0 0 0 0 0 0 1.00E-02
Psychromonas_ingrahamii 0 0 0 0 0 0 0 0 0 0 0
Pyramidobacter_piscolens 0 0 0 0 0 0 0 0 0 0 0
Rhizobium_leguminosarum 0 0 0 0 0 0 0 5.00E-02 6.00E-02 0 0
Rhodococcus_equi 0 0 0 0 0 0 0 0 0 0 0
Rhodococcus_erythropolis 0 0 0 0 0 0 0 0 0 0 0
Rhodopseudomonas_palustris 2.00E-02 0 0 0 0 0 0 0 0 0 0
Roseburia_hominis 0 0 0 0 0 0 0 0 0 0 0
Roseburia_intestinalis 0 0 0 0 0 0 0 0 0 0 0
Roseburia_inulinivorans 0 0 0 0 0 0 0 0 0 0 0
Rothia_mucilaginosa 0 0 0 0 0 0 0 0 0 0 0
Ruminococcus_albus 0 0 0 0 0 0 0 0 0 0 0
Ruminococcus_champanellensis 0 0 0 0 0 0 0 0 0 0 1.00E-02
Ruminococcus_lactaris 0 0 0 0 0 0 0 0 0 0 0
Ruminococcus_sp._sr1/5 0 0 0 0 0 0 0 0 0 0 0
Salinibacter_ruber 0 0 0 0 0 0 0 0 0 0 2.00E-02
Salmonella_enterica 0 0 1.00E-02 0 0 0 0 0 0 0 3.5
Scardovia_inopinata 0 0 0 0 0 6.00E-02 0 0 0 0 0
Selenomonas_ruminantium 0 0 0 0 0 0 0 0 0 0 0
Serratia_symbiotica 0 0 0 0 0 0 0 1.00E-02 1.00E-02 0 0
Shewanella_baltica 0 0 0 0 0 0 0 0 0 1.00E-02 0
Shigella_boydii 0 0 0 0 0 0 0 0 0 0 0
Shigella_dysenteriae 0 0 0 0 0 0 0 0 0 0 1.00E-02
Shigella_flexneri 0 0 0 0 0 0 0 0 1.00E-02 0 1.9
Shigella_sonnei 0 0 0 0 0 0 0 0 0 0 1.00E-02
Shuttleworthia_satelles 0 0 0 0 0 0 0 0 0 0 0
Simkania_negevensis 0 0 0 0 0 0 0 0 0 0 0
Slackia_heliotrinireducens 0 0 0 0 0 6.00E-02 0 0 0 0 0
Sorangium_cellulosum 7.00E-02 0 0 0 0 6.00E-02 0 0 0 0 0
Sphingomonas_wittichii 0 0 0 0 0 0 0.11 0 0 0 0
Sphingopyxis_alaskensis 0 0 0 0 0 0 0 0 0 0 0
Spirochaeta_africana 0 0 0 0 0 0 0 0 0 0 0
Stackebrandtia_nassauensis 0 0 0 0 0 0 0 0 0 0 0
Staphylococcus_aureus 0 0 0 0 0 0 0 0 0 0 0
Staphylococcus_epidermidis 0 3.00E-02 1.00E-02 0 0 0 0.32 0 0 0 0.12
Staphylococcus_haemolyticus 0 0 0 0 0 0 0 0 0 0 9.00E-02
Staphylococcus_hominis 0 0 0 0 0 0 0 0 0 0 2.00E-02
Staphylococcus_lugdunensis 0 0 0 0 0 0 0 0 0 0 0
Staphylococcus_pseudintermedius 0 0 0 0 0 0 0 0 0 0 0
Staphylococcus_saprophyticus 0 0 0 0 0 0 0 0 0 0 0
Staphylococcus_warneri 0 0 0 0 0 0 0 0 0 0 0
Streptobacillus_moniliformis 0 0 0 0 0 0 0 0 0 0 0
Streptococcus_agalactiae 0 1.23 1.00E-02 0 5.66 6.00E-02 0 0 0 0 1.00E-02
Streptococcus_anginosus 0.19 3.00E-02 3.00E-02 0 0.6 27.17 0 0 4.00E-02 1.00E-02 0.8
Streptococcus_dysgalactiae 0 3.00E-02 0 0 0 0 0 0 0 0 0
Streptococcus_equi 2.00E-02 0 0 0 0 0 0 0 0 0 0
Streptococcus_equinus 0 0 0 0 0 6.00E-02 0 0 0 0 0
Streptococcus_gallolyticus 0 0 0 0 0 0.44 0 0 0 0 0
Streptococcus_infantarius 0 0 0 0 0 0 0 0 0 0 1.00E-02
Streptococcus_intermedius 1.46 0 1.00E-02 0 0 0.72 0 0 0 0 5.00E-02
Streptococcus_mitis 0 0 0 0 0 0.44 0.32 0 0 0 1.00E-02
Streptococcus_mutans 5.00E-02 0 0 0 5.00E-02 6.00E-02 0 1.00E-02 0 0 0
Streptococcus_oralis 0 3.00E-02 0 0 0 0.22 0.21 0 0 0 2.00E-02
Streptococcus_parasanguinis 2.00E-02 0 0 0 0 0.17 0.11 4.00E-02 4.00E-02 0 0
Streptococcus_parauberis 0 0 0 0 0 0 0 0 0 0 0
Streptococcus_pneumoniae 0 0 0 0 0 0 0.11 0 0 0 0
Streptococcus_pseudopneumoniae 0 0 0 0 0 0 0 0 0 0 0
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Streptococcus_pyogenes 2.00E-02 6.00E-02 0 0 5.00E-02 6.00E-02 0 0 0 0 0
Streptococcus_salivarius 0 0 0 0 0 0 0 0 0 0 1.00E-02
Streptococcus_sanguinis 5.00E-02 0 0 0 0 0.22 0 1.00E-02 0 0 1.00E-02
Streptococcus_suis 0 9.00E-02 3.00E-02 0 0 0 0 0 0 1.00E-02 0
Streptococcus_thermophilus 0 0 0 0 0 0 0 0 0 0 1.00E-02
Streptococcus_uberis 0 0 0 0 0 0 0 0 0 0 0
Subdoligranulum_variabile 0 0 0 0 0 0 0 0 0 0 0
Sulfolobus_acidocaldarius 0 0 0 0 0 0 0 0 0 0 0
Sulfolobus_islandicus 0 0 0 0 0 0 0 0 0 0 2.00E-02
Sulfolobus_solfataricus 0 0 0 0 0 0 0 0 0 0 0
Sulfolobus_tokodaii 0 0 0 0 0 0 0 0 0 0 0
Sutterella_wadsworthensis 0 0 0 0 0 0 0 0 0 1.00E-02 1.00E-02
Synechocystis_sp._pcc_6803 0 0 0 0 0 0 0 0 0 0 1.00E-02
Teredinibacter_turnerae 0 0 0 0 0 0 0 0 0 0 0
Tetragenococcus_halophilus 0 0 0 0 0 0 0 0 0 0 0
Thermoanaerobacterium_thermosaccharolyticum 0 0 0 0 0 0 0 0 0 0 0
Thermobispora_bispora 0 0 0 0 0 0 0 0 0 0 0
Thermosediminibacter_oceani 0 0 0 0 0 0 0 0 0 0 0
Thermovirga_lienii 0 0 0 0 0 0 0 0 0 0 0
Turicella_otitidis 0 0 0 0 0 0 0 0 0 0 0
Ureaplasma_parvum 0 0 0 0 0 0 0 0 0 0 0
Ureaplasma_urealyticum 0 0 0 0 0 0 0 0 0 0 0
Variovorax_paradoxus 0 0 3.00E-02 7.00E-02 0 0 0 0 0 1.00E-02 0
Veillonella_parvula 0 0 0 0 0 0 0 0 0 0 1.00E-02
Weeksella_virosa 0 0 0 0 0 0 0 0 0 0 0
Wolinella_succinogenes 0 0 0 0 0 0 0 0 0 0 0
Xanthomonas_campestris 0 0 0 0 0 0 0 0 0 0 0
Zymomonas_mobilis 0 3.00E-02 1.00E-02 0 5.00E-02 0 0 0 0 3.00E-02 0
  
171 
 
Table 23. (cont.)  
 
 
 
Bacterial species 125_1 125_2 125_3 125_4 125_6 201_1 201_2 201_3 201_5 202_1 202_2
[Bacteroides]_pectinophilus 0 0 0 0 0 0 0 0 0 0 0
[Clostridium]_bartlettii 0 0 0 0 0 0 0 0 0 1.00E-02 0
[Clostridium]_sticklandii 0 0 0 0 0 0 0 0 0 0 0
[Ruminococcus]_gnavus 0 0 0 0 0 0 0 0 0 1.00E-02 0
[Ruminococcus]_obeum 0 0 0 0 0 0 0 0 0 1.00E-02 0
[Ruminococcus]_torques 0 0 0 0 0 0 0 0 0 0 0
Acetobacterium_woodii 0 0 0 0 0 0 0 0 0 0 0
Acholeplasma_laidlawii 0 0 0 1.00E-02 0 0 0 0 0 0 0
Acidimicrobium_ferrooxidans 0 0 0 0 0 0 0 0 0 0 0
Acidothermus_cellulolyticus 0 0 0 0 0 0 0 0 0 0 0
Aciduliprofundum_boonei 0 0 0 0 0 0 0 0 0 0 0
Acinetobacter_baumannii 0 0 0 0 0 0 1.00E-02 0 0 0 0
Acinetobacter_junii 0 0 0 0 0 0 0 0 0 0 0
Acinetobacter_lwoffii 0 0 0 0 0 0 0 0 0 0 0
Actinobacillus_succinogenes 0 1.00E-02 0 0 0 0 0 0 0 0 0
Actinomyces_coleocanis 0 0 0 0 0 0 0 0 0 0 0
Actinomyces_urogenitalis 0 0 0 0 0 0 0 0 0 0 0
Aggregatibacter_aphrophilus 0 0 0 0 0 0 0 0 0 0 0
Alistipes_finegoldii 0 0 0 0 0 0 0 0 0 0 0
Alistipes_shahii 0 0 0 0 0 0 0 0 0 1.00E-02 0
Alkaliphilus_metalliredigens 0 0 0 0 0 0 0 0 0 0 0
Allochromatium_vinosum 0 0 0 0 0 0 0 0 0 0 0
Alteromonas_macleodii 0 0 0 0 0 0 0 0 0 1.00E-02 0
Alteromonas_sp._sn2 0 0 0 0 2.00E-02 0 0 0 0 0 0
Amycolatopsis_mediterranei 0 0 0 0 0 0 0 0 0 0 0
Amycolicicoccus_subflavus 0 0 0 0 0 0 0 0 0 0 0
Anaerococcus_hydrogenalis 0 1.00E-02 0 0 0.1 0 0 0 0 1.00E-02 0
Anaerococcus_lactolyticus 0 2.00E-02 7.00E-02 0 7.00E-02 1.00E-02 0 0 0 2.00E-02 1.00E-02
Anaerococcus_prevotii 0 1.00E-02 1.00E-02 0 0 0 0 0 0 1.00E-02 0
Anaerococcus_tetradius 0 2.00E-02 0.11 0 0 0 0 0 0 0 0
Anaerococcus_vaginalis 0 1.00E-02 0 0 0.17 0 0 0 0 1.00E-02 0
Anaerotruncus_colihominis 0 0 0 0 0 0 0 0 0 1.00E-02 0
Arcobacter_nitrofigilis 0 0 0 1.00E-02 0 0 0 0 0 0 0
Atopobium_parvulum 0 0 0 0 0 0 0 0 0 0 0
Atopobium_vaginae 1.00E-02 0 0 1.85 90.13 4.00E-02 0 2.00E-02 5.00E-02 0 0
Azospira_oryzae 0 0 0 0 0 0 0 0 0 0 0
Bacillus_cereus 1.00E-02 0 0 0 0 0 0 0 0 4.00E-02 1.00E-02
Bacillus_clausii 0 0 0 0 0 0 0 0 0 0 0
Bacillus_pseudofirmus 0 1.00E-02 0 1.00E-02 0 0 0 0 0 0 0
Bacillus_thuringiensis 0 0 0 0 0 0 1.00E-02 0 0 0 0
Bacteriovorax_marinus 1.00E-02 0 0 0 0 0 0 0 0 1.00E-02 0
Bacteroides_caccae 0 0 0 0 0 0 0 0 0 1.00E-02 0
Bacteroides_cellulosilyticus 0 0 0 0 0 0 0 0 0 2.00E-02 0
Bacteroides_dorei 0 0 0 0 0 0 0 0 0 4.00E-02 0
Bacteroides_fragilis 0 0 0 1.00E-02 0 0 0 0 0 3.00E-02 0
Bacteroides_ovatus 0 0 0 0 0 0 0 0 0 5.00E-02 0
Bacteroides_stercoris 0 0 0 0 0 0 0 0 0 0 0
Bacteroides_thetaiotaomicron 0 0 0 0 0 0 0 0 0 2.00E-02 0
Bacteroides_uniformis 0 0 0 0 0 0 0 0 0 8.00E-02 0
Bacteroides_vulgatus 0 0 0 0 0 0 0 0 0 0.12 0
Bifidobacterium_adolescentis 0 0 0 0 0 0 0 0 0 0 0
Bifidobacterium_angulatum 0 0 0 0 0 0 0 0 0 0 0
Bifidobacterium_animalis 0 0 0 0 0 0 0 0 0 0 0
Bifidobacterium_bifidum 0 0 0 0 0 0 0 0 0 0 0
Bifidobacterium_breve 0 0 0 0 5.00E-02 0 0 0 0 1.00E-02 0
Bifidobacterium_catenulatum 0 0 0 0 0 0 0 0 0 0 0
Bifidobacterium_dentium 0 0 0 0 0 0 0 0 0 0 2.00E-02
Bifidobacterium_gallicum 0 0 0 0 0 0 0 0 0 0 3.00E-02
Bifidobacterium_longum 0 0 0 0 0 0 0 0 0 0 1.00E-02
Bifidobacterium_pseudocatenulatum 0 0 0 0 0 0 0 0 0 0 3.00E-02
Bilophila_wadsworthia 0 0 0 0 0 0 0 0 0 0 0
Blautia_hydrogenotrophica 0 0 0 1.00E-02 0 0 0 0 0 0 0
Brevibacterium_mcbrellneri 0 0 0 0 0 0 0 0 0 0 0
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Buchnera_aphidicola 0 0 0 0 0 0 0 0 1.00E-02 1.00E-02 1.00E-02
Burkholderia_glumae 0 0 0 0 0 0 0 0 0 0 0
Burkholderia_phytofirmans 0 0 0 0 0 0 0 0 0 0 0
Burkholderia_pseudomallei 0 0 0 0 0 0 0 0 0 0 0
Butyrivibrio_crossotus 0 0 0 0 0 0 0 0 0 0 0
Butyrivibrio_fibrisolvens 0 0 0 0 0 0 0 0 0 1.00E-02 0
Butyrivibrio_proteoclasticus 0 0 0 0 0 0 0 0 0 0 0
Caldicellulosiruptor_bescii 0 0 0 0 0 0 0 0 0 0 0
Campylobacter_fetus 0 0 0 0 0 0 0 0 0 0 0
Campylobacter_gracilis 0 0 0 0 0 0 0 0 0 0 0
Campylobacter_hominis 0 0 0 0 0 0 0 0 0 0 0
Campylobacter_lari 0 0 0 0 0 0 0 0 0 0 0
Campylobacter_upsaliensis 0 0 0 0 0 0 0 0 0 0 0
Candidatus_accumulibacter_phosphatis 0 0 0 0 0 0 0 0 0 0 0
Candidatus_azobacteroides_pseudotrichonymphae 1.00E-02 0 0 0 0 0 0 0 0 2.00E-02 0
Candidatus_baumannia_cicadellinicola 0 0 0 0 0 0 0 0 0 0 0
Candidatus_carsonella_ruddii 0 0 0 0 0 1.00E-02 0 0 0 0 0
Candidatus_nitrospira_defluvii 0 0 0 0 0 0 0 0 0 0 0
Candidatus_portiera_aleyrodidarum 3.00E-02 0 0 2.00E-02 0 4.00E-02 2.00E-02 3.00E-02 2.00E-02 0 0
Candidatus_puniceispirillum_marinum 0 0 0 0 0 0 0 0 0 0 0
Candidatus_riesia_pediculicola 0 0 0 0 0 0 0 0 0 0 0
Candidatus_zinderia_insecticola 2.00E-02 7.00E-02 1.00E-02 5.00E-02 0 9.00E-02 6.00E-02 8.00E-02 9.00E-02 0 0
Carboxydothermus_hydrogenoformans 0 0 0 0 0 0 0 0 0 0 0
Catenibacterium_mitsuokai 0 0 0 0 1.00E-02 0 0 0 0 0 0
Cellulophaga_algicola 0 0 0 0 0 0 0 0 0 0 0
Cellulosilyticum_lentocellum 0 0 0 0 0 0 0 0 0 0 0
Chitinophaga_pinensis 0 0 0 0 0 0 0 0 0 0 0
Chlamydia_trachomatis 1.00E-02 3.00E-02 4.00E-02 2.00E-02 0 0 0 0 0 0 0
Chlamydophila_felis 0 0 0 0 0 0 0 0 0 0 7.00E-02
Chryseobacterium_gleum 0 0 0 0 0 0 0 0 0 0 0
Clostridiales_genomosp._bvab3 0 0 0 0 0 0 0 0 0 0 0
Clostridium_acidurici 0 0 0 0 0 0 0 0 0 0 0
Clostridium_botulinum 1.00E-02 0 0 0 1.00E-02 0 0 0 0 1.00E-02 1.00E-02
Clostridium_cellulovorans 0 0 0 0 0 0 0 0 0 0 0
Clostridium_leptum 0 0 0 0 0 0 0 0 0 1.00E-02 0
Clostridium_novyi 0 0 0 0 0 0 0 0 0 0 0
Clostridium_perfringens 0 0 0 0 2.00E-02 0 0 0 0 0 0
Clostridium_sp._sy8519 0 0 0 0 0 0 0 0 0 0 0
Collinsella_aerofaciens 0 0 0 0 0 0 0 0 0 0 0
Comamonas_testosteroni 0 0 0 0 0 0 0 0 0 0 0
Coprococcus_catus 0 0 0 0 0 0 0 0 0 0 0
Coprococcus_comes 0 0 0 0 0 0 0 0 0 0 0
Coprococcus_eutactus 0 0 0 0 0 0 0 0 0 0 0
Coprothermobacter_proteolyticus 3.00E-02 1.00E-02 0 0 0 2.00E-02 0 3.00E-02 2.00E-02 0 0
Corynebacterium_accolens 0 0 0 0 0 0 0 0 0 0 0
Corynebacterium_ammoniagenes 0 0 0 0 0 0 0 0 0 0 0
Corynebacterium_amycolatum 0 0 0 0 0 0 0 0 0 0 0
Corynebacterium_aurimucosum 0 0 0 0 0 0 0 0 0 0 0
Corynebacterium_glucuronolyticum 0 0 1.00E-02 0 0 0 0 0 0 0 0
Corynebacterium_glutamicum 0 0 0 0 0 0 0 0 0 0 0
Corynebacterium_jeikeium 0 0 0 0 0 0 0 0 0 0 0
Corynebacterium_kroppenstedtii 0 1.00E-02 0 0 0 0 0 0 0 0 0
Corynebacterium_lipophiloflavum 1.00E-02 0 0 0 0 0 0 0 0 0 0
Corynebacterium_matruchotii 0 0 0 0 0 0 0 0 0 0 0
Corynebacterium_pseudogenitalium 0 0 0 0 0 0 0 0 0 0 0
Corynebacterium_striatum 0 0 0 0 0 0 0 0 0 0 0
Corynebacterium_tuberculostearicum 0 0 0 0 0 0 0 0 0 0 0
Corynebacterium_ulcerans 0 0 0 0 0 0 0 0 0 0 0
Corynebacterium_urealyticum 0 0 1.00E-02 0 0 0 0 0 0 0 0
Cronobacter_sakazakii 0 0 0 0 0 0 0 0 0 0 0
Cupriavidus_necator 0 0 0 1.00E-02 0 0 0 0 0 0 0
Cytophaga_hutchinsonii 2.00E-02 0 0 0 0 0 0 0 0 2.00E-02 2.00E-02
Deinococcus_proteolyticus 0 0 0 0 0 0 0 0 0 0 0
Delftia_acidovorans 0 0 0 0 0 0 0 0 0 0 0
Desulfitobacterium_hafniense 0 0 0 0 0 0 0 0 0 0 0
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Desulfomonile_tiedjei 0 0 0 0 0 0 0 0 0 0 0
Dialister_invisus 0 0 0 0 0 0 0 0 0 4.00E-02 0
Dichelobacter_nodosus 0 0 0 0 0 0 0 0 0 0 0
Dickeya_dadantii 0 0 0 0 0 0 0 0 0 0 0
Dorea_longicatena 0 0 0 0 0 0 0 0 0 1.00E-02 0
Enterobacter_asburiae 0 0 0 0 0 0 0 0 0 0 0
Enterobacter_cloacae 0 0 0 0 0 0 0 0 0 0 0
Enterobacter_sp._638 0 0 0 0 0 0 0 0 0 0 0
Enterococcus_faecalis 0 0 0 1.00E-02 0 0 0 0 0 0 0
Enterococcus_faecium 0 0 0 0 0 0 0 0 0 2.00E-02 2.00E-02
Erysipelothrix_rhusiopathiae 0 0 0 0 0 0 0 0 0 0 0
Erythrobacter_litoralis 0 0 0 0 0 0 0 0 0 0 0
Escherichia_coli 6.00E-02 4.00E-02 0.15 0.51 0 4.00E-02 2.00E-02 1.00E-02 3.00E-02 1.00E-02 2.00E-02
Escherichia_fergusonii 0 0 0 0 0 0 0 0 0 0 0
Eubacterium_eligens 0 0 0 0 1.00E-02 0 0 0 0 1.00E-02 0
Eubacterium_hallii 0 0 0 0 0 0 0 0 0 1.00E-02 0
Eubacterium_limosum 0 0 0 0 0 0 0 0 0 0 0
Eubacterium_rectale 0 0 0 0 0 0 0 0 0 0.35 0
Eubacterium_siraeum 0 0 0 0 0 0 0 0 0 0 0
Faecalibacterium_prausnitzii 0 0 0 0 0 0 0 0 0 0.1 0
Ferroglobus_placidus 1.00E-02 1.00E-02 1.00E-02 1.00E-02 0 0 0 0 0 0 0
Fervidobacterium_pennivorans 1.00E-02 0 0 0 0 0 0 0 0 0 0
Filifactor_alocis 7.00E-02 7.00E-02 0 4.00E-02 3.00E-02 6.00E-02 7.00E-02 0.13 4.00E-02 0 0
Finegoldia_magna 1.00E-02 8.00E-02 1.00E-02 0 3.00E-02 0 0 0 0 0 0
Flavobacterium_johnsoniae 0 0 0 0 0 0 0 0 0 0 0
Fusobacterium_mortiferum 0 0 0 0 0 0 0 0 0 0 1.00E-02
Fusobacterium_nucleatum 0 0 0 0 0 0 0 0 0 0 0
Fusobacterium_periodonticum 0 0 0 1.00E-02 0 0 0 0 0 0 0
Gardnerella_vaginalis 4.00E-02 3.00E-02 0.11 9.64 3.00E-02 4.00E-02 6.00E-02 2.00E-02 4.00E-02 0 57.25
Gemella_haemolysans 0 0 0 0 0 0 0 0 0 0 1.00E-02
Gemella_morbillorum 0 0 0 0 0 0 0 0 0 0 0
Gemmatimonas_aurantiaca 0 0 0 0 0 0 0 0 0 0 0
Geobacter_uraniireducens 0 0 0 0 0 0 0 0 0 0 0
Haemophilus_influenzae 0 0 0 0 0 0 0 0 0 0 0
Haemophilus_parainfluenzae 0 0 0 0 0 0 0 0 0 2.00E-02 0
Halothermothrix_orenii 0 0 0 0 0 0 0 0 0 0 0
Helicobacter_bilis 0 0 0 0 0 0 0 0 0 0 1.00E-02
Helicobacter_cetorum 0 0 0 0 0 0 0 0 0 0 0
Helicobacter_mustelae 0 0 0 0 1.00E-02 0 0 0 0 0 0
Helicobacter_pylori 0 0 0 0 2.00E-02 0 0 0 0 0 0
Hippea_maritima 0 0 0 0 0 0 0 0 0 0 3.00E-02
Holdemania_filiformis 0 0 0 0 0 0 0 0 0 0 0
Ignavibacterium_album 0 0 0 0 0 0 0 0 0 0 0
Isoptericola_variabilis 0 0 0 0 0 0 0 0 0 0 0
Jannaschia_sp._ccs1 0 0 0 0 0 0 0 0 0 0 0
Jonquetella_anthropi 0 0 0 0 4.00E-02 0 0 0 0 0 0
Kangiella_koreensis 1.00E-02 0 1.00E-02 0 0 0 0 0 0 0 0
Kineococcus_radiotolerans 0 0 0 0 0 0 0 0 0 0 0
Kitasatospora_setae 0 0 0 0 0 0 0 0 0 0 0
Klebsiella_oxytoca 0 0 0 0 0 0 0 0 0 0 0
Klebsiella_pneumoniae 0 0 0 0 0 0 0 0 0 0 0
Kribbella_flavida 0 0 0 0 0 0 0 0 0 0 0
Lactobacillus_acidophilus 0 0 0 0 0 0 0 0 0 0 1.00E-02
Lactobacillus_amylolyticus 0 0 0 0 0 0 1.00E-02 0 0 0 0
Lactobacillus_amylovorus 0 0 0 0 0 0 0 0 0 0 0
Lactobacillus_antri 0 0 0 0 0 0 2.00E-02 0 1.00E-02 0 0
Lactobacillus_casei 0 0 0 0 0 0 0 0 0 0 0
Lactobacillus_coleohominis 0 0 0 0 0 0 0 0 0 0 0
Lactobacillus_crispatus 5.00E-02 2.00E-02 7.00E-02 6.00E-02 0 0 2.00E-02 0 0 1.00E-02 2.00E-02
Lactobacillus_delbrueckii 0 2.00E-02 0 0 0 1.00E-02 2.00E-02 1.00E-02 1.00E-02 1.00E-02 1.00E-02
Lactobacillus_fermentum 0 1.00E-02 0 0 0 0 0 0 1.00E-02 0 0
Lactobacillus_gasseri 10.86 7.00E-02 0.11 0.35 5.00E-02 8.00E-02 6.00E-02 7.00E-02 0.1 82.08 31.58
Lactobacillus_helveticus 1.00E-02 1.00E-02 6.00E-02 4.00E-02 2.00E-02 1.00E-02 2.00E-02 2.00E-02 1.00E-02 1.00E-02 0
Lactobacillus_iners 55.92 60.95 54.48 52.38 5.00E-02 88.91 88.95 89.04 88.78 1.00E-02 6.00E-02
Lactobacillus_jensenii 22.08 28.22 33.68 23.75 0 0 0 0 0 0 0
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Lactobacillus_johnsonii 0.79 0 0 7.00E-02 0 0 1.00E-02 1.00E-02 2.00E-02 6.39 2.32
Lactobacillus_kefiranofaciens 0 0 0 0 0 0 0 0 0 0 0
Lactobacillus_plantarum 2.00E-02 4.00E-02 4.00E-02 4.00E-02 0 0 0 0 0 2.00E-02 1.00E-02
Lactobacillus_reuteri 0 0 1.00E-02 0 0 0 0 0 1.00E-02 0 0
Lactobacillus_rhamnosus 0 0 0 0 0 0 0 0 0 0 0
Lactobacillus_sakei 0 0 0 0 0 0 0 0 0 0 0
Lactobacillus_ultunensis 0 0 0 0 0 0 0 0 0 0 1.00E-02
Lactobacillus_vaginalis 0.14 0.55 0.87 1.1 2.00E-02 0 0 0 0 0 0
Lactococcus_garvieae 0 0 0 0 0 0 0 0 0 0 0
Lactococcus_lactis 0 0 0 0 0 0 0 0 0 0 0
Lawsonia_intracellularis 0 0 0 0 0 0 0 0 0 0 1.00E-02
Leadbetterella_byssophila 0 0 0 0 0 0 0 0 0 0 0
Lysinibacillus_sphaericus 0 0 0 0 0 0 0 0 0 0 0
Mahella_australiensis 0 0 0 0 0 0 0 0 0 0 0
Mannheimia_haemolytica 0 0 0 0 0 0 0 0 0 0 0
Marvinbryantia_formatexigens 0 0 0 0 0 0 0 0 0 0 0
Mesoplasma_florum 1.00E-02 1.00E-02 0 0 3.00E-02 0 0 0 0 0 0
Methanobrevibacter_ruminantium 0 2.00E-02 1.00E-02 1.00E-02 0 0 0 0 0 0 1.00E-02
Methylacidiphilum_infernorum 0 0 0 0 0 0 0 0 0 0 3.00E-02
Methylomicrobium_alcaliphilum 0 0 0 0 0 0 0 0 0 0 0
Micrococcus_luteus 0 0 0 0 0 1.00E-02 0 0 0 0 0
Microlunatus_phosphovorus 0 0 0 0 0 0 0 0 0 0 0
Micromonospora_sp._l5 0 0 0 0 0 0 0 0 0 0 0
Mobiluncus_curtisii 0 0 6.00E-02 0 1.00E-02 0 0 0 0 0 1.00E-02
Mycobacterium_abscessus 0 0 0 0 0 0 0 0 0 0 0
Mycobacterium_chubuense 0 0 0 0 0 0 0 0 0 0 0
Mycobacterium_smegmatis 0 0 0 0 0 0 0 0 0 0 0
Mycobacterium_vanbaalenii 0 0 0 0 0 0 0 0 0 0 0
Mycoplasma_arthritidis 1.00E-02 1.00E-02 1.00E-02 1.00E-02 0 0 0 0 0 0 0
Mycoplasma_crocodyli 0 1.00E-02 0 0 0 2.00E-02 3.00E-02 1.00E-02 1.00E-02 0 0
Mycoplasma_gallisepticum 0 0 0 0 0 0 0 0 0 2.00E-02 3.00E-02
Mycoplasma_haemofelis 0 0 0 0 3.00E-02 0 0 0 0 0 0
Mycoplasma_hominis 1.00E-02 0 1.00E-02 1.00E-02 0 2.00E-02 1.00E-02 0 1.00E-02 0 0
Mycoplasma_hyopneumoniae 0.12 8.00E-02 7.00E-02 7.00E-02 0 0.13 0.13 0.15 0.13 1.00E-02 0
Mycoplasma_synoviae 0 0 0 1.00E-02 0 4.00E-02 1.00E-02 4.00E-02 3.00E-02 1.00E-02 2.00E-02
Nanoarchaeum_equitans 0 0 0 0 0 0 0 0 0 0 0
Oenococcus_oeni 0 0 0 0 0 0 0 0 0 0 1.00E-02
Opitutus_terrae 0 0 0 0 0 0 0 0 0 0 0
Orientia_tsutsugamushi 0 0 0 0 0 0 0 0 0 1.00E-02 1.00E-02
Oscillibacter_valericigenes 0 0 0 0 0 0 0 0 0 1.00E-02 0
Owenweeksia_hongkongensis 0 0 0 0 0 0 0 0 0 2.00E-02 1.00E-02
Pantoea_ananatis 0 3.00E-02 1.00E-02 0 0 1.00E-02 0 0 0 0 0
Parabacteroides_distasonis 0 0 0 0 0 0 0 0 0 1.00E-02 0
Parabacteroides_johnsonii 0 0 0 0 0 0 0 0 0 1.00E-02 0
Parabacteroides_merdae 0 0 0 0 0 0 0 0 0 4.00E-02 0
Parascardovia_denticolens 0 0 0 0 0 0 0 0 0 0 6.00E-02
Parvimonas_micra 0 0 0 0 0 0 0 0 0 0 0
Pasteurella_multocida 0 0 0 0 0 0 0 0 0 1.00E-02 0
Peptoniphilus_lacrimalis 0 0 1.00E-02 0 0 0 0 0 0 0 0
Peptoniphilus_sp._oral_taxon_386 0 0 0 0 0 0 0 0 0 0 0
Peptostreptococcus_anaerobius 0 0 0 0 0 0 0 0 0 0 0
Peptostreptococcus_stomatis 0 0 0 0 1.00E-02 0 0 0 0 0 0
Phycisphaera_mikurensis 0 0 0 0 0 0 0 0 0 0 0
Polynucleobacter_necessarius 0 0 0 0 0 0 0 0 0 0 1.00E-02
Porphyromonas_asaccharolytica 0 0 3.00E-02 0 0 0 0 0 0 1.00E-02 0
Porphyromonas_uenonis 0 0 0 0 2.00E-02 0 0 0 0 0 0
Prevotella_amnii 0 0 0 0 0 0 0 0 0 0 0
Prevotella_bergensis 0 0 0 0 2.00E-02 0 0 0 0 0 0
Prevotella_bivia 0 0 0 0 0.11 0 0 0 0 0 0
Prevotella_buccalis 0 0 3.00E-02 0 2.00E-02 0 0 0 0 0 0
Prevotella_copri 0 0 0 0 0 0 0 0 0 0 0
Prevotella_melaninogenica 0 0 0 0 0 0 0 0 0 0 0
Prevotella_ruminicola 0 0 0 0 0 0 0 0 0 0 0
Prevotella_sp._oral_taxon_299 0 0 0 0 0 0 0 0 0 1.00E-02 0
Prevotella_timonensis 1.00E-02 9.00E-02 0.22 0 0.91 0 0 0 0 1.00E-02 1.00E-02
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Prochlorococcus_marinus 0 0 0 0 0 0 0 0 0 0 0
Propionibacterium_acnes 0 0 0 0 0 0 1.00E-02 1.00E-02 1.00E-02 0 1.00E-02
Propionibacterium_freudenreichii 0 0 0 0 0 0 0 0 0 0 0
Pseudoalteromonas_haloplanktis 0 1.00E-02 0 0 0 0 0 0 0 0 0
Pseudomonas_aeruginosa 0 0 0 0 0 0 0 0 0 0 0
Pseudomonas_fluorescens 0 0 0 0 0 0 0 0 0 1.00E-02 0
Pseudomonas_mendocina 0 0 0 0 0 1.00E-02 1.00E-02 0 0 0 0
Pseudomonas_putida 0 0 0 0 0 0 0 0 0 0 0
Pseudomonas_stutzeri 0 0 0 0 0 0 0 0 0 0 0
Psychromonas_ingrahamii 0 0 0 0 0 0 0 0 0 0 0
Pyramidobacter_piscolens 0 0 0 0 1.00E-02 0 0 0 0 0 0
Rhizobium_leguminosarum 0 0 0 0 2.00E-02 0 0 0 0 0 0
Rhodococcus_equi 0 1.00E-02 0 0 0 0 0 0 0 0 0
Rhodococcus_erythropolis 0 0 0 0 0 0 0 0 0 0 0
Rhodopseudomonas_palustris 0 0 0 0 0 0 0 0 0 0 0
Roseburia_hominis 0 0 0 0 0 0 0 0 0 1.00E-02 0
Roseburia_intestinalis 0 0 0 0 0 0 0 0 0 5.00E-02 0
Roseburia_inulinivorans 0 0 0 0 0 0 0 0 0 3.00E-02 0
Rothia_mucilaginosa 0 0 0 0 0 0 0 0 0 0 0
Ruminococcus_albus 0 0 0 0 0 0 0 0 0 0 0
Ruminococcus_champanellensis 0 0 0 0 0 0 0 0 0 0 0
Ruminococcus_lactaris 0 0 0 0 0 0 0 0 0 1.00E-02 0
Ruminococcus_sp._sr1/5 0 0 0 0 0 0 0 0 0 1.00E-02 0
Salinibacter_ruber 0 0 0 0 0 0 0 0 0 0 0
Salmonella_enterica 2.00E-02 1.00E-02 0 4.00E-02 0 0 0 0 0 0 0
Scardovia_inopinata 0 0 0 0 0 0 0 0 0 0 0
Selenomonas_ruminantium 0 0 0 0 0 0 0 0 0 0 0
Serratia_symbiotica 0 0 0 0 0 0 0 0 0 0 0
Shewanella_baltica 0 0 0 0 0 0 0 0 0 0 0
Shigella_boydii 0 0 0 0 0 0 0 0 0 0 0
Shigella_dysenteriae 0 0 0 0 0 0 0 0 0 0 0
Shigella_flexneri 0 0 1.00E-02 4.00E-02 0 0 0 0 0 0 0
Shigella_sonnei 0 0 0 0 0 0 0 0 0 0 0
Shuttleworthia_satelles 0 0 0 0 0 0 0 0 0 0 0
Simkania_negevensis 0 0 0 0 0 0 0 0 0 0 0
Slackia_heliotrinireducens 0 0 0 0 0 0 0 0 0 0 0
Sorangium_cellulosum 0 0 0 0 0 0 0 0 0 0 0
Sphingomonas_wittichii 0 0 0 0 0 0 0 0 0 0 0
Sphingopyxis_alaskensis 0 0 0 0 0 0 0 0 0 0 0
Spirochaeta_africana 0 0 0 0 0 0 0 0 0 0 0
Stackebrandtia_nassauensis 0 0 0 0 0 0 0 0 0 0 0
Staphylococcus_aureus 0 0 0 0 0 0 0 0 0 0 0
Staphylococcus_epidermidis 0 0 1.00E-02 0 0 0 0 0 1.00E-02 0 0
Staphylococcus_haemolyticus 0 0 1.00E-02 0 0 0 0 0 0 0 0
Staphylococcus_hominis 0 0 3.00E-02 0 0 0 0 0 0 0 0
Staphylococcus_lugdunensis 0 0 0 0 0 0 0 0 0 0 0
Staphylococcus_pseudintermedius 2.00E-02 2.00E-02 1.00E-02 1.00E-02 0 1.00E-02 4.00E-02 4.00E-02 3.00E-02 0 0
Staphylococcus_saprophyticus 0 0 0 0 0 0 0 0 0 0 0
Staphylococcus_warneri 0 0 0 0 0 0 0 0 0 0 0
Streptobacillus_moniliformis 0 0 0 0 0 0 0 0 0 0 0
Streptococcus_agalactiae 0 0 0 0 0 0 0 0 0 0 0
Streptococcus_anginosus 1.00E-02 0 0 0 0 0 0 0 0 0.15 6.00E-02
Streptococcus_dysgalactiae 0 0 0 0 0 0 0 0 0 1.00E-02 0
Streptococcus_equi 0 0 0 0 0 0 0 0 0 0 0
Streptococcus_equinus 0 0 0 0 0 0 0 0 0 0 0
Streptococcus_gallolyticus 0 0 0 0 0 0 0 0 0 0 1.00E-02
Streptococcus_infantarius 0 0 0 0 0 0 0 0 0 0 0
Streptococcus_intermedius 1.00E-02 2.00E-02 1.00E-02 0 0 0 0 0 0 0 0
Streptococcus_mitis 0 0 0 0 0 0 0 0 0 1.00E-02 0
Streptococcus_mutans 1.00E-02 0 0 0 0 0 0 0 0 0 0
Streptococcus_oralis 0 0 0 0 0 0 0 0 0 0 3.00E-02
Streptococcus_parasanguinis 0 0 0 0 0 0 0 0 0 6.00E-02 2.00E-02
Streptococcus_parauberis 0 0 1.00E-02 0 0 0 0 0 0 0 0
Streptococcus_pneumoniae 0 0 0 0 0 0 0 0 0 0 0
Streptococcus_pseudopneumoniae 0 0 0 0 0 0 0 0 0 0 0
  
176 
 
Table 23. (cont.)  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Streptococcus_pyogenes 0 0 0 0 0 0 0 0 0 0 0
Streptococcus_salivarius 0 0 0 0 0 0 0 0 0 0 0
Streptococcus_sanguinis 0 0 0 0 0 0 0 1.00E-02 1.00E-02 1.00E-02 1.00E-02
Streptococcus_suis 2.00E-02 1.00E-02 4.00E-02 4.00E-02 0 0 0 0 0 0 0
Streptococcus_thermophilus 0 0 0 0 0 0 0 0 0 2.00E-02 0
Streptococcus_uberis 0 0 0 0 0 0 0 0 0 0 0
Subdoligranulum_variabile 0 0 0 0 0 0 0 0 0 0 0
Sulfolobus_acidocaldarius 0 0 0 0 0 1.00E-02 2.00E-02 0 1.00E-02 0 0
Sulfolobus_islandicus 0 0 0 0 0 0 0 0 0 0 0
Sulfolobus_solfataricus 0 0 0 0 0 0 0 0 0 0 0
Sulfolobus_tokodaii 0 0 0 0 0 0 0 0 0 0 0
Sutterella_wadsworthensis 0 0 0 0 0 0 0 0 0 0 0
Synechocystis_sp._pcc_6803 0 0 0 0 0 0 0 0 0 0 0
Teredinibacter_turnerae 0 0 0 0 0 0 0 0 0 0 0
Tetragenococcus_halophilus 0 0 0 0 3.00E-02 0 0 1.00E-02 0 0 0
Thermoanaerobacterium_thermosaccharolyticum 0 0 0 0 0 0 0 0 0 1.00E-02 1.00E-02
Thermobispora_bispora 0 0 0 0 0 0 0 0 0 0 0
Thermosediminibacter_oceani 0 0 0 0 0 0 0 0 0 0 0
Thermovirga_lienii 0 0 0 0 0 0 0 0 0 0 2.00E-02
Turicella_otitidis 0 0 0 0 0 0 0 0 0 0 0
Ureaplasma_parvum 0 0 4.00E-02 0.12 0 0 0 0 1.00E-02 0.72 0.32
Ureaplasma_urealyticum 0 0 1.00E-02 0 0 0 0 0 0 1.00E-02 3.00E-02
Variovorax_paradoxus 0 0 0 0 0 0 0 0 0 0 0
Veillonella_parvula 0 0 0 0 0 0 0 0 0 0 0
Weeksella_virosa 0 1.00E-02 0 1.00E-02 0 0 0 0 0 0 0
Wolinella_succinogenes 0 0 0 0 0 1.00E-02 0 1.00E-02 2.00E-02 0 0
Xanthomonas_campestris 0 0 0 0 0 0 1.00E-02 0 0 1.00E-02 0
Zymomonas_mobilis 0 0 0 0 0 0 0 0 0 0 0
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Bacterial species 202_3 202_4 202_6 203_1 203_2 203_3 203_4 203_5 203_6 205_1 205_2
[Bacteroides]_pectinophilus 0 0 0 0 0 0 0 2.00E-02 0 0 0
[Clostridium]_bartlettii 0 0 0 0 0 0 0 0 0 0 0
[Clostridium]_sticklandii 0 0 0.15 0 0 0 0 1.00E-02 0 0 0
[Ruminococcus]_gnavus 0 0 0 0 0 0 0 0 0 0 0
[Ruminococcus]_obeum 0 0 0 0 0 0 0 0 0 0 0
[Ruminococcus]_torques 0 0 0 0 0 0 0 0 0 0 0
Acetobacterium_woodii 0 0 0 0 0 0 0 0 0.14 0 0
Acholeplasma_laidlawii 0 0 0 0 3.00E-02 0 0 1.00E-02 0 0 0
Acidimicrobium_ferrooxidans 0 0 0 2.00E-02 0 0 0 0 0 0 0
Acidothermus_cellulolyticus 0 0 0 0 0 0 0 0 0 0 0
Aciduliprofundum_boonei 0 0 0 0 0 0 0 1.00E-02 0 0 0
Acinetobacter_baumannii 0 0 0 0 0 0 0 0 0 0 0
Acinetobacter_junii 0 0 0 0 0 0 0 0 0 0 0
Acinetobacter_lwoffii 1.00E-02 0 0 0 0 0 0 0 0 0 0
Actinobacillus_succinogenes 0 0 0 0 0 0 0 0 0 0 0
Actinomyces_coleocanis 0 0 0.15 0 0 0 0 0 0.14 0 0
Actinomyces_urogenitalis 0 0 0 0 0 0 0 0 0 0 0
Aggregatibacter_aphrophilus 0 0 0 0 0 0 0 4.00E-02 0 0 0
Alistipes_finegoldii 0 0 0.15 0 0 0 0 0 0 0 0
Alistipes_shahii 0 0 0 0 0 0 0 0 0 0 0
Alkaliphilus_metalliredigens 0 0 0.15 0 0 0 0 0 0 0 0
Allochromatium_vinosum 0 0 0 0 0 0 0 1.00E-02 0 0 0
Alteromonas_macleodii 1.00E-02 1.00E-02 0 0 0 0 0 1.00E-02 0 0 0
Alteromonas_sp._sn2 0 0 0 0 0 0 0 0 0 0 0
Amycolatopsis_mediterranei 0 0 0 0 0 0 0 1.00E-02 0 0 0
Amycolicicoccus_subflavus 0 0 0.15 0 0 0 0 0 0 0 0
Anaerococcus_hydrogenalis 0 0 1.2 0 3.00E-02 0 0 0.58 0.69 0 0
Anaerococcus_lactolyticus 1.00E-02 1.00E-02 9.27 0 0 0 0 0.41 29.08 0 0
Anaerococcus_prevotii 0 0 0.15 0 0 0 0 2.00E-02 0.27 0 1.00E-02
Anaerococcus_tetradius 0 0 0.15 0 0 0 0 0 0 0 0
Anaerococcus_vaginalis 0 0 2.69 0 0 0 0 2.00E-02 2.06 0 0
Anaerotruncus_colihominis 0 0 0 0 0 0 0 0 0 0 0
Arcobacter_nitrofigilis 0 0 0 0 0 0 0 0 0 0 0
Atopobium_parvulum 0 0 0 0 0 0 0 0 0 0 0
Atopobium_vaginae 3.00E-02 5.00E-02 0 0 0 0 0 0 0.27 0 0
Azospira_oryzae 0 0 0 0 0 0 0 0 0 0 0
Bacillus_cereus 1.00E-02 1.00E-02 0 0 0 0 0 0 0.14 0 0
Bacillus_clausii 0 0 0 0 0 0 0 0 0.14 0 0
Bacillus_pseudofirmus 0 0 0 0 0 0 0 0 0 0 0
Bacillus_thuringiensis 0 0 0 0 0 0 0 0 0 0 0
Bacteriovorax_marinus 0 2.00E-02 0 0 0 0 0 0 0.14 0 0
Bacteroides_caccae 0 0 0 0 0 0 0 0 0 0 0
Bacteroides_cellulosilyticus 0 0 0 0 0 0 0 0 0 0 0
Bacteroides_dorei 0 0 0 0 0 0 0 0 0 0 0
Bacteroides_fragilis 0 0 0.15 0 0 0 0 2.00E-02 0 0 0
Bacteroides_ovatus 0 0 0 0 0 0 0 0 0 0 0
Bacteroides_stercoris 0 0 0 0 0 0 0 0 0 0 0
Bacteroides_thetaiotaomicron 0 0 0 0 0 0 0 0 0 0 0
Bacteroides_uniformis 0 0 0 0 0 0 0 0 0 0 0
Bacteroides_vulgatus 0 0 0 0 0 0 0 0 0 0 0
Bifidobacterium_adolescentis 0 0 0 0 0 0 0 0 0 0 0
Bifidobacterium_angulatum 0 0 0 0 0 0 0 0 0 0 0
Bifidobacterium_animalis 0 0 0 0 2.00E-02 0 0 0 0.14 0 0
Bifidobacterium_bifidum 0 0 0 9.00E-02 5.00E-02 0 0 6.00E-02 0 0 0
Bifidobacterium_breve 0 0 0 0 0 0 0 2.00E-02 0 0 0
Bifidobacterium_catenulatum 0 0 0 0 0 0 0 0 0 0 0
Bifidobacterium_dentium 4.00E-02 2.00E-02 0 0 0 0 0 0 0 0 0
Bifidobacterium_gallicum 1.00E-02 1.00E-02 0 0 0 0 0 0 0 0 0
Bifidobacterium_longum 1.00E-02 1.00E-02 0 9.00E-02 8.00E-02 0 0.1 2.04 0 0 0
Bifidobacterium_pseudocatenulatum 3.00E-02 2.00E-02 0 0 0 0 0 0 0 0 0
Bilophila_wadsworthia 0 0 0 0 0 0 0 0 0 0 0
Blautia_hydrogenotrophica 0 0 0 0 0 0 0 1.00E-02 0 0 0
Brevibacterium_mcbrellneri 0 0 0 0 0 0 0 0 0 0 0
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Buchnera_aphidicola 0 0 0 0 0 0 0 0 0 0 0
Burkholderia_glumae 0 0 0 0 0 0 0 0 0 0 0
Burkholderia_phytofirmans 0 0 0 0 5.00E-02 0 0 0 0 0 0
Burkholderia_pseudomallei 0 0 0 0 0 0 0 0 0 0 0
Butyrivibrio_crossotus 0 0 0 0 0 0 0 0 0 0 0
Butyrivibrio_fibrisolvens 0 0 0 0 0 0 0 0 0 0 0
Butyrivibrio_proteoclasticus 0 0 0 0 0 0 0 0 0 0 0
Caldicellulosiruptor_bescii 0 0 0 0 0 0 0 0 0 0 0
Campylobacter_fetus 0 0 0.75 0 0 0 0 0 0 0 0
Campylobacter_gracilis 0 0 0 0 0 0 0 0 0 0 0
Campylobacter_hominis 0 0 0.9 0 0 0 0 0 0.14 0 0
Campylobacter_lari 0 0 0.15 0 0 0 0 0 0 0 0
Campylobacter_upsaliensis 0 0 0 0 0 0 0 0 0 0 0
Candidatus_accumulibacter_phosphatis 0 0 0 0 0 0 0 0 0 0 0
Candidatus_azobacteroides_pseudotrichonymphae 0 1.00E-02 0 0 0 0 0 0 0 0 0
Candidatus_baumannia_cicadellinicola 0 0 0 0 0 0 0 0 0 2.00E-02 1.00E-02
Candidatus_carsonella_ruddii 0 0 0 0 0 0 0 0 0 0 0
Candidatus_nitrospira_defluvii 0 0 0 0 0 0 0 0 0 4.00E-02 2.00E-02
Candidatus_portiera_aleyrodidarum 0 0 0 0 0 0 0 0 0 0 0
Candidatus_puniceispirillum_marinum 0 0 0 0 0 0 0 0 0 0 0
Candidatus_riesia_pediculicola 1.00E-02 0 0 0 0 0 4.00E-02 0 0 0 0
Candidatus_zinderia_insecticola 0 0 0 0 0 0 0 0 0 0 0
Carboxydothermus_hydrogenoformans 0 0 0 0 0 0 0 0 0 0 0
Catenibacterium_mitsuokai 0 0 0 0 0 0 0 0 0 0 0
Cellulophaga_algicola 0 0 0 0 0 0 0 0 0 0 0
Cellulosilyticum_lentocellum 0 0 0 0 0 0 0 1.00E-02 0.14 0 0
Chitinophaga_pinensis 0 0 0 0 0 0 0 0 0 0 0
Chlamydia_trachomatis 0 0 0 0 0 0 0 0 0 0 0
Chlamydophila_felis 8.00E-02 7.00E-02 0 0 0 0 0 0 0 0 0
Chryseobacterium_gleum 0 0 0 0 0 0 0 0 0 0 0
Clostridiales_genomosp._bvab3 0 0 0 0 0 0 0 0 0 2.00E-02 1.00E-02
Clostridium_acidurici 0 0 0.15 0 0 0 0 0 0.69 0 0
Clostridium_botulinum 1.00E-02 2.00E-02 0.3 0 0 0 0 0 0.27 0 0
Clostridium_cellulovorans 0 0 0 0 0 0 0 0 0.14 0 0
Clostridium_leptum 0 0 0 0 0 0 0 0 0 0 0
Clostridium_novyi 0 0 0 0 0 0 0 0 0.14 0 0
Clostridium_perfringens 0 0 0 0 0 0 0 0 0.27 0 0
Clostridium_sp._sy8519 0 0 0 0 0 0 0 0 0 0 0
Collinsella_aerofaciens 0 0 0 0 0 0 0 0 0 0 0
Comamonas_testosteroni 0 0 0 0 0 0 0 0 0 0 0
Coprococcus_catus 0 0 0 0 0 0 0 1.00E-02 0 0 0
Coprococcus_comes 0 0 0 0 0 0 0 0 0 0 0
Coprococcus_eutactus 0 0 0.15 0 0 0 0 1.00E-02 0 0 0
Coprothermobacter_proteolyticus 0 0 0 0 0 0 0 0 0 0 0
Corynebacterium_accolens 0 0 0 0 0 0 0 1.00E-02 0 0 0
Corynebacterium_ammoniagenes 0 0 0 0 0 0 0 0 0 0 0
Corynebacterium_amycolatum 0 0 0.45 0 0 0 0 0 0 0 0
Corynebacterium_aurimucosum 0 0 0 0 0 0 0 2.00E-02 0.14 0 1.00E-02
Corynebacterium_glucuronolyticum 0 0 0.15 0 0 0 0 6.00E-02 0 0 0
Corynebacterium_glutamicum 0 0 0 0 0 0 0 0 0 0 0
Corynebacterium_jeikeium 0 0 0 0 0 0 0 0.17 0 0 2.00E-02
Corynebacterium_kroppenstedtii 0 0 0 0 0 0 0 0 0 0 0
Corynebacterium_lipophiloflavum 0 0 0.3 0 0 0 0 5.00E-02 0 0 0
Corynebacterium_matruchotii 0 0 0 0 0 0 0 0 0 0 0
Corynebacterium_pseudogenitalium 0 0 0 0 0 0 0 5.00E-02 0.14 0 1.00E-02
Corynebacterium_striatum 0 0 0 0 0 0 0 1.00E-02 0 0 0
Corynebacterium_tuberculostearicum 0 0 0 0 0 0 0 4.00E-02 0 0 0
Corynebacterium_ulcerans 0 0 0 0 0 0 0 0 0 0 0
Corynebacterium_urealyticum 0 0 0 0 0 0 0 6.00E-02 0 0 0
Cronobacter_sakazakii 0 0 0 0 0 0 0 0 0 0 0
Cupriavidus_necator 0 0 0 0 0 0 0 0 0 0 0
Cytophaga_hutchinsonii 1.00E-02 1.00E-02 0 0 0 0 0 0 0 0 0
Deinococcus_proteolyticus 0 0 0.15 0 0 0 0 0 0 0 0
Delftia_acidovorans 0 0 0 0 0 0 0 0 0 0 0
Desulfitobacterium_hafniense 0 0 0 0 0 0 0 0 0.14 0 0
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Desulfomonile_tiedjei 0 0 0 0 0 0 0 0 0 0 0
Dialister_invisus 0 0 0.75 0 0 0 0 0 1.1 0 0
Dichelobacter_nodosus 0 1.00E-02 0 0 0 0 0 0 0 0 0
Dickeya_dadantii 0 0 0 0 0 0 0 0 0 0 0
Dorea_longicatena 0 0 0 0 0 0 0 0 0 0 0
Enterobacter_asburiae 0 0 0 0 0 0 0 0 0 0 0
Enterobacter_cloacae 0 0 0 0 0 0 0 0 0 0 0
Enterobacter_sp._638 0 0 0 0 0 0 0 0 0 0 0
Enterococcus_faecalis 0 0 0 0 0 0 0 0 0 0 0
Enterococcus_faecium 1.00E-02 1.00E-02 0 0 0 0 0 0 0 0 0
Erysipelothrix_rhusiopathiae 0 0 0 0 0 0 0 1.00E-02 0 0 0
Erythrobacter_litoralis 0 0 0 0 0 0 0 0 0 0 0
Escherichia_coli 1.00E-02 1.00E-02 0.15 7.00E-02 3.00E-02 2.00E-02 2.00E-02 2.00E-02 0.14 3.00E-02 1.00E-02
Escherichia_fergusonii 0 0 0 0 0 0 0 0 0 0 0
Eubacterium_eligens 0 0 0 0 0 0 0 4.00E-02 0 0 0
Eubacterium_hallii 0 0 0 0 0 0 0 0 0 0 0
Eubacterium_limosum 0 0 0 0 0 0 0 0 0.14 0 0
Eubacterium_rectale 0 0 0 0 0 0 0 0 0 0 0
Eubacterium_siraeum 0 0 0 0 0 0 0 0 0.14 0 0
Faecalibacterium_prausnitzii 0 0 0 0 0 4.00E-02 0 0 0 0 0
Ferroglobus_placidus 0 0 0 0 0 0 0 0 0 0 0
Fervidobacterium_pennivorans 0 0 0 0 0 0 0 0 0 0 0
Filifactor_alocis 0 0 0 0 0 0 0 0 0 0 0
Finegoldia_magna 0 0 1.35 0 0 0 0 0.66 4.66 0 1.00E-02
Flavobacterium_johnsoniae 1.00E-02 0 0 0 0 0 0 0 0 0 0
Fusobacterium_mortiferum 0 0 0 0 0 0 0 0 0 0 0
Fusobacterium_nucleatum 0 0 0.15 0 0 0 0 0 0.27 0 0
Fusobacterium_periodonticum 0 0 0 0 0 0 0 0 0 0 0
Gardnerella_vaginalis 70.7 66.94 0.9 92.38 92.33 0.96 5.58 43.95 0.82 3.00E-02 8.00E-02
Gemella_haemolysans 0 0 0 0 0 0 0 0 0 0 0
Gemella_morbillorum 0 0 0 0 0 0 0 0 0 0 0
Gemmatimonas_aurantiaca 0 0 0 0 0 0 0 0 0 0 0
Geobacter_uraniireducens 1.00E-02 0 0 0 0 0 0 0 0 0 0
Haemophilus_influenzae 0 0 0 0 0 0 0 0.13 0 0 0
Haemophilus_parainfluenzae 0 0 0 0 0 0 0 1.33 0 0 0
Halothermothrix_orenii 0 0 0 0 0 0 0 0 0.14 0 0
Helicobacter_bilis 2.00E-02 2.00E-02 0 0 0 0 0 0 0 0 0
Helicobacter_cetorum 0 0 0 0 0 0 0 0 0 0 0
Helicobacter_mustelae 0 0 0 0 0 0 0 0 0 0 0
Helicobacter_pylori 0 0 0 0 0 0 0 0 0.27 1.00E-02 2.00E-02
Hippea_maritima 0 1.00E-02 0 0 0 0 0 0 0 0 0
Holdemania_filiformis 0 0 0 0 0 0 0 0 0 0 0
Ignavibacterium_album 0 1.00E-02 0 0 0 0 0 0 0 0 0
Isoptericola_variabilis 0 0 0.15 0 0 0 0 0 0 0 0
Jannaschia_sp._ccs1 0 0 0 0 0 0 0 0 0 0 0
Jonquetella_anthropi 0 0 0 0 0 0 0 0 0 0 0
Kangiella_koreensis 0 0 0 0 0 0 0 0 0 0 0
Kineococcus_radiotolerans 0 0 0 0 0 0 0 0 0 0 0
Kitasatospora_setae 0 0 0 5.00E-02 5.00E-02 0 0 0 0 0 0
Klebsiella_oxytoca 0 0 0 0 0 0 0 0 0 0 0
Klebsiella_pneumoniae 0 0 0 0 0 0 0 0 0 0 0
Kribbella_flavida 0 0 0 0 0 0 0 0 0 0 0
Lactobacillus_acidophilus 0 0 0.15 0 5.00E-02 21.42 19.63 4.01 0.14 0.18 0.14
Lactobacillus_amylolyticus 0 0 0 0 0 1.02 0.83 0.28 0 0 0
Lactobacillus_amylovorus 0 0 0 4.00E-02 0 12.91 11.82 2.38 0.41 0 0
Lactobacillus_antri 0 0 0 0 0 0 0 0 0 0 0
Lactobacillus_casei 0 0 0 0 0 0 0 0 0 0 0
Lactobacillus_coleohominis 0 0 0 0 0 0 0 0 0 0 0
Lactobacillus_crispatus 0 0 0.3 2.00E-02 0 4.66 5.02 0.83 0.14 86.21 86.27
Lactobacillus_delbrueckii 0 0 0 0 0 0.2 0.27 4.00E-02 0 5.00E-02 2.00E-02
Lactobacillus_fermentum 0 0 0 0 0.24 0.76 2.37 4.00E-02 0 0 0
Lactobacillus_gasseri 19.73 22.7 0.3 0 0 6.00E-02 0.12 4.00E-02 0.27 0.18 8.00E-02
Lactobacillus_helveticus 1.00E-02 0 0 0 0 6.25 5.18 1.31 0 1.96 1.8
Lactobacillus_iners 2.00E-02 7.00E-02 0 0 0 0 0.15 0 0 8.00E-02 4.00E-02
Lactobacillus_jensenii 0 0 0 0 0 0.22 0.33 6.00E-02 0 2.00E-02 2.00E-02
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Lactobacillus_johnsonii 1.37 1.73 0 0 0 0.2 0.19 7.00E-02 0 0 0
Lactobacillus_kefiranofaciens 0 0 0 0 0 1.24 1.35 0.18 0 0 0
Lactobacillus_plantarum 0 0 0 0 0 0 0 0 0 0 0
Lactobacillus_reuteri 0 1.00E-02 0 0 0 0 0 0 0 1.00E-02 1.00E-02
Lactobacillus_rhamnosus 0 0 0 0 0 0 0 0 0 0 0
Lactobacillus_sakei 0 0 0 2.00E-02 0 0 0 0 0 0 0
Lactobacillus_ultunensis 0 0 0 0 0 2.7 2.6 0.44 0 0 0
Lactobacillus_vaginalis 0 0 0 0 0 0 0 0 0 0.31 0.4
Lactococcus_garvieae 0 0 0 0 0 0 0 0 0.14 0 0
Lactococcus_lactis 0 0 0 0 0 0 0 0 0 1.00E-02 0
Lawsonia_intracellularis 1.00E-02 1.00E-02 0.15 0 0 0 0 0 0 0 0
Leadbetterella_byssophila 0 0 0 4.00E-02 6.00E-02 0 0 0 0 0 0
Lysinibacillus_sphaericus 0 0 0 0 0 0 0 0 0 3.00E-02 5.00E-02
Mahella_australiensis 0 0 0 0 0 0 0 0 0.27 0 0
Mannheimia_haemolytica 0 0 0 0 0 0 0 1.00E-02 0 0 0
Marvinbryantia_formatexigens 0 0 0 0 0 0 0 1.00E-02 0.14 0 0
Mesoplasma_florum 0 0 0 0 0 0 0 0 0 0 0
Methanobrevibacter_ruminantium 1.00E-02 0 0 0 0 0 0 0 0 0 0
Methylacidiphilum_infernorum 3.00E-02 4.00E-02 0 0 0 0 0 0 0 0 0
Methylomicrobium_alcaliphilum 0 0 0 0 2.00E-02 0 0 1.00E-02 0 0 0
Micrococcus_luteus 0 0 0 0 0 0 0 0 0 0 0
Microlunatus_phosphovorus 0 0 0 0 0 0 0 1.00E-02 0 0 0
Micromonospora_sp._l5 0 0 0 0 0 0 0 1.00E-02 0 0 0
Mobiluncus_curtisii 0 0 2.84 0 0 0 0 0 0 0 0
Mycobacterium_abscessus 0 0 0 0 0 0 0 0 0 0 0
Mycobacterium_chubuense 0 0 0 0 0 0 0 0 0 0 0
Mycobacterium_smegmatis 0 0 0 0 0 0 0 0 0.14 0 0
Mycobacterium_vanbaalenii 0 0 0 0 0 0 0 0 0 0 0
Mycoplasma_arthritidis 0 0 0 0 0 0 0 0 0 0 0
Mycoplasma_crocodyli 0 0 0 0 0 0 0 0 0 0 0
Mycoplasma_gallisepticum 1.00E-02 0 0 0 0 0 0 1.00E-02 0 1.00E-02 4.00E-02
Mycoplasma_haemofelis 0 0 0 0 0 0 0 0 0 0 0
Mycoplasma_hominis 0 0 0 0 0 0 0 0 0 0 0
Mycoplasma_hyopneumoniae 1.00E-02 0 0 0 0 0.15 6.00E-02 1.00E-02 0.14 0 0
Mycoplasma_synoviae 0 0 0 0 0 0 0 0 0 0 1.00E-02
Nanoarchaeum_equitans 0 0 0 0 0 2.00E-02 0 0 0 0 0
Oenococcus_oeni 3.00E-02 4.00E-02 0 0 0 0 0 0 0 0 0
Opitutus_terrae 0 0 0.15 0 0 0 0 0 0 0 0
Orientia_tsutsugamushi 0 0 0 0 0 0 0 0 0 0 0
Oscillibacter_valericigenes 0 0 0 0 0 0 0 0 0 0 0
Owenweeksia_hongkongensis 0 1.00E-02 0 0 0 0 0 0 0 0 0
Pantoea_ananatis 0 0 0 0 0 0 0 0 0 0 0
Parabacteroides_distasonis 0 0 0 0 0 0 0 0 0 0 0
Parabacteroides_johnsonii 0 0 0 0 0 0 0 0 0 0 0
Parabacteroides_merdae 0 0 0 0 0 0 0 0 0 0 0
Parascardovia_denticolens 2.00E-02 5.00E-02 0 0 0 0 0 0 0 0 0
Parvimonas_micra 0 0 0.15 0 0 0 0 0 0 0 0
Pasteurella_multocida 0 0 0 0 0 0 0 0 0 0 0
Peptoniphilus_lacrimalis 0 0 0.15 0 0 0 0 0 0.82 0 0
Peptoniphilus_sp._oral_taxon_386 0 0 0.15 0 0 0 0 0 0 0 0
Peptostreptococcus_anaerobius 0 0 11.21 0 0 0 0 0 0.27 0 0
Peptostreptococcus_stomatis 0 0 0 0 0 0 0 1.00E-02 0 0 0
Phycisphaera_mikurensis 0 0 0 0 0 0 0 0 0 0 0
Polynucleobacter_necessarius 1.00E-02 1.00E-02 0 4.00E-02 5.00E-02 0 0 0 0 0 0
Porphyromonas_asaccharolytica 0 0 7.17 0 0 0 0 0 1.1 0 0
Porphyromonas_uenonis 0 1.00E-02 7.62 0 0 0 0 0 0.69 0 0
Prevotella_amnii 0 0 0 0 0 0 0 0 0 0 0
Prevotella_bergensis 0 0 0.9 0 0 0 0 0 0 0 0
Prevotella_bivia 0 0 0 0 0 0 0 0 0 0 0
Prevotella_buccalis 0 0 5.23 0 0 0 0 4.00E-02 0.27 0 0
Prevotella_copri 0 0 0 0 0 0 0 1.00E-02 0 0 0
Prevotella_melaninogenica 0 0 0 0 2.00E-02 0 0 0 0 0 0
Prevotella_ruminicola 0 0 0.15 0 0 0 0 0 0 0 0
Prevotella_sp._oral_taxon_299 0 0 0 0 0 0 0 0 0 0 0
Prevotella_timonensis 3.00E-02 6.00E-02 0.9 2.00E-02 0 0 0 7.00E-02 11.39 0 0
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Prochlorococcus_marinus 0 0 0 0 0 0 0 1.00E-02 0 2.00E-02 1.00E-02
Propionibacterium_acnes 0 0 0 0 0 0 0 0 0 1.00E-02 1.00E-02
Propionibacterium_freudenreichii 0 0 0.3 0 0 0 0 1.00E-02 0.14 0 0
Pseudoalteromonas_haloplanktis 0 0 0 0 0 0 0 0 0 0 0
Pseudomonas_aeruginosa 0 0 0 0 2.00E-02 0 0 0 0 0 0
Pseudomonas_fluorescens 0 0 0 0 0 0 0 0 0 0 0
Pseudomonas_mendocina 0 0 0 0 0 0 0 0 0 0 0
Pseudomonas_putida 0 0 0 0 0 0 0 1.00E-02 0 0 0
Pseudomonas_stutzeri 0 0 0 0 0 0 0 0 0 0 0
Psychromonas_ingrahamii 0 0 0 0 0 0 0 1.00E-02 0 0 0
Pyramidobacter_piscolens 0 0 0 0 0 0 0 0 0 0 0
Rhizobium_leguminosarum 0 0 0 0.11 2.00E-02 0 0 5.00E-02 0 0 0
Rhodococcus_equi 0 0 0 0 0 0 0 0 0 0 0
Rhodococcus_erythropolis 0 0 0 0 0 0 0 0 0 0 0
Rhodopseudomonas_palustris 0 0 0 0 0 0 0 0 0 0 0
Roseburia_hominis 0 0 0 0 0 0 0 0 0 0 0
Roseburia_intestinalis 0 0 0 0 0 0 0 0 0 0 0
Roseburia_inulinivorans 0 0 0 0 0 0 0 0 0 0 0
Rothia_mucilaginosa 0 0 0 0 0 0 0 0 0 0 0
Ruminococcus_albus 0 0 0 0 0 0 0 0 0.14 0 0
Ruminococcus_champanellensis 0 0 0 0 0 0 0 1.00E-02 0 0 0
Ruminococcus_lactaris 0 0 0 0 0 0 0 0 0 0 0
Ruminococcus_sp._sr1/5 0 0 0 0 0 0 0 0 0 0 0
Salinibacter_ruber 0 0 0.15 0 0 0 0 0 0 0 0
Salmonella_enterica 0 0 0 0 0 0 0 0 0 1.00E-02 0
Scardovia_inopinata 0 0 0 0 0 0 0 0 0 0 0
Selenomonas_ruminantium 0 0 0 0 0 2.00E-02 0 0 0 0 0
Serratia_symbiotica 0 0 0 0 0 0 0 0 0 0 0
Shewanella_baltica 0 0 0 0 0 0 0 0 0 0 0
Shigella_boydii 0 0 0.15 0 0 0 0 0 0 0 0
Shigella_dysenteriae 0 0 0 0 0 0 0 0 0 0 0
Shigella_flexneri 0 0 0 0 0 0 0 0 0 0 0
Shigella_sonnei 0 0 0 0 0 0 0 0 0 0 0
Shuttleworthia_satelles 0 0 0 0 0 0 0 0 0.14 0 0
Simkania_negevensis 0 0 0 0 0 0 0 0 0 0 0
Slackia_heliotrinireducens 0 0 0 0 0 0 0 0 0 0 0
Sorangium_cellulosum 0 0 0 0 0 0 0 0 0 0 0
Sphingomonas_wittichii 0 0 0 0 0 0 0 0 0 0 0
Sphingopyxis_alaskensis 0 0 0 0 0 0 0 0 0 0 0
Spirochaeta_africana 0 0 0 0 0 0 0 1.00E-02 0 0 0
Stackebrandtia_nassauensis 0 0 0 0 0 0 0 0 0 0 0
Staphylococcus_aureus 0 0 0 0 0 0 4.00E-02 0 0 0 0
Staphylococcus_epidermidis 0 0 0 0 0 0 0 0.15 0 2.00E-02 2.00E-02
Staphylococcus_haemolyticus 1.00E-02 0 0.15 0 0 0 0 0.21 0 0 0
Staphylococcus_hominis 0 0 0 2.00E-02 0 0 0 0.13 0 0 1.00E-02
Staphylococcus_lugdunensis 0 0 0 0 0 0 0 1.00E-02 0 0 0
Staphylococcus_pseudintermedius 0 0 0 0 0 0 0 0 0 0 0
Staphylococcus_saprophyticus 0 0 0 0 0 0 0 0 0 0 0
Staphylococcus_warneri 0 0 0 0 0 0 0 0 0 0 0
Streptobacillus_moniliformis 0 0 0 0 0 0 0 0 0.41 0 0
Streptococcus_agalactiae 0 0 0.15 2.00E-02 0 0 0 12.52 1.65 0 0
Streptococcus_anginosus 6.00E-02 2.00E-02 0 7.00E-02 2.00E-02 2.00E-02 2.00E-02 7.28 2.61 2.00E-02 0
Streptococcus_dysgalactiae 0 0 0 0 0 0 0 1.00E-02 0 0 0
Streptococcus_equi 0 0 0 0 0 0 0 4.00E-02 0.14 0 0
Streptococcus_equinus 0 0 0 0 0 0 0 4.00E-02 0.14 0 0
Streptococcus_gallolyticus 1.00E-02 0 0 0 0 0 0 0.12 0.27 0 0
Streptococcus_infantarius 0 0 0 0 0 0 0 5.00E-02 0 0 0
Streptococcus_intermedius 0 0 0 0 0 0 0 0.27 0.27 0 0
Streptococcus_mitis 0 0 0 0 0 0 0 8.00E-02 0 0 0
Streptococcus_mutans 0 0 0 0 0 0 0 5.00E-02 0.14 0 0
Streptococcus_oralis 6.00E-02 7.00E-02 0 0 0 0 0 7.00E-02 0 0 0
Streptococcus_parasanguinis 2.00E-02 0 0 0 0 0 0 0 0 0 0
Streptococcus_parauberis 0 0 0 0 0 0 0 0 0 0 0
Streptococcus_pneumoniae 0 0 0 0 0 0 0 1.00E-02 0 0 0
Streptococcus_pseudopneumoniae 0 0 0 0 0 0 0 0 0 0 0
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Streptococcus_pyogenes 0 0 0 0 0 0 0 0.5 0.27 0 0
Streptococcus_salivarius 0 0 0 0 0 0 0 1.00E-02 0 0 0
Streptococcus_sanguinis 0 0 0 0 0 0 0 9.00E-02 0 0 0
Streptococcus_suis 0 0 0 0 0 0 6.00E-02 8.00E-02 0 3.00E-02 4.00E-02
Streptococcus_thermophilus 0 0 0 0 0 0 0 5.00E-02 0 0 0
Streptococcus_uberis 0 1.00E-02 0 0 0 0 0 0 0 0 0
Subdoligranulum_variabile 0 0 0 0 0 0 0 0 0 0 0
Sulfolobus_acidocaldarius 0 0 0 0 0 0 0 0 0 0 0
Sulfolobus_islandicus 0 0 0 0 0 0 0 0 0 0 0
Sulfolobus_solfataricus 0 0 0 0 0 0 0 0 0 0 0
Sulfolobus_tokodaii 1.00E-02 0 0 0 0 0 0 0 0 0 0
Sutterella_wadsworthensis 0 0 0 0 0 0 0 0 0 0 0
Synechocystis_sp._pcc_6803 0 0 0 0 0 0 0 0 0 0 0
Teredinibacter_turnerae 0 1.00E-02 0 0 0 0 0 0 0 0 0
Tetragenococcus_halophilus 0 0 0 0 0 0 0 0 0 0 0
Thermoanaerobacterium_thermosaccharolyticum 0 0 0 0 0 0 0 0 0 0 0
Thermobispora_bispora 0 0 0 2.00E-02 0 0 0 0 0 0 0
Thermosediminibacter_oceani 0 0 0 0 0 0 0 0 0.14 0 0
Thermovirga_lienii 0 1.00E-02 0 0 0 0 0 0 0.14 0 0
Turicella_otitidis 0 0 0 0 0 0 0 1.00E-02 0 0 0
Ureaplasma_parvum 0.34 0.43 0 0 0 0 0 0 0 0 0
Ureaplasma_urealyticum 0 3.00E-02 0 0 0 0 0 0 0 0 0
Variovorax_paradoxus 0 0 0 0 0 0 0 0 0 0 3.00E-02
Veillonella_parvula 0 0 0 0 0 0 0 0.49 0 0 0
Weeksella_virosa 0 0 0 0 0 0 0 0 0 0 0
Wolinella_succinogenes 0 0 0 0 0 0 0 0 0 0 0
Xanthomonas_campestris 0 1.00E-02 0.3 2.00E-02 0 0 0 0 0.82 0 0
Zymomonas_mobilis 0 0 0 0 0 0 0 0 0 3.00E-02 2.00E-02
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Bacterial species 205_3 205_5 205_6 206_1 206_2 206_3 206_4 206_5 206_6
[Bacteroides]_pectinophilus 0 0 0 0 0 0 0 0 0
[Clostridium]_bartlettii 0 0 0 0 0 0 0 0 0
[Clostridium]_sticklandii 0 0 0 0 0 0 0 0 0
[Ruminococcus]_gnavus 0 0 0 0 0 0 0 0 0
[Ruminococcus]_obeum 0 0 0 0 0 0 0 0 0
[Ruminococcus]_torques 0 0 0 0 0 0 0 0 0
Acetobacterium_woodii 0 0 0 0 0 0 0 0 0
Acholeplasma_laidlawii 0 0 0 0 0 0 0 0 0
Acidimicrobium_ferrooxidans 0 0 0 0 0 0 0 0 0
Acidothermus_cellulolyticus 0 0 0 0 1.00E-02 0 0 0 0
Aciduliprofundum_boonei 0 0 0 0 0 0 0 0 0
Acinetobacter_baumannii 0 0 0 0 0 0 0 0 0
Acinetobacter_junii 0 6.00E-02 0 0 0 0 0 0 0
Acinetobacter_lwoffii 0 6.00E-02 0 0 0 0 0 0 0
Actinobacillus_succinogenes 0 0 0 0 0 0 0 0 0
Actinomyces_coleocanis 0 0 0 0 0 0 0 0 0
Actinomyces_urogenitalis 0 6.00E-02 0 0 0 0 0 0 0
Aggregatibacter_aphrophilus 0 0 0 0 0 0 0 0 0
Alistipes_finegoldii 0 0 0 0 0 0 0 0 0
Alistipes_shahii 0 0 0 0 0 0 0 0 0
Alkaliphilus_metalliredigens 0 0 0 0 0 0 0 0 0
Allochromatium_vinosum 0 0 0 0 0 0 0 0 0
Alteromonas_macleodii 0 0 0 0 0 0 0 0 0
Alteromonas_sp._sn2 0 0 0 0 0 0 0 0 0
Amycolatopsis_mediterranei 0 0 0 0 0 0 0 0 0
Amycolicicoccus_subflavus 0 0 0 0 0 0 0 0 0
Anaerococcus_hydrogenalis 0 0 0 0 0 0 0 0 0.66
Anaerococcus_lactolyticus 0 0.36 0 0 0 0 0 0 1.76
Anaerococcus_prevotii 0 0 0 0 0 0 0 0 0.88
Anaerococcus_tetradius 0 0 0 0 0 0 0 0 0.22
Anaerococcus_vaginalis 0 0 0 0 0 0 0 0 5.51
Anaerotruncus_colihominis 0 0 0 0 0 0 0 0 0
Arcobacter_nitrofigilis 0 0 0 0 0 0 0 0 0
Atopobium_parvulum 0 6.00E-02 0 0 0 0 0 0 0
Atopobium_vaginae 0 0 0 0 0 0 0 0 0
Azospira_oryzae 0 0 0 0 0 0 0 0 0
Bacillus_cereus 0 0 0 0 0 4.00E-02 0 0 0
Bacillus_clausii 0 0 0 0 0 0 0 0 0
Bacillus_pseudofirmus 0 0 0 0 0 0 0 0 0
Bacillus_thuringiensis 0 0 0 0 0 0 0 0 0
Bacteriovorax_marinus 0 0 0 0 0 0 0 0 0
Bacteroides_caccae 0 0 0 0 0 0 0 0 0
Bacteroides_cellulosilyticus 0 0 0 0 0 0 0 0 0
Bacteroides_dorei 0 0 0 0 0 0 0 0 0
Bacteroides_fragilis 0 0 0 0 0 0 0 0 0
Bacteroides_ovatus 0 0 0 0 0 0 0 0 0
Bacteroides_stercoris 0 6.00E-02 0 0 0 0 0 0 0
Bacteroides_thetaiotaomicron 0 0 0 0 0 0 0 0 0
Bacteroides_uniformis 0 0 0 0 0 0 0 0 0
Bacteroides_vulgatus 0 6.00E-02 0 0 0 0 0 0 0
Bifidobacterium_adolescentis 0 0.12 0 0 0 0 0 0 0
Bifidobacterium_angulatum 0 0 0 0 0 0 0 0 0
Bifidobacterium_animalis 0 0 0 0 0 0 0 0 0
Bifidobacterium_bifidum 0 0.3 0 0 0 0 0 0 0
Bifidobacterium_breve 0 0 0 0 0 0 0 0 0
Bifidobacterium_catenulatum 0 6.00E-02 0 0 0 0 0 0 0
Bifidobacterium_dentium 0 0 0 5.00E-02 6.00E-02 0 0 4.00E-02 0
Bifidobacterium_gallicum 0 0 0 5.00E-02 4.00E-02 0 0 2.00E-02 0
Bifidobacterium_longum 0 6.00E-02 0 3.00E-02 1.00E-02 0 0 1.00E-02 0
Bifidobacterium_pseudocatenulatum 0 0 0 0 0 1.00E-02 0 2.00E-02 0.22
Bilophila_wadsworthia 0 0 0 0 0 0 0 0 0
Blautia_hydrogenotrophica 0 0 0 0 0 0 0 0 0
Brevibacterium_mcbrellneri 0 0 0 0 0 0 0 0 0.44
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Buchnera_aphidicola 0 0 0 0 0 0 0 0 0
Burkholderia_glumae 0 0 0 0 0 0 0 0 0
Burkholderia_phytofirmans 0 0 0 0 0 0 0 0 0
Burkholderia_pseudomallei 0 0 0 0 0 0 0 0 0
Butyrivibrio_crossotus 0 0 0 0 0 0 0 0 0
Butyrivibrio_fibrisolvens 0 0 0 0 0 0 0 0 0
Butyrivibrio_proteoclasticus 0 0 0 0 0 0 0 0 0.22
Caldicellulosiruptor_bescii 0 0 0 0 0 0 0 0 0
Campylobacter_fetus 0 0 0 0 0 0 0 0 0
Campylobacter_gracilis 0 0 0 0 0 0 0 0 0
Campylobacter_hominis 0 0 0 0 0 0 0 0 1.98
Campylobacter_lari 0 0 0 0 0 0 0 0 0
Campylobacter_upsaliensis 0 0 0 0 0 0 0 0 0
Candidatus_accumulibacter_phosphatis 0 0 0 0 0 0 0 0 0
Candidatus_azobacteroides_pseudotrichonymphae 0 0 0 0 0 1.00E-02 0.1 0 0
Candidatus_baumannia_cicadellinicola 3.00E-02 0 1.00E-02 0 0 0 0 0 0
Candidatus_carsonella_ruddii 0 0 0 0 0 0 0 0 0
Candidatus_nitrospira_defluvii 3.00E-02 0 2.00E-02 0 0 0 0 0 0
Candidatus_portiera_aleyrodidarum 0 0 0 0 0 0 0 0 0.22
Candidatus_puniceispirillum_marinum 0 6.00E-02 0 0 0 0 0 0 0
Candidatus_riesia_pediculicola 0 0 0 0 0 0 0 0 0
Candidatus_zinderia_insecticola 0 0 0 0 0 0 0 0 0
Carboxydothermus_hydrogenoformans 0 0 0 0 0 0 0 0 0.22
Catenibacterium_mitsuokai 0 0 0 0 0 0 0 0 0
Cellulophaga_algicola 0 0 0 0 0 0 0 0 0
Cellulosilyticum_lentocellum 0 0 0 6.00E-02 3.00E-02 0 0 2.00E-02 0
Chitinophaga_pinensis 0 0 0 0 0 0 0 0 0
Chlamydia_trachomatis 0 0 0 0 0 0 0 0 0
Chlamydophila_felis 0 0 0 0 0 0 0 0 0
Chryseobacterium_gleum 0 6.00E-02 0 0 0 0 0 0 0
Clostridiales_genomosp._bvab3 0 0 1.00E-02 0 0 0 0 0 0
Clostridium_acidurici 0 6.00E-02 0 0 0 0 0 0 0
Clostridium_botulinum 0 0 0 0 0 5.00E-02 0 0 0.44
Clostridium_cellulovorans 0 0 0 0 0 0 0 0 0
Clostridium_leptum 0 0 0 0 0 0 0 0 0
Clostridium_novyi 0 0 0 0 0 0 0 0 0
Clostridium_perfringens 0 0 0 0 0 0 0 0 0
Clostridium_sp._sy8519 0 0 0 0 0 0 0 0 0
Collinsella_aerofaciens 0 0.12 0 0 0 0 0 0 0
Comamonas_testosteroni 0 6.00E-02 0 0 0 0 0 0 0
Coprococcus_catus 0 0.12 0 0 0 0 0 0 0
Coprococcus_comes 0 0.12 0 0 0 0 0 0 0
Coprococcus_eutactus 0 0 0 0 0 0 0 0 0
Coprothermobacter_proteolyticus 0 0 0 0 0 0 0 0 0
Corynebacterium_accolens 0 6.00E-02 0 0 0 0 0 0 0
Corynebacterium_ammoniagenes 0 0.12 0 0 0 0 0 0 0
Corynebacterium_amycolatum 0 0.12 0 0 0 0 0 0 0.88
Corynebacterium_aurimucosum 0 0.65 0 0 0 0 0 0 0
Corynebacterium_glucuronolyticum 0 0.12 0 0 0 0 0 0 0
Corynebacterium_glutamicum 0 0 0 0 0 0 0 0 0
Corynebacterium_jeikeium 0 0 0 0 0 0 0 0 0
Corynebacterium_kroppenstedtii 0 0 0 0 0 0 0 0 0
Corynebacterium_lipophiloflavum 0 0.18 0 0 0 0 0 0 0
Corynebacterium_matruchotii 0 6.00E-02 0 0 0 0 0 0 0
Corynebacterium_pseudogenitalium 0 6.00E-02 0 0 0 0 0 0 0.22
Corynebacterium_striatum 0 0.18 0 0 0 0 0 0 0.44
Corynebacterium_tuberculostearicum 0 0.24 0 0 0 0 0 0 0.22
Corynebacterium_ulcerans 0 0 0 0 0 0 0 0 0
Corynebacterium_urealyticum 0 6.00E-02 0 0 0 0 0 0 0
Cronobacter_sakazakii 0 0 0 0 0 0 0 0 0
Cupriavidus_necator 0 0 0 0 0 0 0 0 0
Cytophaga_hutchinsonii 0 0 0 0 0 5.00E-02 0.1 0 0
Deinococcus_proteolyticus 0 0 0 0 0 0 0 0 0
Delftia_acidovorans 0 6.00E-02 0 0 0 0 0 0 0
Desulfitobacterium_hafniense 0 0 0 0 0 0 0 0 0
  
185 
 
Table 23. (cont.)   
 
Desulfomonile_tiedjei 0 0 0 0 0 0 0 0 0
Dialister_invisus 0 0 0 0 0 0 0 0 0.22
Dichelobacter_nodosus 0 0 0 0 0 0 0 0 0
Dickeya_dadantii 0 0 0 0 0 0 0 0 0
Dorea_longicatena 0 6.00E-02 0 0 0 0 0 0 0
Enterobacter_asburiae 0 0 0 0 0 0 0 0 0
Enterobacter_cloacae 0 0 0 0 0 0 0 0 0
Enterobacter_sp._638 0 0 0 0 0 0 0 0 0
Enterococcus_faecalis 0 0 0 0 0 0 0 0 0
Enterococcus_faecium 0 0 0 0 0 5.00E-02 0.1 0 0
Erysipelothrix_rhusiopathiae 0 0 0 0 0 0 0 0 0
Erythrobacter_litoralis 0 0.12 0 0 0 0 0 0 0
Escherichia_coli 1.00E-02 0 2.00E-02 2.00E-02 7.00E-02 4.00E-02 0.19 0 0.88
Escherichia_fergusonii 0 0 0 0 0 0 0 0 0
Eubacterium_eligens 0 6.00E-02 0 0 0 0 0 0 0
Eubacterium_hallii 0 0 0 0 0 0 0 0 0
Eubacterium_limosum 0 0 0 0 0 0 0 0 0
Eubacterium_rectale 0 6.00E-02 0 0 0 0 0 0 0
Eubacterium_siraeum 0 0 0 0 0 0 0 0 0
Faecalibacterium_prausnitzii 0 0.18 0 0 0 0 0 0 0
Ferroglobus_placidus 0 0 0 0 0 0 0 0 0
Fervidobacterium_pennivorans 0 0 0 0 0 0 0 0 0
Filifactor_alocis 0 0 0 0 0 0 0 0 0
Finegoldia_magna 0 0.42 0 0 0 0 0 0 1.54
Flavobacterium_johnsoniae 0 0 0 0 0 0 0 0 0
Fusobacterium_mortiferum 0 0 0 0 0 0 0 0 0
Fusobacterium_nucleatum 0 0.18 0 0 0 0 0 0 0
Fusobacterium_periodonticum 0 0 0 0 0 0 0 0 0
Gardnerella_vaginalis 5.00E-02 3.81 2.00E-02 91.51 90.45 1.2 36.67 85.16 29.3
Gemella_haemolysans 0 0 0 0 0 0 0 0 0
Gemella_morbillorum 0 0 0 0 0 0 0 0 0
Gemmatimonas_aurantiaca 0 0 0 0 0 0 0 0 0
Geobacter_uraniireducens 0 0 0 0 0 0 0 0 0
Haemophilus_influenzae 0 0 0 0 0 0 0 0 0
Haemophilus_parainfluenzae 0 6.00E-02 0 0 0 0 0 0 0
Halothermothrix_orenii 0 0 0 0 0 0 0 0 0
Helicobacter_bilis 0 0 0 0 1.00E-02 0 0 1.00E-02 0
Helicobacter_cetorum 0 0 0 0 0 1.00E-02 0 0 0
Helicobacter_mustelae 0 0 0 0 0 0 0 0 0
Helicobacter_pylori 2.00E-02 0 0 0 0 0 0 0 0
Hippea_maritima 0 0 0 0 0 0 0 0 0
Holdemania_filiformis 0 0 0 0 0 0 0 0 0.22
Ignavibacterium_album 0 0 0 0 0 0 0 0 0
Isoptericola_variabilis 0 0 0 0 0 0 0 0 0
Jannaschia_sp._ccs1 0 6.00E-02 0 0 0 0 0 0 0
Jonquetella_anthropi 0 0 0 0 0 0 0 0 0.66
Kangiella_koreensis 0 0 0 0 0 0 0 0 0
Kineococcus_radiotolerans 0 0 0 0 0 0 0 0 0
Kitasatospora_setae 0 0 0 0 0 0 0 0 0
Klebsiella_oxytoca 0 0 0 0 0 0 0 0 0
Klebsiella_pneumoniae 0 0 0 0 0 0 0 0 0
Kribbella_flavida 0 0 0 0 0 0 0 0 0
Lactobacillus_acidophilus 0.13 0.24 0.1 0 0 0 0 0 0
Lactobacillus_amylolyticus 0 0 1.00E-02 0 0 0 0 0 0
Lactobacillus_amylovorus 0 0 0 0 0 0 0 0 0
Lactobacillus_antri 0 0 0 0 0 0 0 0 0
Lactobacillus_casei 0 0 0 0 0 0 0 0 0
Lactobacillus_coleohominis 0 0 1.00E-02 0 0 0 0 0 0
Lactobacillus_crispatus 87.16 70.36 86.75 0.36 0.9 0.49 0.29 1.00E-02 0.22
Lactobacillus_delbrueckii 4.00E-02 0 3.00E-02 0 0 4.00E-02 0 0 0
Lactobacillus_fermentum 0 0 0 0 0 0 0 0 0
Lactobacillus_gasseri 0.22 0.54 1.00E-02 1.00E-02 0.2 83.89 49.61 2.45 1.98
Lactobacillus_helveticus 1.58 1.13 1.73 0 1.00E-02 2.00E-02 0 0 0
Lactobacillus_iners 8.00E-02 0.48 4.00E-02 0 0 0 1.26 0 2.2
Lactobacillus_jensenii 1.00E-02 0 3.00E-02 0 0 0 0 0 0
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Lactobacillus_johnsonii 1.00E-02 0 0 0 0 5.78 3.79 0.18 0.22
Lactobacillus_kefiranofaciens 0 0 0 0 0 0 0 0 0
Lactobacillus_plantarum 0 6.00E-02 0 0 0 0 0.1 0 0
Lactobacillus_reuteri 0 0 1.00E-02 0 0 0 0 0 0
Lactobacillus_rhamnosus 0 0 0 0.16 0.33 1.00E-02 0 0 0
Lactobacillus_sakei 0 0 0 0 0 0 0 0 0
Lactobacillus_ultunensis 0 0 0 0 0 0 0 0 0
Lactobacillus_vaginalis 0.46 0.42 0.2 0 0 1.00E-02 0 0 0
Lactococcus_garvieae 0 0 0 0 0 0 0 0 0
Lactococcus_lactis 1.00E-02 0 1.00E-02 0 0 0 0 0 0
Lawsonia_intracellularis 0 0 0 0 0 0 0 0 0
Leadbetterella_byssophila 0 0 0 0 0 0 0 0 0
Lysinibacillus_sphaericus 6.00E-02 6.00E-02 6.00E-02 0 1.00E-02 0 0 0 0
Mahella_australiensis 0 0 0 0 0 0 0 0 0
Mannheimia_haemolytica 0 0 0 0 0 0 0 0 0
Marvinbryantia_formatexigens 0 0 0 0 0 0 0 0 0
Mesoplasma_florum 0 0 0 0 0 0 0 0 0
Methanobrevibacter_ruminantium 0 0 0 0 0 1.00E-02 0 0 0
Methylacidiphilum_infernorum 0 0 0 0 0 0 0 0 0
Methylomicrobium_alcaliphilum 0 0 0 0 0 0 0 0 0
Micrococcus_luteus 0 0 0 0 0 0 0 0 0
Microlunatus_phosphovorus 0 0 0 0 0 0 0 0 0
Micromonospora_sp._l5 0 0 0 0 0 0 0 0 0
Mobiluncus_curtisii 0 0 0 0 0 0 0 0 0.88
Mycobacterium_abscessus 0 0 0 0 0 0 0 0 0
Mycobacterium_chubuense 0 6.00E-02 0 0 0 0 0 0 0
Mycobacterium_smegmatis 0 0.12 0 0 0 0 0 0 0
Mycobacterium_vanbaalenii 0 6.00E-02 0 0 0 0 0 0 0
Mycoplasma_arthritidis 0 0 0 0 0 0 0 0 0
Mycoplasma_crocodyli 0 0 0 0 0 0 0 0 0
Mycoplasma_gallisepticum 4.00E-02 0 1.00E-02 0 0 2.00E-02 0 0 0
Mycoplasma_haemofelis 0 0 0 0 0 0 0 0 0
Mycoplasma_hominis 0 0 0 0 0 0 0 0 0
Mycoplasma_hyopneumoniae 0 0 0 0 0 1.00E-02 0 0 0
Mycoplasma_synoviae 0 0 0 0 0 2.00E-02 0 0 0
Nanoarchaeum_equitans 0 0 0 0 0 0 0 0 0
Oenococcus_oeni 0 0 0 0 0 0 0 0 0
Opitutus_terrae 0 0 0 0 0 0 0 0 0
Orientia_tsutsugamushi 0 0 0 0 0 1.00E-02 0 0 0
Oscillibacter_valericigenes 0 0 0 0 0 0 0 0 0
Owenweeksia_hongkongensis 0 0 0 0 0 5.00E-02 0 0 0
Pantoea_ananatis 0 0 0 0 0 0 0 0 0
Parabacteroides_distasonis 0 0 0 0 0 0 0 0 0
Parabacteroides_johnsonii 0 0 0 0 0 0 0 0 0
Parabacteroides_merdae 0 0 0 0 0 0 0 0 0
Parascardovia_denticolens 0 0 0 9.00E-02 9.00E-02 0 0 7.00E-02 0
Parvimonas_micra 0 0 0 0 0 0 0 0 0
Pasteurella_multocida 0 0 0 0 0 0 0 0 0
Peptoniphilus_lacrimalis 0 0 0 0 0 0 0 0 0
Peptoniphilus_sp._oral_taxon_386 0 0 0 0 0 0 0 0 0
Peptostreptococcus_anaerobius 0 0.18 0 0 0 0 0 0 2.2
Peptostreptococcus_stomatis 0 0 0 0 0 0 0 0 0
Phycisphaera_mikurensis 0 0 0 1.00E-02 0 0 0 0 0
Polynucleobacter_necessarius 0 0 0 0 0 0 0 0 0
Porphyromonas_asaccharolytica 0 0 0 0 0 0 0 0 0.66
Porphyromonas_uenonis 0 0 0 0 0 0 0 0 1.32
Prevotella_amnii 0 0 0 0 0 0 0 0 0
Prevotella_bergensis 0 0 0 0 0 0 0 0 3.3
Prevotella_bivia 0 6.00E-02 0 0 0 0 0 1.14 0.22
Prevotella_buccalis 0 0 0 0 0 0 0 0 1.1
Prevotella_copri 0 0 0 0 0 0 0 0 0
Prevotella_melaninogenica 0 0 0 0 0 0 0 0 0
Prevotella_ruminicola 0 0 0 0 0 0 0 0 0
Prevotella_sp._oral_taxon_299 0 0 0 0 0 0 0 0 0
Prevotella_timonensis 0 0.36 0 0 0 0 0 0 20.26
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Prochlorococcus_marinus 0 0 3.00E-02 0 0 0 0 0 0
Propionibacterium_acnes 1.00E-02 0.36 1.00E-02 0 3.00E-02 0 0 1.00E-02 0.22
Propionibacterium_freudenreichii 0 0 0 0 0 0 0 0 0
Pseudoalteromonas_haloplanktis 0 0 0 0 0 0 0 0 0
Pseudomonas_aeruginosa 0 0 0 0 0 0 0 0 0
Pseudomonas_fluorescens 0 6.00E-02 0 0 0 0 0 0 0
Pseudomonas_mendocina 0 0 0 0 0 0 0 0 0
Pseudomonas_putida 0 0 0 0 0 0 0 0 0
Pseudomonas_stutzeri 0 0 0 0 0 0 0 0 0
Psychromonas_ingrahamii 0 0 0 0 0 0 0 0 0
Pyramidobacter_piscolens 0 0 0 0 0 0 0 0 0
Rhizobium_leguminosarum 0 0 0 0 0 0 0 0 0
Rhodococcus_equi 0 6.00E-02 0 0 0 0 0 0 0
Rhodococcus_erythropolis 0 0 0 0 0 0 0 0 0.22
Rhodopseudomonas_palustris 0 0 0 0 0 0 0 0 0
Roseburia_hominis 0 0 0 0 0 0 0 0 0
Roseburia_intestinalis 0 0 0 0 0 0 0 0 0
Roseburia_inulinivorans 0 0 0 0 0 0 0 0 0
Rothia_mucilaginosa 0 6.00E-02 0 0 0 0 0 0 0
Ruminococcus_albus 0 0 0 0 0 0 0 0 0
Ruminococcus_champanellensis 0 0 0 0 0 0 0 0 0
Ruminococcus_lactaris 0 0 0 0 0 0 0 0 0
Ruminococcus_sp._sr1/5 0 6.00E-02 0 0 0 0 0 0 0
Salinibacter_ruber 0 0 0 0 0 0 0 0 0
Salmonella_enterica 0 0 0 0 0 0 0 0 0
Scardovia_inopinata 0 0 0 0 0 0 0 0 0
Selenomonas_ruminantium 0 0 0 0 0 0 0 0 0
Serratia_symbiotica 0 0 0 0 0 0 0 0 0
Shewanella_baltica 0 0 0 0 0 0 0 0 0
Shigella_boydii 0 0 0 0 0 0 0 0 0
Shigella_dysenteriae 0 0 0 0 0 0 0 0 0
Shigella_flexneri 0 0 0 0 0 1.00E-02 0 0 0
Shigella_sonnei 0 0 0 0 0 0 0 0 0
Shuttleworthia_satelles 0 0 0 0 0 0 0 0 0
Simkania_negevensis 0 0 0 0 0 0 0 0 0
Slackia_heliotrinireducens 0 0 0 0 0 0 0 0 0
Sorangium_cellulosum 0 0 0 0 0 0 0 0 0
Sphingomonas_wittichii 0 0 0 0 0 0 0 0 0
Sphingopyxis_alaskensis 0 6.00E-02 0 0 0 0 0 0 0
Spirochaeta_africana 0 0 0 0 0 0 0 0 0
Stackebrandtia_nassauensis 0 6.00E-02 0 0 0 0 0 0 0
Staphylococcus_aureus 0 0 0 0 0 0 0 0 0
Staphylococcus_epidermidis 1.00E-02 0.42 1.00E-02 0 0 0 0 0 0
Staphylococcus_haemolyticus 0 0.18 0 0 0 0 0 0 0
Staphylococcus_hominis 0 0 0 0 0 0 0 0 0
Staphylococcus_lugdunensis 0 0 0 0 0 0 0 0 0
Staphylococcus_pseudintermedius 0 0 0 0 0 0 0 0 0
Staphylococcus_saprophyticus 0 0.12 0 0 0 0 0 0 0
Staphylococcus_warneri 0 6.00E-02 0 0 0 0 0 0 0
Streptobacillus_moniliformis 0 0 0 0 0 0 0 0 0
Streptococcus_agalactiae 0 0 0 0 0 0 0 1.00E-02 0
Streptococcus_anginosus 0 1.01 0 0 0 0 0 0 0
Streptococcus_dysgalactiae 0 0 0 0 0 0 0 0 0
Streptococcus_equi 0 0 0 0 0 0 0 0 0
Streptococcus_equinus 0 0 0 0 0 0 0 0 0
Streptococcus_gallolyticus 0 6.00E-02 0 0 0 0 0 0 0
Streptococcus_infantarius 0 0 0 0 0 0 0 0 0
Streptococcus_intermedius 0 0.12 0 0 0 0 0 0 0
Streptococcus_mitis 0 6.00E-02 0 0 0 0 0.19 1.38 1.1
Streptococcus_mutans 0 0 0 0 0 1.00E-02 0 0 0
Streptococcus_oralis 0 6.00E-02 0 0.14 4.00E-02 0 0 0.31 0.44
Streptococcus_parasanguinis 0 0 0 0 0 8.00E-02 0 1.00E-02 0
Streptococcus_parauberis 0 0 0 0 0 0 0 0 0
Streptococcus_pneumoniae 0 0 0 0 0 0 0.19 0.54 0.66
Streptococcus_pseudopneumoniae 0 6.00E-02 0 0 0 0 0 0.21 0.22
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Note: X_X represents subject ID_time point. 1, 2, 3, 4, 5, and 6 represent samples 
collected at 8–12, 17–21, 26–30, and 35–38 weeks of gestation, during labor, and at 6 
weeks post-partum, respectively. 
 
 
 
 
 
 
 
 
 
 
Streptococcus_pyogenes 0 0 0 0 0 0 0 0 0
Streptococcus_salivarius 0 0 0 0 0 0 0 0 0
Streptococcus_sanguinis 0 0 0 0 0 1.00E-02 0 1.00E-02 0
Streptococcus_suis 2.00E-02 0 2.00E-02 0 0 0 0 0 0
Streptococcus_thermophilus 0 0 0 0 0 0 0 0 0
Streptococcus_uberis 0 0 0 0 0 0 0 0 0
Subdoligranulum_variabile 0 0.18 0 0 0 0 0 0 0
Sulfolobus_acidocaldarius 0 0 0 0 0 0 0 0 0
Sulfolobus_islandicus 0 0 0 0 0 0 0 0 0
Sulfolobus_solfataricus 0 0 0 0 0 0 0 0 0
Sulfolobus_tokodaii 0 0 0 0 0 0 0 0 0
Sutterella_wadsworthensis 0 0 0 0 0 0 0 0 0.44
Synechocystis_sp._pcc_6803 0 0 0 0 0 0 0 0 0
Teredinibacter_turnerae 0 6.00E-02 0 0 0 0 0 0 0
Tetragenococcus_halophilus 0 0 0 0 0 0 0 0 0
Thermoanaerobacterium_thermosaccharolyticum 0 0 0 0 0 0 0 0 0
Thermobispora_bispora 0 0 0 0 0 0 0 0 0
Thermosediminibacter_oceani 0 0 0 0 0 0 0 0 0
Thermovirga_lienii 0 0 0 2.00E-02 4.00E-02 0 0 2.00E-02 0
Turicella_otitidis 0 0 0 0 0 0 0 0 0
Ureaplasma_parvum 0 0 0 0 0 0 0 0 0
Ureaplasma_urealyticum 0 0 0 0 0 0 0 0 0
Variovorax_paradoxus 2.00E-02 0 1.00E-02 0 0 0 0 0 0
Veillonella_parvula 0 0 0 0 0 0 0 0 0
Weeksella_virosa 0 0 0 0 0 0 0 0 0
Wolinella_succinogenes 0 0 0 0 0 0 0 0 0
Xanthomonas_campestris 0 0 0 0 0 0 0 0 0
Zymomonas_mobilis 3.00E-02 0 2.00E-02 0 0 0 0 0 0
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Table 24. Taxonomic abundance determined from the metagenomic assembly in 
women with and without a previous preterm birth history (%). 
 
Bacterial species 110_1 110_2 110_3 110_4 110_5 110_6 117_1 117_2 117_3 117_4 117_5
Acinetobacter_baumannii 0 0 0 0 0 0 0 0 0 0 0
Aerococcus_urinae 0 0 0 0 0 0 0 0 0 0 0
Aerococcus_viridans 0 0 0 0 0 0 0 0 0 0 0
Anaerococcus_hydrogenalis 0 0 0 0 0 0.03 0 0 0 0 0
Anaerococcus_lactolyticus 0 0 0.01 0 0 0.08 0 0 0 0 0
Anaerococcus_prevotii 0 0 0 0 0 0.02 0 0 0 0 0
Anaerococcus_tetradius 0 0 0 0 0 0.01 0 0 0 0 0
Atopobium_vaginae 0.06 0.17 0.41 0.04 0.24 4.54 0.39 0.03 0.09 0.08 0.11
Bacteroides_fragilis 0 0 0 0 0 0 0 0 0 0 0
Bifidobacterium_adolescentis 0 0 0 0 0 0 0 0 0 0 0
Bifidobacterium_breve 0.02 0.02 0.03 0.02 0.03 0.08 0.02 0.02 0.02 0.02 0.02
Bifidobacterium_dentium 0 0 0 0 0 0 0 0 0 0 0
Bifidobacterium_longum 0 0 0.01 0 0.01 0.05 0 0 0 0 0
Bifidobacterium_thermophilum 0 0 0 0 0 0 0 0 0 0 0
Capnocytophaga_ochracea 0 0 0 0 0 0 0 0 0 0 0
Clostridiales_genomosp._BVAB3 0 0 0 0 0 0.01 0 0 0 0 0
Clostridium_pasteurianum 0 0 0 0 0 0 0 0 0 0 0
Clostridium_perfringens 0 0 0 0 0 0 0 0 0 0 0
Coprococcus_sp._ART55/1 0 0 0 0 0 0 0 0 0 0 0
Corynebacterium_lipophiloflavum 0 0 0 0 0 0 0 0 0 0 0
Dialister_microaerophilus 0 0 0 0 0 0 0 0 0 0 0
Eggerthella_sp._YY7918 0 0 0 0 0 0 0 0 0 0 0
Enterococcus_faecalis 0.1 0.22 0.52 0.05 0.25 6.8 0.26 0.03 0.1 0.08 0.18
Enterococcus_faecium 0.23 0.51 1.17 0.11 0.57 14.75 0.58 0.08 0.23 0.19 0.42
Eremococcus_coleocola 0 0 0 0 0 0 0 0 0 0 0
Escherichia_coli 0.03 0.05 0.17 0.02 0.14 1.3 0.08 0.01 0.03 0.03 0.04
Escherichia_fergusonii 0 0 0 0 0 0 0 0 0 0 0
Eubacterium_siraeum 0 0 0 0 0 0 0 0 0 0 0
Finegoldia_magna 0 0 0.01 0 0.01 0.16 0 0 0 0 0
Frankia_symbiont_of_Datisca_glomerata 0 0 0 0 0 0 0 0 0 0 0
Gardnerella_vaginalis 0.26 0.17 0.27 0.06 0.2 1.44 0.11 0.06 0.07 0.07 0.09
Klebsiella_oxytoca 0 0 0 0 0 0.01 0 0 0 0 0
Klebsiella_pneumoniae 0 0 0 0 0 0 0 0 0 0 0
Lactobacillus_acidophilus 0 0 0.02 0 0.02 0.15 0.01 0 0 0 0
Lactobacillus_amylovorus 0 0.01 0.04 0.01 0.04 0.21 0.02 0 0.01 0.01 0.01
Lactobacillus_coleohominis 0 0 0 0 0 0.01 0 0 0 0 0
Lactobacillus_crispatus 0.53 0.49 1.66 98.67 96.33 2.21 92.56 98.82 98.41 98.28 96.46
Lactobacillus_delbrueckii 0 0 0 0 0 0 0 0 0 0 0
Lactobacillus_fermentum 0 0 0 0 0 0 0 0 0 0 0
Lactobacillus_gasseri 0.15 0.2 0.33 0.28 0.5 1.59 0.19 0.1 0.12 0.12 0.15
Lactobacillus_helveticus 0 0 0 0 0 0 0 0 0 0 0
Lactobacillus_iners 97.83 97.57 94.1 0.23 0.51 61.01 0.24 0.2 0.2 0.19 0.2
Lactobacillus_jensenii 0.19 0.2 0.41 0.33 0.58 1.59 5.11 0.47 0.47 0.73 2.06
Lactobacillus_johnsonii 0.22 0.16 0.16 0.06 0.06 0.15 0.06 0.07 0.06 0.05 0.06
Lactobacillus_kefiranofaciens 0 0 0.01 0 0.01 0.04 0.01 0 0 0 0
Lactobacillus_oris 0.08 0.06 0.06 0.03 0.03 0.06 0.03 0.03 0.03 0.02 0.03
Lactobacillus_reuteri 0 0 0 0 0 0 0 0 0 0 0
Lactobacillus_salivarius 0 0 0 0.01 0.01 0.01 0 0 0 0 0
Lactobacillus_vaginalis 0 0 0.02 0 0.02 0.12 0.03 0.03 0.04 0.02 0.04
Megasphaera_genomosp 0 0 0 0 0 0.01 0 0 0 0 0
Megasphaera_sp._UPII_135-E 0 0 0 0 0 0 0 0 0 0 0
Megasphaera_sp_UPII_199-6 0 0 0 0 0 0.01 0 0 0 0 0
Mobiluncus_curtisii 0.01 0.01 0.01 0 0 0.01 0 0 0 0 0
Mobiluncus_mulieris 0 0 0 0 0 0 0 0 0 0 0
Neisseria_gonorrhoeae 0.19 0.03 0.19 0.02 0.05 0.85 0.14 0.02 0.03 0.02 0.04
Odoribacter_splanchnicus 0 0 0 0 0 0 0 0 0 0 0
Peptoniphilus_duerdenii 0 0 0 0 0 0.04 0 0 0 0 0
Peptoniphilus_harei 0 0 0 0 0 0.03 0 0 0 0 0
Peptoniphilus_lacrimalis 0 0 0 0 0 0.05 0 0 0 0 0
Porphyromonas_asaccharolytica 0 0 0 0 0 0 0 0 0 0 0
Porphyromonas_gingivalis 0 0 0 0 0 0 0 0 0 0 0
Porphyromonas_uenonis 0 0 0 0 0 0.01 0 0 0 0 0
Prevotella_amnii 0 0 0 0 0 0.03 0 0 0 0 0
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Prevotella_bivia 0.02 0.03 0.13 0.02 0.13 0.75 0.05 0.01 0.02 0.02 0.02
Prevotella_buccalis 0 0 0 0 0 0.05 0 0 0 0 0
Prevotella_dentalis 0 0 0 0 0 0 0 0 0 0 0
Prevotella_denticola 0 0 0 0 0 0.05 0 0 0 0 0
Prevotella_disiens 0 0 0 0 0.01 0.08 0 0 0 0 0
Prevotella_intermedia 0 0 0 0 0 0 0 0 0 0 0
Prevotella_melaninogenica 0 0 0 0 0 0 0 0 0 0 0
Prevotella_oralis 0 0 0 0 0 0 0 0 0 0 0
Prevotella_timonensis 0 0 0 0 0 0.11 0 0 0 0 0
Proteus_mirabilis 0 0 0 0 0 0 0 0 0 0 0
Salmonella_enterica 0 0 0 0 0 0 0 0 0 0 0
Shigella_dysenteriae 0 0 0 0 0 0 0 0 0 0 0
Shigella_flexneri 0 0 0 0 0 0 0 0 0 0 0
Shigella_sonnei 0 0 0 0 0 0 0 0 0 0 0
Staphylococcus_aureus 0 0 0 0 0 0 0 0 0 0 0
Staphylococcus_lugdunensis 0 0 0 0 0 0 0 0 0 0 0
Staphylococcus_simulans 0 0 0 0 0 0 0 0 0 0 0
Streptococcus_agalactiae 0.01 0.02 0.06 0.01 0.06 0.33 0.03 0 0.01 0.01 0.01
Streptococcus_bovis 0 0 0 0 0 0.07 0 0 0 0 0
Streptococcus_dysgalactiae 0 0 0 0 0 0 0 0 0 0 0
Streptococcus_equi 0 0 0 0 0 0 0 0 0 0 0
Streptococcus_gallolyticus 0 0 0 0 0 0 0 0 0 0 0
Streptococcus_gordonii 0 0 0 0 0 0.01 0 0 0 0 0
Streptococcus_infantarius 0 0 0 0 0 0 0 0 0 0 0
Streptococcus_intermedius 0 0 0 0 0 0.03 0 0 0 0 0
Streptococcus_macedonicus 0 0 0 0 0 0 0 0 0 0 0
Streptococcus_mitis 0.01 0.01 0.04 0 0.04 0.3 0.02 0.01 0.01 0.01 0.01
Streptococcus_oligofermentans 0 0 0 0 0 0.01 0 0 0 0 0
Streptococcus_oralis 0 0 0 0 0 0.02 0 0 0 0 0
Streptococcus_parasanguinis 0 0 0 0 0 0.01 0 0 0 0 0
Streptococcus_pneumoniae 0.01 0.01 0.04 0.01 0.04 0.24 0.01 0 0.01 0.01 0.01
Streptococcus_pseudopneumoniae 0.01 0.01 0.03 0 0.03 0.16 0.01 0 0.01 0.01 0.01
Streptococcus_pseudoporcinus 0 0 0 0 0 0.02 0 0 0 0 0
Streptococcus_pyogenes 0 0 0 0 0 0 0 0 0 0 0
Streptococcus_salivarius 0 0 0 0 0 0.01 0 0 0 0 0
Streptococcus_sanguinis 0 0 0 0 0 0 0 0 0 0 0
Streptococcus_suis 0 0 0 0 0 0.01 0 0 0 0 0
Streptococcus_thermophilus 0 0 0 0 0 0 0 0 0 0 0
Streptococcus_urinalis 0.03 0.03 0.03 0.01 0.02 0.11 0.01 0.01 0.01 0.01 0.01
Syntrophus_aciditrophicus 0 0 0 0 0 0 0 0 0 0 0
Tannerella_forsythia 0 0 0 0 0 0 0 0 0 0 0
Treponema_denticola 0 0 0 0 0 0 0 0 0 0 0
Ureaplasma_parvum 0 0 0.01 0 0.01 0.08 0 0 0 0 0
Ureaplasma_urealyticum 0 0 0 0 0 0.01 0 0 0 0 0
Veillonella_ratti 0 0 0 0 0 0.02 0 0 0 0 0
Vibrio_cholerae 0 0 0 0 0 0 0 0 0 0 0
Xanthomonas_campestris 0 0 0 0 0 0 0 0 0 0 0
Yersinia_pseudotuberculosis 0 0 0 0 0 0 0 0 0 0 0
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Bacterial species 117_6 119_1 119_2 119_3 119_4 119_6 120_1 120_2 120_3 120_4 120_6
Acinetobacter_baumannii 0 0 0 0 0 0 0 0 0 0 0.09
Aerococcus_urinae 0 0 0 0 0 0 0 0 0 0 0
Aerococcus_viridans 0 0 0 0 0 0 0 0 0 0 0
Anaerococcus_hydrogenalis 0 0 0 0 0 0.08 0 0 0 0 0
Anaerococcus_lactolyticus 0.01 0.01 0 0.01 0.01 0.35 0.02 0 0 0 0
Anaerococcus_prevotii 0 0 0 0 0 0.4 0.01 0 0 0 0
Anaerococcus_tetradius 0 0 0 0 0 0.3 0 0 0 0 0
Atopobium_vaginae 0.91 0.68 0.35 2.05 1.54 2.79 2.91 0.28 0.18 0.15 0.05
Bacteroides_fragilis 0 0 0 0 0 0 0 0 0 0 0
Bifidobacterium_adolescentis 0.09 0 0 0 0 0 0 0 0 0 0
Bifidobacterium_breve 54 0.04 0.22 0.08 0.02 37.38 0.3 0.09 0.08 0.02 0.05
Bifidobacterium_dentium 2.51 0 0.01 0 0 1.62 0 0 0 0 0.03
Bifidobacterium_longum 32.41 0.02 0.11 0.03 0.01 21.93 0.07 0.04 0.06 0 0.01
Bifidobacterium_thermophilum 0 0 0 0 0 0 0 0 0 0 0
Capnocytophaga_ochracea 0 0 0 0 0 0 0 0 0 0 0
Clostridiales_genomosp._BVAB3 0.02 0 0 0 0 0.05 0.06 0.08 0.15 0.01 0.02
Clostridium_pasteurianum 0 0 0 0 0 0 0 0 0 0 0
Clostridium_perfringens 0 0 0 0 0 0 0 0 0 0 0
Coprococcus_sp._ART55/1 0 0 0 0 0 0 0 0 0 0 0
Corynebacterium_lipophiloflavum 0 0 0 0 0 0 0 0 0 0 0.01
Dialister_microaerophilus 0 0 0 0 0 0.03 0 0 0 0 0
Eggerthella_sp._YY7918 0 0 0 0 0 0 0 0 0 0 0
Enterococcus_faecalis 0.88 1.04 0.31 1.69 1.51 4.44 5.18 0.57 0.27 0.22 0.14
Enterococcus_faecium 2.07 2.3 0.68 3.76 3.36 9.9 11.62 1.27 0.56 0.49 0.31
Eremococcus_coleocola 0 0 0 0 0 0 0 0 0 0 0
Escherichia_coli 0.49 0.28 0.09 0.49 0.35 0.91 1.31 0.08 0.14 0.11 92.15
Escherichia_fergusonii 0 0 0 0 0 0 0 0 0 0 0.02
Eubacterium_siraeum 0 0 0 0 0 0 0 0 0 0 0
Finegoldia_magna 0.02 0.01 0 0.02 0.01 0.44 0.05 0 0 0 0.01
Frankia_symbiont_of_Datisca_glomerata 0.03 0 0 0 0 0.02 0 0 0 0 0
Gardnerella_vaginalis 0.91 0.31 0.13 0.55 0.49 1.68 43.77 38.77 53.94 2.76 4.06
Klebsiella_oxytoca 0.01 0 0 0 0.01 0.01 0.02 0 0 0 1.78
Klebsiella_pneumoniae 0 0 0 0 0 0 0 0 0 0 0.04
Lactobacillus_acidophilus 0.06 0.02 0.01 0.06 0.04 0.09 0.09 0.01 0 0 0
Lactobacillus_amylovorus 0.11 0.05 0.02 0.1 0.07 0.15 0.21 0.01 0 0.01 0
Lactobacillus_coleohominis 0 0 0 0 0 0 0 0 0 0 0
Lactobacillus_crispatus 1.12 89.5 93.73 83.75 84.98 2.21 1.89 0.89 0.75 94.36 0.08
Lactobacillus_delbrueckii 0 0 0 0 0 0 0 0 0 0 0
Lactobacillus_fermentum 0 0 0 0 0 0 0 0 0 0 0
Lactobacillus_gasseri 0.8 0.48 0.24 0.84 0.61 1.19 25.32 56.52 42.59 0.59 0.15
Lactobacillus_helveticus 0 0 0 0 0 0 0 0 0 0 0
Lactobacillus_iners 0.65 0.44 0.24 0.8 0.77 1.61 1.79 0.34 0.36 0.2 0.06
Lactobacillus_jensenii 0.87 0.79 0.55 1.21 0.76 1.2 1.35 0.15 0.12 0.33 0.04
Lactobacillus_johnsonii 0.01 0.06 0.06 0.06 0.06 0.03 0.07 0.11 0.08 0.05 0
Lactobacillus_kefiranofaciens 0.03 2.73 2.83 2.67 2.52 0.05 0.04 0.01 0 0 0
Lactobacillus_oris 0.01 0.02 0.02 0.04 0.03 0.01 0.06 0.14 0.12 0.1 0
Lactobacillus_reuteri 0 0 0 0 0 0 0 0 0 0 0
Lactobacillus_salivarius 0 0.01 0.01 0.01 0.01 0.24 0 0 0 0 0
Lactobacillus_vaginalis 0.07 0.03 0.01 0.07 0.04 0.13 0.16 0.44 0.42 0.45 0.13
Megasphaera_genomosp 0.01 0 0 0 0 0.1 0 0 0 0 0
Megasphaera_sp._UPII_135-E 0 0 0 0 0 0.06 0 0 0 0 0
Megasphaera_sp_UPII_199-6 0 0 0 0 0 0.11 0 0 0 0 0
Mobiluncus_curtisii 0 0 0 0 0 0 0 0 0 0 0
Mobiluncus_mulieris 0 0 0 0 0 0 0 0 0 0 0
Neisseria_gonorrhoeae 0.27 0.25 0.14 0.54 0.51 1.37 1.22 0.11 0.05 0.06 0.02
Odoribacter_splanchnicus 0 0 0 0 0 0 0 0 0 0 0
Peptoniphilus_duerdenii 0.02 0.01 0 0.01 0.01 0.36 0.02 0 0 0 0
Peptoniphilus_harei 0 0 0 0 0 0.25 0.01 0 0 0 0
Peptoniphilus_lacrimalis 0.01 0 0 0.01 0.01 0.49 0.02 0 0 0 0
Porphyromonas_asaccharolytica 0 0 0 0 0 0 0 0 0 0 0
Porphyromonas_gingivalis 0 0 0 0 0 0 0 0 0 0 0
Porphyromonas_uenonis 0.01 0 0 0 0 0 0 0 0 0 0
Prevotella_amnii 0.02 0.01 0 0.01 0.01 0.05 0.02 0 0 0 0
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Prevotella_bivia 0.48 0.21 0.08 0.35 0.2 1.12 0.77 0.03 0.04 0.02 0.03
Prevotella_buccalis 0.06 0.01 0 0.01 0.01 0.06 0.03 0 0 0 0
Prevotella_dentalis 0 0 0 0 0 0 0 0 0 0 0
Prevotella_denticola 0.02 0 0 0.01 0 0.04 0.02 0 0 0 0
Prevotella_disiens 0.03 0.01 0 0.01 0 0.08 0.03 0 0 0 0
Prevotella_intermedia 0 0 0 0 0 0 0 0 0 0 0
Prevotella_melaninogenica 0 0 0 0 0 0 0 0 0 0 0
Prevotella_oralis 0 0 0 0 0 0 0 0 0 0 0
Prevotella_timonensis 0.04 0 0 0.01 0.01 0.09 0.04 0 0.01 0 0
Proteus_mirabilis 0 0 0 0 0 0 0 0 0 0 0.08
Salmonella_enterica 0 0 0 0 0 0 0 0 0 0 0.33
Shigella_dysenteriae 0 0 0 0 0 0 0 0 0 0 0
Shigella_flexneri 0 0 0 0 0 0 0 0 0 0 0.04
Shigella_sonnei 0 0 0 0 0 0 0 0 0 0 0.08
Staphylococcus_aureus 0 0 0 0 0 0 0 0 0 0 0
Staphylococcus_lugdunensis 0 0 0 0 0 0 0 0 0 0 0
Staphylococcus_simulans 0 0 0 0 0 0 0 0 0 0 0
Streptococcus_agalactiae 0.22 0.37 0.04 0.18 1.43 0.44 0.32 0.01 0.01 0.01 0.01
Streptococcus_bovis 0.05 0.03 0 0.02 0.12 1.46 0.05 0 0 0 0.01
Streptococcus_dysgalactiae 0 0 0 0.01 0 0.02 0 0 0 0 0
Streptococcus_equi 0 0 0 0 0 0 0 0 0 0 0
Streptococcus_gallolyticus 0 0 0 0 0 0.05 0 0 0 0 0
Streptococcus_gordonii 0 0 0 0 0 0.01 0.01 0 0 0 0
Streptococcus_infantarius 0 0 0 0 0 0 0 0 0 0 0
Streptococcus_intermedius 0.01 0 0 0.01 0.03 1.09 0.01 0 0 0 0.01
Streptococcus_macedonicus 0 0 0 0 0 0 0 0 0 0 0
Streptococcus_mitis 0.16 0.06 0.02 0.13 0.09 0.8 0.3 0.01 0.01 0.01 0.01
Streptococcus_oligofermentans 0.01 0 0 0 0 0.01 0 0 0 0 0
Streptococcus_oralis 0.01 0 0 0.01 0 0.09 0.02 0 0 0 0
Streptococcus_parasanguinis 0 0 0 0 0 0.07 0 0 0 0 0
Streptococcus_pneumoniae 0.15 0.06 0.02 0.15 0.08 0.72 0.31 0.01 0.01 0.01 0.01
Streptococcus_pseudopneumoniae 0.11 0.05 0.02 0.09 0.07 0.52 0.24 0.01 0 0.01 0.01
Streptococcus_pseudoporcinus 0.02 0.01 0 0.01 0.04 0.36 0.02 0 0 0 0
Streptococcus_pyogenes 0 0 0 0 0 0 0 0 0 0 0
Streptococcus_salivarius 0 0 0 0 0 0.04 0 0 0 0 0
Streptococcus_sanguinis 0 0 0 0 0 0.03 0 0 0 0 0
Streptococcus_suis 0 0 0 0 0 0.05 0 0 0 0 0
Streptococcus_thermophilus 0 0 0 0 0 0 0 0 0 0 0
Streptococcus_urinalis 0.11 0.04 0.01 0.04 0.12 0.69 0.05 0.01 0.01 0.01 0.01
Syntrophus_aciditrophicus 0 0 0 0 0 0 0 0 0 0 0.03
Tannerella_forsythia 0 0 0 0 0 0 0 0 0 0 0
Treponema_denticola 0 0 0 0 0 0.01 0 0 0 0 0
Ureaplasma_parvum 0.04 0.02 0 0.04 0.02 0.06 0.07 0 0 0 0
Ureaplasma_urealyticum 0 0 0 0 0 0 0 0 0 0 0
Veillonella_ratti 0.01 0 0 0.01 0 0.06 0.01 0 0 0 0
Vibrio_cholerae 0 0 0 0 0 0 0 0 0 0 0.02
Xanthomonas_campestris 0 0 0 0 0 0 0 0 0 0 0.02
Yersinia_pseudotuberculosis 0 0 0 0 0 0 0 0 0 0 0
  
193 
 
Table 24. (cont.)                      
 
 
Bacterial species 125_1 125_2 125_3 125_4 125_6 201_1 201_2 201_3 201_5 202_1 202_2
Acinetobacter_baumannii 0 0 0 0 0 0 0 0 0 0 0
Aerococcus_urinae 0 0 0 0 0 0 0 0 0 0 0
Aerococcus_viridans 0 0 0 0 0 0 0 0 0 0 0
Anaerococcus_hydrogenalis 0 0 0 0 0 0 0 0 0 0 0
Anaerococcus_lactolyticus 0 0 0.01 0 0 0 0 0 0 0 0
Anaerococcus_prevotii 0 0 0 0 0 0 0 0 0 0 0
Anaerococcus_tetradius 0 0 0 0 0 0 0 0 0 0 0
Atopobium_vaginae 0.17 0.35 0.51 2.32 94.06 0.3 0.38 0.28 0.28 0.19 0.27
Bacteroides_fragilis 0 0 0 0 0 0 0 0 0 0 0
Bifidobacterium_adolescentis 0 0 0 0 0 0 0 0 0 0 0
Bifidobacterium_breve 0.01 0.01 0.02 0.04 0.08 0.02 0.02 0.02 0.02 0 0.13
Bifidobacterium_dentium 0 0 0 0 0 0 0 0 0 0 0
Bifidobacterium_longum 0 0 0.01 0 0 0 0 0 0 0 0.01
Bifidobacterium_thermophilum 0 0 0 0.01 0.23 0 0 0 0 0 0
Capnocytophaga_ochracea 0 0 0 0 0 0 0 0 0 0 0
Clostridiales_genomosp._BVAB3 0.02 0.03 0.02 0.05 1.03 0 0 0 0 0 0.09
Clostridium_pasteurianum 0 0 0 0 0 0 0 0 0 0 0
Clostridium_perfringens 0 0 0 0 0 0 0 0 0 0 0
Coprococcus_sp._ART55/1 0 0 0 0 0.07 0 0 0 0 0 0.03
Corynebacterium_lipophiloflavum 0 0 0 0 0 0 0 0 0 0 0
Dialister_microaerophilus 0 0 0 0 0 0 0 0 0 0 0.12
Eggerthella_sp._YY7918 0 0 0 0 0.05 0 0 0 0 0 0
Enterococcus_faecalis 0.31 0.49 0.72 0.57 0.29 0.57 0.49 0.5 0.61 0 0.32
Enterococcus_faecium 0.68 1.09 1.65 1.38 0.64 1.18 0.98 0.98 1.24 0 0.72
Eremococcus_coleocola 0 0 0 0 0 0 0 0 0 0 0
Escherichia_coli 0.18 0.25 0.45 1.64 0.05 0.08 0.09 0.06 0.07 0.01 0.06
Escherichia_fergusonii 0 0 0 0 0 0 0 0 0 0 0
Eubacterium_siraeum 0 0 0 0.02 0.74 0 0 0 0 0 0
Finegoldia_magna 0 0 0.01 0 0.01 0 0.01 0 0 0 0.09
Frankia_symbiont_of_Datisca_glomerata 0 0 0 0 0 0 0 0 0 0 0
Gardnerella_vaginalis 0.16 0.18 0.31 11.04 0.71 0.21 0.24 0.19 0.2 0.04 51.83
Klebsiella_oxytoca 0 0 0 0.03 0 0 0 0 0 0 0
Klebsiella_pneumoniae 0 0 0 0 0 0 0 0 0 0 0
Lactobacillus_acidophilus 0 0.01 0.02 0.02 0 0 0.01 0 0 0 0.01
Lactobacillus_amylovorus 0.01 0.01 0.03 0.02 0 0.01 0.02 0.01 0 0 0.01
Lactobacillus_coleohominis 0 0.01 0.01 0 0 0 0 0 0 0 0
Lactobacillus_crispatus 0.75 0.56 0.76 0.58 0.07 0.5 0.6 0.44 0.43 1.1 0.58
Lactobacillus_delbrueckii 0 0 0 0 0 0 0 0 0 0 0
Lactobacillus_fermentum 0 0 0 0 0 0 0 0 0 0 0
Lactobacillus_gasseri 17.78 0.33 0.51 0.81 0.09 0.27 0.26 0.28 0.29 94.36 43.16
Lactobacillus_helveticus 0 0 0 0 0 0 0 0 0 0 0
Lactobacillus_iners 52.21 60.91 53.34 55.08 0.52 95.34 95.26 95.82 95.54 0.26 0.57
Lactobacillus_jensenii 27.11 34.92 40.4 25.15 0.02 0.32 0.38 0.3 0.29 3.56 1.63
Lactobacillus_johnsonii 0.17 0.14 0.16 0.12 0.01 0.2 0.17 0.16 0.16 0.23 0.09
Lactobacillus_kefiranofaciens 0 0 0.01 0.01 0 0 0 0 0 0 0
Lactobacillus_oris 0.05 0.06 0.06 0.07 0 0.07 0.06 0.06 0.06 0.04 0.02
Lactobacillus_reuteri 0 0 0 0 0 0 0 0 0 0 0
Lactobacillus_salivarius 0 0 0 0 0 0 0 0 0 0 0
Lactobacillus_vaginalis 0.06 0.27 0.33 0.48 0.01 0.01 0.01 0.01 0.01 0 0.01
Megasphaera_genomosp 0.05 0.06 0.06 0.05 0.2 0 0 0 0 0 0
Megasphaera_sp._UPII_135-E 0 0 0 0 0 0 0 0 0 0 0.01
Megasphaera_sp_UPII_199-6 0.06 0.06 0.05 0.04 0.1 0 0 0 0 0 0
Mobiluncus_curtisii 0 0 0 0.01 0.04 0.01 0.01 0.01 0.01 0 0
Mobiluncus_mulieris 0 0 0 0 0 0 0 0 0 0 0
Neisseria_gonorrhoeae 0.11 0.08 0.17 0.13 0.05 0.22 0.19 0.18 0.13 0.06 0.07
Odoribacter_splanchnicus 0 0 0 0 0 0 0 0 0 0 0
Peptoniphilus_duerdenii 0 0 0.01 0 0 0 0 0 0 0 0
Peptoniphilus_harei 0 0 0 0 0 0.2 0.21 0.21 0.21 0 0
Peptoniphilus_lacrimalis 0 0 0 0 0.06 0 0 0 0 0 0.02
Porphyromonas_asaccharolytica 0 0 0 0 0 0 0 0 0 0 0
Porphyromonas_gingivalis 0 0 0 0 0.01 0 0 0 0 0 0
Porphyromonas_uenonis 0 0 0 0 0 0 0 0 0 0 0
Prevotella_amnii 0 0 0.01 0 0.03 0 0 0 0 0 0
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Prevotella_bivia 0.03 0.04 0.11 0.08 0.25 0.02 0.07 0.02 0.02 0.02 0.05
Prevotella_buccalis 0 0.01 0.02 0 0.08 0 0 0 0 0.01 0
Prevotella_dentalis 0 0 0 0 0 0 0 0 0 0 0
Prevotella_denticola 0 0 0 0 0.02 0 0 0 0 0 0
Prevotella_disiens 0 0 0.02 0 0.05 0 0 0 0 0.01 0
Prevotella_intermedia 0 0 0 0 0 0 0 0 0 0 0
Prevotella_melaninogenica 0 0 0 0 0 0 0 0 0 0 0
Prevotella_oralis 0 0 0 0 0 0 0 0 0 0 0
Prevotella_timonensis 0 0.01 0.02 0 0.09 0 0 0 0 0.01 0
Proteus_mirabilis 0 0 0 0 0 0 0 0 0 0 0
Salmonella_enterica 0 0 0 0.01 0 0 0 0 0 0 0
Shigella_dysenteriae 0 0 0 0 0 0 0 0 0 0 0
Shigella_flexneri 0 0 0 0 0 0 0 0 0 0 0
Shigella_sonnei 0 0 0 0 0 0 0 0 0 0 0
Staphylococcus_aureus 0 0 0 0 0 0 0 0 0 0 0
Staphylococcus_lugdunensis 0 0 0 0 0 0 0 0 0 0 0
Staphylococcus_simulans 0 0 0 0 0 0 0 0 0 0 0
Streptococcus_agalactiae 0.01 0.02 0.05 0.04 0 0.01 0.03 0.01 0.01 0 0.02
Streptococcus_bovis 0 0 0.01 0 0 0.13 0.13 0.13 0.13 0.01 0
Streptococcus_dysgalactiae 0 0 0 0 0 0 0 0 0 0 0
Streptococcus_equi 0 0 0 0 0 0 0 0 0 0 0
Streptococcus_gallolyticus 0 0 0 0 0 0 0 0 0 0 0
Streptococcus_gordonii 0 0 0 0 0 0 0 0 0 0 0
Streptococcus_infantarius 0 0 0 0 0 0 0 0 0 0 0
Streptococcus_intermedius 0 0 0 0 0 0 0 0 0 0 0
Streptococcus_macedonicus 0 0 0 0 0 0 0 0 0 0 0
Streptococcus_mitis 0.01 0.01 0.03 0.03 0 0.01 0.02 0.01 0 0 0.01
Streptococcus_oligofermentans 0 0 0 0 0 0 0 0 0 0 0
Streptococcus_oralis 0 0 0 0 0 0 0 0 0 0 0
Streptococcus_parasanguinis 0 0 0 0 0 0 0 0 0 0 0
Streptococcus_pneumoniae 0.01 0.01 0.03 0.03 0 0.01 0.02 0.01 0.01 0 0.01
Streptococcus_pseudopneumoniae 0.01 0.01 0.02 0.02 0 0.01 0.02 0 0 0 0.01
Streptococcus_pseudoporcinus 0 0 0 0 0 0.26 0.24 0.25 0.25 0 0
Streptococcus_pyogenes 0 0 0 0 0 0 0 0 0 0 0
Streptococcus_salivarius 0 0 0 0 0 0 0 0 0 0 0
Streptococcus_sanguinis 0 0 0 0 0 0 0 0 0 0 0
Streptococcus_suis 0 0 0 0 0 0 0 0 0 0 0
Streptococcus_thermophilus 0 0 0 0 0 0 0 0 0 0 0
Streptococcus_urinalis 0.02 0.02 0.03 0.03 0.14 0.03 0.03 0.03 0.03 0.02 0.01
Syntrophus_aciditrophicus 0 0 0 0 0 0 0 0 0 0 0
Tannerella_forsythia 0 0 0 0 0 0 0 0 0 0 0
Treponema_denticola 0 0 0 0 0 0 0 0 0 0 0
Ureaplasma_parvum 0 0.01 0.02 0.02 0 0 0.01 0 0 0.05 0.03
Ureaplasma_urealyticum 0 0 0 0 0 0 0 0 0 0 0
Veillonella_ratti 0 0 0 0 0.16 0 0 0 0 0 0
Vibrio_cholerae 0 0 0 0 0 0 0 0 0 0 0
Xanthomonas_campestris 0 0 0 0 0 0 0 0 0 0 0
Yersinia_pseudotuberculosis 0 0 0 0 0 0 0 0 0 0 0
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Bacterial species 202_3 202_4 202_6 203_1 203_2 203_3 203_4 203_5 203_6 205_1 205_2
Acinetobacter_baumannii 0 0 0 0 0 0 0 0.01 0 0 0
Aerococcus_urinae 0 0 0.01 0 0 0 0 0 0.05 0 0
Aerococcus_viridans 0 0 0 0 0 0 0 0 0 0 0
Anaerococcus_hydrogenalis 0 0 0.21 0 0 0 0 0.02 0.32 0 0
Anaerococcus_lactolyticus 0 0 0.93 0 0 0 0 0.12 1.78 0 0
Anaerococcus_prevotii 0 0 0.11 0 0 0 0 0.01 0.11 0 0
Anaerococcus_tetradius 0 0 0.18 0 0 0 0 0.01 0.19 0 0
Atopobium_vaginae 0.28 0.29 8.52 0.61 0.63 0.75 0.67 1.38 6.82 0.3 0.11
Bacteroides_fragilis 0 0 0 0 0 0 0 0 0 0 0
Bifidobacterium_adolescentis 0 0 0 0 0 0 0 0 0 0 0
Bifidobacterium_breve 0.16 0.16 0.49 0.29 0.3 0.03 0.07 1.83 0.38 0.03 0.02
Bifidobacterium_dentium 0 0 0.01 0 0 0 0 0.08 0.02 0 0
Bifidobacterium_longum 0.01 0.01 0.07 0.03 0.04 0 0.02 0.98 0.21 0.01 0
Bifidobacterium_thermophilum 0 0 0 0 0 0 0 0 0 0 0
Capnocytophaga_ochracea 0 0 0.01 0 0 0 0 0 0.01 0 0
Clostridiales_genomosp._BVAB3 0.13 0.1 0.08 0 0 0 0 0.02 0.1 0 0
Clostridium_pasteurianum 0 0 0.03 0 0 0 0 0 0.01 0 0
Clostridium_perfringens 0 0 0.01 0 0 0 0 0 0 0 0
Coprococcus_sp._ART55/1 0.04 0.04 0.01 0 0 0 0 0 0.01 0 0
Corynebacterium_lipophiloflavum 0 0 0 0 0 0 0 0 0 0 0
Dialister_microaerophilus 0.16 0.14 0.05 0 0 0 0 0.01 0.05 0 0
Eggerthella_sp._YY7918 0 0 0 0 0 0 0 0 0 0 0
Enterococcus_faecalis 1.53 0.32 15.07 1.68 0.91 1.32 0.97 0.61 3.4 0.32 0.15
Enterococcus_faecium 3.77 0.71 33.3 3.74 2.01 3.05 2.31 1.34 7.39 0.69 0.35
Eremococcus_coleocola 0 0 0 0 0 0 0 0.02 0 0 0
Escherichia_coli 0.01 0.04 2.5 0.27 0.13 0.17 0.18 1.06 4.49 0.2 0.07
Escherichia_fergusonii 0 0 0 0 0 0 0 0 0 0 0
Eubacterium_siraeum 0 0 0.01 0 0 0 0 0 0.01 0 0
Finegoldia_magna 0.11 0.11 1.69 0.01 0 0.01 0.01 0.18 3.34 0.01 0
Frankia_symbiont_of_Datisca_glomerata 0 0 0 0 0 0 0 0 0 0 0
Gardnerella_vaginalis 65.43 63.81 3.45 90.93 94.45 0.84 5 47.48 6.47 0.23 0.16
Klebsiella_oxytoca 0 0 0.03 0 0 0 0 0.01 0.04 0 0
Klebsiella_pneumoniae 0 0 0 0 0 0 0 0 0 0 0
Lactobacillus_acidophilus 0 0 0.21 0.03 0.01 13.76 13.17 3.52 0.72 0.02 0.01
Lactobacillus_amylovorus 0 0 0.41 0.05 0.02 26.37 25.51 6.68 1.41 0.04 0.02
Lactobacillus_coleohominis 0 0 0.01 0 0 0 0 0 0.02 0 0
Lactobacillus_crispatus 0.29 0.39 2.73 0.28 0.12 42.88 41.32 12.52 10.12 96.04 97.69
Lactobacillus_delbrueckii 0 0 0 0 0 0.04 0.04 0.01 0.02 0 0
Lactobacillus_fermentum 0 0 0.01 0 0.02 0.05 0.11 0.01 0.01 0 0
Lactobacillus_gasseri 26.31 31.9 1.84 0.19 0.08 5.89 5.52 2.88 8.03 0.55 0.39
Lactobacillus_helveticus 0 0 0.01 0 0 0.77 0.81 0.21 0.04 0 0
Lactobacillus_iners 0.58 0.6 2.35 0.42 0.37 0.33 0.5 1.86 7.58 0.37 0.23
Lactobacillus_jensenii 0.89 1.03 1.77 0.22 0.07 0.76 0.84 2.33 9.68 0.53 0.38
Lactobacillus_johnsonii 0.06 0.08 0.07 0 0 1.4 1.34 0.37 0.06 0.05 0.05
Lactobacillus_kefiranofaciens 0 0 0.06 0.01 0 0.56 0.54 0.2 0.27 0.01 0
Lactobacillus_oris 0.01 0.02 0.01 0 0.03 0.09 0.15 0.02 0.04 0.03 0.03
Lactobacillus_reuteri 0 0 0 0 0 0 0 0 0 0 0
Lactobacillus_salivarius 0 0 0.01 0 0 0.07 0.1 0.09 0.02 0.01 0
Lactobacillus_vaginalis 0 0 0.2 0.02 0.01 0.02 0.04 0.18 0.75 0.09 0.11
Megasphaera_genomosp 0 0 0.13 0.06 0.07 0 0 0.07 0.21 0 0
Megasphaera_sp._UPII_135-E 0.01 0.01 0.91 0 0 0 0 0.02 0.48 0 0
Megasphaera_sp_UPII_199-6 0 0 0.15 0 0 0 0 0.03 0.28 0 0
Mobiluncus_curtisii 0.01 0.01 0 0 0 0 0 0 0.01 0 0
Mobiluncus_mulieris 0 0 0.01 0 0 0 0 0.01 0.01 0 0
Neisseria_gonorrhoeae 0.1 0.1 7.18 0.82 0.57 0.66 0.47 0.96 5.97 0.1 0.03
Odoribacter_splanchnicus 0 0 0.02 0 0 0 0 0 0.01 0 0
Peptoniphilus_duerdenii 0 0 1.26 0 0 0 0 0.1 1.36 0 0
Peptoniphilus_harei 0 0 0.33 0 0 0 0 0.06 0.36 0 0
Peptoniphilus_lacrimalis 0.03 0.03 0.74 0 0 0 0 0.16 0.85 0 0
Porphyromonas_asaccharolytica 0 0 0.37 0 0 0 0 0 0.03 0 0
Porphyromonas_gingivalis 0 0 0 0 0 0 0 0 0.01 0 0
Porphyromonas_uenonis 0 0 0.27 0 0 0 0 0 0.03 0 0
Prevotella_amnii 0 0 0.75 0 0 0 0 0.03 0.35 0 0
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Prevotella_bivia 0.03 0.03 2.83 0.1 0.03 0.05 0.1 0.99 5.03 0.12 0.06
Prevotella_buccalis 0 0 1.28 0 0 0 0 0.04 0.36 0 0
Prevotella_dentalis 0 0 0.03 0 0 0 0 0 0.01 0 0
Prevotella_denticola 0 0 0.8 0 0 0 0 0.03 0.31 0 0
Prevotella_disiens 0 0 2.25 0 0 0 0 0.05 0.6 0 0
Prevotella_intermedia 0 0 0.03 0 0 0 0 0 0.02 0 0
Prevotella_melaninogenica 0 0 0 0 0 0 0 0 0 0 0
Prevotella_oralis 0 0 0.04 0 0 0 0 0 0.01 0 0
Prevotella_timonensis 0 0 1.39 0 0 0 0 0.04 0.43 0 0
Proteus_mirabilis 0 0 0 0 0 0 0 0 0 0 0
Salmonella_enterica 0 0 0 0 0 0 0 0 0 0 0
Shigella_dysenteriae 0 0 0 0 0 0 0 0 0 0 0
Shigella_flexneri 0 0 0 0 0 0 0 0 0 0 0
Shigella_sonnei 0 0 0 0 0 0 0 0 0 0 0
Staphylococcus_aureus 0 0 0.01 0 0 0 0 0 0 0 0
Staphylococcus_lugdunensis 0 0 0 0 0 0 0 0.01 0.01 0 0
Staphylococcus_simulans 0 0 0 0 0 0 0 0 0 0 0
Streptococcus_agalactiae 0 0.01 0.42 0.05 0.02 0.02 0.04 7.06 2.38 0.06 0.03
Streptococcus_bovis 0 0 0.18 0.01 0 0 0 0.76 0.3 0.01 0
Streptococcus_dysgalactiae 0 0 0.01 0 0 0 0 0.05 0.04 0 0
Streptococcus_equi 0 0 0 0 0 0 0 0 0 0 0
Streptococcus_gallolyticus 0 0 0 0 0 0 0 0.03 0.02 0 0
Streptococcus_gordonii 0 0 0 0 0 0 0 0 0.01 0 0
Streptococcus_infantarius 0 0 0 0 0 0 0 0 0 0 0
Streptococcus_intermedius 0 0 0.02 0 0 0 0 0.17 0.11 0 0
Streptococcus_macedonicus 0 0 0 0 0 0 0 0 0 0 0
Streptococcus_mitis 0 0 0.23 0.03 0.01 0.02 0.03 0.52 1.43 0.04 0.02
Streptococcus_oligofermentans 0 0 0.01 0 0 0 0 0.02 0.05 0 0
Streptococcus_oralis 0 0 0.02 0 0 0 0 0.03 0.07 0 0
Streptococcus_parasanguinis 0 0 0.01 0 0 0 0 0.01 0.01 0 0
Streptococcus_pneumoniae 0 0 0.29 0.03 0.01 0.02 0.03 0.5 1.45 0.04 0.02
Streptococcus_pseudopneumoniae 0 0 0.23 0.02 0.01 0.01 0.02 0.35 1.04 0.03 0.01
Streptococcus_pseudoporcinus 0 0 0.46 0 0 0 0 0.27 0.53 0 0
Streptococcus_pyogenes 0 0 0 0 0 0 0 0.09 0.01 0 0
Streptococcus_salivarius 0 0 0.03 0 0 0 0 0.66 0.05 0 0
Streptococcus_sanguinis 0 0 0 0 0 0 0 0 0.01 0 0
Streptococcus_suis 0 0 0 0 0 0 0 0.02 0.03 0 0
Streptococcus_thermophilus 0 0 0 0 0 0 0 0 0 0 0
Streptococcus_urinalis 0.01 0.01 0.48 0.01 0.02 0.03 0.03 0.6 0.7 0.01 0.01
Syntrophus_aciditrophicus 0 0 0 0 0 0 0 0 0 0 0
Tannerella_forsythia 0 0 0 0 0 0 0 0 0 0 0
Treponema_denticola 0 0 0.01 0 0 0 0 0 0.04 0 0
Ureaplasma_parvum 0.02 0.04 0.04 0.01 0 0 0.01 0.1 0.45 0.01 0.01
Ureaplasma_urealyticum 0 0 0.01 0 0 0 0 0.01 0.03 0 0
Veillonella_ratti 0 0 0.35 0 0 0 0 0.04 0.48 0 0
Vibrio_cholerae 0 0 0 0 0 0 0 0 0 0 0
Xanthomonas_campestris 0 0 0 0 0 0 0 0 0 0 0
Yersinia_pseudotuberculosis 0 0 0 0 0 0 0 0 0 0 0
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Bacterial species 205_3 205_5 205_6 206_1 206_2 206_3 206_4 206_5 206_6
Acinetobacter_baumannii 0 0 0 0 0 0 0 0 0
Aerococcus_urinae 0 0 0 0 0 0 0 0 0
Aerococcus_viridans 0 0 0 0 0 0 0 0 0
Anaerococcus_hydrogenalis 0 0 0 0 0 0 0.01 0 0.04
Anaerococcus_lactolyticus 0 0.02 0 0 0 0 0.05 0 0.16
Anaerococcus_prevotii 0 0.01 0 0 0 0 0.01 0 0.03
Anaerococcus_tetradius 0 0.01 0 0 0 0 0.02 0 0.02
Atopobium_vaginae 0.11 2 0.06 0.43 0.83 0.28 3.24 0.02 6.83
Bacteroides_fragilis 0 0 0 0 0 0 0 0 0.01
Bifidobacterium_adolescentis 0 0 0 0 0 0 0 0 0
Bifidobacterium_breve 0.02 0.24 0.02 0.3 0.24 0.01 0.19 0.29 0.31
Bifidobacterium_dentium 0 0 0 0 0 0 0.01 0 0.01
Bifidobacterium_longum 0 0.06 0 0.01 0.01 0 0.09 0 0.11
Bifidobacterium_thermophilum 0 0 0 0 0 0 0 0 0
Capnocytophaga_ochracea 0 0 0 0 0 0 0 0 0
Clostridiales_genomosp._BVAB3 0 0.01 0 0.01 0.02 0 0.02 0.01 0.02
Clostridium_pasteurianum 0 0 0 0 0 0 0 0 0
Clostridium_perfringens 0 0 0 0 0 0 0 0 0
Coprococcus_sp._ART55/1 0 0 0 0 0 0 0 0 0
Corynebacterium_lipophiloflavum 0 0 0 0 0 0 0 0 0
Dialister_microaerophilus 0 0 0 0 0 0 0.01 0 0.02
Eggerthella_sp._YY7918 0 0 0 0 0 0 0 0 0
Enterococcus_faecalis 0.18 2.54 0.08 0.65 1.55 0.43 3.88 0.03 10.23
Enterococcus_faecium 0.41 5.61 0.17 1.47 3.55 0.95 8.51 0.06 22.73
Eremococcus_coleocola 0 0 0 0 0 0 0 0 0
Escherichia_coli 0.04 0.56 0.04 0.19 0.27 0.09 1.74 0.01 3.02
Escherichia_fergusonii 0 0 0 0 0 0 0 0 0
Eubacterium_siraeum 0 0 0 0 0 0 0.01 0 0.01
Finegoldia_magna 0 0.03 0 0.01 0.01 0 0.1 0 0.28
Frankia_symbiont_of_Datisca_glomerata 0 0 0 0 0 0 0 0 0
Gardnerella_vaginalis 0.09 2.85 0.07 94.05 89.48 1.16 19.06 87.64 19.3
Klebsiella_oxytoca 0 0.01 0 0 0 0 0.02 0 0.04
Klebsiella_pneumoniae 0 0 0 0 0 0 0 0 0
Lactobacillus_acidophilus 0.01 0.04 0.01 0.02 0.02 0.01 0.19 0 0.3
Lactobacillus_amylovorus 0.01 0.09 0.01 0.04 0.04 0.01 0.41 0 0.61
Lactobacillus_coleohominis 0 0 0 0 0 0 0.01 0 0.02
Lactobacillus_crispatus 97.72 80.59 98.51 1.04 1.8 1.83 3.94 0.15 4.64
Lactobacillus_delbrueckii 0 0 0 0 0 0 0 0 0.01
Lactobacillus_fermentum 0 0 0 0 0 0 0 0 0
Lactobacillus_gasseri 0.55 1.34 0.29 0.32 0.49 93.91 46.6 4.36 5.25
Lactobacillus_helveticus 0 0 0 0 0 0 0.01 0 0.01
Lactobacillus_iners 0.2 0.92 0.18 0.29 0.28 0.45 3.06 0.11 4.84
Lactobacillus_jensenii 0.32 0.78 0.33 0.28 0.31 0.26 3.13 0.02 4.26
Lactobacillus_johnsonii 0.05 0.05 0.06 0 0 0.21 0.14 0.01 0.03
Lactobacillus_kefiranofaciens 0 0.01 0 0.01 0.01 0 0.07 0 0.13
Lactobacillus_oris 0.04 0.03 0.03 0 0 0.08 0.05 0.01 0.02
Lactobacillus_reuteri 0 0 0 0 0 0 0 0 0
Lactobacillus_salivarius 0 0.01 0.01 0 0 0 0 0.02 0.01
Lactobacillus_vaginalis 0.12 0.1 0.05 0.02 0.03 0.01 0.24 0 0.4
Megasphaera_genomosp 0 0 0 0 0 0 0.01 0 0.02
Megasphaera_sp._UPII_135-E 0 0 0 0 0 0 0 0 0.01
Megasphaera_sp_UPII_199-6 0 0 0 0 0 0 0.01 0 0.04
Mobiluncus_curtisii 0 0 0 0 0 0 0 0 0
Mobiluncus_mulieris 0 0 0 0 0 0 0 0 0.01
Neisseria_gonorrhoeae 0.07 0.77 0.02 0.16 0.36 0.12 0.79 0.01 2.47
Odoribacter_splanchnicus 0 0 0 0 0 0 0 0 0.01
Peptoniphilus_duerdenii 0 0.02 0 0.01 0 0 0.05 0 0.16
Peptoniphilus_harei 0 0.01 0 0 0 0 0.01 0.01 0.08
Peptoniphilus_lacrimalis 0 0.01 0 0.26 0.26 0 0.07 0.18 0.18
Porphyromonas_asaccharolytica 0 0 0 0 0 0 0 0.01 0.04
Porphyromonas_gingivalis 0 0 0 0 0 0 0 0 0
Porphyromonas_uenonis 0 0 0 0 0 0 0 0.01 0.05
Prevotella_amnii 0 0.02 0 0 0 0 0.04 0.07 0.84
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Table 24. (cont.)                      
 
Note: X_X represents subject ID_time point. 1, 2, 3, 4, 5, and 6 represent samples 
collected at 8–12, 17–21, 26–30, and 35–38 weeks of gestation, during labor, and at 6 
weeks post-partum, respectively.       
                     
Prevotella_bivia 0.02 0.37 0.02 0.14 0.13 0.05 1.39 2 3.95
Prevotella_buccalis 0 0.03 0 0 0 0 0.04 0.08 0.95
Prevotella_dentalis 0 0 0 0 0 0 0 0 0.01
Prevotella_denticola 0 0.01 0 0 0 0 0.03 0.06 0.51
Prevotella_disiens 0 0.04 0 0.01 0 0 0.04 0.13 1.42
Prevotella_intermedia 0 0.01 0 0 0 0 0 0.01 0.03
Prevotella_melaninogenica 0 0 0 0 0 0 0 0 0
Prevotella_oralis 0 0 0 0 0 0 0 0 0.03
Prevotella_timonensis 0 0.02 0 0 0 0 0.04 0.09 1.03
Proteus_mirabilis 0 0 0 0 0 0 0 0 0
Salmonella_enterica 0 0 0 0 0 0 0 0 0
Shigella_dysenteriae 0 0 0 0 0 0 0 0 0
Shigella_flexneri 0 0 0 0 0 0 0 0 0
Shigella_sonnei 0 0 0 0 0 0 0 0 0
Staphylococcus_aureus 0 0 0 0 0 0 0 0 0
Staphylococcus_lugdunensis 0 0 0 0 0 0 0 0 0
Staphylococcus_simulans 0 0 0 0 0 0 0 0 0
Streptococcus_agalactiae 0.01 0.13 0.01 0.07 0.08 0.02 0.73 0 1.01
Streptococcus_bovis 0 0.05 0 0.01 0 0 0.07 0.25 0.19
Streptococcus_dysgalactiae 0 0 0 0 0 0 0.01 0 0.02
Streptococcus_equi 0 0 0 0 0 0 0 0 0
Streptococcus_gallolyticus 0 0 0 0 0 0 0 0 0.01
Streptococcus_gordonii 0 0 0 0 0 0 0.01 0.03 0.01
Streptococcus_infantarius 0 0 0 0 0 0 0 0 0
Streptococcus_intermedius 0 0.01 0 0.01 0 0 0.02 0 0.04
Streptococcus_macedonicus 0 0 0 0 0 0 0 0 0
Streptococcus_mitis 0.01 0.15 0.01 0.05 0.05 0.02 0.54 1.65 0.99
Streptococcus_oligofermentans 0 0 0 0 0 0 0.02 0.05 0.01
Streptococcus_oralis 0 0.02 0 0 0 0 0.03 0.07 0.05
Streptococcus_parasanguinis 0 0 0 0 0 0 0 0 0
Streptococcus_pneumoniae 0.01 0.15 0.01 0.05 0.05 0.02 0.55 1.33 0.91
Streptococcus_pseudopneumoniae 0 0.12 0.01 0.03 0.03 0.01 0.37 1.12 0.61
Streptococcus_pseudoporcinus 0 0.02 0 0 0 0 0.02 0.03 0.11
Streptococcus_pyogenes 0 0 0 0 0 0 0 0 0.01
Streptococcus_salivarius 0 0 0 0 0 0 0.01 0.01 0.02
Streptococcus_sanguinis 0 0 0 0 0 0 0.01 0.01 0.01
Streptococcus_suis 0 0 0 0 0 0 0.01 0.01 0.01
Streptococcus_thermophilus 0 0 0 0 0 0 0 0 0
Streptococcus_urinalis 0.01 0.04 0.01 0.01 0.02 0.03 0.1 0.04 0.17
Syntrophus_aciditrophicus 0 0 0 0 0 0 0 0 0
Tannerella_forsythia 0 0 0 0 0 0 0 0 0
Treponema_denticola 0 0 0 0 0 0 0 0 0.01
Ureaplasma_parvum 0 0.02 0 0.01 0.02 0.01 0.13 0 0.17
Ureaplasma_urealyticum 0 0 0 0 0 0 0.01 0 0.02
Veillonella_ratti 0 0.01 0 0 0 0 0.01 0 0.09
Vibrio_cholerae 0 0 0 0 0 0 0 0 0
Xanthomonas_campestris 0 0 0 0 0 0 0 0 0
Yersinia_pseudotuberculosis 0 0 0 0 0 0 0 0 0
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